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Abstract 
Body composition (BC) is an important prognostic factor in patients with cystic fibrosis 
(CF).  International guidelines recommend monitoring growth and nutritional status in 
children with CF using simple anthropometry.  However, methodological issues with 
simple techniques are more significant in children due to growth and maturation, and 
even more problematic in patients, perhaps accounting for inconsistent findings in 
previous BC research in children with CF. 
My thesis addressed three aims: 1) comparison of BC in young children with CF and 
controls using the criterion four-component model (4CM), cross-sectionally and 
longitudinally using pair-, group-match and reference database comparison ;  2)  
investigation of relationships between BC and lung function (FEV1); and 3) evaluation 
of simpler BC techniques for clinical assessment of children with CF. 
Results 
1)  Using the 4CM I found sex differences not identified by simpler techniques; girls 
with CF had abnormal baseline body composition, whilst longitudinal analysis showed 
deteriorating fat-free mass (FFM) in both sexes. Conclusions differed according to the 
comparison group used, perhaps accounting for some inconsistencies between previous 
studies. 
2)  Contrary to previous research, using the 4CM fat mass was positively associated with 
FEV1 in girls; this association was not apparent at 2 year follow-up despite declining 
FEV1.  FEV1 was associated with FFM in boys and bone mass in girls, in accord with 
previous research. 
3)  Simple BC techniques were not interchangeable, and dual-energy X-ray 
absorptiometry (DXA) on its own or in combination with bio-electrical impedance 
(BIA) gave results closest to the criterion method. 
 
Conclusion 
Using the 4CM, abnormal BC and associations between BC and lung function were 
detected, which were not apparent using simple anthropometry. The findings emphasise 
the importance of using appropriate techniques to measure BC in children with CF, and 
suggest that DXA with or without BIA may be most appropriate in clinical practice.
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Chapter 1.  Introduction 
 
 
 
Cystic fibrosis (CF) is a lethal, autosomal recessive genetic disorder most prevalent in 
the white populations of Europe, North America and Australasia.  A recent survey of the 
European CF registry notes 29,000 people affected in 35 countries, 16,500 of whom are 
children (1).  The disease is characterized by malnutrition due to decreased absorption 
and increased nutritional loss and increased work of breathing due to chronic infection 
and inflammation.  Consequently there is a negative energy balance which is associated 
with poor growth, reduced physical activity, lack of appetite and poor lung function.  
Improvement in diagnosing and treating children has increased life expectancy and 
consequently there is a growing need to address long-term as well as short-term health. 
 
Assessment of growth and nutrition is an important part of the management of patients 
with CF, and there is increasing interest in measuring body composition because simple 
measures of weight and height cannot distinguish between predominantly metabolically 
active tissue (fat-free mass, FFM) and predominantly storage tissue (fat-mass, FM).  
Investigation of body composition in children with CF may be beneficial because of the 
potential to; (i) aid understanding of the mechanisms that underlie deficits in patients 
with CF, (ii) assess the effectiveness of medical and nutritional interventions and (iii) 
identify those children at most risk of deterioration. However, body composition 
measurements in children with CF are difficult because; 
 Children are growing and maturation occurs at different rates, therefore, age and 
sex specific equations to calculate body composition must be used.  However, 
these are often generated from healthy children and may not be appropriate for 
children with CF.   
 Reference data on body composition in healthy children has, in the past, been 
limited.  New reference data from our group, using a wide range of techniques, 
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allows assessment of patients’ body composition by calculating standard 
deviation scores (SDS) (2).   
 The readily available simple techniques used for measuring body composition 
either do not give any information about body composition (height, weight and 
body mass index (BMI)) or merely predict it from some other characteristic of 
the body (skinfold thickness; SFT, bio-electrical impedance; BIA). 
 The most accurate body composition techniques are expensive, not readily 
available, are time consuming and require a high level of compliance from the 
child. 
 
Much of the research and monitoring of the growth of children with CF have used 
simple measures of height and weight and crude measures of body composition such as 
SFT.  In recent years there has been a growing use of more sophisticated and clinically 
available techniques such as dual-energy X-ray absorptiometry (DXA) in research 
studies but no studies have ever used a ‘criterion’ method of assessing body 
composition.  The use of simple techniques or techniques that are biased in 
children/patients have led to inconsistent findings across research studies which have 
sometimes been confounded by large age ranges, no consideration of sexual dimorphism 
or no adjustment for short stature. 
 
The aim of the work in this thesis is; (i) to investigate the effect of CF on the body 
composition of young children and whether this changes with growth and maturity, (ii) 
to relate components of body composition to lung function to identify whether baseline 
measurements or change over time predict later outcome and (iii) to compare the simple 
readily available body composition techniques to a criterion method in order to improve 
accuracy of body composition measurement in this group of children.  
 
The organisation of the thesis is as follows:  Chapter 2 covers the background to my 
research and a review of the previous research and the pertinent issues.  Chapter 3 
outlines the different techniques for measuring body composition and advantages and 
disadvantages of measuring children and patients with these techniques.  Chapter 4 
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contains the hypotheses and the methods used to test them and Chapter 5 covers the pair-
matched baseline measurements.  The baseline and 2 year group-matched data (with 
reduced number) is presented in Chapter 6 and the data for longitudinal change in 
Chapter 7.  Chapter 8 covers an assessment of clinical tools for measuring body 
composition compared to a criterion method in children with CF and Chapter 9 is an 
overall discussion and summary of the research with limitations of the study, 
recommendations for future research and clinical implications of the findings. 
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Chapter 2.  Background 
 
 
2.1 Cystic fibrosis 
 
 
2.1.1 Incidence and aetiology of cystic fibrosis     
                                                                                                                                                                  
Cystic fibrosis is the most common Caucasian lethal autosomal recessive genetic disorder, 
1 in 25 people in the UK are carriers and 1/2500 live births are affected (3).  A report of 
incidence in 35 European countries found there were 29,000 individuals with CF, 16,500 of 
whom were children (1).  CF is caused by a mutation on the long arm of chromosome 7 and 
results in an abnormal functioning protein in epithelial cells, the CF trans-membrane 
conductance regulator (CFTR).  The gene responsible is present in all cells but only 
expressed in certain cells: airway, sweat gland, pancreatic duct, vas deferens, bile duct and 
bowel epithelium and also the kidney and ependymal lining of the brain ventricles. 
 
Figure 2.1. Inheritance pattern in cystic fibrosis 
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Over 1000 different mutations have been identified world-wide but in the UK 58% of 
people with CF are homozygous for ΔF508 and 36% have 1 copy of ΔF508 (4).  The 
ΔF508 mutation is associated with more severe clinical manifestations (5;6).  There is a 
wide range of clinical presentation and severity with most presenting in early childhood 
with persistent respiratory tract infections and failure to thrive and around 15% of infants 
presenting with meconium ileus. 
 
2.1.2 Symptoms  
 
Severity of disease is not just related to genotype but is a reflection of a combination of 
factors including environment, adherence to therapy and genetic background.  The CFTR 
protein regulates the movement of chloride (Cl) and sodium (Na) ions across epithelial 
surfaces and an inability to re-absorb Cl and Na ions from the sweat gland ducts leads to a 
high salt content of sweat and is therefore used as a diagnostic test.  The major dysfunction 
of interest to the work presented in this thesis is exhibited in; 
 
1) The lung; although the mechanism is not completely understood it is likely that an 
inability to secrete Cl and excess re-absorption of Na ions in the lung epithelia may lead to 
poor hydration of the airway mucus.  This leads to thick sticky mucus which impairs ciliary 
clearance and results in plugging and bacterial infection (typically Pseudomonas aeruginosa 
and Staphylococcus aureus), in turn inducing a damaging inflammatory response and 
irreversible lung damage.  Lung disease has the greatest impact on morbidity and mortality 
(7) and there is a specific decline in lung function over time dependent on initial lung 
function and gender (8).  Sex differences in survival of young people with severe CF 
related lung disease have been noted by Aurora et al (9) who calculated survival odds were 
lower in girls considering several factors in children referred for lung transplantation.  The 
inter-relationship between lung function and nutritional status has been well documented 
but the direction of the relationship is unclear (10;11).   
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2)The pancreas; dehydrated, protein-rich secretions block the proximal ducts and digestive 
enzymes are retained in the pancreatic ducts causing a loss of functioning tissue which is 
replaced by fibrosis and fatty tissue.  Pancreatic insufficiency occurs in 85% of cases with 
consequent malabsorption of fat, protein and fat soluble vitamins leading to steatorrhoea 
and malnutrition.  Malabsorption of carbohydrates is minimal (12).  The prevalence of 
malnutrition defined by weight for height has been reported as 19% of 2-6 year German 
children in 2000 (13), 23% of those children on the US registry in 2005 (14) based on 
weight and height <90% expected and data from the UK CF registry revealed that the mean 
weight SDS of the males were between −0.25 and −0.5 until the age of 10 years after which 
time both weight and BMI SDS declined. The mean weight SDS of females was stable over 
time at −0.5 but they had a declining BMI after the age of 5 years (15). 
 
The combination of lung pathology and malabsorption inevitably impacts on overall energy 
balance.  Approximately 60-70% of total energy expenditure (TEE) is accounted for by 
resting energy expenditure (REE) and studies of patients with CF suggest that there is an 
increase of 7-35% (16-18). 
 
Figure 2.2.  Components of total energy expenditure 
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Magoffin et al (18) studied children with CF and found that REE was elevated compared to 
controls and that this was higher in the girls with CF (109% ± 9.5% of predicted) compared 
to boys with CF (103% ± 7.0% of predicted) and the difference was apparent throughout 
puberty.  This sex difference is supported by a study by Allen et al (19).  In a study of 19 
infants with CF compared to controls Bronstein et al (20) found that increased REE 
expenditure may not be associated with increased TEE if differences in body composition 
are accounted for.  In this study they found that energy expenditure was greater in children 
with CF compared to healthy controls if calculated on the basis of weight using kilocalories 
per kilogram per day but not if based on FFM using kilocalories per kilogram of FFM per 
day.   Another explanation for no increase in TEE in children with CF may be that 
increased REE is compensated for by reduced physical activity (16;20). 
 
REE may be raised due to pulmonary infection and inflammation (21;22) although a more 
recent study reported that pancreatic status is the most influential factor for increased REE 
(23) and another suggests that there is no association of REE with lung function or liver 
disease either cross-sectionally or longitudinally (18). 
 
In summary, typical symptoms for an untreated person with CF are; recurrent respiratory 
infections, coughing, failure to thrive, loose stools and male infertility.  In addition 
complications including sinusitis, pancreatitis, nasal polyps, liver disease, diabetes, 
gallstones, oesophageal reflux, and low bone mineral density and energy imbalance are 
possible.  
 
2.1.3 Overview of treatment 
 
At birth the lungs are normal and therefore the primary goal of management is to maintain 
good lung function by the prevention of infection, reduction of mucus viscosity and 
removal of secretions.  A regimen of regular chest physiotherapy or airway clearance is 
usually instituted, inhaled medication and antibiotics are usual.  For patients with chronic 
infections it may additionally be necessary for oral antibiotics, inhaled mucolytics and in 
  
22 
 
some, intra-venous antibiotics.  Birth weight is not different from that of healthy children 
(24-26) but weight gain is lower if a diagnosis is not made in the neonatal period (27;28) 
and one study found that those children diagnosed and treated from birth were heavier, 
longer, with larger head circumference after 13 years than those in whom diagnosis was 
delayed (28).  Another study of infants with CF at birth found lower length SDS (-1.24), 
weight SDS (-0.72) and head circumference SDS (-1.82) (29) although a third of the 
subjects were affected by meconium ileus which is associated with worse outcomes.  After 
4 years length and weight SDS had improved although head circumference SDS remained 1 
SDS below the mean.  Pancreatic damage may occur before birth (30) and dietetic 
management is important because of the recognised relationship between optimal 
nutritional status and improved lung function, reduced medical intervention and improved 
mortality.  Whereas malnutrition was once an inevitable outcome, improved treatment and 
nutritional support has reduced the prevalence (31).   
 
Dietary management involves an increased energy intake of between 120-140% of the 
usual recommended intake to counteract the detrimental effects of the increased respiratory 
effort, chronic infection and inflammation, decreased absorption and increased nutritional 
loss.  To achieve this increased energy intake, some patients may require oral supplements 
or enteral nutrition, for example by gastrostomy feeding.  Patients with pancreatic 
insufficiency take oral pancreatic enzyme supplements to assist in nutrient absorption 
although this may not completely correct malabsorption (32).   In addition, fat soluble 
vitamins are given and calcium supplements may be required.  
  
A study by White at al. (33) found that 58 children with CF aged 5 – 16 years had wide 
ranging energy intakes of between 44-163% of the recommended amount and that despite a 
higher energy intake per kg of body weight than controls they were unable to achieve 
optimal growth.  Appetite and energy intake may be deleteriously affected by gastro-
oesophageal reflux, intestinal obstruction, inflammatory response to infection and CF 
related diabetes.  In addition, psycho-social factors may impact on appetite and energy 
intake. 
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Delay in onset of puberty and menarche has been reported in patients with CF and 
nutritional problems (34;35) and also in well-nourished females (35). However, other 
studies have found that puberty is not significantly delayed in girls with CF compared to 
controls (36).  As the child grows other issues such as low bone density, gastro-intestinal 
and liver complications and CF related diabetes may need to be addressed and lung 
transplantation for those with serious lung disease is an option.  Survival after 
transplantation has been reported as 82% after one year, 70% at three years, 62% at five 
years and 51% after 10 years (37).  For adults with CF, fertility and pregnancy introduce 
more challenges to clinical management.  For both children and adults psycho-social 
factors may impact on the efficacy of treatment regimens.  
 
2.1.4 Prognosis 
 
Early diagnosis, improved treatment, lung transplantation and overall better understanding 
of the disease process have increased life expectancy considerably; the median estimated 
life expectancy of children born in 1990 is 40 years (38).  However, several long term 
complications such as osteoporosis have become apparent in young adults with CF and it 
has been recognised that it is important to optimise nutrition in childhood to improve 
quality of life and prognosis (39).  
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2.2 Body Composition changes during normal growth 
 
 
Sexual dimorphism in body composition is evident from foetus to adult but becomes most 
apparent during puberty.  Wells’(40) comprehensive paper on sexual dimorphism of body 
composition explains why, in humans, increased energy needed for lactation which 
provides energy for the growth of a large brain in the offspring, has favoured smaller, fatter 
females compared to males.  At birth, the sexes have similar FM but boys are longer and 
have more FFM adjusted for height than girls.  This can be seen in the following Hattori 
chart of FM index (FMI: FM/height
2
) plotted against FFM index (FFM/height
2
) from birth 
to 1 year.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Hattori graph showing change in fat mass adjusted for height (fat mass 
index; FMI) v fat-free mass adjusted for height (fat-free mass index; FFMI) in children 
from birth to 1 year. (41) 
(Permission to reproduce this has been granted by Professor JCK Wells). 
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The following 2 graphs from age 1 to 10 years and 10.5 – 18 years demonstrate how the 
differences remain throughout childhood and adolsecence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.  Hattori graph showing change in fat mass adjusted for height (fat mass 
index; FMI) v fat-free mass adjusted for height (fat-free mass index; FFMI) in children 
from 1 year to 10 years (41)  
(Permission to reproduce this has been granted by Professor JCK Wells). 
 
These graphs adjust for the difference in height between the sexes and the males show 
greater overall FFM  (including mineral mass; MM) and lower FM after age 5 than females.  
However, females enter puberty earlier, have more rapid pubertal development whereas 
boys have a longer growth period (42).  Bone mineral content (BMC) is similar in the sexes 
till age 16 years (43) but is significantly different after that age (44;45), males having 
greater BMC particularly in the appendicular skeleton.  Shape and regional tissue 
distribution also differs so that ratios such as waist to hip and SFT measures need to be 
compared within a sex.  
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Figure 2.5.  Hattori graph showing change in fat mass adjusted for height (fat mass 
index; FMI) v fat-free mass adjusted for height (fat-free mass index; FFMI) in children 
from 10.5 to 18.5 years(41). 
(Permission to reproduce this has been granted by Professor JCK Wells). 
 
2.3 The impact of nutrition on body composition 
 
Childhood and adolescence are periods of rapid growth and development requiring a diet 
providing sufficient quantities of the 3 major food groups; fats, carbohydrates and 
proteins and minerals and vitamins. Body composition is influenced by many factors; 
genetic, hormonal, activity level and state of health but a major factor is that of 
nutritional intake.  There is little research on the direct impact of nutritional intake on 
body composition in children with more likely outcomes of weight, height and BMI.  
Monitoring child growth by measuring height and weight gives an indication of under- 
and over-nutrition and wasting and stunting may be the first sign of a problem. 
 
10.5y 
18.5y 
18.5y 
18.5y 
10.5y 
10.5y 
18.5y 
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2.3.1 Under-nutrition 
 
Under-nutrition leads to weight loss or failure to increase weight in the growing child 
due to an imbalance between nutrient intake and requirements.  Chronic under-nutrition 
in children may lead to stunting. The imbalance may be due to reduced intake and/or 
absorption or increased requirements such as during sepsis, trauma, cancer or 
hypermetabolic states (46) or a combination of both.  Where there is a deficit between 
intake and nutrient needs then body stores are used first to maintain the brain, since 
injury is rapid in the absence of glucose or ketones and second to maintain the structural 
elements of the body, cells and extracellular fluid containing protein.  Energy is stored in 
the body as carbohydrates, protein and fat.  Carbohydrate stored in the form of glycogen 
is only sufficient to provide energy for 24 hours and although body protein is sufficient 
to provide for the energy requirements for 30 days the structure of the organs would be 
lost.  Fat is an expendable source of energy although it is not able to supply essential 
glucose for the brain.  During periods of inadequate nutrition glucose for the brain is 
obtained by gluconoegenesis from protein catabolism and glycerol from lipolysis.  If the 
energy deficit is prolonged fatty acids being transported to the liver are converted 
ketones which the brain can utilise and thus protein is spared.  A study by Keys et al (47) 
examined the effect of 6 months of famine on a group of conscientious objectors in 1943 
and showed that volunteers on this low calorie, low protein diet lost on average 17% of 
their lean mass and a marked fat loss of 73%.  These volunteers returned to normal body 
composition after 1 year on a normal diet but malnutrition in patients may not be so 
easily corrected. 
 
In patient groups, malnutrition may not be only be due to inadequate intake or 
absorption but may be affected by abnormal hormone and cytokine profiles as a 
consequence of sepsis or trauma resulting in an increased metabolic rate or an abnormal 
metabolism due to disease.  A study of patients with CF from 1 month to 17 years found 
that, although 12 infants diagnosed by neonatal screening had low body cell mass that 
was corrected by 1 year with therapy, children aged 2-17 years showed an increasing 
tendency with age for inadequate accretion of body cell mass (48).  This is despite early 
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diagnosis and treatment.  The same group report catch-up growth (weight, length and 
body cell mass) in 25 neonates with CF receiving conventional pancreatic enzyme and 
dietary therapy (24).  In this group however, the mean FM remained significantly lower 
than expected at 1 year.  Shepherd (49) in her review of nutrition in CF identifies the 
major consequences of malnutrition in CF as growth retardation, delayed puberty and 
specific deficiencies of protein, fatty acids, vitamins and minerals.  If left untreated 
failure to thrive, growth failure, wasting and gross motor delay are likely.  If the infant is 
fed a reduced useable protein source such as soya or has a low intake of protein, as in 
unsupplemented breast milk, secondary hypoproteinaemia with generalised oedema have 
been reported.  Therapeutic regimes aim to correct the deficiencies.  In a study of 10 
growth retarded children with CF given nocturnal feeds of 120-140% of normal 
requirement for protein and energy for 1 year it was found that all had catch-up weight 
by 6 months and 9 catch-up height. Catabolism was reduced and there was a reversal in 
the trend for deteriorating lung function (50). 
 
2.3.2 Over-nutrition 
 
A positive imbalance between intake and expenditure over time will result in the excess 
energy being stored.  In adults the consequent weight in relation to height (BMI) is used 
as a screening tool for overweight (greater or equal to 25) and obesity (greater or equal 
to 30).  In adults BMI has a U shaped relationship with mortality.  In children FM, FFM 
and height are changing rapidly, at different rates and particularly around the period of 
puberty where the timing may be affected by the amount of FM itself and therefore BMI 
cannot be used to classify overweight and obesity. In the paediatric setting BMI adjusted 
for age and sex, as centiles or SDS are used.  However, even BMI centiles or SDS 
cannot distinguish between high FM and low FFM and vice versa for a given weight.  
Where nutritional therapy has been based on the weight of a child any weight gain may 
mask low FFM, in a study of patients with cerebral palsy given gastrostomy feeds it was 
reported that the gain in weight was due to a high FM (51).  The universally 
recommended dietary intake for a child with CF is 120-140% of that of a healthy child.  
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Without measurements of actual body composition rather than just weight and BMI it is 
possible that the targeted weight gain may be excess FM rather than FFM and there is 
mounting evidence of obesity in children with CF (52).  It is likely that if excess FM in a 
child with CF continues into adolescence and adulthood then the risk of complications 
such as those associated with cardio-vascular disease will be increased.  
 
The effect of habitual diet on body composition is complicated particularly in children 
and patients where energy requirements may vary according to sex, age, puberty, 
activity and disease process.  An accurate record of dietary intake over time is difficult, 
particularly in this group of children where appetite can change frequently.  An 
experimental intervention with body composition as the outcome is the best way to 
investigate this relationship.  This thesis does not take account of dietary intake although 
it is acknowledged that diet will impact on body composition.        
 
2.4 Previous studies investigating the effect of cystic fibrosis on 
growth and body composition 
 
 
 
A full explanation of the advantages and disadvantages of different body composition 
techniques is presented in Chapter 3.  I will present here the findings of previous studies 
according to the techniques used with an explanation of the relevance of the technique in 
this particular group of patients.  A summary of the most pertinent studies is presented in 
Table 2.1. 
 
2.4.1 Anthropometry 
 
Measurements of height, weight, circumferences and SFT have been used for many years 
for the assessment of growth and body composition.  They are not recommended for 
evaluating body composition clinically in individuals or for short term changes in FM (53). 
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Indices of height and weight have been, and still are used to assess nutritional status in 
children by plotting on centile charts or by the calculation of percentage weight for age, 
percentage height for age, percentage weight for height and percentage of ideal body 
weight (%IBW).  In 2001 in the UK the Royal College of Paediatrics and Child Health 
advised the use of BMI centile charts in preference to percentage weight for height and in 
2002 the UK CF Trust recommended the use of software that uses UK 1990 growth data to 
generate SDS for height, weight and BMI (54).  A study by Wiedemann et al (55) found 
that 4577 children with CF were reasonably nourished by %IBW but when using BMI 
centiles they were below the reference median.  Another study (56) reported that %IBW 
underestimated malnutrition in children with short stature and overestimated it in those who 
are tall.  In the United States the CF Foundation recommended the use of BMI centiles for 
the assessment of children and adolescents in 2008 (14).  However, BMI cannot distinguish 
between FM and FFM as evidenced from the following graphs showing the body 
composition of 2 children measured for this thesis. 
 
  
Figure 2.6.  Graphs of body mass index (BMI; weight/height
2
) indicated in blue, fat 
mass index (FMI; fat mass/height
2
) in green and lean mass index (FFMI; fat-free 
mass/height
2
) in orange, standard deviations scores (SDS) for two children with cystic 
fibrosis.   
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The first graph illustrates that this child has a higher FFM and lower FM SDS compared 
to BMI SDS and the second graph depicts a child with high FM and low FFM compared 
to BMI SDS. 
 
Stunting (57) and wasting (58) have been shown to be independent predictors of survival 
and the lack of short stature amongst adults may be due to survival of well nourished 
patients rather than improved growth in the undernourished (59).  Low weight for height in 
adults occurs particularly in females and is correlated with more severe lung disease and 
reduced survival (60;61).  McNaughton et al (62) comparing indices of height and weight 
with nutritional status assessed by total body potassium counting found that height and 
weight were not sensitive indicators of suboptimal nutritional status defined by total body 
potassium SDS of ≤ -2 or < 80% of predicted  in 226 children with CF.  The literature is 
consistent in finding  that children with CF tend to be shorter and lighter than their healthy 
counterparts (15;55;63-65) and a recent study in Poland (66) noted that the children were 
disproportionately shorter in the legs compared to the trunk. 
 
Longitudinal studies suggest that weight for age and height for age decline over time, are 
associated with declining lung function and that there are differences between the sexes 
(10;13;67;68).  However, despite CF being a disease of malabsorption there are now reports 
of obesity.  Kastner-Cole (52) reviewed the records of 3,000 patients, from infant to adult, 
on the UK CF registry and found the incidence of obesity to be 1.4% in boys and 1% in 
girls under 18 years and 1.6% in men and 0.2% in women.  My own data of BMI SDS in 
young children with CF (69) found an obesity level of 10.8% in boys and 0.02% in girls.  
However, due to the inability of BMI to distinguish between FM and FFM the proportion 
with a high BMI due to elevated FM (assessed by the 4-component model; 4CM) was only 
8% of boys.  In ‘healthy’ populations high BMI has a negative relationship with forced 
expiratory volume in 1 second percentage of expected (FEV1%) in children (70) and adults  
(71) although in the CF population a positive relationship has been demonstrated (11;72) 
and Forrester et al (73) found that high BMI SDS independent of muscle mass in 2096 
clinically stable adults with CF was associated with better FEV1.  This study used serum 
creatinine as a marker of total skeletal muscle and the authors acknowledged the need for 
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caution when using this marker in those with extremes of muscle mass.  However, the fact 
that BMI is positively associated with FEV1 regardless of muscle mass is interesting and 
the finding that those with BMI ≥ 25 kg/m2 have the highest values for FEV1 may be a 
reflection of their better clinical status compared to those with lower BMI.  As previously 
discussed BMI does not distinguish between FM and FFM and the discordance between the 
negative relationship between BMI and spirometry in healthy subjects and the positive 
relationship in adults with CF may suggest that a given BMI represents different body 
composition in these two groups.  
 
SFT at 3 or 4 sites is often used as a proxy for overall body fat.  Some studies 
inappropriately quantify FFM using SFT (74;75) (since measuring sub-cutaneous fat does 
not give information regarding FFM), whilst other studies introduce error by converting 
raw SFT data to % fat using published equations that may not be relevant to children with 
CF (76). Indeed, in my own study comparing SFT converted to FM by 2 different 
prediction equations, I found that the bias varied between 3 and 21% of the mean value 
depending on equation, sex and whether the child was healthy or had CF (69).  Arm 
anthropometry (mid-upper arm circumference; MUAC and tricep SFT) plotted on centiles 
from reference data (77) has been recommended in a US consensus document on the 
management of CF (78) to monitor FM and FFM clinically.  However, a study by Chomtho 
et al (79) comparing arm anthropometry to the criterion 4CM and DXA in 110 healthy 
children and 40 children with CF found the measurements predicted FM but not FFM.  
 
2.4.2 Bio-electrical impedance 
 
BIA is a prediction technique, that is to say TBW is predicted by resistance to a flow of 
electricty through the body rather than actually measuring FFM.  The accuracy of 
prediction techniques such as BIA is assessed by comparing to a robust reference method 
(one that is not a prediction technique).  Thereafter, using regression analysis a population 
specific prediction equation can then be generated for use in a similar population.  Suitable 
reference techniques actually measure FFM or a proxy of FFM such as water or body 
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potassium and include the 4CM, total potassium counting, DXA and hydrometry (described 
in Chapter 3).  Prediction equations are often generated in healthy populations which may 
not be suitable for patient groups and few equations have been derived for patients with CF. 
 
Previous body compositon studies have concluded that BIA predicts total body water 
(TBW) (80;81) or total body potassium (82) in children and adolescents with CF and may 
be used with equations derived from CF populations to predict FFM.  Other studies have 
used inappropriate reference methods for comparison with BIA such as SFT and MUAC 
and therefore the conclusions can be questioned  (83;84).   A study of adults with CF by 
King et al (75) compared FFM predicted from 2 BIA equations based on healthy adults 
(85;86) compared to DXA and found that although FFM by each technique was correlated, 
one equation overestimated FFM in women and the other underestimated FFM in men with 
CF.  Eisenmann et al (87) studied 3-8 year old children and compared BIA to DXA 
concluding that BIA has ‘limited utility in estimating body composition’.  However, 
although several studies have generated prediction equations for FFM in a paediatric 
population by the incorporation of the relationship between height
2
/impedance and factors 
such as age, sex and weight (88-91), there is limited research specifically in children with 
CF.  A literature search revealed only one study that generated a prediction equation for 
TBW in CF children and adolsecents by comparing to deuterium dilution (92).  Prediction 
of TBW and thereby FFM may be affected deleteriously in the CF population by 
disturbances in skin electrolyte composition, abnormal fluid distribution, sodium depletion 
and hydration level (80;93;94).  Using BIA a previous study found the greatest decline in 
nutritional status occurs after the onset of puberty, particularly in girls (59) although other 
studies using DXA, suggest that deterioration in growth and nutritional status occurs 
throughout childhood  (36;95). 
 
2.4.3 Hydrometry 
 
Some studies have utilised hydrometry, often in conjunction with other techniques to 
investigate body composition of children with CF.  Where hydration of the FFM is within 
normal range this technique is one of the more accurate ways to calculate FFM.  I am not 
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aware of any studies of children with CF that have noted abnormal hydration of the FFM. 
Stettler (96) noted a reduction in FFM in boys only and another study found both boys and 
girls had less FM and FFM than controls (74) using hydrometry and SFT.  Not all studies 
identify deficits of body composition in children with CF; Marin et al (97) using 
anthropometry and hydrometry found no difference between 15 children with CF and 
controls, however, not all subjects were matched with same sex controls. 
 
2.4.4 Dual-energy X-ray absorptiometry  
 
Low bone mineral density (BMD) has been reported in both children (64) and adults (98) 
although other studies report normal BMD in young children (99;100).  There has been 
extensive research into the relationship between bone and clinical outcome in CF but for 
the purposes of this thesis I will be concentrating on the relationship between soft tissues 
and clinical outcome.  Soft tissue assessment by DXA has become more widely used due to 
its increased availability in recent years.  There are inherent problems for soft tissue 
assessment because of the assumptions made in the software and a large study of healthy 
children by Shypailo et al (101) concluded that it could not be considered a reference 
method. In my own  study comparing DXA to the criterion 4CM in healthy children and 
those with a variety of diseases I found that bias was affected by size, sex and whether the 
subject was healthy, obese or had CF or glycogen storage disease (102).  DXA significantly 
underestimated FFM in girls with CF but not boys although the age range was narrow (8-11 
years) and the numbers small (n=26).  However, despite its limitations DXA is the most 
sophisticated of the body composition techniques likely to be available in a clinical setting.  
There is a paucity of research into the best way to utilise the data from DXA in this group 
of patients; whole body and regional bone and soft tissue data is generated but there is a 
lack of reference data in children and a lack of research as to whether the components of 
body composition should be size adjusted when compared to a reference group.  
 
Several recent studies of children and young people with CF using DXA have noted a 
reduction of FM, FFM and BMD (36;65;103).  Depletion of these tissues becomes more 
severe with increasing age (36;67).  Even with normal BMI, FFM and BMD depletion has 
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been noted in adults (75;104) and in one study of children and adolescents 54% were found 
to have a lean mass of ≤ -2 SDS with % IBW of ≥ 85% (105) although size adjustment  in 
this study may not have been ideal.  This is referred to as ‘hidden depletion of FFM’ 
because monitoring using BMI would not reveal a problem.   
 
2.4.5 Total body potassium  
 
 
Body cell mass (BCM) is the metabolically active part of FFM and therefore if accrual 
during growth is suboptimal nutritional status will be affected.  98% of 40K is in BCM so 
the most common way to measure BCM is with a total body potassium counter.  These are 
quite rare and the research using this technique in patients with CF is predominantly from 
Toronto where several studies have investigated the effects of different feeding regimens 
(106-108) or from Brisbane where the research question often addresses the relationship 
between BCM and growth and nutritional status and, more recently, REE (24;48).  Because 
this technique does not measure absolute values of FM and FFM, direct comparison with 
other body composition techniques is difficult.  The technique is hampered by the fact that 
conversion of total body potassium to BCM uses an equation derived in healthy adults 
(109) and in addition there is sparce reference data that allows for adjustment for height and 
sex although the Brisbane group have generated their own. 
 
Shepherd et al (89)  evaluated total body potassium in 140 patients with CF and found 
suboptimal growth was associated with deficits in growth of BCM.  Thomson et al (95) 
found that in 61 children with CF, those with normal BCM had significantly less decline in 
spirometry over 2.4 years and they recommended the use of the technique to predict those 
children at risk of greatest decline.  Murphy et al (110) assessed BCM in a group of 64 
children aged 10.6± 2.9 with CF and using their own reference data found that the children 
had a mean BCM SDS of 0.54 with boys slightly higher than girls but with more variability 
between individuals.  Only 2 children were considered to have suboptimal nutritional 
status.  Neonatal screening for CF has been common place in Australia for several years, 
unlike the UK and this may account for the good nutritional status of these children. 
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2.4.6 Longitudinal studies of body composition in cystic fibrosis 
 
One of the problems of interpretating data from published studies is the different age 
ranges, particularly in the growing, maturing child, and particularly with the changes 
associated with pubertal development.  However, longitudinal studies have the advantage 
of investigating body composition at different time points in the child’s development and 
may give a clearer picture of the effects of the progress of the disease.  There are few 
longitudinal studies of body composition in children with CF.  Stettler et al (96) using SFT, 
deuterium dilution for TBW and total body electrical conductivity to measure 25, 5-10 year 
children with CF over 3 years concluded that statural growth, FM and FFM acquisition was 
slower in the CF boys compared to the control group.  Using SFT the girls with CF 
increased in FM compared to controls.  However, the control children were chosen to 
match the height and weight of the children with CF and therefore may not be 
representative of healthy children generally. Bianchi et al (65) used DXA to compare 136 
patients with CF ranging in age from 3-24 years over a 2 year period.  The study was 
predominantly investigating BMD and found deficits occured in all of the 3 sub-groups; 
prepubertal, pubertal to age 18 years and adults.  At baseline FM and FFM were diminished 
in both sexes but it is not clear from the reported data what changes occured in body 
composition over time, simply that baseline and change in FFM was significantly 
correlated with FEV1%.  The findings of this study may not be directly comparable to other 
studies because the reported FFM appears to be lean mass by DXA (non-fat soft tissue) and 
it is not clear whether the relationship between FFM (lean mass) and FEV1 has been size 
adjusted.  One would expect absolute values of FFM to correlate with FEV1 since 
increasing absolute FFM is related to increasing size and FEV1 increases with increasing 
size.   
 
Two longitudinal studies from Brisbane assessed BCM in 25 infants (24) and  64 children 
(110).  The study of infants found birthweight within the normal range and although weight 
SDS dropped initially, after 1 year it was not significantly different from zero; length SDS 
was low at baseline and remained low after 1 year (mean ±SD; -0.25±0.12).  BCM SDS 
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was depleted initially (-1.42±0.78) and within the normal range by 1 year of age; FM SDS 
assessed by anthropometry was low at baseline (-0.74±0.38)  and remained low  
(-1.13±0.15) after 1 year.  Mindful that all these infants had been identified by neonatal 
screening and received early treatment the findings of reduced length and low FM after 1 
year are interesting.  The authors suggest that increasing  physical activity and pulmonary 
and pancreatic pathology may be a factor and that with growth, increasing BCM reaches a 
critical point at which energy intake becomes a limiting factor for normal rates of accretion 
of FM.  Murphy et al (110) studied 64 children with CF aged from 5 years and found them 
to be well nourished assessed by BCM at baseline with only 2 children with suboptimal 
nutritional status and after 2 years only 5 children were assessed as suboptimal.  
Deterioration in BCM SDS had occured more in boys than girls although the girls at 
baseline were lower than the boys (girls; 0.30±0.94, v boys; 0.76±1.39).  At baseline the 
children were also short (height SDS; mean±SD, -0.59±0.92) and light (weight SDS;  
-0.32±0.99) but change in height and weight SDS were not reported.  There was no 
deterioration in FEV1 over the study period.  The authors acknowledge that the equation 
used to convert total body potassium to BCM may not be appropriate to either a patient or 
paediatric population.  The finding that, in this study, boys had greater deterioration in 
nutritional status compared to girls is in accord with some previous studies (96;111) 
although it is contrary to the findings in other studies (10;112) and to expectations 
considering the better prognosis in males compared to females with CF (3;112).  As 
discussed previously, it is likely that the cohort studied, who were diagnosed following 
neonatal screening, would have received early treatment and therefore are likely to have a 
better nutritional status than those children with CF who were diagnosed following 
symptoms of failure to thrive and persistent chest infections.  
 
The cohort studied by Murphy et al was also part of a larger group including adolescents 
and adults (n=153) studied by Buntain et al (100); the children and adolescents were 
followed up in 2006 (36).  Using DXA and measures of BCM and anthropometry the 2004 
study was mainly concerned with bone status finding no bone deficits in the children, some 
deficit in adolescents and severe deficits in the adults with CF.  They conclude that factors 
indicating nutritional status such as BCM and BMI, physical activity and spirometry are 
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postively related to BMD and days in hospital and number of admissions negatively 
associated with BMD.  Although BCM was reported between the controls and patients the 
values were expressed in grams and therefore not comparable between groups since the 
numbers of males and females were different and the ages are not clear.  The follow-up 
study in 2006 using DXA, only examined the children and adolescents (n=85) and found 
that the CF children (aged 5-10 years) were not significantly different from controls at the 
start but did not increase lumbar spine (LS) BMD as much as the control group.  The older 
group (11-18 years) started with deficits of total, LS and femoral neck BMD and did not 
gain total body and femoral neck BMD at the same rate as the controls.  In summary, the 
children with CF at age 5-10 years were not significantly different from the controls but 
over 2 years they fail to accrue bone at the same rate as the controls at the LS only.  
However, the older children at age 11-18 already have lower BMD at all 3 sites, fail to 
accrue bone at the neck of femur and total body at the same rate as controls but maintain a 
similar rate of gain to controls at the LS. Lean tissue mass (non-fat soft tissue) by DXA was 
similar at the start between children with CF and controls and accrual was similar despite a 
smaller weight change in the children with CF.  The adolescent group had less lean tissue at 
the start but accrual was similar and weight change was similar.  Interestingly, the 
adolescents with CF had a non-significant higher gain in height than the controls which 
does not appear to be related to timing of puberty.  Pubertal stage and menarche was 
reported as similar in both groups of girls however, the boys with CF were reported as 
having delayed pubertal development at the start compared to controls and this difference 
persisted over 2 years.  Lung function was stable in the children over 2 years but declined 
in the adolescents. Activity was reported as greater in the CF children at the start of the 
study and remained higher whereas adolescents started with a similar activity level which 
diminished over time compared to controls  
 
In summary, no previous study has used a criterion technique to assess body composition in 
children with CF and different techniques, sexual dimorphism, whether there has been size 
adjustment, varying age ranges and the difference in average time of diagnosis related to 
neonatal screening programmes make comparison between studies difficult.  Available 
studies suggest that deficits of FM, FFM and bone are most severe in adults and reports in 
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children vary between no difference from controls to depletion of either or both of FM and 
FFM (including bone).  There is agreement that deficits become apparent with increasing 
age (10;95;100).  BMI has been shown to be a poor indicator of nutritional status since 
hidden depletion of FFM has become apparent in both adults and young people.  
Surprisingly, since this is a disease characterised by undernutrition, obesity is increasingly 
becoming a problem that, with longevity is likely to be related to increasing difficulties in 
adult life.  Sex differences have been noted, some studies reporting worse nutritional status 
in boys compared to girls (96;111) and some reporting that girls have poorer nutritional 
status than boys (10;112).   There are reports of pubertal delay in girls (35) and young boys 
(36) and also of no pubertal delay (100). 
 
2.5 Relationship between growth, body composition and 
spirometry 
 
 
A seminal paper by Corey in 1988 (39) comparing growth and lung function between 
Boston and Toronto patients showed that although lung function was similar, growth in 
patients was greater and survival longer in Toronto compared to Boston patients.  This was 
attributed to the high fat diet prescribed in Toronto.  There is also evidence that improving 
nutrition can delay deterioration of lung function  and improve survival (50;106) and that 
children with short stature have poorer lung function later in life (57).   FEV1 predicts 
mortality (113) and yearly rate of decline in FEV1 is a better predictor of mortality 
(114;115).  A study in the UK (58) found that FEV1% and % IBW predicted survival at 5 
years.    
 
2.5.1 Cross-sectional reports of body composition and spirometry 
 
Reviews of national databases of CF patients allow for the study of large numbers of 
patients and therefore confidence in the findings, although, typically the available data is 
limited to weight, height, spirometry and clinical factors.  Rather than body composition, 
nutritional status is reported in terms of stunting or wasting.  Whilst these studies are 
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informative the cross-sectional design cannot reveal the nature of the relationship between 
spirometry and nutritional status.  The cross-sectional part of a study of the German CF 
registry data (n=3298) by Steinkamp et al (13) found that weight, height and lung function 
decreased with age, FEV1 was negatively related to malnutrition and Pseudomonas 
aeruginosa infection but not related to sex and that those malnourished had lower FEV1 and 
higher markers of inflammation regardless of Pseudomonas aeruginosa infection. Kastner-
Cole et al (52) reviewed the UK registry data regarding the prevalence of overweight and 
obesity and emphasied the positive relationship between high BMI and lung function 
especially in children.  However, the large age range and type of data available limits the 
conclusions that can be drawn from these retrospective studies.  Smaller, prospective 
studies that distinguish between differing growth stages such as pre-pubertal, adolescent 
and adult and the sexes may give more information about the relationship between growth, 
body composition and lung function.  A large study which evaluated 114 children and 
adolescents in 3 age groups; under 6, 6-10 and 11-18 years using DXA found the mean 
value for FFM SDS was < -2 in the 2 youngest groups and -4 in adolescents and was 
positively correlated with FEV1 (116).  Unfortunately FFM was adjusted for weight not 
height which would have been more appropriate given they were all short (children-0.5, 
adolescents, -0.9 height SDS).  This may account for the very low FFM SDS noted even in 
the very young children and the subsequent report of a large proportion of the subjects (50-
60%) with hidden depletion of FFM (% ideal weight for height >85% and FFM SDS <-2).   
 
Many studies have low numbers, crude techniques, do not adjust for short stature or fail to 
address the sexes separately.  Even so, a consistent positive relationship between lean mass 
(bone and FFM) and lung function has been noted in both adults (117-119) and children 
(36;65).  It has been suggested that lung function is influenced by body muscle mass (8) 
and loss of FFM is associated with loss of diaphragm muscle (120).  In addition, exercise 
improves lung function and sex differences in exercise habit contribute to sex differences in 
lung function (121).  However, Ahmed et al (111) reports a positive relationship between 
spirometry and both FFM and FM in boys only using SFT and Pedreira et al (11) using 
DXA report a relationship between FM and and FEV1 (non-significant).  
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2.5.2  Longitudinal reports of body composition and spirometry 
 
The mechanisms of the inter-relationship between lung function and nutritional status are 
complex and not completely understood and the direction of the relationship is unclear 
(10;11).  Although it is not possible to define cause and effect, longitudinal studies have the 
advantage of demonstrating the relationship between changes in nutritional status and 
changes in clinical status.   
 
A report of the longitudinal data from the German CF registry (13) found that in 536 
children and 477 adolescents those with normal weight had a smaller decrease in FEV1% 
over 2 years than those who were underweight for their height and those with improved 
nutritional status showed improved FEV1%.   Another large study (n=931) showed that 
those children at age 3 who were at or below the 5th centile for weight-for-age had poorer 
lung function at age 6 years compared to those who had a weight-for-age over the 75th 
centile at 3 years (122).  Those children who had improved weight SDS had improved 
FEV1% and no difference was found in growth and nutritional status between the sexes or 
between age 3 and 6.  This is in accord with another large study (n=319) of children from 6 
to 8 years (68) that found baseline weight was significantly associated with FEV1% and 
those with at least a 100g weight gain per month had significant increases in FEV1% 
compared to those who did not.  This is further supported by intervention studies 
demonstrating that overnight gastrostomy feeds for just over a year stabilised spirometry in 
the treated group whereas in the severity matched control group FEV1 decreased by 13% 
(106) and overnight feeds given for 1-2 years resulted in a reversal of declining FEV1 (50).  
Zemel et al (10) performed another large analysis (n=968) using the US CF registry data for 
children aged 5-8 and found declining FEV1 over 4 years with most decline in those with 
FEV1  ≥ 90% at baseline.  The authors suggest that young children with good lung function 
and intercurrent pulmonary illness may not be treated as aggressively as those with poor 
lung function.  Deteriorating lung function was worse in girls compared to boys. This study 
found clear sex differences in this young age group; height SDS improved in boys but 
deteriorated in girls and weight SDS deteriorated in both sexes but more so in the girls. 
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Bianchi et al (65) investigated 136 patients with CF dividing the data into pre-pubertal, 
adolescent and adult subjects.  Surprisingly they found that 40% had low BMD with no 
difference between the age groups and no difference using size adjusted BMD SDS.  
Change in BMD over 2 years positively predicted change in FEV1 whereas change in FFM 
was only weakly related to change in FEV1.  This may, in part, be explained by the fact that 
the authors use ‘FFM’ as ‘the soft tissue proportion of non-fat region’.  It is likely that if 
bone was included in FFM the relationship with FEV1 would be stronger. 
 
The fact that changes in body composition are related to changes in lung function seems 
clear but it is difficult to draw conclusions about cause and effect.  Some evidence from 
animal studies suggest that sub-optimal nutrition has a detrimental effect on the lung. The 
malnourished mouse model of respiratory infections in CF suggests that malnutrition 
contributes to compromised lung defences, bacterial colonisation and systemic 
inflammatory response (123). The timing of undernutrition has an effect in rats, in young 
animals causing a retardation of growth and sometimes irreversible non-development of the 
lung and in adults an alteration to the architecture of the terminal air spaces similar to 
emphysema (124).  Fetal undernutrition has been suggested as a cause of lower FEV1 in a 
study of men over 60; those with the lowest birthweight had the lowest FEV1 after adjusting 
for current height and age (125).    
 
It could also be argued that CF related lung disease affects body composition due to the 
inflammatory response to chronic bacterial infection leading to an altered protein-energy 
balance, lack of appetite and reduced activity. Much research into the relationship between 
severity of lung disease, protein catabolism and systemic inflammation and the detrimental 
effect on FFM including bone has been undertaken by a group of researchers from the 
University of Wales College of Medicine.  Using measures of systemic inflammation 
(serum tumour necrosing factor-α and interleukin-6), protein breakdown (urinary 
pseudourine) and connective tissue breakdown (cross-linked N telopeptides of type 1 
collagen) they found that inflammatory mediators were higher in clinically stable adults 
with CF compared to controls and were related to increased protein and connective tissue 
breakdown which were in turn related to impaired FEV1 and low FFM as measured by 
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DXA (118).  This finding of inflammatory and catabolic response is supported by other 
studies of patients with CF concluding that chronic lung disease is a major factor in altered 
body composition and metabolic complications (16;126;127).  Similarly for patients with 
chronic obstructive pulmonary disease (chronic bronchitis and emphysema) lung damage is 
followed by an inflammatory response and narowing of the airway and typically weight 
loss (128).  Studies of patients with CF suggest that loss of FFM generally will impact on 
inspiratory lung muscle and its function adding to the difficulties of breathing (120;129-
131) and may reduce response to antibiotic treatment (132) and therefore generate a vicious 
cycle of pulmonary inflammation and progressive lung disease (133).   
 
Insulin-like growth factor (IGF-1) is an important hormone that has an anabolic effect on 
the body by promoting protein synthesis and inhibiting protein degradation (134).  Increase 
in muscle mass has been demonstrated  where IGF-1 has been given to patients (135) and 
animal studies have shown that IGF-1 prevents diaphragm atropy due to malnutrition (136). 
A study by Sermut-Gaudelus et al. (105) of 24 children with CF found that those with a 
reduction of ≥1 SDS lean mass by DXA after 1 year had the lowest levels of IGF-1 at 
baseline and that this was independent from weight and FM.  They conclude that reduction 
of IGF-1 may not only reflect but contribute to overall nutritional status.  Growth hormone 
stimulates linear growth and is a potent anabolic agent and has been used clinically to 
improve nutritional status and protein catabolism in acquired immune deficiency syndrome 
and burns patients (137;138).  Its use in patients with CF has been shown to improve 
growth and clinical status (139) and protein catabolism (140) in a randomised clinical trial 
in pre-pubertal children. 
 
It is likely that the relationship between lung function and body composition is not simply 
one of cause and effect  but more about inter-dependence, deterioration in either impacting 
on the other via complex body mechanisms.  
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2.6 Summary 
 
 
 Age at diagnosis impacts on clinical outcome. 
 Historically, growth (weight, height and BMI) has been related to morbidity and 
mortality, however, the impact of body composition cannot be determined using 
these measurements.  BMI cannot detect hidden depletion of lean mass and may 
not correctly identify obesity. 
 There is deterioration in growth, nutritional status and body composition in 
patients with CF over time which may start at a very young age.  Although 
research has shown that CF has a detrimental effect on growth, studies have 
variously found either no, or deficits in FM, FFM and bone in children and 
young people with CF.   
 Sex differences are apparent but there is no agreement between studies.  Given 
the poorer prognosis in females this merits attention. 
 There is not agreement about whether pubertal delay occurs and in which sex.  
 Consistent findings of a relationship between BMI or FFM (including BMD) and 
spirometry are reported.  
 The differing methodologies in past studies make comparison difficult.  Cross-
sectional observational studies have limited utility in defining the multi-factorial 
relationship between spirometry and body composition.  Longitudinal studies 
have the advantage of the ability to relate change in body composition to change 
in spirometry. 
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Table 2.1.  Studies of body composition and lung function in patients with cystic fibrosis. 
 
Only details relating to body composition and lung function are noted in the table. 
Study N  
Age yrs 
Duration/ 
details 
Outcome 
variables 
Adjusted Sexes 
separate 
Findings 
 
 
Cross-sectional studies 
Steinkamp  
2002 (13) 
3298 
≥ 2 
Cross-sectional 
German  
CF registry 
Weight, height, 
FEV1, PA 
 Yes Weight, height and lung function decrease with age. 
FEV1 related to malnutrition & PA but not to sex at all ages 
Patient with malnutrition had ↓FEV1, ↑inflammation independent of PA 
Kastner- 
Cole  
2005 (52) 
2987 
1-56 
UK CF registry 
Homo ΔF 508 
Weight, height,  
BMI, FEV1  
 Yes Prevalence overweight; children, 8% M, 10% F, adults 13% M, 5% F 
Prevalence obesity; children, 1% M&F, adults, 1.6% M, 0.2% F 
Children; BMI SDS +ve association with FEV1% through entire range of 
BMI (-4 to +3)  
Adults; + ve association with FEV1 until BMI 23 kg/m
2  
Rochat  
1994 (119) 
12  
19-24 
Cross-sectional 
malnourished  
CF vs controls 
DXA LM, BMC, 
FM, FEV1 Weight 
Height 
normalised 
to 170cm 
No ↓BMC & LM  
FEV1 correlates with weight, LM & BMC  but not FM 
Stallings  
2005 (72) 
16 females 
8-29 
Cross-sectional  
Pre & post puberty,  
CF vs controls 
DXA FM, FFM 
arm anthropometry 
FEV1 REE 
None Only  
females 
CF ↓height, arm muscle area, ↑REE but not different in FM & FFM 
BMI +ve association with FEV1 and age – ve association with FEV1 
Conclude; poor growth, nutritional status and delayed menarche associated with  
poorer lung function 
King 
2010 (117) 
86 
19-59 
Cross-sectional 
CF vs ref data 
DXA FFM, BMI,  
FEV1  
Height Yes FFM depletion in 14%, low BMI in18.6% 
FEV1 associated with FFM in both sexes 
Pedriera 
2005 (11) 
50 
7-17 
Cross-sectional 
Mild lung disease 
CF vs  ref data 
Weight, height,  
BMI 
DXA FM, FFM 
None No BMI SDS strong +ve association with FEV1  
FFM SDS weaker significant association with FEV1 
FM SDS non-significant +ve association with FEV1 
 
FEV1; forced expiratory volume in 1 sec, PA; pseudomonas aeruginosa, BMI; body mass index, M; male, F; female, SDS; standard deviation score (Z), DXA; dual-energy X-ray absorptiometry, 
LM; lean mass (non-bone),  CF; cystic fibrosis, BMC; bone mineral content, FM; fat mass, FFM; fat-free mass, REE; resting energy expenditure, BMD; bone mineral density, BCM; body cell 
mass, LS lumbar spine, %IBW; percent ideal body weight, BIA; bio-electrical impedance analysis, SFT; skinfold thickness, TBW; total body water, FVC; forced vital capacity, TOBEC; total 
body electrical conductivity.   
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Table 2.1 continued.  Studies of body composition and lung function in patients with cystic fibrosis. 
Only details relating to body composition and lung function are noted in the table. 
Study N  
Age yrs 
Duration/ 
details 
Outcome 
variables 
Adjusted Sexes 
separate 
Findings 
 
Cross-sectional studies continued 
Henderson 
1999 (64) 
40 
5-20 
Cross-sectional 
Pair-match 
DXA BMD,  
FM, LM 
None No Mean weight and height SDS -0.7.  Reduction of 19% BMC, 18% FM and  
12% LM.  Weak correlation LM and FEV1 
Large age range 
Buntain 
2004 (100) 
153 
5-56 
Cross-sectional 
Child 
Adolescent 
Adult 
CF vs controls 
BMD, BCM, FEV1 Height 
Sex 
 
No Adolescents ↓weight & height, adults ↓ weight 
LS & total BMD ↓ adolescents and adults 
BCM ↓ in child/adolescents 
Children & adolescent; BMI, BCM and FEV1 predicted BMD 
Adults: BCM & no. of days in hospital predicted BMD 
No pubertal delay 
Sermut-Gaudelus 
2007 (116) 
114 
2-18 
Cross-sectional 
CF vs ref data 
<6,  
6-10   
11-18yrs 
DXA BMD,  
FM,FFM 
Weight 
 
No All 3 groups had FFM SDS < -2 (adolescents -4), FM was > 0 in the 2  
youngest groups and -1.1 in adolescents. All were short <-0.5 with adolescents 
shortest -0.9   
FFM SDS significantly correlated with FEV1.  LS BMD <-1 in all groups. 
Mean FEV1 declined after age 10, osteocalcin correlated with FEV1 and FFM 
50-60% normal weight (%IWH > 85%) had FFM SDS < -2 ie hidden  
depletion FFM 
Pubertal delay in both sexes. 
Ionescu  
2002 (118) 
40 
23±0.8 
Cross-sectional 
CF vs control 
DXA FM, FFM 
FEV1  
Height No Clinically stable adults catabolic and this related to lung disease severity,  
systemic inflammation and body composition 
FEV1 related to FFM 
Those with low FFM had lowest FEV1 
Ionescu 
2003 (104) 
56 
17-38 
Cross-sectional 
CF vs control 
DXA FM, FFM 
BIA FFM 
Lung function 
Height No Apparent or hidden loss of FFM related to overall disease severity. 
Hidden depletion of FFM associated with ↑ loss BMD and systemic 
inflammation 
FEV1 related to BMI and FFM 
FEV1; forced expiratory volume in 1 sec, PA; pseudomonas aeruginosa, BMI; body mass index, M; male, F; female, SDS; standard deviation score (Z), DXA; dual-energy X-ray absorptiometry, 
LM; lean mass (non-bone),  CF; cystic fibrosis, BMC; bone mineral content, FM; fat mass, FFM; fat-free mass, REE; resting energy expenditure, BMD; bone mineral density, BCM; body cell 
mass, LS lumbar spine, %IBW; percent ideal body weight, BIA; bio-electrical impedance analysis, SFT; skinfold thickness, TBW; total body water, FVC; forced vital capacity, TOBEC; total 
body electrical conductivity.   
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 Table 2.1 continued.  Studies of body composition and lung function in patients with cystic fibrosis. 
 
Only details relating to body composition and lung function are noted in the table. 
Study N  
Age yrs 
Duration/ 
details 
Outcome 
variables 
Adjusted Sexes 
separate 
Findings 
 
Longitudinal studies  
Shepherd 
1986 (50) 
10 
3-13 
1 yr supplementary 
feeding 
Weight, growth 
Infections 
FEV1 FVC 
 No Weight↑, height ↑ and fewer infections 
Reversal of lung function decline 
Initial catabolic state → anabolic by 6-12 months 
Zemel 
2000 (10) 
968 
5-8 
4 yr longitudinal 
US CF registry 
Weight, height,  
%height for ideal  
weight, FEV1  
 Yes Decline in FEV1 % over time with most decline in those highest at start ≥90% 
and girls >  boys. 
Baseline weight SDS, height SDS +ve association with FEV1% 
Sex difference; Δ height SDS boys ↑, girls ↓, Δ weight SDS ↓for both but girls > boys. 
Steinkamp 
2002 (13) 
536 6-12 
477 12-18 
Longitudinal 1 or 2 yr 
German CF registry 
Δ weight/height 
Δ FEV1  
 No 1 yr Δ weight/height: ↓→↓FEV1, normal & stable → stable FEV1, ↑→↑FEV1  
2 yr child & adolescents with normal nutrition had smaller decreases in FEV1  
than malnourished 
Fall in weight/height ≥5% predicted associated with ↓FEV1 and vice versa 
Improved weight/height → = or ↑ FEV1 
Konstan 
2003 (122) 
931 
3yrs 
3yr longitudinal 
US & Canada 
Weight, height 
Lung function 
 Yes Weight and height SDS -0.5 at age 3 & 6 yrs 
No difference in growth & nutritional status between sexes and at 3 & 6 yrs 
Weight, height status at age 3 strongly associated with lung function at 6 yrs. 
Δ weight ↑ → ↑ lung function 
Peterson 
2003 (141) 
319 
6-8 
2 yr longitudinal Weight, FEV1  No 1kg higher initial weight→ 55ml ↑ FEV1  
2yr 1 kg weight gain → 32ml ↑ FEV1 
Ahmed 
2004 (111) 
143 
2-18 
1-8 yr  
longitudinal  
CF vs controls 
Weight, height, 
BMI, SFT, FEV1 
Weight  Yes Weight, height & BMI SDS ↓ decreasing with age 
Girls < FM till 13yrs and then the same, <FFM at all ages 
Boys <FM and FFM especially in late puberty.  
Boys FEV1 +ve association with FM & FFM & -ve association with age  
Girls no association of body composition and FEV1 
FEV1; forced expiratory volume in 1 sec, PA; pseudomonas aeruginosa, BMI; body mass index, M; male, F; female, SDS; standard deviation score (Z), DXA; dual-energy X-ray absorptiometry, 
LM; lean mass (non-bone),  CF; cystic fibrosis, BMC; bone mineral content, FM; fat mass, FFM; fat-free mass, REE; resting energy expenditure, BMD; bone mineral density, BCM; body cell 
mass, LS lumbar spine, %IBW; percent ideal body weight, BIA; bio-electrical impedance analysis, SFT; skinfold thickness, TBW; total body water, FVC; forced vital capacity, TOBEC; total 
body electrical conductivity.   
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Table 2.1 continued.  Studies of body composition and lung function in patients with cystic fibrosis. 
Only details relating to body composition and lung function are noted in the table. 
Study N  
Age yrs 
Duration/ 
details 
Outcome 
variables 
Adjusted Sexes 
separate 
Findings 
 
Longitudinal studies continued 
Zemel  
1996 (67) 
26 
5-10 
3 yr longitudinal 
CF vs control 
mild lung disease 
Weight, height,  
arm anthropometry,  
TBW(FFM), FEV1,  
FVC, REE 
FM weight 
FFM none 
Yes ↑REE not associated with declining lung function 
Sex differences; girls REE increased, boys lung function decreased in 3 yr, 
Δ height SDS ↓ in girls and boys. 
%IBW and genotype predict Δ lung function 
REE adjusted for FFM was CF>controls, CF boys>CF girls, the differences  
increasing with age. 
No account of the relationship between body composition and lung function 
Stettler 
2000 (96) 
25 
5-10 
3 yr longitudinal 
CF  vs control  
matched for weight 
mild lung disease  
SFT, TBW(FFM), 
TOBEC 
None Yes Sex difference; boys Δ height SDS ↓, ↓FFM, ↓FM and girls Δ height SDS ↓,  
↑FM compared to controls who are atypical. 
No account of the relationship between body composition and lung function 
Buntain 
2006 (36) 
85 
5-18 
2 yr longitudinal 
5-10 
11-18 
CF vs controls 
BMD, BMC, 
DXA LM 
FEV1, FVC 
Height 
Sex 
No 
 
At start weight and height is similar in children and ↓ for CF adolescents 
Δ weight ↓ children and same in adolescents who had NS ↑ Δ height 
At start no BMD deficit in children but Δ LS BMD ↓ compared to controls 
At start adolescents BMD ↓ compared to controls but rate of change the same  
for LS and ↓ for total and femoral neck BMD 
Children; FVC related to total BMD & LM related to LS BMD 
Adolescents; FEV1 & LM related to total and LS BMD 
Bianchi 
2006 (65) 
136 
3-24 
2 yr longitudinal 
Pre-pubertal child 
Adolescent 
Adult 
BMC, BMD 
DXA FM, LM 
For ‘body 
size’ 
Sex 
 
 40% had BMD SDS < -2 no significant difference between age groups even 
when size adjusted  
BMD correlated with FEV1  and Δ BMD correlated with Δ FEV1  
At start both FM & LM ↓ , LM correlated with FEV1 
Δ FFM weakly correlated with Δ FEV1  
No sex differences 
FEV1; forced expiratory volume in 1 sec, PA; pseudomonas aeruginosa, BMI; body mass index, M; male, F; female, SDS; standard deviation score (Z), DXA; dual-energy X-ray absorptiometry, 
LM; lean mass (non-bone),  CF; cystic fibrosis, BMC; bone mineral content, FM; fat mass, FFM; fat-free mass, REE; resting energy expenditure, BMD; bone mineral density, BCM; body cell 
mass, LS lumbar spine, %IBW; percent ideal body weight, BIA; bio-electrical impedance analysis, SFT; skinfold thickness, TBW; total body water, FVC; forced vital capacity, TOBEC; total 
body electrical conductivity.  
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Chapter 3.  Body composition measurement techniques in 
children and adolescents 
 
 
3.1 Introduction 
 
 
The gold standard for body composition measurement at the molecular level is 
cadaver analysis, whereas in vivo techniques do not measure body composition 
directly but rather predict it from measurement of other body properties (142).  
Consequently methodological error whilst acquiring the raw data and theoretical 
error when converting raw data to body composition variables must be considered 
when assessing the value of techniques. 
 
There is increasing interest in measuring body composition because simple measures 
of weight and height cannot distinguish between predominantly metabolically active 
tissue (FFM) and predominantly storage tissue (FM).  The issue is most pertinent in 
patients in whom the magnitude of specific components of body composition impact 
on disease progression and management.  For example, calculating drug dose based 
on weight in a normal weight child with low FFM and therefore high FM could mean 
that the dose is not metabolised as fast as expected (143).  The problem of accurate 
assessment of body composition in children is made more difficult because with 
growth and chemical maturation of the lean tissue, the relative proportions of protein, 
mineral and water change at different rates in individuals and between the sexes.  In 
addition, for patients there may be a disruption to the ‘normal’ proportions of the 
constituents of lean mass.   
   
Investigation of body composition in children with CF may be beneficial because of 
the potential to; (i) aid understanding of the mechanisms that underlie deficits in 
patients with CF, (ii) assess the effectiveness of medical and nutritional interventions 
and (iii) identify those children at most risk of deterioration.   
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Wang (144) proposed a structural framework for studying body composition 
describing 5 levels of increasing complexity; I) atomic, II) molecular, III) cellular, 
IV) tissue system and V) whole body (see Figure 3.1).  Information can be 
transformed between levels, for example, using the chemical constant required to 
convert nitrogen to protein (Level I to II) or the density of the whole body to derive 
FM (Level V to II).  This chapter reviews the merits of the most commonly used 
methods available to assess growth and body composition in children and 
adolescents. 
 
 
 
Image removed for copyright purposes 
 
 
 
Figure 3.1. Five levels of body composition (Wang 1992).   
 
3.2 Simple measures 
 
3.2.1 Weight, height and body mass index (Level V) 
 
Although weight, height and BMI are commonly used to classify growth by use of 
centile charts or by SDS the measures do not actually distinguish the different 
components of body weight.  There is generally an assumption that BMI relates to 
fatness without consideration to the amount of lean tissue present.  Therefore in 
normal or low BMI patients with low FFM, for example, some patients with CF, the 
BMI categorisation masks the high FM component which may be putting them at 
higher risk of metabolic syndrome.  Indeed Wells et al.(145) reports data on patients 
with congenital myasthenia where a low BMI masks high FM (by isotope dilution 
and SFT) Figure 3.2 
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. 
 
 
 
Figure 3.2.  “Data from infant patients with congenital myasthenia, a condition in 
which the development of connective tissue is impaired.  Despite extremely low BMI 
SDS, the patients have body fat levels higher than the average in healthy children.  
This paradox can be attributed to extremely low levels of lean mass.  Though they 
are underweight, energy intake is not itself constraining their growth”. Wells et 
al.(146) 
 
(Permission to reproduce this has been granted by Professor JCK Wells). 
 
Another study by Wells et al. (147) (Figure 3.3) shows two-fold variation in fat for a 
given BMI in individual children. 
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Figure 3.3.  “Hattori graph for children aged 8 showing fat mass adjusted for height 
(fat mass index; FMI) v fat-free mass adjusted for height (fat-free mass index; 
FFMI).  The individuals A and B represent 2 girls with similar BMI (approximately 
18 kg/m
2
) but with A having twice the FMI of B.  The individuals B and C have 
similar percent fat, but very different BMI and FFMI” (Wells et al (148). 
 
(Permission to reproduce this has been granted by Professor JCK Wells). 
 
Similarly, BMI is not a reliable predictor of lean tissue either (149) and there are 
several reports of hidden depletion of lean mass (low lean with normal BMI) in 
adults (104;117) and children (105;150).  Although height and weight indices are 
commonly used to calculate weight for height and height for age in paediatric 
patients, rarely is genetic potential or pubertal delay, which is common in children 
with CF, taken into account. 
 
3.2.2  Regional skinfold thickness (Level IV) 
 
SFT measurement is a cheap, quick and simple technique to rank relative fatness and 
assess specific subcutaneous fat depots.  The measurements are made usually at 3 or 
4 sites by ‘pinching’ a skinfold, pulling it away from the underlying muscle and then 
measuring using a calliper.   
 
A 
C 
B 
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Figure 3.4.  Measurement of bicep skinfold thickness 
 
There is an assumption that subcutaneous fat is proportional to total body fat 
although it does in fact vary with age, sex and ethnicity (151).  Inter and intra-
operator error in general is low compared to individual variation but it is a technique 
that requires experience.  In obese individuals the precision and accuracy is poorer.  
This technique is inappropriate to derive FFM (weight-FM) because only properties 
of FM are assessed. 
 
The measurements are usually made at several sites most commonly of the overlying 
skin of the sub-scapular, supra-iliac, bicep and tricep sites.  Other sites may be used 
but may be more difficult to measure.  The raw measurements can then be used to 
rank fatness or converted to SDS (152;153) to allow longitudinal assessment of 
regional fatness.  Until recently the SFT reference data was old (154) but more 
contemporary data (155) has been used in this study although not yet generally 
available. 
 
3.2.3 Waist circumference 
 
Waist circumference is a quick and easy measurement that has been shown to relate 
to visceral adiposity (156;157).  In adults, increased waist circumference has been  
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shown to relate to obesity related diseases such as cardio-vascular disease (158) and 
even in children a relationship with adverse blood lipoprotein profile (159;160).  
Waist circumference is a better predictor of central adiposity than waist to hip ratio 
(142) and waist to height ratio is more closely linked to morbidity in childhood than 
BMI (161).  There is a dearth of studies investigating the  relationship between FFM 
and waist circumference but a large study of adults concluded that increased waist 
circumference was more closely associated with increased FM than FFM in both 
men and women (162). 
 
3.3 Predictive techniques 
 
 
Prediction techniques are those which depend on measuring some characteristic of 
the body to predict components of body composition. 
 
3.3.1 Skinfold thickness to derive whole body fat 
 
SFT measurements may be used in the raw state or converted to SDS as described 
above or may be used as a predictive technique by applying appropriate equations 
(151;163-165).  The use of predictive equations is problematic because the 
equations; (i) are population specific and have generally been derived in healthy 
white populations, (ii) convert individuals to the average and (iii) are derived by 
regression using some other body composition method which typically, has not been 
a criterion technique.  Consequently accuracy in individuals is poor (limits of 
agreement ± 9% fat) and varies with magnitude of fatness (166;167). 
 
3.3.2  Bioelectrical impedance analysis (Level V) 
 
Single frequency BIA is a quick, easy, non-invasive technique where a small 
alternating current is passed through the body from one electrode to another (at hand 
and foot) and the voltage drop (by which impedance is derived) is measured by 2 
more electrodes.  It is based on the principle that FFM contains water and 
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electrolytes and therefore acts as a conductor whereas FM is relatively anhydrous 
and therefore resists the flow of the current.   
 
 
 
    
 
 
 
 
Figure 3.5.  Bioelectrical impedance analysis 
 
 
 
Impedance (Z) is the frequency dependent opposition of a conductor to the flow of 
an alternating electrical current and is composed of resistance (R) and reactance (Xc).  
Biological conductors have both resistive and reactive components, however, the 
reactive component is so small (<4% of Z) that R is assumed to be equivalent to Z.  
The theoretical model also assumes that the body is an isotrophic cylinder of constant 
width, with its length proportional to the subject’s height.  
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The resistance of the cylinder is represented by; 
 
Z = K * HT/A      Equation 3.1 
 
Where Z is impedance, K is a constant, HT is the length of the cylinder and A is the 
cross-sectional area of the cylinder. 
 
Alternatively; 
 
A = K* HT/Z       Equation 3.2 
 
Since;  
HT * A = Volume      Equation 3.3 
 
Multiplying both sides of the equation by HT; 
Volume = K * HT
2
/Z      Equation 3.4 
 
The volume or TBW can therefore be calculated from HT and Z once K has been 
calculated for that specific population.  K is calculated by regressing Z on TBW 
measured by a criterion technique. 
 
However, the body is not an isotrophic cylinder and regional body weight does not 
match distribution of impedance (168;169) since long thin cylinders such as the arms 
have more resistance than the wider cylinder of the trunk.  This is a problem where 
proportions differ in growing children and patients with altered proportions (142).  
One solution is to divide the body into segments of similar sized cylinders (trunk, 
right and left arm and leg) and measure the segments separately, thereby improving 
accuracy. In addition, the slope of the regression equations between height and Z 
may be affected by sex, age and other characteristics and therefore need to be 
calculated for specific populations.  This is particularly pertinent in patient groups 
and although whole body equations have been derived for some patient groups 
(89;92;170;171) the accuracy in individuals is poor and may be affected by clinical 
status.  In healthy populations error is typically ± 8% fat (167) and Puiman (92) 
reports an underestimation of 6% of TBW in patients aged 4 to 18 yrs with CF.  
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Since K is proportional to fluid volume and inversely proportional to the number of 
free ions, changes in geometry (volume), electrolyte concentration or body 
temperature can affect Z (172). 
 
The use of prediction equations, either those used for the equipment print-out or 
those derived in specific populations require an assumption that each individual has 
an impedance value equal to the mean and thereby may introduce error.  An 
alternative to this method is to use the raw impedance data (height 
2 
/Z) and convert 
this to SDS compared to a reference population (155).   
 
3.3.3 Total body conductivity (Level V) 
 
Total body electrical conductivity is similar to BIA in that the theoretical assumption 
is that body electrical conductivity predicts body composition (173).  The body is 
passed through a coiled wire (solenoid) and changes in the electromagnetic field are 
measured to indicated the conductivity of the tissues and thereby TBW and FFM.   
 
However, the instrument is bulky and affected by environmental factors and 
hydration of the subject and performs best after a 6 hr fast, making it unsuitable for 
paediatric use.  Manufacture of devices stopped in 1994 and therefore availability is 
limited. 
 
3.4 Two-component models (2CM) 
 
 
The two-component (2CM) divides body weight into FM and FFM the former being 
homogenous and the latter although heterogeneous, for the purpose of 2CM is 
assumed to be of constant density.  Accuracy depends on the assumption of 
constancy of the FFM which depends on sex, age, pubertal development, ethnicity 
and disease state.  Therefore, wherever possible population specific values for the 
nature of the FFM should be used.  
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3.4.1 Hydrometry (Level II) 
 
Total body water can be measured on the principle that it is equal to the amount of 
stable isotope added to the body divided by the concentration of the isotope in the 
water compartment of the body after the equilibrium period (174).  Deuterium oxide 
(
2
H2
16
O) is commonly used but other stable isotopes can also be used such as 18-
oxygen. The fact that deuterium oxide differs from ordinary water (
1
H2
16
O) by 1 
neutron means that it is quantifiable by mass spectrometry.  Once ingested the 
hydrogen atoms of deuterium are exchangeable with the hydrogen atoms of the water 
pool (175).  The equilibrium period depends on the sample of body fluid used; blood 
sampling is problematic in children, urine sampling is unsatisfactory because it is 
difficult to predict a time when the urine content of the bladder is typical of the 
whole body water and therefore saliva samples are the best option for all except 
babies.  The equilibrium period is longer for urine (4-6hrs) than saliva (3-4 hrs) 
(176), although the saliva equilibrium period is extended in the obese (177;178). 
 
The calculation of TBW will be affected by any isotope leaving the body during the 
early equilibrium period due to sweating or voiding although such loss is minimal 
and not considered in calculation of TBW.  Drinks taken do need to be accounted for 
as they will dilute the isotope leading to a lower concentration and therefore 
overestimation of TBW. 
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The equation is: 
 
N = TA * (Ea-Et) 
         A     (Es-Ep)      Equation 3.5 (179) 
 
Where N = dilution space (ml) 
 T = amount of tap water in which portion a is diluted (ml) 
 A = amount of isotope (g) 
 a = portion of dose used in analysis (g) 
E = isotopic enrichments in delta units relative to an international standard, 
Vienna Standard Mean Ocean Water (VSMOW) 
  Ea enrichment of portion of dose 
  Et enrichment of tap water used 
  Es enrichment of post dose sample 
  Ep enrichment of pre-dose sample 
 
There is a difference between TBW and dilution space measured by isotopic 
exchange due to non-aqueous exchange of either 18-oxygen or deuterium with 
oxygen and hydrogen ions (180;181).  This is addressed by applying a correction 
factor; 
  
TBW = N/1.044  in mls for deuterium 
          = N/1.01 in mls for 18-oxygen  (180) 
  
Once TBW has been calculated the amount of fluid consumed is subtracted to avoid 
an overestimation of water and consequently overestimation of FFM.  FFM is 
calculated using age and sex specific constants for hydration of FFM; 
 
FFM = TBW 
 Hydration of FFM     Equation 3.6 
 
The constant for adults is considered to be 0.73 and for babies around 0.80 but the 
relationship for the period between the two is not linear (182).   Fomon’s landmark 
paper in 1982 and Lohman’s later merging of data with that of Fomon (183) has been 
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widely used in calculating FFM however, not all age points were measured, 
extrapolation being used for the missing time points.  Recently, I collected data for a 
comprehensive study of more than 500, 4 to 22 year old subjects that provided 
measured hydration factors throughout the range (184).  The same study provided the 
data to generate SDS for TBW.  Using a SDS for an individual avoids the problem of 
introducing an error by assuming they have an average value for hydration when 
converting TBW to FFM. 
 
3.4.2 Densitometry (Level V) 
 
Densitometric techniques are based on the principle that, if the density of two 
components are known and the overall density of the two components combined is 
known then it is possible to work out the proportion of one to the other.  Body 
volume and mass are measured to calculate overall density and then assumed 
densities of FM and FFM used to calculate %fat:  
 
% fat = (C1/body density – C2) x 100   Equation 3.7 
 
Where C1 = (densitylean x densityfat) 
          (densitylean – densityfat) 
And C2 = densityfat 
     (densitylean – densityfat) 
 
For adults, the density of fat is considered to be 0.9007 kg/L and the density of lean 
1.100 kg/L 
Therefore: 
% fat = (495/body density) – 450    Equation 3.8 (185) 
 
Fat is homogenous and therefore assumed to be of constant density (186) whereas 
lean tissue is heterogeneous, the relative amounts of protein, mineral and water 
varying with growth and different between the sexes.  This is a severe limitation 
when using densitometric techniques to measure children.  Until recently reference 
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data for children has been sparse and based on small numbers of limited age range 
(182;187) although our recent reference data for 4 to 22 years from our centre should 
improve the accuracy of prediction of FM and FFM (155;184).   
 
3.4.2.1 Under-water weighing/ hydro-densitometry 
This technique requires the person to be weighed and then completely immersed in 
water whilst being weighed again.   
 
 
 
 
 
Image removed for copyright purposes 
 
 
 
 
 
Figure 3.6.  Under-water weighing apparatus. 
 
Based on Archimedes principle whole body density can be calculated: 
 
Density of an object = Weight 
Density of the fluid  Weight – apparent immersed weight 
 
The total immersion in a tank of water means that this technique is not suitable for 
the young, sick or infirm and is not suitable for field studies.
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3.4.2.2 Air-displacement plethysmography (ADP)  
 
   
 
 
 
 
 
 
Figure 3.7.  Air-displacement plethysmography 
(Boodpod; Cosmed, Rome, Italy)  
 
A newer technique to assess body density relies on Boyle’s Law of the relation 
between the volume, pressure and temperature of gases.  The volume of gas in the 
front measurement chamber is measured; (i) empty, (ii) with the 50 L calibration 
cylinder and (iii) with the subject inside.  The front chamber is connected to the rear 
reference chamber by oscillating diaphragms which induce small pressure changes.  
Raw body volume is calculated from the volume of air without and with the subject 
present and then an adjustment made for residual lung volume and surface area 
artefact generated by the warmer air in contact with the skin.  The residual lung 
volume may be measured but the technique is very difficult for children to perform 
and therefore predicted volume is often calculated. The equations used to calculate 
lung volume, surface area artefact and % fat in the machine’s software are not 
appropriate for children.  When measuring children the raw body volume is adjusted 
using age and sex appropriate predicted residual lung volume (188;189) and surface 
area artefact (190). 
 
ADP has been shown to correlate well with under water weighing (191;192), 
however, ADP has better precision (191;193;194). The equipment is large and 
requires a stable temperature in the measuring room making it unsuitable for field 
studies.  The technique requires the subject to sit still inside the machine for several 
periods of about a minute and is therefore not suitable for very young children 
(<4yrs) or those who are claustrophobic.  In the last few years new equipment has 
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allowed for the measurement of whole body density in infants (<8kg) which, 
although similar in principle, is able to accommodate movement and crying (PEA 
POD; Cosmed, Rome, Italy). 
 
3.4.3 Dual-energy X-ray absorptiometry (DXA; Level V)  
 
 
 
 
 
 
 
 
 
 
Figure 3.8.  
Dual-energy X-ray absorptiometry (Lunar Prodigy, GE Medical Systems, USA) 
 
DXA, first developed for assessment of bone mass has been shown to be both precise 
and accurate when used for this purpose.  Over the past decade, DXA has 
increasingly been used to assess body composition in research and clinical practice 
due to the additional information on total FM and FFM and their distribution in the 
trunk and upper and lower limbs.  Its rapid uptake may be attributed to its ease of 
use, availability, and low radiation exposure (less than 2µSv per scan), which is 
lower than background radiation.  However, although precision and accuracy for 
bone is good (<1%) and precision of soft tissue assessment is good (<2%) (195) 
accuracy is variable (102;196;197).  The principle on which DXA is based is that 
different tissues attenuate the photons passing through the body differently.  Bone 
has high attenuation, lean tissue medium and fat low attenuation.  Pixel-by-pixel 
estimation of body composition using a series of assumptions is complicated by the 
fact that wherever there is bone in the pixel the software is unable to determine the 
nature of the soft tissue.  More than 40% of a whole body scan contains bone (196) 
and therefore in those pixels the machine cannot distinguish between FM and non-
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bone FFM and an assumption is made that this tissue is in similar proportions to the 
half of the body that does not contain bone in the pixels.  This is one possible source 
of error and studies find that assessment of soft tissue is subject to bias according to 
sex, size, fatness, and disease state of those being measured, which indicates that 
DXA is unreliable for patient case-control studies and longitudinal studies of persons 
who undergo significant changes in nutritional status between measurements 
(102;198).  The large size and cost of DXA limit its use in non-hospital settings. 
 
3.5 Multi-component models (Level II) 
 
 
2CM techniques overcome the limitations of the predictive techniques by addressing 
both components of body weight, FM and FFM.  FM is homogenous but FFM, 
composing of mainly protein mass (PM), MM and water varies in the relative 
proportions of each depending on growth and maturation and is different in the sexes 
and may be disrupted in disease.  To improve accuracy of quantifying both 
components it is possible to measure one or two of the components of FFM. 
 
 2-component              3-component                4-component 
 model    model    model 
 
 
 
 
 
 
 
 
 
Figure 3.9.  Multi-component models of body composition 
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Fat mass 
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The 3-component model (3CM) utilises the measurement of total body water and 
thereby removes the assumption about constant values for the hydration of FFM 
although assumes a constant ratio of PM to MM (199).  The 4CM used in this study 
additionally utilises the measurement of mineral by DXA and thereby overcomes the 
assumptions of the 3CM, although there is still an assumption about the ratio of 
osseous to non-osseous mineral (199).  The measurement of water and mineral and 
overall density quantify both FM and the components of FFM more accurately and 
allow for calculation of the hydration of FFM and ratio of PM to MM ratio. 
 
The 4CM is considered a ‘criterion’ method for in vivo techniques because it is the 
most robust to detect inter-individual variability in FFM as well as accuracy over a 
range of FM (200). 
 
FM (kg) = 2.747 BV – 0.710 TBW + 460 BMC – 2.050 BW  
Equation 3.9 (167;199) 
       
BV = body volume (L) from ADP adjusted for surface area artefact and lung volume 
TBW = total body water (L) from deuterium dilution 
BMC = bone mineral content (Kg) from whole body DXA 
BW = body weight (Kg) 
 
3.5.1 Propagation of error for measurements of FM and FFM 
 
One might presume that using measurements from several techniques would 
introduce additional error.  This was examined by Wells and Fuller (167;194) (see 
Table 3.1) and it is clear that the sum of errors associated with multiple 
measurements does not mean overall precision is poor.  On the contrary, multi-
component models are more accurate because assumptions about the nature of the 
FFM are minimal. 
 
Error in measurement may be due to methodological variation, biological variation 
and a combination of both.  Propagated error is the total observed error as a function 
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of the independent and additive technical errors (methodological and biological) and 
is represented by the formula; 
 
Vt
2
 = Vm
2
 + Vb
2
       Equation 3.10 
 
Where Vb is the biological variation, Vm is the methodological variation and Vt is the 
total observed variation.   
 
 
Table 3.1.  Propagation of error on fat mass and fat-free mass values from different 
models of body composition. 
 
 Error calculating 
FM/FFM (Kg) 
% FM %FFM 
4C model 0.22 3.1 0.50 
3C model  0.20 2.8 0.50 
2C models: 
Deuterium 0.27 3.8 1.3 
UWW 1.00 13.8 3.8 
BOD POD 0.30 5.2 1.1 
 DXA 0.20-0.40 3.0 1.5 
 
From Wells et al (167)and Wells and Fuller (194).  “The error is calculated from 30 
children aged 5-16 years; average weight assumed to be 48.7 kg (41.5 kg FM and 
7.2 kg FFM).  FM; fat mass; FFM; fat-free mass; UWW; under-water weighing; 
DXA; dual-energy X-ray absorptiometry.  4CM uses deuterium, BOD POD and 
DXA; 3CM use deuterium and BOD POD”. 
 
(Permission to reproduce this has been granted by Professor JCK Wells). 
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3.6 Other techniques 
 
 
3.6.1  Magnetic resonance imaging (Level V)  
 
 
 
Image removed for copyright purposes 
 
 
Figure 3.10. Magnetic resonance imaging equipment 
 
Magnetic resonance imaging (MRI) is a technique which measures volume rather 
than mass.  Images are produced as a result of the alignment of hydrogen protons in 
water or fat either with, or against a strong magnetic field around the body.  The 
absorption or emission of energy by the protons are then analysed to produce cross-
sectional images of the body which can be used to calculate tissue volumes. 
 
Despite good quality imaging, comparison with other techniques is difficult because 
MRI quantifies adipose tissue not FM.  The proportion of fat in adipose tissue is 
variable and it is therefore difficult to calculate FM.  The advantage of MRI is that it 
can identify regional body composition and is the only current viable technique for 
identifying intra-abdominal adipose tissue.  Although now widely available it is an 
expensive technique and may be difficult for young children unless sedated.  
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3.6.2  X-ray computed tomography (CT; Level IV) 
 
 
  
 
Image removed for copyright purposes 
 
 
 
Figure 3.11.  X-ray computed tomography. 
 
X-ray computed tomography (CT) uses X-rays to differentiate between tissues and 
image quality is superior to MRI although the high radiation doses make it unsuitable 
in paediatric research.  
 
3.6.3  Total body potassium (Level I)  
 
Total body potassium scanning is based on measuring the emission of radioactive 
40
K by the BCM.  Scanning takes place with the subject supine and takes about 15 
minutes and is a simple procedure although some subjects may experience 
claustrophobia.  Information about BCM is helpful since it reflects better the 
functional component of weight but calculation of FFM is hampered by the 
uncertainty of the K component of FFM in children and a lack of reference data in 
the UK. 
  
69 
 
3.7 Summary 
 
 
 Measurements of height and weight do not give any information about the 
components of body composition. 
 The method of body composition analysis used will depend on availability, 
cost, environment and ease of use for measuring children.  
 Accuracy and precision are important considerations for longitudinal analysis 
if true significant changes are to be identified.    
 All techniques have limitations although the 4CM is considered a criterion 
method because assumptions are minimal; 
o Prediction techniques use regional or superficial proxies (sub-
cutaneous SFT or resistance to an electrical current) and assume a 
relationship with body components (whole body FM and hydration of 
FFM) to predict FM or FFM.  The value of predicted techniques is 
limited because; (i) they convert everyone to the average and (ii) are 
population specific (predominantly healthy). 
o 2CM utilise age and sex specific constant values for the nature of the 
FFM and therefore convert everyone to the average.  Since these 
constants are derived from healthy populations the accuracy in 
patients who may have altered hydration or mineralisation may be 
reduced.  
o 3CM have greater accuracy than 2CM because they address the 
hydration of FFM, however, there is an assumption about the 
relationship between PM and MM which may be disrupted in illness.  
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Chapter 4.  Hypotheses, recruitment, methods, ethical 
considerations and study plan 
 
 
4.1 Hypotheses 
 
Based on the issues highlighted in Chapter 2, I propose the following hypotheses to 
be tested in this thesis: 
Hypothesis 1:  There is no significant difference in body composition between children 
with CF and healthy children at baseline but differences will become apparent over 
time, with reductions in FM and FFM in CF patients. 
 
This hypothesis was tested by matching each 6-12 year old CF child with a healthy 
child of the same sex and ethnic background and within 1 year of age and performing 
4CM body composition measurements to establish baseline data.  Group comparison 
was also made between CF and healthy children at 2 years from baseline using all 
available control children. 
 
The research and analyses addressing this hypothesis can be found in Chapters 5, 6 
and 7. 
 
Hypothesis 2:  Specific components of body composition at baseline and changes over 
time are associated with spirometry in children with CF and predict clinical outcome.  
 
Since FEV1 has been an outcome measure in many previous studies this was chosen as 
the primary clinical outcome measure.  Furthermore, studies have shown a relationship 
between FEV1 and mortality in patients with CF (39;113).  In addition, genotype and 
pancreatic insufficiency was recorded.  Physical activity was assessed by questionnaire 
given at the time of body composition measurements.  A second measurement after 2 
years allowed for the relationship between changes in body composition and change in 
spirometry to be investigated. 
The research and analyses addressing this hypothesis can be found in Chapters 5, 6 
and 7. 
  
71 
 
Hypothesis 3:  The conclusions are the same regardless of whether matched- pairs, 
group comparisons or comparison with reference data are used. 
 
To test this hypothesis I analysed the data using; (i) matched-pair controls at baseline 
and group comparisons at baseline and longitudinally and (ii) reference data derived 
from a large cohort of contemporary children aged 4 to 22 years. 
 
The research and analyses addressing this hypothesis can be found in Chapters 5, 6 
and 7. 
 
Hypothesis 4:  The simple prediction techniques to assess body composition (BIA and 
SFT) and 2CM  techniques (hydrometry and DXA) will not be accurate enough to 
identify depletion or change in body composition over time in this group of children 
with CF due to systematic and/or random  bias. 
 
This hypothesis was tested by comparing SDS (derived from our previously measured 
large contemporary reference population) for FM assessed by DXA and SFT and FFM 
assessed by DXA, TBW and BIA with values from the 4CM. 
 
The research and analyses addressing this hypothesis can be found in Chapter 8. 
 
4.2 Aims 
This thesis had 3 aims; 
1. To investigate the effect of CF on body composition in young children with 
CF and whether this changes with growth and maturity.  In addition, to 
investigate whether the type of comparison (pair-, group-match or compared 
to a reference population) affects the outcome of the analysis. 
2. To investigate the relationship between body composition and clinical status 
assessed by FEV1. 
3. To investigate simple body composition techniques to define which would be 
most appropriate in clinical practice where 4CM is not available. 
 
 
  
72 
 
4.3 Recruitment and exclusion criteria 
 
 
Children with CF aged 6 to 12 years under the care of Great Ormond Street Hospital 
NHS Trust, London were approached to take part in the study.  The children with CF 
were diagnosed on the basis of confirmatory genetics or a positive sweat test with 
chloride values of > 60 mmol/L.  Those recruited were clinically stable, that is to say 
free from lower respiratory tract infections and not requiring a change in antibiotics, 
steroids or bronchodilator treatment during the previous 14 days and emotionally able to 
undergo the measurements.  Children with other conditions affecting body composition 
such as growth hormone therapy, diabetes and liver disease were excluded. 
 
Healthy children for pair-matched, group-matched and cross-sectional reference 
comparison were recruited for another study of body composition at University 
College London, Institute of Child Health, London via schools and adverts in two 
London newspapers.  The study started in February 2002 and those recruited were 
not premature (<36 weeks gestation), had a birth weight ≥ 2 kg and did not have any 
medical conditions or medication affecting body composition.  The measurements 
were performed by myself using identical techniques and equipment. Measurements 
in 533, 4-22 year healthy subjects were used to generate SDS for SFT, BIA, TBW, 
4C FM, 4C FFM, 4C PM, 4CMM, DXA FM and DXA FFM and 100 (6 – 12 years) 
of the original cohort were measured after 2 years for comparison with the children 
with CF.  Measuring age-matched control children longitudinally allows adjustment 
for factors such as activity level and pubertal status and additionally has the benefit 
of comparing both groups of children longitudinally at similar points in time and not 
just as a cross-sectional comparison with a cohort who may or may not be 
contemporary.     
 
 
 
 
 
  
73 
 
4.4 Methods 
 
4.4.1 Anthropometry 
 
Body weight was measured as an integral stage of the Bodpod procedure to within 
0.01kg with the child dressed in a swimsuit.  Accuracy was confirmed by use of two 
solid weights of known mass.  Standing height was measured to within 0.1cm with a 
wall-mounted digital display stadiometer (Holtain, Dyfed, United Kingdom). BMI 
was calculated as weight (kg) divided by the square of height (m). Waist, hip and 
MUAC were measured to 1 mm using a fibreglass tape and bicep, tricep, subscapular 
and supra-iliac SFT were taken in triplicate to nearest 2 mm and averaged.  The waist 
was measured at the ‘natural waist’, half way between the 10th rib and iliac crest  
Measurements were taken on the left side according to the method of Lohman et al 
(1988) using a Holtain skinfold calliper. Intra-operator technical error of 
measurement (TEM) was calculated on 50 children with CF and 50 control children 
using measurements made at the beginning of the study.  The TEM varied according 
to the measurement type ranging from zero for weight, 0.2 mm (0.1%) for height and 
0.8mm (10.6%) to 0.1mm (0.6%) for skinfold thickness depending on site.   
 
4.4.2 Bio-electrical impedance  
 
The Tanita Body Fat Analyzer (BC-418 MA), measures impedance using a constant 
current  source (50kHz, 90µA) and 8 electrodes (2 on each foot and hand) which allows 
measurement of resistance in the whole body and segmentally (trunk, right and left arm 
and leg.  A print-out of impedance and %fat, FM, FFM and TBW for these segments is 
obtained after the subject stands bare-foot on the foot plates and holds the hand grips for 
about one minute.  Only impedance is measured, the other outcomes being calculated 
from equations in the machine’s software.  Only raw impedance from the print-out was 
used and converted to SDS (155) for the purposes of this thesis.   
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 4.4.3 Dual-energy X-ray aborptiometry  
 
Whole body bone mineral content (BMC), bone mineral density (BMD), FM and 
lean mass (non-osseous fat-free mass) was determined using a Lunar Prodigy whole-
body fan beam scanner (GE Medical Systems, USA) in conjunction with software 
v.8.2 or 12.1.  The scan was performed with the subject lying supine and took 5 to 10 
minutes depending on height.   In addition a scan of the LS (L2-L4) was performed 
with the subject supine and with the legs elevated on a soft padded block to derive 
LS BMC, BMD and bone area.  The position of the legs aids contact of the lower 
spine with the scanner bed.  All scans were performed with the subject wearing light 
indoor clothing and with no removable metal objects present.  The scans are analysed 
automatically although manual changes by the operator may be made if the regions 
are inaccurate.  The radiation exposure per whole-body scan is estimated to be 2Sv, 
lower than daily background level.  All scans were performed by one operator.  
Precision of bone density, established by repeat measurements of phantoms on 6 
successive days, was <2%.   
 
As mentioned previously, DXA has limitations when measuring soft tissue 
(102;196;197). However, soft tissue analysis by DXA is a readily available, practical 
alternative to more expensive methods such as CT and MRI.  Regional soft tissue 
analysis (trunk, arms and legs) as well as whole body was therefore compared to 
4CM in this thesis. Data from DXA was used for modelling the 4CM and for 
comparisons of simpler techniques compared to the 4CM in Chapter 8.  In addition 
DXA FM was used as a covariate instead of 4C FM when investigating change in  
4C FFM and DXA FFM used instead of 4C FFM for change in 4C FM, thereby 
using two independent outcomes in the analyses.   
 
4.4.4 Deuterium oxide dilution   
 
TBW was assessed by deuterium dilution, using a dose equivalent to 0.05 g 
deuterium per kg body weight (99.9 atom percent excess, Sigma Chemical Co. 
Chemicals, Poole, UK)).  Doses were made up with water to approximately 100ml.  
Saliva samples were taken pre-dose and 4-5 hours post dose using absorbent 
  
75 
 
salivettes (Sarstedt, Rommelsdorf, Germany) at least 30 minutes after the last 
ingestion of food or drink.  Samples were spun as soon as possible using a centrifuge 
and stored at -20
0
C until analysed by Iso-Analytical Ltd (Sandbach, UK) using the 
equilibration method of Scrimgeour (1993).  Briefly, 0.3 ml of liquid, along with a 
vial of 5% platinum on alumina powder (Sigma-Aldrich, Poole, UK), was placed in a 
septum sealed container (Labco, High Wycombe, UK) and flushed for 2 minutes 
with hydrogen.  Low enrichment and high enrichment standard waters were similarly 
prepared, in order to normalise data against Vienna Standard Mean Ocean Water 
standards.  Samples equilibrated at room temperature for 3 days prior to analysis.  
The head spaces in the containers were then analysed for deuterium enrichment on a 
continuous flow isotope ratio mass spectrometer (Geo20-20, Europa Scientific, 
Crewe, UK).  The accuracy of analyses was checked by measuring an intermediate 
water standard within each batch of samples. All samples were prepared and 
analysed in duplicate.  The mean standard deviation of deuterium analyses by the 
equilibration technique in the laboratory is < 2.5 %. 
 
Deuterium dilution space was assumed to overestimate TBW by a factor of 1.044 
(180) and correction was made for fluid intake during the equilibrium period to 
derive actual body water.  Data was used in modelling the 4CM and also in the 
comparison of 2CM techniques in Chapter 8.  An example of the saliva collection 
information sheet may be found in Appendix 6. 
 
4.4.5 Air-displacement plethysmography  
 
Body volume was measured using air displacement plethysmography (ADP; 
Bodpod, Cosmed, Rome, Italy) whilst the subject wore a close fitting swimming 
costume and hat.  The procedure (193) involves warming up the equipment by 
several ‘autoruns’ for 30 mins and then calibrating using a 50 litre metal cylinder.  
The subject sits in the anterior chamber which is connected to a posterior 
measurement chamber by oscillating diaphragms (which induce pressure change in 
the anterior chamber) whilst breathing normally.  The procedure for one complete 
measurement is at least 2 measurements of body volume (taking 50 secs each) unless 
they differed by more than 150 mls in which case a 3
rd
 volume measurement is 
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performed automatically by the machine.  The raw volume values that appear 
transiently on the screen were recorded and to improve precision the whole 
procedure was repeated until two mean values for raw density of within 0.007kg/l 
were obtained (194).  Where it was not possible to achieve two such measurements 
(possibly due to breathing irregularities in the CF children) the mean of all raw 
volume values was used after values ±2SD were discarded (achieved over four 
separate tests of a minimum of 8 and maximum of 12 volumes).  An adjustment of 
the mean raw volume was then made using predicted lung volume (189;201) and 
surface area (190) using children’s equations to obtain the actual body volume.   All 
measurements were made by one of two operators (JEW, CMW) and the data was 
used in the 4CM.  
  
4.4.6 Spirometry 
 
Laboratory spirometry, FEV1 was measured by technicians in the lung function 
laboratory at Great Ormond Street Hospital NHS Trust according to protocols based 
on American Thoracic Society and European Respiratory Society standards for 
spirometry (202) adapted for children (203) using a Jaegar MasterScreen spirometer. 
Values for analysis were calculated as FEV1 % and SDS compared to a large 
reference population (204).  Children with FEV1% <45% were classified as having 
severe impairment, FEV1% ≥45 and <65% as moderate impairment, ≥65% and <85% 
as mild impairment and ≥85% as normal lung function.  
4.5  Outcome measures used for calculation of body 
composition 
 
 
Weight (kg) 
Total body BMC (kg) from DXA 
TBW (L) from isotope dilution 
Body volume (L) from ADP 
FM (kg) and FFM (kg) from DXA 
Z (Ώ) from BIA 
SFT (mm) 
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4.5.1  Simple body composition techniques 
 
4.5.1.1  Anthropometry 
 
SDS for bicep, tricep, subscapular and supra-iliac SFT were calculated compared to 
our large contemporary population (4.6.2).  
 
4.5.1.2  Bio-electrical impedance analysis 
 
Whole body BIA was performed and height
2
/Z calculated and converted to SDS 
compared to the reference population (4.6.2).  Values of FM and FFM from the 
printout were not used due to the assumptions used in generation of the data which 
would be inappropriate for this population. 
  
4.5.1.3  Dual-energy X-ray absorptiometry (DXA) 
 
FM and lean mass values were obtained from a whole body DXA scan as described 
above and FFM was calculated as: 
 
FFM = lean mass + BMC        Equation 4-1 
Absolute values of FM and FFM and SDS (4.6.2) were used for whole body and 
regional (trunk, legs and arms) body measurements. 
 
4.5.1.4  Deuterium oxide dilution 
 
TBW may be used to calculate FFM, assuming an age and sex specific hydration 
factor of FFM, (Hffm) according to published values (183;184).  
 
FFM = TBW/ Hffm       Equation 4-2 
FM was then calculated as; 
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FM = weight – FFM       Equation 4-3 
And  
%fat = (FM/weight) x 100      Equation 4-4 
 
Weight, FM and FFM in kg, TBW in L 
 
However, as discussed previously this method requires an assumption that the child 
has an average hydration.  For the purposes of this thesis TBW SDS were also 
calculated for comparison of techniques. 
 
4.5.1.5  Air–displacement plethysmography 
 
Whole body density was calculated from body volume (which has been adjusted for 
residual lung volume and surface area artefact) and weight. 
 
Body density = weight / volume     Equation 4-5 
 
% fat = (527/body density) – 485 (Wells 1999)   Equation 4-6 
And  
FM = (%fat x weight) / 100      Equation 4-7 
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4.5.2 Four-component model 
 
The 4CM uses values of BMC, weight, body volume and TBW to derive values for 
MM, TBW mass, FM and PM as described previously (167;199).  Assumed densities 
of the four components were accounted for when calculating FM from the 
measurements; 
 
FM(kg) = [(2.747 x volume) – (0.710 x TBW)] + [(1.460 x BMC) – (2.050 x 
weight)] 
         Equation 4-8 
FFM was calculated as the difference between weight and FM: 
 
FFM = weight – FM       Equation 4-9 
 
TBWmass = TBW volume x 0.99823    Equation 4-10 
     
Hydration of the FFM (HFFM) can be calculated as the ratio of TBWmass to FFM; 
 
HFFM = TBWmass/FFM      Equation 4-11 
 
Mineral mass (MM) can be calculated as: 
 
MM = BMC x 1.2471,  
this assumes a constant relationship between osseous to non-osseous mineral and is the 
only assumption in the 4CM  
 
PM can then be calculated as; 
 
PM = Weight – FM – TBWmass – MM    Equation 4-12 
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4.6 Assessment of confounding factors 
 
Confounding factors were assessed by structured questionnaires.  
4.6.1 Age 
 
Age (years) was calculated as: 
 
Date of measurement – date of birth/ 365.25   Equation 4-13 
4.6.2 Medical data   
 
A brief medical history (Appendix 5) was obtained from the parent or guardian and 
included: 
Serious childhood illness or surgery 
Medication 
Pancreatic status, genotype, presence of liver disease, diabetes, Pseudomonas 
aeruginosa and Staphylococcus aureus infection (in children with CF and confirmed 
with medical notes).  
 
4.6.3 Physical activity  
 
Physical activity level was assessed by asking the parent to give a rating of the 
child’s activity as follows; 1) Much less than peers, 2)  Less than peers, 3) Same as 
peers, 4) More than peers and 5) Much more than peers.  This simple method has 
been shown to correlate well with physical fitness and BMI in children (205) 
although in a large survey of 13-14 year old children (206) it was fat deposition in 
girls and not BMI that was related to physical activity.  Due to small numbers the 
lower two and upper two categories were combined resulting in three groups; less 
than, same as, and more than peers. In addition the number of hours spent in 
vigorous physical activity was recorded.  
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Examples of questionnaires and data collection sheets may be found in Appendix 5 
and saliva collection information in Appendix 6. 
 
4.6.4 Pubertal status 
 
Pubertal stage was self-assessed using line drawings showing the different Tanner 
stages for breast or genital development (Appendix 8).  This avoids undressing and 
has been shown to be in good agreement with doctor assessment (207).  For the 
purposes of analysis pre-pubertal (stage1) subjects were considered distinct from 
pubertal subjects (stages 2-5). 
 
4.7 Statistical analyses 
 
 
All analyses were performed using Statistical Package for Social Sciences 18.0 
(SPSS Inc., Chicago) and p<0.05 was considered significant. 
 
4.7.1 Sample size 
 
When deciding on the sample size required to show a difference between groups, 
type I and II error need to considered.  Type I error is the probability of rejecting the 
hypothesis when it is true and type II the probability of not rejecting the hypothesis 
when it is false (208).  Therefore it is important to have sufficient numbers to address 
the research question confidently without subjecting more children than necessary to 
the research process. 
 
Studies of children with CF have shown a positive relationship between BMI SDS 
and spirometry both cross-sectionally (52;72) and longitudinally (13;122) with 
Kastner-Cole et al noting an extra 10% of predicted FEV1 for a 1 SDS higher BMI.  
The sample size was therefore calculated on the basis that a 0.5 difference in BMI 
SDS is likely to impact on clinical outcome and since BMI is a combination of FMI 
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and FFMI the calculated sample size should be sufficient to detect significant 
differences in both these tissues. 
 
4.7.1.1 Matched pairs and longitudinal analysis 
 
The conventional formula used to determine the number of children required to detect a 
difference between paired groups, and longitudinal comparisons where children are 
compared to baseline measurements is: 
 
n = 8(sd
2
/d
2
)      Equation 4-14 
 
where; n is the number per group, sd is the standard deviation, d is the difference 
between groups. This provides 80% power and a significance cut-off of 0.05 (p < 0.05).  
Using this formula the number of subjects needed to detect a given difference can be 
calculated or for a given SD of a trait, the magnitude and difference detectable for a 
given sample size.  Therefore few subjects are needed to detect a large difference and 
more subjects are needed to detect a small difference. It would be useful to detect a 
small effect since; a) most biological factors create relatively small effects and b) 
previous research has not achieved a consensus on the critical values for healthy body 
composition in CF children. The difference (d) is expressed as SDS format which 
simplifies the formula to n = 8/d². Based on the above power calculations 8 subjects per 
group are sufficient to detect a difference of 1 SDS and 32 subjects per group to detect a 
difference of 0.5 SDS.  
 
4.7.1.2 Cross-sectional group comparison 
 
Although the intention was to continue with a matched-pair analysis at the 2 year 
measurement this was not possible due to either, not all the pairs being measured or 
having successful 4CM.  Therefore, all available controls of the same age range as the 
children with CF were used.  The formula to determine the number of children required 
to detect a difference with 80% power at 5% significance when using an independent t-
test is: 
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n = 16(sd
2
/d
2
)      Equation 4-15 
 
Based on the power calculation above, 16 subjects per group are sufficient to detect a 
difference of 1 SDS and 64 per group to detect a difference of 0.5 SDS. 
 
This study aimed to recruit more than 64 (to maintain 64 throughout the study) in order 
to fulfill the sample size needed for between-group comparisons.  Buntain et al. (36) 
quotes 23.5% of CF and 17% of controls dropping out over a 2 year study and Stettler et 
al. (96) reported a drop-out rate of 16% in CF children over 3 years. Since this study 
was constrained by time and available population (n = 116) all eligible children were 
approached for recruitment. 
 
4.7.2 Size adjustment and calculation of standard deviation scores 
 
Characteristics of all the children were compared to 1990 UK reference data (54;209) 
to generate SDS for weight, height, BMI and waist circumference using the 
lmsGrowth program© (210).  A method analogous to that of BMI (weight/height
2
) 
was applied to absolute values of FM, FFM, PM and MM to remove the effect of 
height; FM index (FMI; FM/height
2
), FFM index (FFMI; FM/height
2
), PM index 
(PMI; PM/height
2
) and MM index (MMI; MM/height
2
) (211;212).  The index 2, 
although appropriate to remove the relationship of height with FFM (including PM 
and MM) may not be the most appropriate for FM because FM is more variable and 
the index depends on age, sex and pubertal development.  In patients, the appropriate 
index may be different from healthy people, for example, for this study at 6-12 years 
the index was, boys; CF 2.5, control 3.4 and girls; CF 2.9, control 2.4.  At 8-14 years 
the index was all boys; 3.9 and girls; CF 4.6 and control girls 3.  However, with our 
large reference population of 533 aged 4 to 22 years the index was 2.8.  The problem 
of the appropriate index to use to adjust FM was addressed in a paper by Wells and 
Cole (211).  They suggest 3 possible approaches; (1) where each group is of similar 
height the use of height
2
 is appropriate, (2) where the groups are slightly different in 
height, check for real differences by regressing logn height on logn FM with group 
(patient v control) and height as independent variables and (3) where the height 
difference is great a log-log regression will give the power by which to raise height 
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in order to remove any effect of height on FMI.  Wells and Cole suggest that 
approach 1 is valid because both groups are being compared with equal adjustment 
and in addition the error in FMI is considered trivial.  They calculated that in the 
group of 8 year children studied, the variability in FMI due to height was 7.5%, 
much less than the variation due to fatness.  I used approach (2) to investigate 
whether there were any differences in the slopes of data from CF children compared 
to controls in my cohort, and when log height was regressed on log FM I found that 
only log height was highly significant; group and group x log height interaction term 
were not significant.  This suggests that the slope of each group does not differ 
significantly and approach 1 is valid.  I have therefore used height
2
 to adjust FM in 
this thesis, an index which is most likely to be used clinically given the difficulties of 
calculation and the variability of the appropriate index.  The indices mentioned above 
were calculated using approach 3.   
 
Using the lmsGrowth program© (210) the indexed variables were compared to 
measurements performed in a contemporary reference population of 533 healthy 
children aged 4 to 22 years (155) to produce SDS.   
 
Total LS BMD SDS were generated from the Lunar Prodigy software using machine 
reference data matched for age, sex and ethnic group.  BMD is a 2-dimensional 
measurement, which does not take into account bone size.  Small children may have 
low BMC or BMD either because they have small bones and/or because they have 
less mineral than expected for the size of bone (213).  To adjust for size the bone 
mineral apparent density (BMAD) a 3-dimensional ‘volumetric’ measurement was 
calculated for the LS as follows, from BMC and bone area (214). 
 
BMAD = BMC/ bone area^
1.5
     Equation 4-16 
 
and then size adjusted SDS were calculated using UK reference data collected for the 
GE Lunar Prodigy (215). 
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4.7.3 Cross-sectional comparison of body composition variables 
 
Using one-sided, independent and paired-sample t-tests comparison was made 
between; (i) both CF and control children and the 1990 UK reference population for 
anthropometric SDS, (ii) both CF and control children and the contemporary 
reference population for body composition variables SDS, (iii) between pair-matched 
(baseline) and group-matched (baseline and year 2) children with CF and healthy 
children for all anthropometry and body composition variables using absolute values 
and SDS.  Initial analysis indicated a strong significant difference between the sexes 
and therefore they were analysed separately.   
General linear models were used to examine the difference between children with CF 
and healthy controls taking into account factors predicting body composition 
variables, with matched-pair or group and puberty as fixed factors and age and height 
(for non-indexed variables) as continuous variables.  Since total MM is 
predominantly bone mineral, MM was also adjusted for bone area to account for the 
effect of bone size as well as length (height).  The same analysis was performed for 
baseline and 2 year measurements and may be found in Chapters5 and 6.  
 
4.7.4 Cross-sectional comparison of body composition and 
spirometry 
 
Regression analysis was used to investigate the relationship between body 
composition variables and spirometry (FEV1 % or FEV1 SDS) in the children with 
CF.  Height was included in the model rather than indexed body composition 
variables.  The same analysis was performed for baseline and 2 year measurements 
and may be found in Chapters 5 and 6.
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4.7.5 Longitudinal body composition and spirometry data analysis 
 
To investigate the predictors of change in body composition variables over a 2 year 
period between measurements, it is necessary not only to consider the change but 
also the baseline value since the same absolute value of change will be very different 
for a child with optimum body composition compared to a child with suboptimal 
body composition.  One possible way to account for this is to include both the 
baseline measurement and the change in the model.  An alternative method uses the 
conditional change, that is, the amount of change once the effect of the baseline 
measurement has been removed.  In this method the regression residuals (the values 
of the difference between the expected change and the actual change) are calculated 
for each child and these are the conditional change (216).  The residuals have no 
relationship with the baseline measurement and therefore avoid auto-correlations.  
The expected change is calculated in the control boys and girls separately by 
regressing the baseline value on the 2 year value for each of the body composition 
variables.  The regression equation is then used in the CF group to calculate the 
difference between actual change and the change expected if the child is growing the 
same as the healthy group (residual or conditional change).  Where there is very little 
change from that which is expected, that is, when an individual is tracking the 
control group, absolute change and conditional change will be similar, as can be seen 
in the girls’ graph (Fig 4.1) of absolute change compared to conditional change in 
FMI SDS.  However, in the boys the differences are greater (Fig 4.2).  Conditional 
values were therefore calculated for all the scale dependent variables and 
independent variables included in the regression.  
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Figure 4.1. Correlation between absolute and conditional change in fat mass index 
(FM/height
2
;FMI SDS)in girls with cystic fibrosis 
 
 
Figure 4.2. Correlation between absolute and conditional change in fat mass index 
(FM/height
2
;FMI SDS)in boys with cystic fibrosis 
 
Conditional change in SDS in those who had longitudinal measurements was 
calculated as change compared to the control boys or girls in this study (n = 95).  
SDS were calculated from a large reference population (n= 533) with only a single 
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measurement, therefore, conditional scores are a comparison within a smaller 
population. 
 
Multiple regression analysis was used to investigate predictors of conditional change 
in either FMI SDS, FFMI SDS or MMI SDS in CF and control children separately 
and also between body composition variables and conditional change in FEV1 SDS 
for children with CF.  Choice of variables included in the models is discussed in 
Chapter 7.  
 
Multiple regression analyses with the 2 year measurement as the dependent variable, 
the baseline as the covariate and condition (CF or control) as fixed factor were 
performed to discover any significant effects of having CF over the change in body 
composition variables.  The analyses can be found in Chapters 7. 
 
 
4.7.6 Cross-sectional comparison of simple techniques and the 4-
component model 
 
Data for males and females and for every available time-point (2001-2011) were pooled 
for purposes of the analyses.  The accuracy of the simpler methods was assessed using 
the criterion 4CM as the reference method for adiposity (4C FM SDS) and leanness (4C 
FFM SDS).  DXA FM, SFT and BMI SDS were used as simple measures of adiposity 
and DXA FFM, TBW and BIA (height
2
/Z) SDS were used as simple measures of 
leanness. 
 
SDS compared to our contemporary reference population (see 4.6.2) for body 
composition variables were calculated for absolute values of 4C FM and FFM, DXA 
FM and FFM (whole body and regional) TBW, BIA and SFT and BMI compared to 
the UK 1990 reference data (54;209).  In addition DXA height adjusted values for 
FM and FFM (whole body and regional) were calculated as described in 4.6.2.  
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Significance of the mean value for all SDS from zero was tested using independent t- 
tests, and paired t- tests were used to compare the mean difference of the simpler 
methods with that of the 4CM.  
The method of Bland and Altman (217) was used to assess agreement between the 
SDS for FM and FFM by the simpler techniques and the criterion 4CM.  The mean 
difference between techniques (bias; simple technique-4CM) and the ± 2 SD of the 
difference between techniques (limits of agreement) were calculated.  The bias was 
then tested for significance from zero by using a paired t- test.  The extent to which 
the magnitude of the bias was related to the magnitude of the variable was calculated 
as the correlation between the difference and the mean of the measured values.   
Correlations were performed unadjusted, adjusted for age and adjusted for age and 
sex.   This comparison is presented in Chapter 8. 
 
Backward regression analyses were used to identify significant predictors of the bias 
in FM(I) and FFM(I) SDS.  Analyses were performed with age, sex and BMI SDS as 
explanatory variables with sex coded as male = 1 and female = 2. 
4.7.6.1 Categorisation of ‘abnormal’ standard deviation scores 
 
A ‘normal’ body composition SDS was classed as an SDS between -2 and +2, the 
values typically used in clinical practice.  The ability of each technique to categorise 
‘normal’ and ‘abnormal’ body composition was assessed by cross-tabulation of the 
simple technique with the 4CM and calculation of Cohen’s kappa coefficient (κ) and 
% agreement.  Whilst % agreement is a measure in absolute terms, Cohen’s kappa 
also takes into account the probability of agreement occurring by chance, a value of 1 
indicating perfect agreement.  This analysis is presented in Chapter 8. 
 
4.7.7 Longitudinal comparison of simple techniques and the 4-
component model 
 
The ability of the simpler techniques to assess longitudinal change in non-indexed 
SDS was compared to change assessed by the 4CM.  Two-year change in 
anthropometric and body composition SDS were compared to no change using 
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independent t- tests.  Bland-Altman analyses were used to compare the bias in 
change (change by simple technique – change by 4CM) of body composition 
variables with limits of agreement of ±2SD.  The degree to which the magnitude of 
the bias was related to the magnitude of the variable was assessed with correlation 
analyses (Chapter 8). 
 
4.7.8 ‘Wisdom of crowds’ approach to determine whether aggregate 
predictions improve accuracy.   
 
In a situation where the more sophisticated body composition techniques are not 
available it would be helpful to be able to use the simplest, readily available 
prediction techniques.  Although the underlying assumptions may be flawed and the 
equations used to predict body composition may not be derived in the appropriate 
population, there is an approach which may allow such prediction techniques to be 
used.  The ‘wisdom of crowds’ approach (218) is based on the theory that using 
many predictions will give an answer closer to the truth than using one or two 
predictions.  In order to achieve improved accuracy four conditions must be satisfied: 
first, many predictions based on diverse criteria must be used; second, the predictions 
must be independent of each other; third, they must be based on different underlying 
assumptions; and fourth, the independent predictions must then be aggregated.  The 
theory suggests that error will be randomly spread across the predictions and tend to 
cancel out, thereby improving the accuracy of the overall prediction.  To test this 
hypothesis in this particular population I used 12 different prediction equations based 
on height, weight, SFT and BIA to calculate FM for each child and then aggregated 
them to compare with the 4CM (Chapter 8).   
  
91 
 
4.8 Study outline 
 
Recruited 
 
 
 
 
 
Successful 
4CM at baseline 
 
 
 
 
Chapter 5  
Cross-sectional  
at baseline 
 
 
Cystic 
fibrosis 
100 
Healthy controls 
for SDS 
572 (4-22 y) 
Healthy controls for pair- 
and group-match analyses 
133 
Age 6-12 y at baseline 
 
of  whom 
Cystic 
fibrosis 
85 
Healthy controls for pair- 
and group-match analyses 
125 
Age 6-12 y at baseline 
 
Cystic 
fibrosis 
85 
Controls 
85 
Healthy controls 
for SDS 
533 (4-22y) 
140 (6-12y) 
1) Pair-match comparison of absolute values and SDS 
2) Compared to reference population (SDS) 
CF 85, Controls 85 
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Study outline continued 
 
Successful                 
4CM at baseline 
 
 
 
 
 
                                                      
                   
                   
                   
                   
                   
                   
                  
Cystic fibrosis 
85 
Age 6-12 y at 
baseline 
 
Healthy controls for pair- 
and group-match analyses 
125 
Age 6-12 y at baseline 
Cystic 
fibrosis 
69 
 
Controls 
93 
Healthy controls 
for SDS generation 
 
533 (4-22 y) 
140 (6-12 y) 
Chapter 6, cross-sectional 
group-match and compared to 
reference population, baseline 
and 2 years 
 
Chapter 7, longitudinal change 
group-matched and reference 
population 
Successful 4CM 
at baseline and 
2 years 
1. Group-match comparison of absolute values and SDS 
2. Compared to reference population (SDS) 
CF 69, Controls 93 
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4.9 Ethical considerations and study plan 
 
 
Ethical permission was obtained from the ethical committee of the Institute of Child 
Health/ Great Ormond Street Hospital for Children NHS Trust.  The project 
complied to the Data Protection Act 1998 and as such all measurement data was 
anonymised and hard copies of names and addresses were kept locked in a separate 
drawer from the measurement data sheets which were also kept locked.  All 
electronic versions were password protected and saliva samples carried the same 
anonymised IDs.    
 
Children with CF and their parent(s) were initially asked if they were interested in 
taking part by one of the doctors in the Respiratory Medicine department.  If they 
agreed their contact details were given to me and I telephoned to give information 
and answer any questions.  The appropriate information sheets were then sent by post 
or email and a follow-up call was made after at least 2 weeks to organise an 
appointment if they agreed and to answer any questions. Samples of information 
sheets and appointment letters can be found in Appendices 2 & 3. 
 
Control children were recruited for an on-going study of the body composition of 
healthy children.  Originally, ethical approval (Appendix 1) was for 1 measurement 
and subsequently those of the appropriate age range (6-12years) were approached for 
two yearly measurements under the ethics approval for the CF study.  After a 
telephone call to ascertain acceptance, the appropriate information sheets were sent 
by post or email and 2 weeks later a telephone call was made to answer questions 
and arrange an appointment. 
 
Measurements took place in the body composition suite sited in the radiology 
department of Great Ormond Street Hospital for Sick Children, taking on average 1hr 
45mins. At the appointment, after explanation of the procedures, written consent was 
obtained from parents or young people over 16years, written assent was obtained 
from children aged 11-15 years and verbal assent was obtained from all the younger 
children.  See Appendix 4 for copies of parent, participant consent forms and child 
  
94 
 
assent forms.  Travel expenses were reimbursed, and all participants received a print-
out of their whole-body DXA scan, a certificate (Appendix 7) and £10 WH Smith 
voucher as a token of appreciation. 
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Chapter 5.  Baseline body composition of 6-12 year old 
children with cystic fibrosis compared to healthy children 
and the relationship with lung function. 
 
 
5.1 Introduction 
 
 
Previous studies of growth and body composition have found that children with CF 
are often shorter and that there may be deficits of FM and FFM although some 
studies found the CF children had healthy body composition when young (see 
Chapter 2).  In addition, the literature notes that FFM is positively related to lung 
function. However, there are many inconsistencies in the literature which may be 
partly due to the methodologies used.  This study uses the more accurate ‘criterion’ 
4CM in order to avoid some of the problems of the simpler methods.  Data from 
simpler techniques is discussed in Chapter 8.  
In this chapter I present a comparison of body composition between CF and healthy 
children using both pair-match and comparison with a reference population with the 
aim of testing hypothesis 1, that there will be no significant differences at baseline.  
In addition, examining associations between spirometry and body composition in 
children with CF to test hypothesis 2, (that specific components of body composition 
are associated with lung function).  
 
5.2 Study design 
 
 
This is a cross-sectional study comparing the body composition of 6-12 year children 
with CF to that of healthy children of the same age and sex and will form the 
baseline measurements for a subsequent measurement at 2 years.  Comparisons were 
made firstly, with age (to within 1 year), sex and ethnicity matched healthy controls 
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and secondly, using SDS calculated from a larger contemporary population (see 
4.6.2).  In addition, the lung function, measured on the same day (or within 4 weeks 
if not possible) was related to components of body composition in the children with 
CF. 
 
5.3 Recruitment and exclusion criteria 
 
 
Children with CF were recruited from the patients at Great Ormond Street Hospital 
NHS Trust and the control children from an on-going study of healthy children at 
University College London, Institute of Child Health. Details can be found in 
Chapter 4. 
 
5.4 Methods 
 
 
Height, weight, waist, hip and MUAC and SFT were measured as described in Chapter 
4.  Body composition was assessed using the 4CM which uses whole body BMC from 
DXA, TBW from isotope dilution and density from ADP.  LS and whole body BMC 
and BMD were measured by DXA to assess bone status.   Confounding factors such as 
pubertal status and activity were assessed with questionnaires, the details of all these 
can be found in Chapter 4 and Appendices 5 and 6.  Due to low numbers in some 
groups the classification of physical activity was recategorised in 3 groups; more than, 
same as and less than peers.  Tanner staging was classified as pre-pubertal (stage 1) or 
pubertal (stages 2-5). 
 
The children with CF also had lung function assessed; details can be found in Chapter 4. 
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5.5 Statistical analyses 
 
5.5.1 Size adjustment and SDS calculation 
 
Characteristics of all the children were compared to 1990 UK reference data to 
generate SDS for weight, height, BMI and waist circumference using the lmsGrowth 
program© (210).  Size adjustment of body composition variables was made as 
described in Chapter 4.  SDS were calculated compared to the contemporary 
reference population (see Chapter 4) for FM, FFM, PM, MM, and SFT. Total and LS 
BMD SDS were generated from the Lunar Prodigy software using machine reference 
data matched for age, sex and ethnic group and a size adjusted BMAD SDS was 
calculated as described in Chapter 4.  
5.5.2 Comparison of body composition variables 
 
Initial analysis indicated a strongly significant difference between the sexes and 
therefore they were analysed separately. 
 
5.5.2.1 Compared to reference data 
 
Using a one-sample t-test comparison was made between; (i) both CF and control 
children and the 1990 UK reference population for anthropometric SDS and (ii) both 
CF and control children and the contemporary reference population for body 
composition variables SDS. 
 
5.5.2.2 Compared to pair-match 
 
Paired sample t- tests were used to compare CF and healthy children for all 
anthropometry and body composition variables.    General linear models were used 
to examine the difference between children with CF and healthy controls taking into 
account factors predicting body composition variables, with matched-pair, group and 
puberty as fixed factors and age and height (for non-indexed variables) as continuous 
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variables.  Since total MM is predominantly bone mineral, MM was also adjusted for 
bone area to account for the effect of bone size as well as length (height).  
  
5.5.3 Lung function 
 
Simple regression analysis was used to investigate the relationship between body 
composition variables and spirometry (FEV1 % and SDS) in the children with CF.  
Height was included in the model rather than using indexed body composition 
variables.  MM was adjusted for LS bone area to account for the size of the bones. 
 
5.6 Results 
 
 
5.6.1 Subjects 
 
100 of 116 eligible children with CF were recruited and complete 4CM 
measurements were obtained in 90 (4 children (3 girls) refused to enter the Bodpod, 
6 post dose isotope dilution samples were inadequate volume for analysis (4 girls)).  
However, body water calculation was implausible for 5 children (3 girls), therefore 
pair-matching with healthy age, sex and ethnicity matched control children was made 
for 85 CF children ((boys; 37 (44%) and girls; 48 (56%)).  85 paired measurements 
should be sufficient to detect a 0.31 SDS difference in BMI and body composition 
variables between the groups with 80% power at 5% significance.  Characteristics of 
the children are shown in Table 5.1.  Self-assessed pubertal status for the 170 
children was pre-pubertal for; boys (CF; 34 (92%), controls; 31 (71%) and girls (CF; 
34 (71%), controls; 29 (60%).  All subjects with CF except for 1 girl were pancreatic 
insufficient; had a wide range of pulmonary disease with a median FEV1% 85.1%, 
with values between 32% and 131%; 8 (7 girls) had a gastrostomy in situ; 4 (3 girls) 
had liver disease and 1 girl was diabetic.  Genotype was homozygous ∆F508 for 59 
children, heterozygous ∆F508 for 19 children, 5 children had non ∆F508 genotype 
and 2 children were of unknown genotype. There were 21 cases (10 boys) of chronic 
pseudomonas aeruginosa of the lungs and 15 cases (7 boys) with chronic 
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staphylococcus aureus infection. Sixteen eligible children with CF (9 girls) who were 
not recruited and 15 children (10 girls) who were measured and not included in the 
analysis were not significantly different with respect to height SDS, weight SDS and 
BMI SDS. 
 
5.6.2 Anthropometry 
5.6.2.1 Compared to UK reference data 
 
Characteristics of the children are shown in Table 5.1.  The healthy children were 
representative of the 1990 UK reference data apart from the girls being significantly 
heavier (p<0.01) and both boys and girls having greater waist circumference 
(p<0.01).  Boys with CF were significantly shorter (p<0.05) but had a higher BMI 
SDS (p<0.01) and waist circumference (p<0.01) and girls with CF were lighter 
(p<0.001), shorter (p<0.001), had lower BMI SDS (p<0.05) but also had greater 
waist circumference (p<0.01) than the 1990 UK reference data.   
5.6.2.2 Compared to pair match  
 
Comparison between children with CF and healthy pair-matched controls indicated 
that the boys with CF were not significantly different apart from higher BMI SDS 
(p<0.01) and waist circumference SDS (p<0.05).  The range of BMI SDS was; boys 
with CF; -1.5 to 2.4 and control boys; -1.9 to 2.0.  The girls with CF were 
significantly shorter (p<0.01) and lighter (p<0.01) with lower anthropometric values 
for all measures apart from waist circumference (non-significant). 
 
5.6.3 Body composition 
 
Comparison by reference populations and case-control can be found in Table 5.2 
with a summary in Table 5.3. 
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5.6.3.1 Compared to reference data 
 
Comparison of CF children with a reference population (Lunar Prodigy reference 
data for bone and reference data for body composition (155) indicated a higher total 
BMD SDS (p<0.001) and FFMI SDS (p<0.01) in boys with CF and lower LS BMD 
SDS (p<0.001), BMAD SDS (size adjusted; p<0.01), FMI SDS (p<0.001), FFMI 
SDS (p<0.05) and MMI SDS (p<0.001) in girls. 
5.6.3.2 Compared to pair-match 
 
Boys with CF had significantly higher total BMD SDS (p<0.05) and FFMI SDS 
(p<0.01) compared to case control boys.  Girls with CF had less total BMD SDS 
(p<0.05) and LS BMD SDS (p<0.001) and significantly lower FMI SDS (p<0.001) 
and MMI SDS (p<0.001).   
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Table 5.1.  Characteristics of cystic fibrosis (CF) and control children in pair-match analyses (Pgroup) and compared to reference data (Pref).  
 CF boys (n=37) CF girls (n=48) Control boys (n=37) Control girls (n=48) 
 Mean SD Pref Pgroup Mean SD Pref Pgroup Mean SD Pref Mean SD Pref 
Age (y) 8.9 1.17 NA 0.336 9.6 1.62 NA 0.570 9.0 1.21 NA 9.6 1.78 NA 
Weight (kg) 29.5 6.35 NA 0.518 30.0 7.19 NA <0.001 28.8 6.68 NA 34.6 9.36 NA 
Height (m) 1.30 0.08 NA 0.068 1.32 0.11 NA <0.001 1.33 0.10 NA 1.37 0.11 NA 
BMI (kg/m
2
) 17.3 2.10 NA 0.009 16.4 1.99 NA 0.001 16.1 1.76 NA 18.1 2.84 NA 
Weight SDS 0.11 1.04 0.505 0.338 -0.56 1.04 0.001 <0.001 -0.11 0.91 0.456 0.42 0.98 0.005 
Height SDS -0.41 1.01 0.017 0.118 -0.59 1.12 0.001 0.001 -0.05 0.95 0.740 0.22 0.87 0.084 
BMI SDS 0.50 0.95 0.003 0.005 -0.33 0.95 0.020 0.001 -0.11 0.87 0.454 0.39 1.10 0.019 
Waist (cm) 63.1 5.92 NA 0.001 60.2 5.5 NA 0.071 58.1 4.41 NA 62.2 7.67 NA 
Waist SDS 1.24 0.79 <0.001 0.001 0.69 0.77 <0.001 0.161 0.34 0.70 0.005 0.94 1.05 <0.001 
Hip (cm) 67.7 6.17 NA 0.876 68.2 7.06 NA <0.001 67.9 6.70 NA 74.6 8.63 NA 
MUAC (cm) 19.8 2.39 NA 0.996 19.7 2.60 NA <0.001 19.8 2.74 NA 22.2 3.31 NA 
Sum 4 skinfold thickness (mm) 34.7 19.8 NA 0.236 37.1 14.6 NA 0.007 29.08 11.7 NA 48.4 21.1 NA 
4 skinfold thickness SDS 0.14 0.95 0.379 0.185 -0.41 0.83 0.001 0.005 -0.14 0.76 0.270 0.14 0.96 0.326 
Pre-pubertal (n,%) 34 92 NA NA 34 71 NA NA 31 84 NA 29 60 NA 
FEV1 % 91.3 20.9 
 
NA 
NA 
NA 
NA 77.6 18.4 NA NA   NA   NA 
FEV1 SDS -0.70 1.66 0.017 NA -1.89 1.56 <0.001 NA   NA   NA 
Pancreatic insufficient (n) 37  NA NA 47  NA NA   NA   NA 
Liver disease (cases) 1  NA NA 1  NA NA   NA   NA 
Diabetes (cases) 0  NA NA 1  NA NA   NA   NA 
Ps aeurug (cases) 10  NA NA 11  NA NA   NA   NA 
Staph aureus (cases) 7  NA NA 8  NA NA   NA   NA 
BMI; body mass index (weight/height2), SDS; standard deviation score compared to UK 1990 reference data (54;209), MUAC; mid-upper arm circumference, Sum 4 skinfold thickness; 
bicep+tricep+subscapular+ suprailiac, n=79, Pgroup paired t-test, CF boys and Control boys or CF girls and Control girls;
 Pref; one sample t-test CF and Controls compared to UK 1990 reference 
data.  FEV1%; forced expired volume in 1s percentage of the expected, FEV1 SDS; compared to reference data (204)). Pre- puberty is based on Tanner staging 1 (pre) to stages 2 – 5 (pubertal), 
Pancreatic insufficient; reduced pancreatic function requiring the oral addition of pancreatic enzymes, Ps aerug; chronic pseudomonas aeruginosa infection of the lungs, Staph aureus; chronic 
staphylococcus aureus infection of the lungs. 
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Table 5.2.  Body composition of cystic fibrosis (CF) and control children used in pair-matched analyses (Pgroup) and compared to reference data 
(Pref). 
 CF boys (n=37) CF girls (n=48) Control boys (n=37)     Control girls (n=48) 
 Mean SD Pref Pgroup Mean SD Pref Pgroup Mean SD Pref Mean SD Pref 
Body volume (L) 28.3 6.4
9 
NA 0.500 27.8 7.09 NA <0.001 27.5 6.51 NA 33.6 9.41 NA 
Total body water (L) 18.0 3.1
2 
NA 0.872 17.1 3.72 NA 0.001 17.9 3.71 NA 18.9 4.31 NA 
Total bone mineral content (kg) 1.05 0.2
1 
NA 0.606 1.01 0.24 NA <0.001 1.07 0.24 NA 1.20 0.33 NA 
Total bone mineral density  (g/cm
2
) 0.90 0.0
6 
NA 0.020 0.87 0.05 NA 0.009 0.88 0.05 NA 0.90 0.07 NA 
Total bone mineral density  SDS 0.58 0.6
6 
<0.001 0.011 -0.11 0.74 0.329 0.028 0.23 0.50 0.007 0.23 0.62 0.012 
LS bone mineral density  (g/cm
2
) 0.73 0.0
8 
NA 0.358 0.73 0.10 NA 0.026 0.71 0.08 NA 0.78 0.11 NA 
LS bone mineral density SDS -0.03 0.7
4 
0.795 0.340 -0.49 1.12 0.004 0.055 -0.19 0.75 0.129 -0.05 0.93 0.688 
LS bone mineral apparent density  SDS 0.18 0.9
6 
0.267 0.149 -0.40 1.19 0.024 0.424 -0.12 0.85 0.413 -0.20 1.06 0.203 
4-Component model   
Fat mass (kg) 5.95 3.66 NA 0.413 6.13 2.93 NA <0.001 5.31 2.80 NA 9.46 4.71 NA 
Fat mass index SDS 0.02 1.01 0.907 0.325 -0.76 0.89 <0.001 0.157 -0.22 0.97 0.166 0.02 0.95 0.861 
Fat (%) 19.0 7.84 NA 0.501 20.4 5.47 NA <0.001 17.8 6.14 NA 26.1 7.46 NA 
Fat-free mass (kg) 23.5 3.60 NA 0.976 22.7 4.98 NA 0.001 23.5 5.09 NA 25.1 5.60 NA 
Fat-free mass index SDS 0.56 1.01 0.002 0.003 -0.39 1.07 0.016 0.157 -0.14 1.04 0.414 -0.08 0.94 0.557 
Fat-free mass hydration (%) 75.9 2.07 NA 0.740 74.9 1.97 NA 0.427 76.0 1.49 NA 75.1 1.54 NA 
Fat-free mass density (kg/L) 1.087 0.007 NA 1.000 1.090 0.007 NA 0.317 1.087 0.005 NA 1.091 0.005 NA 
Protein (kg) 4.31 0.65 NA 0.955 4.46 1.06 NA 0.112 4.30 1.18 NA 4.72 0.99 NA 
Protein mass index SDS 0.36 1.36 0.113 0.103 0.08 1.03 0.585 0.528 -0.16 1.11 0.376 -0.05 0.97 0.731 
Mineral mass (kg) 1.34 0.28 NA 0.637 1.28 0.28 NA <0.001 1.36 0.30 NA 1.52 0.41 NA 
Mineral mas index SDS 0.07 0.84 0.601 0.095 -0.84 1.10 <0.001 0.001 -0.23 0.87 0.11 -0.04 0.92 0.792 
 
 
SDS; standard deviation score, LS ; Lumbar spine (L2-L4) bone mineral apparent density which is a 3-D ‘volumetric’ measurement that is calculated from the 2-D Bone 
Mineral Density (BMD) actually measured by the DXA machine, SDS are calculated from reference data (215).  Fat mass index (fat mass/height
2
), Fat-free mass index (fat-
free mass/height
2
),  Protein mass index (protein mass/height
2
),  Mineral mass index (fat mass/height
2
).   SDS are calculated from reference data collected in 533 contemporary 
healthy children (155).  Pgroup paired t-test, CF boys and Control boys or CF girls and Control girls; Pref one sample t- test CF and Controls compared to reference data 
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Table 5.3. Summary of comparisons (before adjustment for age, height and puberty) 
                                            Boys with CF compared to;                                 Girls with CF compared to; 
                                            Pair-match                Reference                            Pair-match                Reference  
 
Weight SDS                       NS                             NS                                                                           
Height SDS                        NS                                                                                                        
BMI SDS                                                                                                                                     
WAIST SDS                                                                                              NS                                  
FMI SDS                           NS                             NS                                                                          
FFMI SDS                                                                                                 NS                                
PMI SDS                          NS                             NS                                         NS                               NS 
MMI SDS                         NS                             NS                                                                           
 
Paired t-test with pair-match and one sample t-test compared to zero for reference data.  Reference data is UK 1990 (54;209) for weight, height, 
BMI and waist and reference data from 533 children measured by the 4-component model (155).  FMI; fat mass index (FM/height2), FFMI; fat-
free mass index (FFM/height2), PMI; protein mass index (PM/height
2
), MMI; mineral mass index (MM/height
2
). 
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5.6.3.3  Potential confounders affecting body composition outcomes 
 
Table 5.4 (boys) and Table 5.5 (girls) show adjusted mean differences in body 
composition (CF - control) before and after adjustment for height and puberty.  Boys 
with CF had a greater weight (p<0.001) and waist circumference (p<0.001) SDS than 
controls.  In addition, FFMI SDS was significantly higher (p<0.01) in boys with CF 
although the absolute FFM adjusted for actual height was not significantly different.  
Girls with CF had lower weight (p<0.05), height (p<0.001), FM (p<0.01), hip and 
MUAC (p<0.01) than control girls.  In addition, MMI SDS (p<0.01) but not absolute 
MM, was significantly less in CF girls.  An analysis of only pre-pubertal girls (n= 24 
pairs) confirmed the deficit in FM.  Additional adjustment of MM for bone area (to 
adjust for bone size as well as length) did not affect the outcome in either sex.  To 
determine whether differences in body composition were due to different levels of 
activity the parent’s rating of the child’s activity level was added to the model with 
no effect on the outcome (data not shown). 
5.6.3.4 Hidden depletion of fat-free mass 
 
Two girls in this study had BMI SDS in the normal range (> -1.64SDS (5
th
 centile) 
and <1.64) with FFMI SDS below -1.64 (5
th
 centile).  Girl A, aged 8 had a BMI SDS 
of -0.82 and FFMI SDS -4.60 and girl B, aged 7 had a BMI SDS of -1.37 and FFMI 
SDS of -2.53. 
5.6.3.5 High BMI 
 
Four boys with CF had a BMI SDS >1.64 (95
th
 centile).  BMI/FMI SDS for these 
boys were: (a)1.71/1.49, (b) 1.83/1.49, (c) 1.96/0.32 and (d) 2.42/1.99. 
 
5.6.4 Relationship between body composition and spirometry 
 
The mean (SD) FEV1 SDS for 83 patients (1 boy and 1 girl did not perform 
spirometry) was; boys -0.70 (1.66) p<0.05 and girls -1.89 (1.56) p<0.001.  A 
regression analysis of factors associated with FEV1 SDS is presented in Table 5.6.  
FM SDS (p<0.01) and BMI SDS (p<0.05) were significantly positively associated 
with FEV1 SDS in girls only.  A similar model with either FEV1 or FEV1 % indicated 
a similar pattern.  A plot of FEV1% and FMI SDS for girls is shown in Figure 5.1 
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indicating a positive relationship (r=0.40, p=0.005) however, four girls had a high 
FEV1% with a low FMI SDS. 
210-1-2-3-4
30
50
70
90
110
Fat mass index SDS
      FEV1 
(% predicted)
 
Figure 5.1. Relationship between percent predicted forced expiratory volume in 1 s 
(FEV1) and fat mass index (FMI; FM/height
2
) standard deviation scores in girls with 
cystic fibrosis assessed by the 4-component model of body composition. Correlation 
in 47 girls with cystic fibrosis; r = 0.40, p = 0.005 
 
 
5.6.5  Body composition assessed by simple techniques 
 
Data for body composition assessed by simple techniques (SFT, BIA, TBW and 
DXA) compared to the 4CM is presented in Chapter 8. 
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Table 5.4. Difference in size and whole-body composition between boys with cystic fibrosis and control boys (CF minus control, n=37 matched 
pairs).  Positive mean values indicate a higher value in the CF group compared to controls.  
 Adjusted for age Adjusted for age and height Adjusted for age, height and puberty 
 Mean 
SD 
SEM 
Pgroup 
P Mean SEM P Mean SD P 
Weight (kg) 0.65 1.10 0.556 2.04 0.74 0.009 2.13 0.82 0.010 
Weight SDS 0.18 0.24 0.442 0.51 0.14 0.001 0.51 0.14 0.001 
Height (m)
1 
-0.02 0.01 0.109    -0.01 0.01 0.284 
Height SDS
1 
0.36 0.23 0.129    -0.20 0.20 0.328 
BMI (kg/m
2
)
1 
1.01 0.40 0.017    1.13 0.41 0.009 
BMI SDS
1 
0.55 0.20 0.009    0.61 0.20 0.004 
Total body water (L) 0.07 0.45 0.882 0.65 0.29 0.034 0.66 0.30 0.033 
Body volume (L) 0.73 1.14 0.527 2.12 0.79 0.011 2.13 0.81 0.013 
Total body density (kg/L) -0.002 0.004 0.598 -0.004 0.004 0.299 -0.004 0.004 0.328 
Fat mass (kg) 0.66 0.79 0.412 1.29 0.73 0.084 1.28 0.74 0.093 
Fat mass index (kg/m
2
)
1 
0.47 0.40 0.24    0.55 0.41 0.184 
Fat mass index SDS
1 
0.24 0.25 0.351    0.30 0.26 0.250 
Fat-free mass (kg) -0.05 0.62 0.933 0.71 0.43 0.111 0.72 0.44 0.106 
Fat-free mass index SDS
1 
0.60 0.20 0.005    0.64 0.21 0.004 
 
Fat-free mass hydration (%) -0.01 0.46 0.983 -0.02 0.48 0.969 -0.03 0.49 0.941 
Fat-free mass density (kg/L) 0.000 0.001 0.770 0.000 0.002 0.837 0.000 0.002 0.862 
General linear model, adjusting for group, matched pairs and puberty as fixed factors and age and height as continuous variables. SDS; standard deviation 
score, BMI; body mass index (weight/height
2
), 
1 
adjusted for age and puberty only.  Table continues on next page 
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Table 5.4 continued.  Difference in size and whole-body composition between boys with cystic fibrosis and control boys (CF minus control, 
n=37 matched pairs).  Positive mean values indicate a higher value in the CF group compared to controls.   
 Adjusted for age Adjusted for age and height Adjusted for age, height and puberty 
Mean 
SD 
SEM 
Pgroup 
P Mean SEM P Mean SD P 
Protein mass (kg) -0.04 0.19 0.817 0.09 0.18 0.619 0.10 0.18 0.597 
Protein mass index SDS
1 
0.38 0.29 0.189    0.42 0.29 0.161 
Mineral mass (kg) -0.02 0.04 0.599 0.03 0.02 0.225 0.03 0.02 0.218 
Mineral mass adjusted (kg)
2 
-0.002 0.03 0.940 0.03 0.02 0.239 0.03 0.02 0.238 
Mineral mass index SDS
1 
0.23 0.16 0.173    0.25 0.17 0.140 
LS bone mineral density (g/cm
2
) 0.01 0.02 0.499 0.02 0.02 0.340 0.02 0.02 0.307 
LS bone mineral density SDS 0.10 0.16 0.525 0.17 0.16 0.308 0.17 0.16 0.299 
LS bone mineral apparent density  SDS 0.26 0.20 0.204 0.21 0.21 0.336 0.21 0.21 0.330 
Waist circumference (cm) 4.85 1.02 <0.001 5.76 0.90 <0.001 5.76 0.92 <0.001 
Waist circumference SDS 0.87 0.18 <0.001 1.05 0.14 <0.001 1.05 0.15 <0.001 
Hip circumference (cm) -0.18 1.22 0.883 1.22 0.92 0.196 1.20 0.94 0.209 
Mid-upper arm circumference (cm) -0.11 0.54 0.842 0.28 0.51 0.590 0.28 0.52 0.591 
Log 4 skinfold thickness
3 
0.04 0.12 0.753 0.05 0.13 0.678 0.06 0.13 0.643 
4 skinfold thickness  SDS
4 
0.29 0.14 0.049 0.43 0.20 0.042 0.43 0.21 0.045 
General linear model, adjusting for group, matched pairs and puberty as fixed factors and age and height as continuous variables. SDS; standard deviation 
score, LS; lumbar spine bone mineral apparent density (size adjusted bone mineral density) SDS compared to Lunar Prodigy software; anthropometric SDS 
compared to UK 1990 data (54;209), body composition and 4 skinfold SDS compared to contemporary reference data (155). 
1 
Adjusted for age and puberty 
only, 
  2
Adjusted for LS bone area, 
3
 Log 4 skinfold thicknesses (bicep, tricep, subscapular and supra-iliac) n=36 pairs, 
4 
Mean of bicep, tricep, subscapular and 
supra-iliac SDS n= 36 pairs  
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Table 5.5.  Difference in size and whole-body composition between girls with cystic fibrosis and control girls (CF minus control, n=48 matched 
pairs).   Positive mean values indicate a higher value in the CF group compared to controls. 
 Adjusted for age Adjusted for age and height Adjusted for age, height and puberty 
 Mean 
SD 
SEM 
Pgroup 
P Mean SEM P Mean SD P 
Weight (kg) -5.71 1.31 <0.001 -1.95 1.02 0.063 -1.99 0.87 0.027 
Weight SDS -1.01 0.22 <0.001 -0.35 0.15 0.029 -0.35 0.14 0.014 
Height (m)
1 
-0.05 0.01 <0.001    -0.05 0.01 0.001 
Height SDS
1 
-0.36 0.23 0.232    -0.73 0.21 0.001 
BMI (kg/m
2
)
1 
-1.76 0.48 0.001    -1.35 0.39 0.001 
BMI SDS
1 
-0.75 0.20 0.001    -0.58 0.17 0.001 
Total body water (L) -1.88 0.55 0.001 -0.02 0.30 0.937 -0.04 0.27 0.890 
Body volume (L) -5.85 1.34 <0.001 -2.16 1.09 0.053 -2.21 0.93 0.022 
Total body density (kg/L) 0.01 0.003 0.001 0.009 0.004 0.015 0.009 0.003 0.008 
Fat mass (kg) -3.39 0.75 <0.001 -2.11 0.78 0.009 -2.14 0.69 0.003 
Fat mass index (kg/m
2
)
1 
-1.53 0.35 <0.001    -1.26 0.30 <0.001 
Fat mass index SDS
1 
-0.81 0.19 <0.001    -0.69 0.17 <0.001 
Fat-free mass (kg) -2.46 0.73 0.002 0.03 0.40 0.939 0.02 0.37 0.965 
Fat-free mass index SDS
1 
-0.34 0.21 0.118    -0.22 0.20 0.284 
Fat-free mass hydration (%) -0.28 0.35 0.427 -0.56 0.40 0.172 -0.57 0.38 0.146 
Fat-free mass density (kg/L) -0.001 0.001 0.329 0.000 0.001 0.934 0.000 0.001 0.911 
General linear model, adjusting for group, matched pairs and puberty as fixed factors and age and height as continuous variables. SDS; standard deviation 
score, BMI; body mass index (weight/height
2
), 
1 
adjusted for age and puberty only. Table continues on next page 
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Table 5.5. continued.  Difference in size and whole-body composition between girls with cystic fibrosis and control girls (CF minus control, 
n=48 matched pairs).   Positive mean values indicate a higher value in the CF group compared to controls. 
 Adjusted for age Adjusted for age and height Adjusted for age, height and puberty 
Mean 
SD 
SEM 
Pgroup 
P Mean SEM P Mean SD P 
Protein mass (kg) -0.26 0.16 0.113 0.23 0.18 0.055 0.23 0.12 0.058 
Protein mass index SDS
1 
0.12 0.21 0.567    0.15 0.21 0.475 
Mineral mass (kg) -0.25 0.06 <0.001 -0.07 0.04 0.063 -0.07 0.04 0.057 
Mineral mass adjusted (kg)
2 
-0.11 0.05 0.018 -0.07 0.038 0.074 -0.07 0.04 0.067 
Mineral mass index SDS
1 
-0.83 0.22 0.001    -0.71 0.21 0.002 
LS bone mineral density (g/cm
3
) -0.05 0.02 0.028 -0.004 0.02 0.847 -0.01 0.02 0.829 
LS bone mineral density SDS -0.45 0.22 0.050 0.01 0.22 0.977 0.002 0.22 0.992 
LS bone mineral apparent density  SDS -0.21 0.26 0.429 0.08 0.29 0.773 0.08 0.28 0.784 
Waist circumference (cm) -2.25 1.08 0.042 -0.33 1.11 0.771 -0.38 0.90 0.675 
Waist circumference SDS -0.29 0.16 0.084 0.04 0.16 0.820 0.03 0.14 0.829 
Hip circumference (cm) -6.39 1.31 <0.001 -3.00 1.13 0.011 -3.05 0.96 0.003 
Mid-upper arm circumference (cm) -2.55 0.56 <0.001 -1.36 0.54 0.015 -1.38 0.48 0.007 
Log 4 skinfold thickness
3 
-0.24 0.09 0.009 -0.11 0.10 0.289 -0.15 0.09 0.124 
4 skinfold thickness  SDS
4 
-0.18 0.10 0.082 -0.31 0.21 0.143 -0.36 0.20 0.074 
 
General linear model, adjusting for group, matched pairs and puberty as fixed factors and age and height as continuous variables. SDS; standard deviation 
score, LS; lumbar spine bone mineral apparent density (size adjusted bone mineral density) SDS compared to Lunar Prodigy software; anthropometric SDS 
compared to UK 1990 data (54;209), body composition and 4 skinfold SDSs compared to contemporary reference data (155).  
1 
Adjusted for age and puberty 
only, 
2 
Adjusted for LS bone area, 
3
 Log 4 skinfold thicknesses (bicep, tricep, subscapular and supra-iliac) n=43 pairs, 
4 
Mean of bicep, tricep, subscapular and 
supra-iliac SDS n= 43 pairs  
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Table 5.6.  Simple regression analysis of factors (adjusted for height)
1
 associated with forced expired volume in 1s standard deviation scores  
 Boys (n=37) Girls (n=48) 
 B SEM t P r
2
 B SEM t P r
2 
BMI SDS 0.41 0.29 1.40 0.171 0.026 0.52 0.23 2.23 0.031 0.079 
Fat mass (kg) 0.10 0.10 1.00 0.324 0.030 0.26 0.09 2.82 0.007 0.124 
Fat-free mass (kg) -0.03 0.18 -0.15 0.880 0.059 0.15 0.13 1.14 0.261 0.005 
Mineral mass (kg)
 2
 0.02 0.15 0.14 0.892 0.090 -0.05 0.15 -0.34 0.734 0.032 
DXA bone mineral content (kg)
2 
0.65 3.20 0.20 0.841 0.090 4.17 2.44 1.77 0.094 0.010 
DXA bone mineral density (g/m
3
) -4.14 6.01 -0.69 0.495 0.044 4.52 5.67 0.80 0.430 -0.019 
 
SDS; standard deviation score, DXA; dual-energy X-ray absorptiometry, 
1
except BMI SDS, 
2
 additionally adjusted for lumbar spine bone area 
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5.7 Discussion 
 
 
In this chapter I; (i) compared the body composition of children with CF to healthy 
children using both case control and reference populations and (ii) investigated 
associations between body composition and lung function in children with CF. 
 
5.7.1 Body composition 
 
Hypothesis 1 cannot be confirmed as this study identified clear sex differences in 
body composition in these young patients, indicating that abnormalities in females 
may be established much earlier than previously considered (59).  Although boys 
with CF had body composition similar to healthy controls, girls had a deficit of FM.  
It is possible that the method we used to categorise pubertal development may not be 
sensitive to early hormonal changes; however, the deficit was seen in pre-pubertal 
girls.  In accordance with previous research, children with CF in this study were 
shorter than healthy children but, surprisingly, boys had higher BMI SDS than 
healthy control boys and the reference population.  This was mainly due to 4 boys 
with BMI SDS > 1.64 (95
th
 centile) and the BMI/FMI SDS ratio for these boys show 
that high BMI SDS does not always reflect excess fat.  Simple SFT measurement 
identified the boy with high FFM and low FM as having less subcutaneous fat than 
the other 3 boys.  It may be prudent to identify the nature of high BMI in these 
patients and implement dietary interventions to avoid the complications of excess fat 
in adult life.  There were 2 girls who had a BMI SDS in the normal range but very 
low (5
th
 centile) FFMI SDS termed ‘hidden depletion of lean mass’ which has 
previously been reported in adults (104;117) and in children (105;150).  The 
prevalence in the 2 studies of children were 54% (105) and 14% (150), much higher 
than this study however, the age range was much wider and included young adults 
and the criteria for normal weight/BMI and FFM varied.  Girls with CF were smaller 
overall than the control girls, perhaps related to the slightly higher than expected 
weight of control girls and the lower proportion of pubertal girls and sub-optimal 
health (indicated by poorer lung function) of girls with CF.  
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I found that the control children had mean waist circumferences significantly greater 
than the UK reference data.  For the girls this was not surprising given that they had 
a mean BMI SDS of 0.39 but the boys BMI SDS was -0.11.  One explanation might 
be that the reference data was collected in 1988 and that the current obesogenic 
environment has produced a population of children with higher waist circumference 
SDS.  Mc Carthy et al (161) who produced the waist circumference SDS used in this 
analysis acknowledged the need for more up-to-date data.  The fact that SFT SDS 
was not high in the control group is likely to be due to the different populations 
measured for the reference data, 8,500 children for waist circumference in 1988 and 
533 children for SFT from 2002 – 2007.   However, the boys with CF had even 
higher waist SDS than the controls (1.24±0.79) and the girls with CF had high waist 
SDS relative to their smaller size (0.69±0.77) and this is in spite of the fact that FM 
SDS is not significantly different in the boys (CF- control; 0.30±0.26) and girls with 
CF having significantly less FM (CF-control; -0.69±0.17).  One explanation might be 
that a distended abdomen commonly seen in children with CF is due to inflammation 
and enlargement of the internal organs rather than FM.  This issue will be addressed 
in subsequent analyses in the following chapters by comparing regional soft tissue 
from DXA. 
Body composition is influenced by many factors such as genotype, nutrition and 
activity.  It is likely that nutritional intake impacts greatly on body composition 
although for the purposes of this thesis it was not possible to acquire accurate records 
of dietary intake and therefore the contribution of diet on body composition has not 
been included.  The body composition of children with CF may be additionally 
affected by the inflammatory response to chronic bacterial infection leading to 
altered protein-energy balance, lack of appetite and reduced activity.  25% of 
children on this study had chronic infection by pseudomonas aeruginosa and 
exacerbations of inflammatory conditions are likely to impact negatively on 
nutritional status.  Unfortunately it was not possible to acquire accurate data on 
inflammatory episodes in the group of children.   
Our group previously reported normal BMD and BMAD in 32 8-12 yr old children 
with CF (99); although boys in the present study had normal BMD and BMAD the 
value for girls was significantly lower.  The 24 pre-pubertal girls had normal bone 
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BMAD but low BMD (p<0.001) suggesting low BMD reflects small size and 
possible delayed puberty. 
Table 5.3 summarises the differences seen when comparing data from patients with 
those from either matched controls or a large reference population, and highlights 
some of the difficulties of comparing studies of different design.  In this study, boys 
were identified as shorter compared to the reference population but not by case-
control analysis, while girls had significantly lower FFMI SDS compared to the 
reference population but not to matched controls.  Previous studies have not been 
consistent in accounting for height and puberty and tables 5.4 and 5.5 illustrate the 
different findings depending on which factors are accounted for in the analysis. The 
method of matching and analysis must be considered when comparing studies.   
Tables 5.4 and 5.5 also give an indication of the differences depending on whether 
raw values are used as opposed to height adjusted SDS.  For example, the girls with 
CF have less mineral than control girls and this is non-significant when using the 
value of MM but significant when using MMI SDS.  This may be in some part due to 
the value of the index used to adjust for height being 2 rather than the ideal index to 
remove the effect of height which, in this study is 2.1 for CF and 1.6 for control girls. 
In addition, there was a difference in outcome depending on comparison using FFMI 
SDS or FFM adjusted for age, puberty and height in boys.  This may explain some of 
the variability in findings of previous studies.  
Whereas body composition variables adjusted for height and converted to SDS are 
useful to monitor an individual’s progress they may not be appropriate in group 
comparisons where adjusting for the individuals’ actual height is an easy alternative.  
   
5.7.2 Spirometry   
 
I chose FEV1 as an outcome measure because it is a good surrogate marker of clinical 
status and predicts mortality, and I found clear sex differences in the relationship 
between  FEV1 and body composition.  Contrary to previous research in adults 
(117;118) and children (11;64;65), FFM was not associated with FEV1 in either boys 
or girls but I identified a significant positive relationship with FM adjusted for height 
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in girls only.  This discordance with previous studies may be due to the 
methodologies used, the narrow age range of young children studied, adjustment of 
FM for stature or analysing the sexes separately.  The sex differences may reflect 
differences in body composition during growth, with relatively greater gains in FFM 
in boys and FM in girls.  It is likely that the positive association between FM and 
lung function in girls is a reflection of their poor nutritional status, given the 
generally low FM in this group.  However, some girls with low FM had good lung 
function (Figure 5.1); of the 4 girls with FMI SDS <-1.5 and FEV1 > 78%, 3 were 
more physically active than their peer group and 1 the same.  This finding warrants 
further investigation and suggests that nutritional and physical therapy perhaps needs 
to be sex specific.  It was not possible to analyse the data by genotype due to low 
numbers in each group. 
5.8 Study limitations 
 
I used predicted rather than measured lung volume when calculating body volume by 
ADP due to the difficulty of performing the technique for young children.  However, 
a study of children with CF deriving FFM from ADP concluded that there was no 
significant difference in FFM calculations between measured or predicted lung 
volumes (219).  
Since exercise will affect the amount of lean tissue we repeated the analyses taking 
into account parental reported exercise level; there was no difference in outcome.  
However, the parental rating may be affected by differing expectations in healthy and 
chronically ill patients and between the sexes and future studies should address this 
by using objective measures of physical activity. 
This study indicates that the children with CF have larger waist circumferences than 
their healthy counterparts and for girls with CF this is despite having less FM than 
the control girls.  Regional measures of FM may indicate whether the reduction in 
whole body FM is generalised throughout the body or restricted to regions.  This 
issue is addressed in Chapter 6 where whole body and regional DXA soft tissue data 
is presented.  
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5.9 Summary 
 
 This is the first study to use a ‘criterion’ method to measure body 
composition in children with CF.   
 My findings do not support Hypothesis 1, that there will be no differences at 
baseline in young children with CF.  I found clear sex differences even in pre-
pubertal children, girls with CF showing deficits of FM and to a lesser degree 
MM and boys with CF having body composition similar to controls.  Given 
the poorer prognosis in girls this warrants further investigation.   
 Four boys with CF had a BMI SDS in the obese range, and in 3 cases this was 
due to excess fat.  It would seem prudent to carefully monitor children with 
high BMI to avoid future health problems due to excess fat.   
 Two girls with CF had depleted FFM with normal BMI highlighting the 
inability of height and weight measurement to monitor body composition.  
 Contrary to previous research I found that FM related to FEV1 in girls only.    
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Chapter 6.  Cross-sectional comparison of the body 
composition of children with cystic fibrosis with that of 
healthy children at 6-12 and 8-14 years and the relationship 
with lung function. 
 
 
6.1  Introduction 
 
 
This chapter presents a cross sectional comparison between children with CF and 
control children at age 6-12 years and 8-14 years and includes only those children in 
whom there were two consecutive (2 years apart), successful 4CM measurements 
thereby insuring that comparison at baseline and 2 years is made in the same group 
of children. The analysis is (i) compared to reference populations and (ii) compared 
to group-matched (sex and age) and the relationship to the analysis in the previous 
chapter is shown in Figure 6.1.  A study outline is shown in Chapter 4 (4.5). 
 
                Chapter 5          Chapter 6 
 
 
 
 
 
 
Figure 6.1.  Description of mode of analysis and subjects in Chapters 5 and 6. 
 
Puberty is the time of greatest changes in body composition under the influence of 
the sex hormones with relatively greater gains in FFM in boys and FM in girls.  Sub-
optimal nutrition at this time is likely to impact negatively on growth and body 
composition. 
 
Cross-sectional, compared to 
reference data and  
pair-matched analyses at baseline 
 
85 CF, 85 Control 
Cross-sectional, compared to 
reference data and group-matched 
analyses at baseline and 2y 
 
69 of 85 CF, 72 of 85 Control + 21 
  
117 
 
The aims of this chapter are to test the hypotheses that; (1) there is no significant 
difference in body composition at baseline but differences will become apparent over 
time, (2) that specific components of body composition are associated with lung 
function in children with CF and hypothesis (3) that the conclusions are the same 
regardless of the mode of analysis, that is whether by comparison with reference 
population or by matching with a smaller control group.  
 
6.2 Study design 
 
 
This is a cross-sectional study comparing the body composition of children with CF 
and controls at age 6-12 years and two years later.  Comparisons were made firstly, 
using SDS calculated from a large reference population (see 4.6.2) and secondly, 
with sex and age-matched (6-12 years at baseline) control children.  In addition, the 
lung function, measured on the same day (or within 4 weeks if not possible) was 
related to components of body composition in the children with CF.  Longitudinal 
analysis is presented in Chapter 7. 
 
6.3 Recruitment and exclusion criteria 
 
 
Children with CF were recruited from patients at Great Ormond Street Hospital for 
Children, the control children from an on-going study of healthy children at 
University College London, Institute of Child Health.  Details can be found in 
Chapter 4. 
 
6.4 Methods 
 
 
Height, weight, waist, hip, MUAC and SFT were measured as described in Chapter 4.  
Body composition was assessed using the 4CM which uses whole body BMC from 
DXA, TBW from isotope dilution and density from ADP.  Simpler techniques (SFT, 
BIA, DXA and TBW) are compared in Chapter 8.  LS and whole body BMC and BMD 
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were measured by DXA to assess bone status and DXA FM and FFM (lean + bone) 
whole body and regional ((trunk and limbs (arms and legs)) to compare tissue 
distribution.   Confounding factors such as pubertal status and activity were assessed 
with questionnaires, the details of all these can be found in Chapter 4 and Appendices 8 
and 5.  Due to low numbers in some groups the classification of physical activity was 
recategorised in 3 groups; more than, same as and less than peers.  Tanner staging was 
classified as pre-pubertal (stage 1) or pubertal (stages 2-5).  The children with CF also 
had lung function assessed, described in Chapter 4. 
 
6.5  Statistical analyses 
 
 
6.5.1 Size adjustment and standard deviation score calculation 
 
Characteristics of all the children were compared to 1990 UK reference data (54;209) 
to generate SDS for weight, height, BMI and waist circumference.  Size adjustment 
of body composition variables was made as described in Chapter 4.  SDS were 
calculated compared to a contemporary reference population (see Chapter 4) for FM, 
FFM, PM, MM and SFT (155). Total and LS BMD SDS were generated from the 
Lunar Prodigy software using machine reference data matched for age, sex and 
ethnic group and a size adjusted BMAD SDS (215)was calculated as described in 
Chapter 4.  
 
6.5.2 Comparison of body composition variables   
                                      
Initial analysis indicated a strongly significant difference between the sexes and 
therefore they were analysed separately. 
6.5.2.1 Compared to reference data 
 
Separate comparisons at baseline and 2 years were made using a one-sample t-test 
between; (i) both CF and control children and the 1990 UK reference population for 
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anthropometric SDS and (ii) both CF and control children and the contemporary 
reference population for body composition variables and SFT. 
6.5.2.2 Compared to control group  
 
Comparison between CF and control children was made at baseline and 2 years; (i) 
using independent sample t- tests and (ii) using general linear models taking into 
account factors predicting body composition variables, with group and puberty as 
fixed factors and age and height (for non-indexed variables) as continuous variables. 
Since total MM is predominantly bone mineral, MM was also adjusted for bone area 
to account for the effect of bone size as well as length (height). Given the findings in 
chapter 5 that both control children and children with CF had higher mean waist 
circumference than expected,  partial correlations were performed to investigate the 
proportion of variability in waist circumference that can be attributed to body 
composition.  The relationship between waist circumference and FM, FFM, age, sex 
and height were calculated individually whilst adjusting for all the other factors.  In 
addition regression analysis was performed with the same factors to determine the 
overall contribution to variability in waist circumference.  
 
6.5.3 Spirometry 
 
Simple regression analysis was used to investigate the relationship between body 
composition variables and FEV1 SDS at baseline and 2 years.  Height was included 
in the model rather than using indexed body composition variables. 
   
6.6 Results 
 
 
6.6.1 Subjects 
 
Of the 100 children measured at baseline there were 16 children who did not have a 
second measurement; 6 left the care of Great Ormond Street Hospital (5 boys), 7 
  
120 
 
declined to be re-measured (2 boys) and 3 did not have time at their annual clinic 
visit (2 boys).  There were no significant differences in respect of height, weight, 
BMI and FEV1 between drop-outs and those remaining in the study (Appendix 9). 
 
Of the 84 left in the study 15 were not used in the second analysis; 9 had failed 4CM 
at baseline, (2 refused complete 4CM measures (1 boy), 5 failed TBW (2boys), 2 
failed ADP (1 boy)) and 6 had failed 4CM at 2years, (2 no saliva sample, 4 failed 
TBW (all girls)). There were no significant differences in the girls remaining in the 
analysis compared to those who were not included but the boys remaining in the 
analysis were significantly lighter with a lower BMI (Table 6.1). 
 
Table 6.1.  Children with cystic fibrosis not included in this analysis compared to 
those remaining 
 
 Removed from baseline analysis Remaining in analysis 
 Boys n= 6 Girls n=10 Boys n= 31 Girls n=38 
 Mean SD P Mean SD P Mean SD Mean SD 
Age 8.64 1.24 0.537 8.94 0.93 0.321 8.97 1.16 9.67 1.72 
Height SDS 0.07 0.89 0.202 -0.59 1.09 0.854 -0.51 1.02 -0.59 1.12 
Weight SDS 1.20 0.76 0.004 -0.74 0.96 0.849 -0.10 0.96 -0.51 1.11 
BMI SDS 1.59 0.60 0.001 -0.64 1.47 0.570 0.29 0.86 -0.26 0.93 
FEV1 SDS -0.61 3.21 0.193 -1.97 1.69 0.693 -1.10 1.54 -1.56 1.44 
 
 
Of the original 85 control children whose data was used in the previous chapter, 72 
had valid 4CM measurements at baseline and 2 years.  Pair-matching with the same 
pairs as the previous chapter would reduce the numbers for analysis considerably and 
therefore, in order to include as many subjects as possible, all available age 
appropriate healthy controls with valid measurements at both time-points were 
included in a group-match analysis.  There was therefore an additional 21 control 
children included.  Age, height, weight and BMI SDS did not differ between the 
control children at baseline in pair-match (Chapters 5) and group-match (Chapter 6) 
analyses (Table 6.2). 
 
 
  
121 
 
Table 6.2.  Comparison of control children at baseline in Chapters 5 and 6. 
 
 Chapter 5 analysis 
N = 85 
Chapter 6 analysis 
N=93 
 Mean SD P Mean SD 
Age 9.31 1.58 0.471 9.49 1.74 
Height SDS 0.10 0.91 0.617 0.17 0.83 
Weight SDS 0.19 0.98 0.878 0.17 0.88 
BMI SDS 0.17 1.03 0.578 0.09 0.94 
 
 
The analysis therefore was performed on data from 69 of the original 85 children 
with CF (31 boys and 38 girls) compared to 72 original and 21 additional control 
children (44 boys and 49 girls) matched for age.  A sample size of 69 would be 
sufficient to detect a difference of 0.48 SDS in a group comparison with 80% power 
at p=0.05. 
 
At baseline 80% of CF and 66% of control children were pre-pubertal and at the 2 
year measurement 45% of CF and 30% of controls were pre-pubertal. For CF 
children genotype was homozygous ∆F508 for 48 children, heterozygous ∆F508 for 
17 children, 3 children had non ∆F508 genotype and 1 child was of unknown 
genotype.  All subjects with CF except 1 girl were pancreatic insufficient, had a wide 
range of pulmonary disease with a baseline mean FEV1%of 83.2%, with values 
between 33% and 123%, 7 (6 girls) had a gastrostomy in situ, 1 girl had liver disease 
and 1 girl was diabetic.  At the 2-year measurement mean FEV1% was 79.4%, with 
values between 32% and 119%, 8 (5 girls) had a gastrostomy in situ, 7 (4 girls) had 
liver disease and 3 girls were diabetic. At baseline 14 children (8 boys) had chronic 
infection of pseudomonas aeruginosa and 11 (6 boys) had chronic infection of 
staphylococcus aureus.  The status of 2 girls was unknown.  After 2 years 24 (15 
boys) had pseudomonas aeruginosa and 14 (6 boys) had chronic staphylococcus 
aureus.  
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6.6.2 Anthropometry 
 
Characteristics of all the children at each time point are presented in Table 6.3 for 
boys and Table 6.4 for girls. 
 
 
6.6.2.1 Compared to reference data 
 
At baseline and 2 years the control boys were not significantly different from the 
reference population in respect of height, weight, BMI and SFT SDS but had 
significantly larger waist SDS (p<0.01).  The control girls were significantly heavier 
and taller (p≤ 0.01) with larger waist circumference (p<0.001) at baseline and 2 
years.  Boys with CF were significantly shorter than the reference data but the deficit 
although significant (p<0.05) was less at the 2 year measurement and the mean waist 
circumference SDS was greater at both time points (p< 0.001) despite SFT SDS 
being average.  CF girls differed more, being lighter and shorter at baseline (p<0.01) 
and 2 year measurement (p<0.05) with larger waist circumference SDS (p<0.001) at 
both time points and SFT SDS below zero (non-significant). 
6.6.2.2 Compared to control group 
 
Boys with CF were shorter than controls with larger waist circumference at both time 
points (p<0.05).  At the 2 year measurement the boys with CF had significantly 
smaller hip and mid-upper arm circumferences (p<0.05).  Girls with CF had 
significantly lower weight and height (p<0.001) and BMI SDS, hip and MUAC 
(p<0.05) at both measurements.  Despite being smaller than the control girls, the girls 
with CF had similar waist circumference at both time-points. 
 
Regression analyses and partial correlations of the relationship between waist 
circumference and age, height, sex, FM and FFM may be found in Appendix 10.  
FM, FFM, age, sex and height explained 86% of the variation in waist circumference 
in children with CF and 91% in control children.  Adjusted partial correlations can be 
found in Figure 6.2. 
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Figure 6.2.  Contribution of body composition, age, sex and height to variability in 
waist circumference in children with cystic fibrosis and controls.  Determined by 
partial correlations, each factor adjusted for the others, % is adjusted R
2
  
 
 
6.6.3 Body Composition 
 
A comparison of body composition at baseline and 2 years is presented in Table 6.5 
(boys) and Table 6.6 (girls) with a summary in Table 6.8. 
 
6.6.3.1 Compared to reference data 
 
Control boys did not differ from the cross sectional reference data in respect of FMI, 
FFMI, PMI and MMI SDS, however, they had significantly higher mean total BMD 
SDS at baseline (p<0.001) but lower total and LS BMD at 2 years (p<0.05).  Size 
adjusted LS BMAD was not significantly different from zero at both time-points.  
Control girls were typical of the reference population apart from a higher mean total 
  
124 
 
BMD SDS at baseline (p<0.01).  Boys with CF had higher mean total BMD SDS 
(p<0.001) at both time-points and higher FFMI SDS at baseline (p<0.05) whereas the 
girls with CF had lower LS BMD and BMAD, FMI, FFMI and MMI SDS (p<0.05) 
at both measurements. 
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Table 6.3.  Characteristics of cystic fibrosis (CF) and control boys at baseline and two years with group comparison (Pgroup) and compared 
to reference data (Pref). 
 Baseline Two years 
 CF n=31 Control n=44 CF n= 31 Control n=44 
 Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
Age (y) 8.97 1.16  0.108 9.50 1.36  11.0 1.19  0.151 11.5 1.36  
Weight (kg) 28.7 6.13  0.244 30.8 6.87  35.1 8.98  0.097 38.7 9.46  
Height (m) 1.30 0.09  0.010 1.36 0.08  1.41 0.10  0.011 1.47 0.10  
BMI (kg/m
2
) 16.8 1.81  0.250 16.3 1.72  17.5 2.03  0.883 17.6 2.41  
Weight SDS -0.10 0.96 0.579 0.826 -0.05 0.87 0.702 -0.13 0.98 0.454 0.337 0.09 1.00 0.548 
Height SDS -0.51 1.02 0.009 0.019 0.03 0.88 0.806 -0.42 1.02 0.032 0.019 0.13 0.91 0.366 
BMI SDS 0.29 0.86 0.071 0.058 -0.09 0.84 0.469 0.15 0.94 0.388 0.561 0.01 1.06 0.951 
Waist (cm) 62.1 5.43  0.016 59.1 4.88  65.6 5.60  0.214 63.8 6.35  
Waist SDS 1.07 0.70 <0.001
0 
<0.001 0.35 0.73 0.002 0.88 0.70 <0.001 0.021 0.41 0.83 0.002 
Hip (cm) 66.9 5.78  0.120 69.2 6.62  72.7 6.40  0.040 76.3 7.95  
MUAC (cm) 19.40 2.26  0.162 20.3 2.74  20.6 2.53  0.043 22.0 3.07  
Sum 4 skinfold thickness (mm)
1 30.2 12.7  0.985 30.1 11.6  33.4 14.4  0.187 38.7 18.9  
4 skinfold thickness SDS
1 -0.10 0.85 0.534 0.971 -0.09 0.79 0.448 0.001 0.85 0.997 0.331 0.20 0.89 0.142 
FEV1 % 86.6 18.8      86.4 18.3      
FEV1 SDS -1.10 1.54 <0.001     -1.15 1.56 <0.001     
Activity (hours per week) 9.39 6.95  0.340 8.05 5.14  9.19 5.18  0.767 8.84 4.94  
Pre-pubertal (n, %) 29 94%   31 71%  21 68%   14 32%  
Pref ; one-sample t- test compared to zero, CF or control compared to reference data (54;155;209).   Pgroup; independent sample t-test, CF boys  v control boys or CF 
girls v control girls, BMI; body mass index (weight/height
2
), SDS; standard deviation score compared to UK 1990 reference data (54;209), MUAC; mid-upper arm 
circumference, Sum 4 skinfold thickness; bicep+tricep+subscapular+ suprailiac, 
1
CF n=30, control n= 44,   FEV1%; forced expired volume in 1s percentage of the 
expected, FEV1 SDS; compared to reference data (204), Pre-puberty is based on Tanner staging 1 (pre) to stages 2 – 5 (pubertal), Pancreatic insufficient; reduced 
pancreatic function requiring the oral addition of pancreatic enzymes, Ps aerug; chronic pseudomonas aeruginosa infection of the lungs, Staph aureus; chronic 
staphylococcus aureus infection of the lungs. 
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Table 6.4.  Characteristics of cystic fibrosis (CF) and control girls at baseline and two years with group comparison (Pgroup) and compared 
to reference data (Pref). 
 
 Baseline Two years 
 CF n=38 Control n=49 CF n= 38 Control n=49 
 Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
Age (y) 9.64 1.76  0.757 9.67 2.03  11.07 1.80  0.666 11.6 2.04  
Weight (kg) 29.7 7.90  0.027 34.0 9.57  37.7 10.7  0.035 42.6 10.7  
Height (m) 1.33 0.11  0.078 1.38 0.13  1.44 0.12  0.061 1.49 0.12  
BMI (kg/m
2
) 16.5 1.97  0.024 17.7 2.44  17.7 2.76  0.051 18.9 2.71  
Weight SDS -0.51 1.11 0.007 <0.001 0.36 0.84 0.004 -0.52 1.30 0.017 <0.001 0.39 0.79 0.001 
Height SDS -0.59 1.12 0.003 <0.001 0.29 0.77 0.010 -0.53 1.18 0.017 0.001 0.39 0.74 0.004 
BMI SDS -0.26 0.93 0.089 0.016 0.25 1.00 0.085 -0.32 1.12 0.091 0.011 0.27 0.97 0.104 
Waist (cm) 60.6 5.67  0.719 61.1 6.93  65.6 7.25  0.903 65.4 6.70  
Waist SDS 0.72 0.77 <0.001 0.657 0.80 0.93 <0.001 0.96 0.91 <0.001 0.858 0.99 0.85 <0.001 
Hip (cm) 69.0 7.72  0.007 73.9 8.74  76.2 9.68  0.019 81.1 9.29  
MUAC (cm) 20.0 2.75  0.006 21.8 3.29  21.50 3.24  0.007 23.4 3.09  
Sum 4 skinfold thickness (mm)
1 38.0 13.4  0.045 45.3 18.2  48.8 21.6  0.225 54.6 21.9  
4 skinfold thickness SDS
1 -0.35 0.80 0.011 0.074  -0.01 0.92 0.081 -0.14 0.96 0.384 0.157 0.16 0.94 0.251 
FEV1 % 80.3 18.1      74.8 19.1      
FEV1 SDS -1.56 1.44 <0.001     -2.05 1.58 <0.001     
Activity (hours per week) 8.13 4.65  0.957 8.08 3.89  6.76 3.47  0.099 8.02 3.50  
Pre-pubertal (n, %) 26 68%   30 61%  10 26%   14 29%  
Pref ; one-sample t-test compared to zero, CF or control compared to reference data (54;209).  Pgroup; independent sample t-test, CF boys  v control boys or CF girls v 
control girls, BMI; body mass index (weight/height
2
), SDS; standard deviation score compared to UK 1990 reference data (54;209), MUAC; mid-upper arm 
circumference, Sum 4 skinfold thickness; bicep+tricep+subscapular+ suprailiac, 
1
CF n=30, control n= 44,   FEV1%; forced expired volume in 1s percentage of the 
expected, FEV1 SDS; compared to reference data (204), Pre- puberty is based on Tanner staging 1 (pre) to stages 2 – 5 (pubertal), Pancreatic insufficient; reduced 
pancreatic function requiring the oral addition of pancreatic enzymes, Ps aerug; chronic pseudomonas aeruginosa infection of the lungs, Staph aureus; chronic 
staphylococcus aureus infection of the lungs. 
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Table 6.5.  Body composition of cystic fibrosis (CF) and control boys with group comparison (Pgroup) and compared to reference data (Pref). 
 Baseline Two years 
 CF n=31 Control n=44 CF n= 31 Control n=44 
 Mean SD Pref 
ref 
Pgroup
pp 
group 
Mean SD Pref 
ref 
Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
Body volume (L) 27.4 6.15  0.250 29.1 6.72  33.6 7.93  0.062 37.7 9.85  
Total body water (L) 17.7 3.13  0.261 18.6 3.58  21.2 4.26  0.149 22.9 5.20  
Total bone mineral content (kg) 1.05 0.23  0.108 1.14 0.24  1.32 0.37  0.114 1.45 0.33  
Total bone mineral density (g/cm
2
) 
(g/cm
2 
0.90 0.06  0.475 0.89 0.06  0.95 0.08  0.001 0.79 0.11  
Total bone mineral density SDS 0.53 0.62 0.001 0.096 0.30 0.50 0.001 0.57 0.76 0.001 0.001 -0.27 0.82 0.033 
LS bone mineral density (g/cm
2
) 0.73 0.08  0.652 0.73 0.08  0.78 0.10  0.565 0.79 0.11  
LS bone mineral density SDS -0.09 0.68 0.467 0.687 -0.16 0.76 0.173 -0.19 0.73 0.154 0.611 -0.29 0.84 0.029 
LS bone mineral apparent density SDS 0.07 0.85 0.656 0.951 0.06 0.90 0.683 0.17 0.93 0.327 0.456 -0.01 1.07 0.938 
4-Component model  
Fat mass (kg) 5.25 2.98  0.381 5.88 3.11  7.02 3.35  0.242 8.15 4.55  
Fat mass index SDS -0.21 0.99 0.242 0.968 -0.20 0.94 0.159 -0.17 0.85 0.286 0.757 -0.10 0.77 0.504 
Fat (%) 17.5 6.70  0.477 18.6 6.30  19.3 6.00  0.539 20.3 7.73  
Fat-free mass (kg) 23.4 3.84  0.246 24.6 4.90  28.2 5.58  0.119 30.5 6.98  
Fat-free mass index SDS 0.49 1.07 0.015 0.003 -0.19 0.89 0.159 0.15 1.03 0.439 0.121 -0.24 1.07 0.140 
Fat-free mass hydration (%) 75.6 2.14  0.868 75.7 1.47  75.3 1.65  0.240 74.9 1.38  
Fat-free mass density (kg/L) 1.088 0.007  0.407 1.089 0.005  1.090 0.006  0.030 1.093 0.004  
Protein mass (kg) 4.33 0.68  0.345 4.55 1.13  5.27 1.01  0.071 5.83 1.48  
Protein mass index SDS 0.43 1.45 0.107 0.057 -0.12 1.06 0.427 0.18 1.12 0.375 0.555 0.03 1.04 0.838 
Mineral mass (kg) 1.33 0.29  0.114 1.45 0.30  1.69 0.47  0.129 1.84 0.42  
Mineral mass index SDS 0.003 0.83 0.983 0.278 -0.22 0.87 0.108 -0.11 0.97 0.546 0.614 -0.23 1.04 0.156 
Pgroup independent t-test; CF boys and control boys or CF girls and control girls; Pref one-sample t-test compared to zero, CF and controls compared to reference data.  
SDS; standard deviation score, LS ; Lumbar spine (L2-L4) bone mineral apparent density which is a 3-D ‘volumetric’ measurement that is calculated from the 2-D 
Bone mineral density (BMD) actually measured by the DXA machine, SDS are calculated from reference data (204).  Fat mass index (fat mass/height
2
), Fat-free mass 
index(fat-free mass/height
2
),  Protein mass index (protein mass/height
2
),  Mineral mass index (fat mass/height
2
).   SDS are calculated from reference data collected in 
533 contemporary healthy children (155).    Table continues on next page. 
  
128 
 
Table 6.5 continued.  Body composition of cystic fibrosis (CF) and control boys with group comparison (Pgroup) and compared to reference 
data (Pref). 
 
 
 
 Baseline Two years 
 CF n=31 Control n=44 CF n= 31 Control n=44 
 Mean SD Pref 
ref 
Pgroup
pp 
group 
Mean SD Pref 
ref 
Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
DXA soft tissue 
Whole body fat mass (kg) 5.01 2.99  0.437 5.58 3.20  7.06 3.64  0.223 8.37 5.04  
Whole body fat-free mass (kg) 23.4 3.62  0.167 24.8 4.79  28.0 5.50  0.145 30.16 6.86  
Trunk fat mass (kg) 2.03 1.38  0.811 2.10 1.36  3.04 1.81  0.290 3.82 3.83  
Trunk fat-free mass (kg) 11.2 1.71  0.972 11.3 2.09  13.4 2.48  0.549 13.0 2.90  
Limb fat mass (kg) 2.58 1.54  0.235 3.05 1.77  3.58 1.79  0.083 4.58 2.79  
Limb fat-free mass (kg) 9.01 1.82  0.021 10.3 2.56  11.4 2.81  0.016 13.3 3.67  
 
 
Pgroup; independent t-test, CF boys and control boys or CF girls and control girls; Pref ; one sample t-test compared to zero, CF and    
controls compared to reference data.  SDS; standard deviation score, LS ; Lumbar spine (L2-L4) bone mineral apparent density which a 3-
D ‘volumetric’ measurement that is calculated from the 2-D Bone Mineral Density (BMD) actually measured by the DXA machine, SDS 
are calculated from reference data (215).  Fat mass index (fat mass/height
2
), Fat-free mass index(fat-free mass/height
2
),  Protein mass index 
(protein mass/height
2
),  Mineral mass index (fat mass/height
2
).   SDS are calculated from reference data collected in 533 contemporary 
healthy children (155).    
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Table 6.6.  Body composition of cystic fibrosis (CF) and control girls with group comparison (Pgroup) and compared to reference data (Pref). 
 Baseline Two years 
 CF n=38 Control n=49 CF n= 38 Control n=49 
 Mean SD Pref 
ref 
Pgroup
pp 
group 
Mean SD Pref 
ref 
Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
Body volume (L) 28.5 7.75  0.025 32.8 9.45  36.3 10.6  0.039 41.1 10.4  
Total body water (L) 17.3 4.10  0.066 19.1 4.90  21.1 5.02  0.026 23.7 5.46  
Total bone mineral content (kg) 1.03 0.26  0.014 1.21 0.37  1.35 0.37  0.014 1.59 0.50  
Total bone mineral density (g/cm
2
) 
(g/cm
2 
0.88 0.08  0.272 0.90 0.08  0.94 0.07  0.244 0.90 0.17  
Total bone mineral density SDS 0.00 0.74 1.000 0.077 0.27 0.66 0.006 -0.20 0.84 0.148 0.265 0.03 1.03 0.847 
LS bone mineral density (g/cm
2
) 0.74 0.11  0.035 0.79 0.12  0.84 0.14  0.077 0.90 0.17  
LS bone mineral density SDS -0.52 1.22 0.013 0.024 0.01 0.94 0.930 -0.66 1.19 0.005 0.005 0.04 1.02 0.804 
LS bone mineral apparent density SDS -0.44 1.28 0.042 0.119 -0.04 1.07 0.789 -0.40 1.07 0.026 0.135 -0.05 1.08 0.739 
4-Component model  
Fat mass (kg) 6.53 3.08  0.010 8.60 4.03  9.28 4.87  0.106 10.9 4.52  
Fat mass index SDS -0.63 0.82 0.001 0.026 -0.16 0.94 0.246 -0.55 1.13 0.010 0.126 -0.18 0.93 0.177 
Fat (%) 21.2 5.25  0.014 24.4 6.53  23.4 7.31  0.301 25.0 6.71  
Fat-free mass (kg) 23.1 5.35  0.080 25.4 6.37  28.4 6.76  0.035 31.7 7.40  
Fat-free mass index SDS -0.33 0.90 0.031 0.157 -0.05 0.91 0.715 -0.47 1.02 0.007 0.008 0.07 0.84 0.560 
Fat-free mass hydration (%) 74.8 1.81  0.477 75.1 1.52  74.1 1.81  0.182 74.6 1.51  
Fat-free mass density (kg/L) 1.091 0.007  0.373 1.092 0.006  1.095 0.006  0.467 1.094 0.007  
Protein mass (kg) 4.53 1.16  0.315 4.77 1.12  5.63 1.42  0.185 6.05 1.45  
Protein mass index SDS 0.08 1.08 0.662 0.797 0.02 0.95 0.878 0.09 1.14 0.645 0.712 0.17 1.07 0.260 
Mineral mass (kg) 1.31 0.32  0.009 1.55 0.47  1.74 0.48  0.019 2.03 0.64  
Mineral mass index SDS -0.83 1.14 0.001 0.001 -0.01 0.98 0.965 -0.66 1.06 0.000 0.001 0.10 1.00 0.503 
Pref ; one-sample t-test CF and controls compared to zero, CF and controls compared to reference data (155), Pgroup; independent sample t-test; CF boys and control 
boys and CF girls and control girls, SDS; standard deviation score, LS ; Lumbar spine (L2-L4) bone mineral apparent density which is a 3-D ‘volumetric’ measurement 
that is calculated from the 2-D Bone Mineral Density (BMD) actually measured by the DXA machine, SDS are calculated from reference data (215).  Fat mass index 
(fat mass/height
2
), fat-free mass index(fat-free mass/height
2
),  protein mass index (protein mass/height
2
),  mineral mass index (fat mass/height
2
).   SDS are calculated 
from reference data collected in 533 contemporary healthy children (155).   Table continues on next page. 
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Table 6.6 continued.  Body composition of cystic fibrosis (CF) and control girls with group comparison (Pgroup) and compared to reference data 
(Pref). 
 
 
 Baseline Two years 
 CF n=31 Control n=44 CF n= 31 Control n=44 
 Mean SD Pref 
ref 
Pgroup
pp 
group 
Mean SD Pref 
ref 
Mean SD Pref 
ref 
Pgroup 
group 
Mean SD Pref 
ref 
DXA soft tissue 
Whole body fat mass (kg) 6.80 3.23  0.019 8.89 4.55  9.80 5.05  0.073 11.8 5.26  
Whole body fat-free mass (kg) 22.6 5.13  0.058 24.9 5.89  27.3 6.27  0.044 30.3 6.88  
Trunk fat mass (kg) 2.92 1.65  0.113 3.60 2.17  4.50 2.63  0.325 5.06 2.65  
Trunk fat-free mass (kg) 11.0 2.69  0.601 11.3 2.76  13.4 3.25  0.775 13.6 3.73  
Limb fat mass (kg) 3.44 1.56  0.003 4.78 2.37  4.81 2.38  0.011 6.22 2.60  
Limb fat-free mass (kg) 8.71 2.32  0.002 10.5 2.97  10.9 2.90  0.001 13.3 3.34  
 
Pref ; one-sample t-test CF and controls compared to zero, CF and controls compared to reference data (155),  Pgroup; independent sample t-
test; CF boys and Control boys or CF girls and Control girls SDS; standard deviation score, LS ; Lumbar spine (L2-L4) bone mineral 
apparent density which is a 3-D ‘volumetric’ measurement that is calculated from the 2-D Bone Mineral Density (BMD) actually measured 
by the DXA machine, SDS are calculated from reference data (215).  Fat mass index (fat mass/height
2
), fat-free mass index(fat-free 
mass/height
2
),  protein mass index (protein mass/height
2
),  mineral mass index (fat mass/height
2
).   SDS are calculated from reference data 
collected in 533 contemporary healthy children.(155)    
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6.6.3.2 Compared to control group 
 
Boys with CF did not differ significantly from the control boys at baseline apart from 
having a higher FFMI SDS (p<0.05), and at the 2 year measurement they had higher 
total BMD (p<0.01) and FFM density (p<0.05).  Comparison in the girls revealed 
more differences than the boys with CF girls lower in total BMC, LS BMD SDS 
(p<0.05) and lower MMI SDS (p<0.001) at both time-points.  Size adjusting LS 
BMD made the difference non-significant although the CF girls had a lower mean 
value.  The CF girls had lower FM although this was only significant at baseline 
(p<0.05) and lower FFM although this was only significant at 2 years (p<0.01). 
 
DXA regional soft tissue analysis revealed that the boys with CF had significantly 
less limb FFM at both time points p<0.05 despite whole body and trunk FFM not 
being significantly different from controls.  Girls with CF had less whole body FM 
and FFM which appears to be due to deficits in the limbs at both time-points. 
 
6.6.3.3 Potential confounders affecting body composition outcomes  
 
Table 6.7 shows adjusted mean differences in body composition (CF- control) after 
adjustment for age, puberty and height for non-indexed variables at baseline and 2 
years with a summary in Table 6.8.  CF boys had greater weight, BMI, FFMI SDS 
and waist circumference at both time points although this was non-significant for 
BMI SDS at 2 years (p<0.05).  They were also shorter by on average, 0.3 SDS 
although this was non-significant and had lower density of FFM at 2 years (p<0.05).  
Girls with CF were significantly shorter with lower BMI SDS, FMI SDS and MMI 
SDS at both time points (p<0.05).  FFMI SDS and MUAC were lower in CF girls at 
baseline (non-significant) and became increasingly lower at 2 years (p<0.05).  To 
determine whether differences in body composition were due to different levels of 
activity the parent’s rating of the child’s activity level was added to the model with 
no effect on the outcome (data not shown). 
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DXA regional body composition indicated that boys with CF had significantly more 
whole body FFM at baseline (p<0.05) and more at 2 years (non-significant).  There 
was a much larger difference in the trunk, boys with CF had greater FFM at baseline 
and 2 years (p<0.001).  Despite whole body FFM being similar in the girls, the girls 
with CF appear to have much more FFM in the trunk than control girls (p<0.005) at 
both time-points and less in the limbs (p<0.001).  The non-significant deficit of 
whole body FM is attributable to deficits of FM in the limbs (p<0.05). 
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Table 6.7.  Difference in size and whole-body composition (cystic fibrosis (CF) minus control) at baseline and two years. Positive mean 
values indicate greater values in children with CF. 
 Boys (CF = 31, control = 44) Girls (CF = 38, control = 49) 
 Baseline Year 2 Baseline Year 2 
 Mean SEM P Mean SEM P Mean SEM P Mean SEM P 
Weight (kg) 1.87 0.74 0.013 1.95 1.10 0.079 -0.77 0.92 0.407 -1.55 1.30 0.238 
Weight SDS 0.36 0.14 0.013 0.33 0.15 0.036 -0.17 0.15 0.273 -0.31 0.18 0.082 
Height (m)
1 
-1.79 1.26 0.159 -2.34 1.68 0.170 -5.04 1.23 <0.001 -6.22 1.33 <0.001 
Height SDS
1 
-0.32 0.21 0.131 -0.31 0.23 0.183 -0.78 0.20 <0.001 -0.97 0.20 <0.001 
BMI (kg/m
2
)
1 
0.87 0.39 0.030 0.76 0.50 0.134 -0.96 0.43 0.030 -1.38 0.53 0.010 
BMI SDS
1 
0.49 0.21 0.020 0.43 0.24 0.072 -0.42 0.21 0.043 -0.63 0.22 0.005 
Total body water (L) 1.04 0.36 0.005 1.14 0.57 0.050 -0.03 0.37 0.943 -0.68 0.47 0.150 
Body volume (L) 1.85 0.76 0.018 1.35 1.31 0.307 -0.83 0.97 0.391 -1.49 1.35 0.275 
4C Fat mass (kg) 0.55 0.61 0.370 0.64 0.89 0.475 -0.88 0.66 0.185 -0.72 0.94 0.447 
4CFat mass index (kg/m
2
)
1 
0.17 0.32 0.604 0.17 0.40 0.683 -0.75 0.31 0.016 -0.67 0.38 0.078 
4C Fat mass index SDS
1 
0.08 0.24 0.753 0.16 0.22 0.486 -0.41 0.19 0.033 -0.42 0.21 0.050 
4C Fat-free mass (kg) 1.28 0.50 0.013 1.31 0.75 0.085 0.08 0.46 0.865 -0.83 0.65 0.203 
4C Fat-free mass index SDS
1 
0.71 0.24 0.004 0.61 0.25 0.019 -0.21 0.19 0.282 -0.58 0.20 0.005 
4C Fat-free mass hydration (%) 0.11 0.44 0.798 0.46 0.38 0.231 -0.33 0.41 0.426 -0.21 0.40 0.594 
4C Fat-free mass density (kg/L) -0.001 0.001 0.347 -0.003 0.001 0.029 0.000 0.001 0.721 0.001 0.001 0.360 
4C Protein mass (kg) 0.19 0.18 0.285 0.11 0.20 0.574 0.19 0.13 0.133 -0.07 0.20 0.740 
4C Protein mass index SDS
1 
0.50 0.31 0.107 0.28 0.27 0.291 0.07 0.22 0.741 -0.11 0.24 0.657 
4C Mineral mass (kg) 
 
0.05 0.03 0.121 0.07 0.06 0.207 -0.09 0.04 0.029 -0.09 0.06 0.139 
4C Mineral mass adjusted (kg)
2 
0.03 0.03 0.402 0.05 0.06 0.394 -0.10 0.04 0.015 -0.10 0.05 0.057 
4C Mineral mass index SDS
1 
0.29 0.21 0.171 0.26 0.25 0.304 -0.74 0.23 0.002 -0.77 0.22 0.001 
General linear model, adjusting for group and puberty as fixed factors and age and height as continuous variables.  P; independent sample t-test, CF v control, SDS; 
standard deviation score, 4C; 4-component model, 
1
adjusted for age and puberty only, 
2
adjusted for lumbar spine bone area .  Table continues on next page.Table 
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6.7 continued.  Difference in size and whole-body composition (CF minus control) at baseline and two years. Positive mean values 
indicate greater values in children with CF. 
 Boys (CF = 31, control = 44) Girls (CF = 38, control = 49) 
 Baseline Year 2 Baseline Year 2 
 Mean SEM P Mean SEM P Mean SEM P Mean SEM P 
DXA LS bone mineral density 0.01 0.02 0.456 0.01 0.02 0.540 -0.01 0.02 0.609 -0.01 0.02 0.596 
DXA LS bone mineral density SDS 0.13 0.18 0.476 0.15 0.21 0.464 -0.01 0.21 0.952 -0.14 0.24 0.554 
DXA LS bone mineral apparent density SDS -0.01 0.21 0.947 0.07 0.25 0.794 -0.19 0.27 0.497 -0.16 0.26 0.547 
DXA whole body fat mass (kg) 0.72 0.60 0.231 0.72 0.97 0.458 -0.82 0.70 0.246 -1.07 1.00 0.287 
DXA whole body fat-free mass (kg) 1.08 0.47 0.026 1.23 0.84 0.151 -0.06 0.40 0.885 -0.35 0.55 0.529 
DXA trunk fat mass (kg) 0.48 0.27 0.082 0.19 0.72 0.796 -0.06 0.35 0.866 -0.07 0.52 0.893 
DXA trunk fat-free mass (kg) 1.04 0.24 <0.001 1.78 0.51 0.001 0.80 0.22 <0.001 1.16 0.40 0.005 
DXA limb fat mass (kg) 0.23 0.32 0.473 0.11 0.51 0.825 -0.73 0.36 0.046 -0.98 0.49 0.048 
DXA limb fat-free mass (kg) -0.003 0.25 0.992 -0.10 0.41 0.806 -0.77 0.22 0.001 -1.22 0.31 <0.001 
Waist circumference (cm) 5.20 0.94 <0.001 4.96 1.16 <0.001 1.26 1.11 0.261 1.47 1.36 0.285 
Waist circumference SDS 0.93 0.15 <0.001 0.69 0.18 <0.001 0.25 0.19 0.185 0.21 0.20 0.311 
Hip circumference (cm) 0.80 0.92 0.389 0.60 1.18 0.613 -2.06 1.06 0.056 -2.39 1.25 0.060 
Mid-upper arm circumference (cm) 0.03 0.54 0.959 0.11 0.56 0.846 -0.88 0.56 0.118 -1.31 0.61 0.036 
Log 4 skinfold thickness
3 
0.09 0.08 0.250 0.03 0.10 0.774 -0.06 0.09 0.496 -0.10 0.10 0.302 
4 skinfold thickness  SDS
4 
0.19 0.19 0.327 0.12 0.20 0.543 -0.12 0.21 0.558 -0.25 0.23 0.265  
General linear model, adjusting for group and puberty as fixed factors and age and height as continuous variables. P; independent t-test, CF v control, 
SDS; standard deviation score, LS; lumbar spine bone mineral apparent density (size adjusted bone mineral density) SDS.  
3
Log 4 skinfolds (bicep, 
tricep, subscapular and supra-iliac).  
4
Mean of bicep, tricep, subscapular and supra-iliac SDS, 
3,4
 n= CF boys 31, control boys 42, CF girls 37, control 
girls 46 at baseline and 2 years n= CF boys 31, control boys 43, CF girls 37, control girls 48. 
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Table 6.8. Summary of comparisons (before and after adjustment for age, puberty and height
1
) 
 
 
Boys with CF compared to; Girls with CF compared to; 
Mode of analysis 
Unadjusted 
Group-match 
Unadjusted 
Reference 
Group-match 
adjusted for, 
age, puberty 
 and height
1 
Unadjusted 
Group-match 
Unadjusted 
Reference 
Group-match 
adjusted for 
age, puberty 
and height
1 
Year 0 2 0 2 0 2 0 2 0 2 0 2 
Weight SDS
1 
NS NS NS NS       NS NS 
Height SDS     NS NS       
BMI SDS NS NS NS NS  NS   NS NS   
Waist SDS
1 
      NS NS   NS NS 
Fat mass index SDS NS NS NS NS NS
 
NS  NS    
 
Fat-free mass index SDS  NS  NS   NS    NS  
Protein mass index SDS NS NS NS NS NS NS NS NS NS NS NS NS 
Mineral mass index SDS NS NS NS NS NS NS       
Unadjusted comparisons using independent t-test for group-match and one sample t-test for reference data.  Adjusted comparisons are a general linear model adjusted 
for age, puberty (pre-pubertal; Tanner stage1 versus Tanner stages 2-5) and 
1
 height for weight and waist SDS.  Reference data is UK 1990 (54;161;209) for weight, 
height, BMI and waist and reference data from 533 children measured by the 4-component model (155).  Fat mass index (fat mass/height
2
), fat-free mass index (fat-
free mass/height
2
), protein mass index (protein mass/height
2
), mineral mass index (mineral mass/height
2
).  Highlights signify disagreement. 
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6.6.4 Relationship between body composition and spirometry 
 
Mean FEV1 SDS was; CF boys, mean (SD), baseline -1.10 (1.54) and 2 years -1.15 
(1.56) (Table 2) and CF girls, baseline -1.56 (1.44) and 2 years -2.05 (1.58) (Table 
6.3).  There was a significant deterioration in the girls lung function (p<0.01) 
between baseline and 2 years of 0.5 SDS. 
 
Separate simple regression analysis of FEV1 SDS and BMI SDS or FM or FFM or 
MM or whole body BMC or BMD were performed with height in the model (except 
for BMI) and additionally adjusting MM, and BMC for LS bone area (Table 6.9) at 
baseline and 2 years.  There were no significant associations in boys apart from FFM 
(p <0.05) at the 2 year measurement.  Only FM at baseline and total BMC at 2 years 
were associated with lung function in girls (p<0.05).  Whole body BMD unadjusted 
for height was also included so that this study is comparable with studies that have 
not adjusted for height. 
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Table 6.9.  Simple regression analysis of factors (adjusted for height)
1
 associated with forced expired volume in 1 sec standard deviation 
score 
 
 Boys n=31 Girls n=38 
 B SEM t P r
2 
B SEM t P r
2 
Year 0 
BMI SDS 0.30 0.32 0.94 0.355 0.004 0.43 0.25 1.76 0.087 0.055 
Fat mass (kg) 0.01 0.13 0.10 0.919 0.067 0.23 0.11 2.21 0.034 0.075 
Fat-free mass (kg) 0.02 0.17 0.11 0.912 0.067 -0.03 0.15 -0.23 0.820 0.055 
Fat-free mass (kg)
 
-0.04 0.17 -0.23 0.818 0.022 -0.02 0.16 -0.11 0.911 0.084 
Mineral mass (kg)
2 
1.79 2.42 0.74 0.465 0.040 1.97 2.08 0.94 0.352 0.056 
DXA bone mineral content (kg)
2 
2.29 3.06 0.75 0.460 0.040 4.53 2.71 1.67 0.104 0.001 
DXA bone mineral density (g/m
3
) 0.20 5.98 0.03 0.974 0.067 0.33 3.55 0.09 0.927 0.057 
Year 2 
BMI SDS 0.47 0.30 1.58 0.126 0.049 0.36 0.23 1.54 0.133 0.037 
Fat mass (kg) 0.003 0.11 0.03 0.977 0.061 0.09 0.08 1.17 0.249 0.014 
Fat-free mass (kg) 0.31 0.12 2.55 0.017 0.145 0.03 0.12 0.28 0.781 0.052 
Fat-free mass (kg)
 
0.21 0.13 1.60 0.121 0.190 0.06 0.13 0.48 0.634 0.072 
Mineral mass (kg)
2 
2.51 1.55 1.63 0.115 0.192 3.15 1.70 1.86 0.073 0.022 
DXA bone mineral content (kg)
2 
3.12 2.00 1.56 0.131 0.183 4.87 2.01 2.42 0.021 0.084 
DXA bone mineral density (g/m
3
) 7.09 5.14 1.38 0.179 0.009 6.73 6.03 1.12 0.272 0.018 
SDS; standard deviation score, DXA; dual-energy X-ray absorptiometry, 
1
except BMI SDS, 
2
 additionally adjusted for lumbar spine bone area 
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6.6.5 Body composition assessed by simple techniques 
 
Body composition assessed by SFT, BIA, DXA and TBW and a comparison with the 
4CM is presented in Chapter 8. 
 
6.7 Discussion 
 
 
The findings of this analysis confirm the clear sex differences presented in Chapter 5 
where deficits in FM and FFM including MM are apparent in the girls with CF 
whereas the boys with CF have body composition much closer to that of controls. 
 
The aims of this chapter were to test the hypotheses that; (1) there is no significant 
difference in body composition at baseline but differences will be apparent over time, 
(2) that specific components of body composition are associated with lung function 
in children with CF and (3) that the conclusions are the same regardless of the mode 
of analysis.  This chapter relates to chapter 5 because it investigates the body 
composition and lung function of children with CF at baseline, albeit a smaller 
number of CF children compared to a larger number of control children.  The 
reduction in numbers of CF children is due to the fact that only children who have 2 
complete 4CM measurements at baseline and 2 years are included.  The reduced 
number of boys in this baseline analysis as opposed to the baseline analysis in 
Chapter 5 means that the average FFM has increased and average FM decreased in 
boys although this does not affect the outcome of the group comparison.  The group 
mean for body composition variables in the CF girls are similar.  
 
Analyses in this chapter are cross-sectional at baseline and 2 years using a control 
group and using a large reference population.  The control group comparison, 
although smaller in number than the reference group has the advantage of being 
contemporary although may not be considered ‘normal’, for example, control girls in 
this study have on average 0.4 SDS greater weight and height than the 1990 UK 
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reference data.  The group matching also allows for comparison of change over time 
(Chapter 7).  Comparison to a reference population assures that the children with CF 
are compared to standardised controls but has the disadvantage that reference data 
becomes out-of-date.  The 1990 UK reference data used in this study for 
anthropometric comparison was collected in 1988 and the body composition and SFT 
data was collected from 2001-2007.  However, in a clinical situation comparison 
with a reference population is the most practical method.  
 
Although one study reported that children with CF do not have delayed puberty (36) 
others report delayed puberty (35;220).  In this study the boys with CF have delayed 
puberty compared to the healthy boys but surprisingly, although there are a few more 
pre-pubertal CF girls at baseline, (68% compared to 61%) at aged 8-14 years there 
are slightly more controls (29% control compared to 27% CF) that are pre-pubertal.  
It is difficult to find an explanation since the CF girls are smaller with lower FMI and 
FFMI SDS than control girls.  If the CF and control girls are divided by Tanner stage 
1 and 2 compared to Tanner stage 3 and above then the results are; stage 1 and 2, CF 
66%, control 59%, Tanner stage ≥3, CF 34%, control 41%.  This indicated that there 
are more control girls in the later stages of puberty than girls with CF and this is a 
stage when the effect of growth and development are the greatest.  It is also possible 
that the girls with CF may be overestimating their own development in line with that 
of their peer group.  An alternative explanation from an evolutionary biology 
perspective would suggest that the less likely an organism is to live then the earlier 
menarche occurs in order to produce offspring earlier (221).       
 
6.7.1 Regarding hypothesis 1; that there will be no significant 
differences in body composition at baseline but differences will 
become apparent over time. 
 
The findings that at baseline the girls with CF have altered body composition does 
not support hypothesis 1 although the boys with CF appear to be similar to control 
children.  After 2 years boys with CF had a reduction in FFM and girls remain with 
deficits of FM, FFM and MM.   
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In accord with previous research (64;72;100) both boys and girls with CF are short at 
both time points.  The smaller hip and mid-upper arm circumference of the children 
with CF suggests they are less mature than their healthy counterparts. 
 
All the children in this study had waist circumferences greater than the 1990 UK 
reference data, however, the group mean was greater in the CF children compared to 
controls, possibly reflecting inflammation and/or enlargement of the abdominal 
organs.  In the absence of higher FM by 4CM or raised SFT it is unlikely that this 
large waist circumference is due to fat.  Regional FM and FFM by DXA indicated 
that boys with CF had more overall FFM and that the difference was totally in the 
trunk at both time-points.  Despite the girls with CF having similar FFM to controls 
they also appeared to have much more FFM in the trunk and an equal deficit in the 
limbs. Compared to controls the girls with CF also have a large deficit of FM in the 
limbs (-0.7 kg baseline and -1.0 kg at 2 years).  DXA regional soft tissue SDS would 
aid the understanding of regional differences. 
 
The reason for identifying high FFM in the trunk may be a true increase or due to 
methodological problems.  It is possible that increased FFM in the trunk is related to 
bowel dysfunction; abdominal pain and discomfort are common in CF with long gut 
transit times reported (222), sub-mucosal fibrosis and stasis of faecal material (223) 
and thickened mucosal covering of the bowel (224) which are all possible reasons for 
the enlarged bowel and waist circumference identified in this group. In addition other 
organs may be enlarged; right ventricle enlargement as a result of pulmonary 
hypertension and liver and spleen enlargement due to hepatobiliary obstruction 
(225).  One might suppose that since the children in this study are young the number 
and severity of these symptoms will be limited; only 1 child had liver disease 
diagnosed at baseline and 7 by the second measurement.  However, it is also likely 
that these problems are preceded by asymptomatic changes and these, combined with 
inflammation and oedema may account for the distended abdomen.    
 
Methodological problems may have some impact on these findings.  DXA 
measurements have been shown to be biased in extremes of fatness and thinness 
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(102;196) which may have several causes.  First, an assumed constant for hydration 
(226); second, subject size may influence bias through the effect of tissue depth 
(196) with increasing tissue depth associated with increasing bias by DXA (227); 
third, soft tissue distribution may affect accuracy because pixels containing bone 
extrapolate soft tissue composition from adjacent regions which may have a different 
composition of FM and FFM from the region overlying the bone (196).  In the trunk 
region there are many more bone to non-bone pixels than other parts of the body and 
this, coupled with a distended abdomen and possible oedema may, in part explain the 
findings of large increases in FFM in the trunk of children with CF.  Comparative 
studies between DXA and MRI may illuminate the question.  However, partial 
correlations suggest that the variability in the waist circumference of the children 
with CF cannot be explained by FM and FFM to the same extent as in controls, (R
2
; 
CF FM 67%, FFM 28% and controls FM 81%, FFM 36%).  Body composition is not 
exerting the same influence on waist circumference in CF children as in controls. 
  
Once an adjustment for age, height and puberty has been made the boys with CF 
differ from the controls at baseline having more FFM.  At 2 years there is no longer a 
significant difference in FFM except where the comparison is made using FFM 
indexed and converted to SDS.  This is an indication of the differing outcome 
depending on whether raw body composition variables (adjusted for actual height), 
indexed variables (adjusted for height
2
) or SDS are used in the analysis. These 
findings are contrary to expectation, the boys with CF have more FFM at baseline 
and at 2 years although no longer statistically significant.  In this study the girls with 
CF have a deficit of FM at baseline which appears stable over time.  The girls with 
CF group-mean FFMI SDS deteriorates over time although the mineral component is 
stable and low suggesting deterioration in the non-mineral lean mass. 
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6.7.2 Regarding hypothesis 3, that the conclusions are the same 
regardless of the mode of analysis. 
 
The question of whether it is better to compare the CF children directly to a group of 
controls or whether to compare to a larger reference population using SDS is 
debatable.  Comparison with a smaller contemporary control group has the advantage 
of comparing two groups of children measured at a similar time and allows for 
comparison of change in one group compared to change in the other over time. 
Comparison with a reference population is preferable in a clinical setting. 
 
Comparison between pair and group-match is difficult in this study because there is a 
reduced number in the group-match.  The boys at baseline in the pair-match (Chapter 
5) are heavier and taller than the reduced number of boys in the group-match analysis 
(Chapter 6).  However, at both analyses they are short (pair-match, -0.41 height SDS, 
group-match -0.51).  The girls with CF have similar mean BMI SDS in the pair  
(-0.33) and group (-0.26) analyses. The question of whether it is better to compare a 
patient group (pair or group-match) to a control group or to a reference group is 
inevitably affected by how typical the control group is.  Clearly, the larger the 
number of control children, the more likely their mean value is typical of healthy 
children and therefore, the use of large reference populations, particularly when they 
are in a similar ethnic group, era or geographic area has even greater benefits.  Such 
reference populations allow for the calculation of SDS thereby allowing comparison 
of the child to a standard and allowing assessment of change over time.  In addition, 
comparison can still be made by pair or group analysis by first standardizing both 
patient and controls to the large reference population by calculating SDS.  Table 6.8 
based on comparison of SDS against reference and group-match and without and 
with adjustment for age, height and puberty indicated that in boys, different 
outcomes are obtained dependent on whether adjustment for age, height and puberty 
has been made. In the analyses of girls’ data the picture is less clear which may, in 
part be due to the control girls being taller and heavier than average.   
       
  
143 
 
6.7.3 Regarding hypothesis 2, that specific components of body 
composition are associated with spirometry in children with cystic 
fibrosis 
 
Girls had poorer lung function than boys, which deteriorated over two years.  This 
may be a reflection of their sub-optimal body composition and prognosis. In accord 
with many previous studies FFM was significantly associated with lung function in 
boys only at 2 years.  There was no such relationship in girls with both FM at 
baseline and total BMC at 2 years positively associated with FEV1 possibly a 
reflection of, or a contribution to their poor nutritional status. 
 
6.8 Study limitations 
 
 
As acknowledged in the previous chapter I used predicted rather than measured lung 
volume when calculating body volume by ADP.  However, a study of children with 
CF deriving FM from ADP concluded that there was no significant difference in FM 
calculations between measured or predicted lung volumes (219).  
Since exercise will affect the amount of lean tissue we repeated the analyses taking 
into account parental reported exercise level; there was no difference in outcome.  
However, the parental rating may be affected by differing expectations in healthy and 
chronically ill patients and between the sexes.  In future studies it will be informative 
to use an objective measure of physical activity. 
This study compares the same children at 6-12 and 8-14 years and therefore the 
numbers are reduced from the original analysis of 85 to 69.  However, this would be 
sufficient to detect a 0.48 SDS difference between groups which is likely to be 
clinically important.     
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6.9 Summary 
 
 
 There were clear sex differences at baseline, with CF boys having more FFM 
and girls with CF have less FM and MM than the reference population.  This 
is consistent with the findings in the larger cohort presented in Chapter 5.   
 After 2 years FFMI SDS is lower in boys (although above zero) and the girls 
remain stable for FM and MM but have lower non-osseus FFM.   
 Increased waist circumference in children with CF is accompanied by 
increased FFM in the trunk as assessed by DXA in the absence of increased 
FM by 4CM or SFT.  The nature of abdominal distension may be better 
identified using MRI. 
 The findings of this study are that, unlike previous research it is FM that relates 
to lung function at baseline in the girls only.  Consistent with previous studies I 
found a relationship between FFM and lung function in boys at age 8-14 years.  
Total BMC also related to lung function in 8-14 year old girls with CF. 
 The sub-optimal body composition in girls may be a reflection of their poor 
lung function. 
 My findings do not support the hypothesis that the conclusions are the same 
regardless of whether matched-pairs, group comparisons or comparison with a 
reference population are used for comparison.  As a consequence it is difficult to 
compare the findings of studies using different methods of analysis and for 
clinical practice the solution is likely to be a pragmatic one.  Clinically, the 
simplest method to identify individual children with sub-optimal body 
composition and to monitor them over time is to use SDS.   
 The limitations of each method of analysis need to be acknowledged and the fact 
that statistical significance does not necessarily equate to clinical significance 
needs to be considered. 
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Chapter 7.  Longitudinal comparison of two-year change in 
body composition of children with cystic fibrosis with that 
of healthy children and the relationship between change in 
body composition and lung function in children with cystic 
fibrosis.  
 
 
7.1  Introduction 
 
 
Although there are several reports of longitudinal growth (height and weight) in 
children with CF (10;13;50;122;141) there are few studies that address the changes 
in body composition over time (36;65;67;96) and none that use a ‘criterion’ body 
composition technique.  This chapter outlines the change in body composition over 2 
years in CF children age 6-12 years using the 4CM and compares the change to that 
of healthy children. The relationship between change in body composition and 
change in lung function in CF children is also presented.  The subjects and methods 
are the same as those presented in the cross-sectional analysis (Chapter 6) and 
Figure 7.1 shows the relationship between the analyses and the subjects in Chapters 
5, 6 and 7. 
 
         Chapter 5   Chapter 6                    Chapter 7 
 
 
 
 
 
 
Figure 7.1.  Description of mode of analyses and subjects in Chapters 5-7. 
 
Longitudinal comparison 
with reference data and  
group-match analyses. 
69 of 85 CF 
72 of 85 Control + 21 
Cross-sectional, comparison 
with reference data and 
group-matched analyses 
69 of 85CF,  
72 of 85Control + 21 
Cross-sectional, 
comparison with reference 
data and pair-match 
analyses 
85 CF, 85 Control 
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The hypothesis addressed in this chapter is that; baseline and change in specific 
components of body composition are associated with disease severity and predict 
clinical outcome. 
   
7.2 Study design 
 
 
This is a longitudinal study comparing the 2 year change in body composition of 
both children with CF and age matched (6-12 years at baseline) controls.  Change 
was investigated in both absolute and conditional (that is unrelated to the baseline) 
terms.  In addition, baseline and conditional change in lung function, measured on 
the same day (or within 4 weeks if not possible) was related to conditional change in 
body composition in the children with CF. 
 
7.3 Recruitment and exclusion criteria 
 
 
Children with CF were recruited from patients at GOSH and the control children 
from an on-going study of healthy children at UCL, ICH.  Details can be found in 
Chapter 4. 
 
7.4 Methods 
 
 
Measures of anthropometry and BMC, TBW and densitometry for 4CM were 
performed as described previously.  LS and whole body BMC and BMD were measured 
by DXA to assess bone status.   Confounding factors such as pubertal status and activity 
were assessed with questionnaires, the details of all these can be found in Chapter 4 and 
Appendices 5 and 6.  The children with CF also had lung function assessed, described in 
Chapter 4. 
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7.5 Statistical analyses 
 
7.5.1 Size adjustment and standard deviation score calculation 
 
Characteristics of all the children were compared to 1990 UK reference data to 
generate SDS for weight, height, BMI and waist circumference.  Size adjustment of 
body composition variables was made as described in 4.6.2.  and SDS were 
calculated compared to a contemporary reference population for FM, FFM, PM, MM 
and SFT. Total and LS BMD SDS were generated from the Lunar Prodigy software 
using machine reference data matched for age, sex and ethnic group and a size 
adjusted BMAD SDS was calculated as described in 4.6.2. Conditional change in 
anthropometric and body composition variables were calculated by generating a 
prediction equation for each parameter using data from the controls and then 
calculating the residuals (predicted – actual) for children with CF as described in 
4.6.6.  Conditional change in FEV1 was calculated using regression analysis in the 
children with CF only. 
 
7.5.2 Comparison of change in anthropometric and body 
composition variables  
                                                 
Initial analysis indicated a strongly significant difference between the sexes and 
therefore data for males and females were analysed separately. 
Change between baseline and two years in CF and controls separately was 
investigated; (i) using paired t-tests between baseline and 2 year variables in both CF 
and control children (absolute change) and (ii) using one-sample t-tests for the 
difference between conditional change (change other than that expected if the CF 
child is tracking growth and body composition of the control group) and zero in CF 
children only. Group means for absolute and conditional change would be similar in 
the control children because the regression equation was derived from this group.  
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(iii) Difference in change (2 year – baseline) between CF and control children was 
investigated using independent t-tests. 
Summary of comparison of change analysis 
1)  CF absolute change 0-2 years    paired t-test 
2)  Control absolute change 0-2 years    paired t-test 
3) CF conditional change 0-2 years    1 sample t-test 
4) CF absolute change compared to control absolute change independent t-test 
 
7.5.3 Effect of predictors of change on anthropometric and body 
composition variables 
 
To identify possible predictors of conditional change in body composition variables 
for inclusion in the regression models, Pearson’s correlation and Spearman’s rho, 
(for skewed data) was performed for data of children with CF.  Factors included 
were; spirometry, activity, anthropometric and body composition variables at 
baseline and conditional change.  In addition pubertal status at baseline and change 
in pubertal status and genotype were included. Multiple backwards regression 
analysis was used separately to investigate predictors of conditional change in FMI 
or FFMI or MMI SDS.  
A general linear model was used to investigate any significant effect of CF on 
change in height, weight, BMI, FMI, FFMI or MMI SDS with the 2 year 
measurement as the dependent variable and the baseline measurement as the 
independent variable with condition (CF=1, control =0) as a fixed factor.  
Considering the significant associations a separate general linear model was 
performed to investigate any interactions between CF and baseline measurements. 
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Summary of effect of predictors analyses 
1) Correlation analysis in CF children to identify possible predictors of 
conditional change in body composition variables for inclusion in subsequent 
multi-variant analyses. 
2) Multiple backwards regression analysis to identify predictors of conditional 
change in FMI SDS, FFMI SDS and MMI SDS in CF and control separately. 
3) General linear model to investigate the possible effect of having CF on 
absolute change in anthropometric and body composition variables. 
4) Considering the results of 3), general linear model to test for any interaction 
between having CF and the baseline measurement in relation to the final 
measurement. 
 
7.5.4 Spirometry 
 
Correlation (Pearson’s for normally distributed and Spearman’s rho for skewed data) 
analysis was used to identify significant associations between absolute change in 
FEV1 SDS and baseline and conditional change in activity, anthropometric and body 
composition variables, puberty and genotype.  Significant factors were included in 
regression analyses to investigate the relationship between body composition 
variables and conditional change in FEV1 SDS in the children with CF.  Conditional 
change in FEV1 SDS was calculated from the CF children only because the control 
children did not perform spirometry.  
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7.6 Results 
 
7.6.1 Subjects 
 
The same 69 (38 girls) CF and 93 (49 girls) control children, who all had 2 complete 
4CM measurements and were included in the cross-sectional analysis of Chapter 6  
were included in this analysis. 
 
7.6.2 Change in anthropometry and body composition 
 
Group absolute and conditional change in anthropometric and body composition 
variables is shown in Table 7.1 (boys) and Table 7.2 (girls).  Change in FMI SDS 
(Figure 7.2) in children with CF was variable and a graph showing change in FFMI 
SDS (Figure 7.3) indicates that many of the children have declining FFMI SDS. 
7.6.2.1 Absolute change in body composition 
 
For SDS, which are comparable over time, control boys showed upward centile 
crossing in weight SDS (p<0.05) and SFT SDS (p=0.001) and downward centile 
crossing for LS BMD SDS (p<0.05) but not size adjusted BMAD.  Boys with CF 
had, on average, downward centile crossing for waist SDS (p<0.05) and FFMI SDS 
(p<0.01). Both control and CF girls showed upward centile crossing waist (p<0.01) 
and SFT SDS (p<0.05).  Table 7.3 shows the mean difference in absolute change (2 
year – baseline) between CF and control children (CF – control).  The significant 
differences were, boys; age difference (mean (SD), CF; 2.08(0.13), control; 
2.03(0.06)), waist SDS, (CF; -0.20 (0.46), control; 0.05 (0.45)), body volume, (CF; 
6.25(3.07), control; 8.53(5.56)) and FFMI SDS, (CF;-0.35 (0.67), control; -0.05 
(0.51)) and girls FFMI SDS, (CF; -0.14 (0.53), control; 0.11 (0.46).  
7.6.2.2 Conditional change in body composition 
 
Conditional change in control children is not presented in the tables 7.1 and 7.2 
because, as expected, the group mean is approximately zero.  Conditional change in 
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boys with CF indicated significantly lower than expected gain in BMI SDS, waist 
SDS (p<0.01) and FFMI SDS (p<0.05), that is to say that they were not following the 
control group pattern of growth and lean tissue acquisition.  However, SFT SDS 
gains were higher than expected (p=0.051).  Girls with CF appear to be tracking the 
control girls’ growth and body composition (albeit with lower values) apart from 
values for FFMI SDS which appear to be reducing (p<0.001).  They also have a 
lower change in exercise time, an average of 1 hour 20 minutes less than the control 
girls (p<0.05). 
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Table 7.1.  Change between baseline and two years in boys 
 CF n=31 Control n= 44 
 Absolute change Conditional change Absolute change 
 
 Mean SD P Mean SD P Mean SD P 
Age (y) 2.08 0.13 <0.001    2.03 0.06 <0.00
1 
Weight SDS -0.04 0.49 0.682 -0.18 0.50 0.060 0.14 0.38 0.018 
Height SDS 0.10 0.29 0.073 -0.01 0.29 0.784 0.09 0.34 0.079 
BMI SDS -0.14 0.54 0.153 -0.28 0.57 0.010 0.10 0.53 0.211 
Waist SDS -0.20 0.46 0.024 -0.26 0.46 0.004 0.05 0.45 0.443 
4 skinfold thickness SDS
1 
0.06 0.61 0.565 0.21 0.58 0.051 0.29 0.53 0.001 
LS bone mineral density SDS -0.10 0.47 0.197 0.02 0.43 0.806 -0.12 0.34 0.018 
LS bone mineral apparent density SDS 0.10 0.43 0.254 0.16 0.46 0.072 -0.07 0.66 0.491 
Fat mass index SDS 0.05 0.69 0.702 -0.07 0.60 0.534 0.11 0.64 0.279 
Fat-free mass index SDS -0.35 0.67 0.007 -0.24 0.66 0.047 -0.05 0.51 0.517 
Protein mass index SDS -0.25 1.15 0.236 -0.16 0.88 0.320 0.16 0.93 0.260 
Mineral mass index SDS -0.11 0.44 0.171 -0.01 0.44 0.893 -0.01 0.49 0.893 
FEV1 SDS -0.06 0.95 0.749       
Activity (hours) -0.19 7.58 0.888 -0.27 5.33 0.783 0.80 5.26 0.322 
 
SDS; standard deviation score, 
1
 n=30 for CF, LS; lumbar spine, bone mineral apparent density; size adjusted (bone area) bone mineral density, FEV1, 
forced expiratory volume in 1 sec.  P; paired t- test for absolute change and 1 sample t-test against zero for conditional change. 
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Table 7.2.  Change between baseline and two years in girls 
 CF n= 38 Control n=49 
 Absolute change Conditional change Absolute change 
 
 Mean SD P Mean SD P Mean SD P 
Age (y) 2.06 0.22 <0.001    2.04 0.14 <0.00
1 
Weight SDS -0.01 0.43 0.866 -0.11 0.46 0.170 0.03 0.28 0.420 
Height SDS 0.06 0.45 0.422 -0.15 0.47 0.060 0.10 0.39 0.077 
BMI SDS -0.05 0.53 0.559 -0.10 0.54 0.261 0.01 0.35 0.799 
Waist SDS 0.24 0.51 0.007 0.10 0.57 0.505 0.19 0.46 0.007 
4 skinfold thickness SDS
1 
0.23 0.63 0.036 0.05 0.60 0.595 0.15 0.47 0.036 
LS bone mineral density SDS -0.14 0.76 0.279 -0.17 0.74 0.176 0.025 0.59 0.768 
LS bone mineral apparent density SDS 0.03 0.72 0.773 0.02 0.66 0.857 -0.01 0.54 0.890 
Fat mass index SDS 0.08 0.70 0.473 0.05 0.72 0.688 -0.03 0.45 0.690 
Fat-free mass index SDS -0.14 0.53 0.104 -0.30 0.54 0.001 0.12 0.45 0.075 
Protein mass index SDS 0.01 1.21 0.965 -0.13 1.09 0.466 0.15 0.85 0.216 
Mineral mass index SDS 0.16 0.74 0.185 -0.04 0.69 0.715 0.10 0.50 0.154 
FEV1 SDS -0.49 0.92 0.003       
Activity (hours) -1.37 4.56 0.073 -1.28 3.23 0.019 -0.06 3.96 0.914 
 
SDS; standard deviation score, 
1
 n=36 for CF and 48 for control, LS; lumbar spine, bone mineral apparent density; size adjusted (bone area) bone 
mineral density, FEV1, forced expiratory volume in 1 sec.  P; paired t- test for absolute change and 1 sample t- test against zero for conditional change. 
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Figure 7.2.  Individual change in fat mass index standard deviation score from baseline to two years 
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Figure 7.3.  Individual change in fat-free mass index standard deviation score from baseline to two years 
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Table 7.3.  Difference in change (cystic fibrosis (CF) minus control) between CF and control children.  
 
Positive values denote larger change in children with CF   
 Boys (CF 31, control 44) Girls (CF38, control 49) 
Mean SEM P Mean SEM P 
Age yrs 0.05 0.02 0.030 0.02 0.04 0.501 
Weight SDS -0.18 0.10 0.081 -0.04 0.08 0.562 
Height SDS 0.03 0.07 0.959 -0.02 0.09 0.646 
BMI SDS -0.25 0.13 0.056 -0.07 0.09 0.502 
Waist SDS -0.25 0.10 0.022 0.07 0.11 0.638 
LS BMD SDS 0.02 0.09 0.768 -0.14 0.14 0.271 
LS BMAD SDS 0.17 0.14 0.456 0.06 0.13 0.135 
FMI SDS -0.06 0.15 0.698 0.08 0.12 0.464 
FFMI SDS -0.32 0.14 0.029 -0.26 0.10 0.017 
PMI SDS -0.41 0.24 0.093 -0.14 0.22 0.518 
MMI SDS -0.10 0.19 0.368 0.04 0.14 0.659 
Sum4 skinfold thickness SDS -0.23 0.13 0.091 0.11 0.12 0.352 
Activity (hours) -0.99 1.48 0.507 -1.37 0.90 0.157 
 
Independent t-test, mean difference is CF minus control, which were as follows; boys, age difference (mean(SD), CF; 2.08(0.13), control; 
2.03(0.06)), waist SDS, (CF; -0.20 (0.46), control; 0.05 (0.45)), body volume, (CF;6.25(3.07), control; 8.53(5.56)) and FFMI SDS,  
(CF;-0.35 (0.67), control; -0.05 (0.51)). 
Difference in girls FFMI SDS was CF; -0.14 (0.53), control; 0.11 (0.46). 
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7.6.3 Predictors of conditional change in fat mass index, fat-free 
mass index and mineral mass index standard deviation scores 
7.6.3.1 Choice of variables. 
 
Conditional change in FMI, FFMI, and MMI SDS were chosen as the dependent 
variables (DV).  Although MM is part of FFM it was included in the analysis 
because the girls with CF showed a deficit at baseline.  It is more usual to assess 
bone mineralisation using BMD SDS obtained by DXA, however, MMI SDS from 
the 4CM is included in the analysis for consistency with FM and FFM.  Initial 
regression analysis in girls suggested that FMI SDS predicts conditional change in 
FFMI SDS and FFMI SDS predicts conditional change in FMI SDS.  However, if 
there is measurement error in FM there will be an equal and opposite error in FFM 
since they are both calculated using the 4CM and this may confound the analysis.  
Therefore, values of FFM from DXA were used to investigate predictors of 4C FM 
and DXA FM to investigate 4C FFM and MM. 
 
Choice of independent variables to enter in a regression model was decided on the 
basis of correlation analyses presented in Table 7.4 for children with CF.   
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Table 7.4.  Correlation analyses of potential predictors of body composition variables in children with cystic fibrosis. 
 Conditional 
FMI SDS 
Conditional 
FFMI SDS 
Conditional 
MMI SDS 
 Boys Girls Boys Girls Boys Girls 
 R P R P R P R P R P R P 
Weight SDS year 0  NS  NS  NS  NS  NS  NS 
Conditional weight 0.60 <0.001 0.63 <0.001 0.58 <0.001  NS 0.40 <0.05 0.54 <0.01 
Height SDS year 0  NS  NS  NS  NS  NS  NS 
Conditional height  NS  NS  NS  NS 0.43 <0.05 0.46 <0.01 
BMI SDS year 0  NS  NS  NS  NS  NS  NS 
Conditional  BMI SDS 0.63 <0.001 0.76 <0.001 0.57 <0.001  NS 0.36 <0.05  NS 
Puberty year 0  NS  NS  NS  NS  NS  NS 
Change in puberty   NS  NS  NS  NS  NS  NS 
FMI SDS year 0  NS  NS  NS  NS  NS  NS 
Conditional FMI SDS      NS  NS  NS  NS 
FFMI SDS year 0  NS  NS  NS  NS  NS  NS 
Conditional FFMI SDS  NS  NS     0.59 <0.001  NS 
MMI SDS year 0  NS  NS  NS 0.36 <0.05  NS  NS 
Conditional  MMI SDS  NS  NS 0.59 <0.001  NS     
Activity year 0  NS  NS  NS  NS  NS  NS 
Hours activity year 0  NS  NS  NS  NS  NS  NS 
Change in hours activity  NS  NS  NS  NS  NS  NS 
FEV1 SDS year 0  NS  NS 0.42 <0.05  NS 0.38 <0.05  NS 
Conditional FEV1SDS 0.41 <0.05  NS  NS  NS  NS  NS 
Genotype  NS  NS  NS  NS  NS  NS 
Correlation analysis is Pearson’s for normally distributed and Spearman’s rho for skewed data, puberty is classed as Tanner stage 1 (pre-pubertal) 
compared to stages 2-5.  Change in puberty from baseline to 2years is; (1) Tanner stage 1, no change, (2) Change from stage 1, (3) no change from stage 
2-5. Activity classed as; less than, same as or more than peers.  Genotype is homozygous versus heterozygous ΔF508 (48 v 17)
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 There was correlation between conditional weight and conditional BMI and the 
body composition variables as expected, since weight is the total of FM and FFM 
and BMI = FMI + FFMI.  Weight and BMI were not included in the model.  
Although change in pubertal status did not show any correlation with the body 
composition variables in this sample, it was included in the regression analysis 
because pubertal development affects body composition.  The independent variables 
included in the backward regression analysis were therefore;   
 
Table 7.5. Dependent and independent variables used in regression analysis to 
identify predictors of body composition variables. 
 
 Dependent variable 
Independent 
variable 
Conditional change 
in FMISDS 
Conditional change 
in FFMI SDS 
Conditional change 
in MMI SDS  
Baseline height 
SDS 
Yes Yes Yes 
Conditional change 
in height SDS 
Yes Yes Yes 
Baseline FMI SDS Yes Yes Yes 
Conditional change 
in FMI SDS 
 Yes Yes 
Baseline FFMI 
SDS 
Yes Yes  
Conditional change 
FFMI SDS 
Yes   
Baseline MMI SDS   Yes 
Conditional change 
MMI SDS 
   
Change in pubertal 
stage 
Yes Yes Yes 
In addition the analysis in children with CF included baseline and conditional change 
in FEV1 SDS. 
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7.6.3.2 Conditional change in body composition of children with cystic 
fibrosis. 
 
Significant predictors from separate multiple backward regression analyses are 
presented in Table 7.6 (boys) and Table 7.7 (girls).  Conditional change in height 
was a positive predictor of conditional change in MMI SDS in all children with CF.  
There were no identified predictors of conditional change in FMI or FFMI SDS in 
girls. 
 
Table 7.6.  Regression analysis of conditional change in; fat-mass index or fat-free 
mass index or mineral mass index standard deviation scores in boys with cystic 
fibrosis. 
 Boys  n=31 
 B 95% confidence interval P 
Conditional change in 4C FMI SDS (DV) 
Conditional change in FEV1SDS 0.27 0.04,      0.51 0.024 
Adjusted R
2 
0.14 
Conditional change in 4C FFMI SDS (DV) 
DXA conditional change in FMI SDS 0.45 0.09,    0.80 0.016 
FFMI SDS year 0 -0.23 -0.42,    -0.05 0.016 
Adjusted R
2 
0.37 
Conditional change in 4C MMI SDS (DV) 
Conditional change in height SDS 0.69 0.21,    1.18 0.007 
FEV1
 
SDS year 0 0.12 0.03,    0.21 0.013 
Adjusted R
2 
0.30 
 
 
 
Table 7.7.  Regression analysis of conditional change in; fat-mass index or fat-free 
mass index or mineral mass index standard deviation scores in girls with cystic 
fibrosis. 
 Girls  n=38 
 B 95% confidence interval P 
Conditional change in 4C FMI SDS (DV) 
No significant predictors
 
 
Conditional change in 4C FFMI SDS (DV) 
No significant predictors  
Conditional change in 4C MMI SDS (DV) 
Height SDS year  0 0.23 0.07,    0.39 0.007 
Conditional change in height SDS 0.62 0.26,    0.99 0.001 
MMI SDS year 0 -0.21 -0.38,   -0.04 0.018 
Adjusted R
2 
0.40 
  
161 
 
7.6.3.3 Absolute change in body composition of control children. 
 
The group mean conditional change in the control group will have a value close to 
zero (because the regression equation is generated from the control data) and 
therefore finding factors that predict such a small value are unrealistic. In the control 
group I used regression analysis to investigate possible predictors of absolute change 
in FMI, FFMI and MMI SDS.  None of the factors considered were significant for 
the body composition variables for boys, the data for girls is shown in (Table 7.8). 
 
Table 7.8.  Regression analysis of absolute change in; fat mass index or fat-free mass 
index or mineral mass index standard deviation scores in control girls. 
 
 Girls  n=49 
 B 95% confidence interval P 
Absolute change in 4C FMI SDS (DV) 
FMI SDS year  0 -0.13 -0.26,    -0.003 0.046 
DXA absolute change in FFMI SDS -0.31 -0.60,    -0.03 0.032 
Adjusted R
2
 0.16 
Absolute change in 4C FFMI SDS (DV) 
FFMI SDS year 0 -0.19 -0.33,    -0.05 0.010 
Adjusted R
2
 0.14 
Absolute change in MMI SDS (DV) 
Height SDS year 0 0.17 0.06,      0.29 0.004 
DXA FMI SDS year 0 0.11 0.01,      0.21 0.033 
MMI SDS year 0 -0.15 -0.25,    -0.05 0.003 
Adjusted R
2 
0.27 
 
 
7.6.4 Effect of cystic fibrosis on change in anthropometric and body 
composition variables 
 
In order to determine whether having CF impacts on change in growth and body 
composition variables (height, weight, BMI, FMI, FFMI or MMI SDS) regression 
analyses were done with the 2 year measurement as the dependent variable, the 
baseline measurement as the covariant and condition (CF=1, control=0) as a fixed 
factor and the findings are presented in Table 7.9.  Boys and girls were analysed 
separately.  Condition was only significant for FFMI SDS in girls (p<0.01) and 
approached significance for BMI SDS in boys (p=0.06).  
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Table 7.9.  General linear model for effect of condition (cystic fibrosis=1, control = 
0) on growth and body composition 
 
 Girls  (CF=38, control =49) 
 B 95% confidence interval P 
FFMI SDS year 2 (DV) 
FFMI SDS year  0 0.88 0.76,    0.99 <0.001 
Condition 0 0.30 0.09,    0.50 0.006 
Adjusted R
2 
0.75 
 Boys  (CF=31, control =44) 
 B 95% confidence interval P 
BMI SDS year 2 (DV) 
BMI SDS year  0 1.01 0.86,    1.16 <0.001 
Condition 0 0.25 -0.01,    0.51 0.060 
Adjusted R
2 
0.71 
 
Estimated means (SE) FFMI SDS in girls at 2 years after adjusting for baseline 
values was; CF -0.33(0.08) and controls -0.04 (0.07) and for BMI SDS at 2 years 
after adjusting for baseline values in boys; CF -0.08(0.10) and controls 0.17(0.08). 
 
A separate general linear model was performed to test for any interaction between 
CF and baseline measurement of BMI SDS or FFMI SDS.  There were no significant 
interactions.  
 
7.6.5 Relationship between two-year change in body composition 
and two-year change in spirometry 
 
Mean FEV1 SDS was; CF boys, mean (SD), baseline -1.10 (1.54) and 2 years -1.15 
(1.56) (Table 7.3) and CF girls, baseline -1.56 (1.44) and 2 years -2.05 (1.58) (Table 
4).  There was a significant deterioration in the girls’ FEV1 (p<0.01) between 
baseline and 2 years of 0.5 SDS. Boys and girls 2 year change in FEV1 SDS 
compared to 2 year change in either FMI SDS or FFMI SDS is presented in Figures 
7.4 and 7.5.  Correlations between change in FEV1 SDS and change in FMI SDS 
were boys; R = 0.51, p<0.01, girls; 0.12, NS and between change in FEV1 SDS and 
change in FFMI SDS, boys; R = 0.07, NS, girls; -0.001, NS.  Correlations between 
conditional change in FEV1 SDS and conditional change in either FMI or FFMI SDS 
gave similar results. 
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a)
 
Figure 7.4 Two year change in FEV1 and fat mass index SDS in a) boys and b) girls  
with cystic fibrosis. 
 
b) 
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a) 
 
Figure 7.5 Two year change in FEV1 and fat-free mass index SDS in a) boys  and b) 
girls with cystic fibrosis. 
b) 
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In the analysis of factors predicting change in body composition variables 
conditional change in FEV1 SDS was a significant predictor of conditional change in 
FMI SDS and baseline FEV 1 SDS predicted conditional change in MMI SDS in boys 
only.  From a clinical perspective it is helpful to know if any body composition, 
anthropometric or other variables predict FEV1 SDS.  Significant correlations were 
therefore investigated and presented in Table 7.10. 
  
Table 7.10.  Correlation between potential predictors and absolute change in FEV1  
standard deviation scores in children with cystic fibrosis 
 Boys Girls 
 R P R P 
Weight SDS Yr 0 -0.18 0.341 0.14 0.401 
Conditional change in weight SDS 0.36 0.050 0.14 0.420 
Height SDS Yr 0 -0.24 0.201 0.11 0.520 
Conditional change in height SDS 0.22 0.236 0.20 0.232 
BMI SDS Yr 0 -0.02 0.927 0.15 0.372 
Conditional change in BMI SDS 0.28 0.139 0.04 0.805 
FMI SDS Yr 0 -0.29 0.120 0.01 0.950 
Conditional change in FMI SDS 0.47 0.009 0.12 0.493 
FFMI SDS Yr 0 0.19 0.313 0.23 0.181 
Conditional change in FFMI SDS 0.07 0.697 0.06 0.723 
MMI SDS Yr 0 0.03 0.865 -0.10 0.549 
Conditional change in MMI SDS 0.15 0.445 0.31 0.069 
LS BMD SDS Yr 0 0.08 0.688 0.09 0.608 
Conditional change in LS BMD SDS 0.24 0.209 0.25 0.144 
LS BMAD SDS Yr0 0.27 0.152 0.07 0.691 
Conditional change in LS BMAD SDS 0.29 0.123 0.10 0.580 
4 skinfolds SDS Yr 0 -0.07 0.716 0.09 0.611 
Conditional change in 4 skinfolds SDS 0.21 0.265 -0.02 0.910 
Pre-pubertal Yr 0 -0.09 0.636 0.08 0.664 
Pre-pubertal Yr 2 -0.12 0.522 0.002 0.990 
Change in pubertal status 0.13 0.491 -0.05 0.761 
Activity level Yr 0 0.36 0.054 0.16 0.351 
Activity (hrs) 0.10 0.591 0.21 0.224 
Conditional activity (hrs) 0.26 0.168 0.14 0.431 
Genotype -0.23 0.230 -0.03 0.879 
 
 
 
Considering the significant associations above, a regression analysis with conditional 
change in FEV1 SDS as the dependent variable and conditional change in weight 
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SDS, FMI SDS, MMI SDS and activity and baseline FEV1 SDS and activity as the 
independent variables was performed in the sexes separately.  Secondly, conditional 
change in FFMI SDS was substituted for MMI SDS in a separate analysis because 
many previous studies have identified a relationship between lean tissue and lung 
function.  The significant predictors of conditional change in FEV1 are presented in 
Table 7.11. 
 
Table 7.11.  Regression analysis of conditional change in FEV1 standard deviation 
scores and potential predictors in children with cystic fibrosis. 
 
 
 Boys  (n=31) 
 B 95% confidence interval P 
Conditional change in FEV1 SDS (DV) 
Conditional change in FMI SDS  0.69 0.20,    1.17 0.007 
Change in activity (hrs) 0.07 0.02,    0.13 0.014 
Adjusted R
2 
0.34 
 Girls (n=38) 
 B 95% confidence interval P 
Conditional change in FEV1 SDS (DV) 
Conditional change in MMI SDS  0.49 0.03,    0.96 0.037 
Adjusted R
2 
0.12 
 
 
 
However, in a clinical situation it is not practical to calculate conditional change and 
therefore absolute change is more likely to be used.  The analysis was repeated with 
absolute change in FEV1 as the dependent variable and baseline and change in 
weight, FMI SDS, MMI SDS (or FFMI SDS) and activity and baseline FEV1 SDS as 
the independent variables (Table 7.12).  No significant predictors were identified in 
girls. 
 
Table 7.12.  Regression analysis of absolute change in FEV1 standard deviation 
scores and potential predictors in boys with cystic fibrosis. 
 
 Boys (n=31) 
 B 95% confidence interval P 
Absolute change in FEV1 SDS (DV) 
Absolute change in FMI SDS  0.69 0.23,    1.15 0.004 
Adjusted R
2 
0.23 
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The relationship between spirometry and body composition and how one influences 
the other is conceptualized in the following diagram. 
 
 
 
Figure 7.6.  Conceptual framework for the relationship between body composition 
and spirometry over time. 
 
I was interested to see to what degree, if any, baseline body composition SDS 
predicts change in FEV1 SDS compared to the opposite situation where baseline 
FEV1 SDS may predict change in body composition SDS.  Using regression analysis 
with no adjustment I found no significant models of baseline FMI or FFMI SDS 
predicting change in FEV1.  For the opposite direction only baseline FEV1 
significantly predicted change in FFMI SDS in boys such that a 1 SDS higher FEV1 
at baseline predicted an additional 0.18 FFMI SDS change with a standard error of 
the mean of 0.07.  Using conditional change in body composition and FEV1 did not 
change the outcome.  Data from the regression analyses may be found in Appendix 
10.  Therefore, in boys with CF change in FM predicts change in lung function and 
baseline lung function predicts change in FFM. 
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7.6.6 Relationship between activity and change in body composition 
 
In this study physical activity was assessed in two ways; (1) as hours per week of 
vigorous activity (sports and physical education) and (2) as the parent’s rating of 
their child compared to other children of the same age (less than, equal to or more 
than peers).  
 
Table 7.13.  Activity rating of children with cystic fibrosis 
 Baseline Year 2 
 Boys Girls Boys Girls 
 Mean SD Mean SD Mean SD Mean SD 
Hours activity per week 8.10 4.29 8.13 4.65 9.21 5.19 6.76 3.48 
Activity level 
Less than peers 12.9% 7.9% 22.6% 13.2% 
Equal to peers 48.4% 50.0% 29.0% 57.9% 
More than peers 38.7% 42.1% 48.4% 28.9% 
 
Baseline activity and change in activity did not have an association with change in 
any body composition variables.  However, there was a correlation between activity 
level at 2 years and conditional change in FFMI SDS (r=0.55, p<0.001) and MMI 
SDS (r= 0.38, p<0.05) in boys with CF only. Using a general linear model adjusting 
for pubertal status at 2 years and conditional change in FEV1, the estimated marginal 
means for the relationship between activity level and conditional change in FMI SDS 
was 0.68 SDS difference between the most active and least active categories.  The 
most active group have a less than expected change in FMI SDS than if they were 
growing according to the control group and the least active have a higher than 
expected gain in FMI SDS.  For conditional change in FFMI SDS the most active 
have, on average 0.94 SDS difference from the least active and were tracking a 
centile compared to the healthy boys, whereas the least active have a less than 
expected change in FFMI SDS.  There was no relationship between activity and 
change in body composition in the girls. 
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7.7 Discussion  
  
 
In this analysis I have investigated changes in body composition variables and 
compared changes in children with CF and controls, and addressed the question of 
whether baseline value and changes in components of body composition are 
associated with clinical outcome as assessed by spirometry in children with CF.  It is 
important to emphasise that it is not possible to determine cause and effect in my 
observational analysis for example, does improved lung function lead to an 
improvement in body composition or vice versa? 
 
7.7.1 Body composition  
 
When comparing patients to a group of control children one would hope that the 
controls have a ‘normal’ growth pattern.  The controls in this study did not change 
SDS for body composition components however the boys increased in weight and 
SFT SDS and the girls in waist and SFT SDS.  In accord with trends presented in 
other studies the boys with CF have a significant reduction in FFMI SDS over 2 
years both in absolute terms and compared to that in control children.  However 
some studies suggest that deficits occur later in adolescence (36;100).  The use of 
simple, easily available measurements of anthropometry could lead to the conclusion 
that the girls with CF are fatter after 2 years because waist and SFT SDS increased.  
However, increases in waist SDS in children with inflammatory conditions cannot be 
assumed to be as a result of central fat deposition since distention of the abdomen 
may be caused by enlarged organs and/or oedema.  The fact that 4C FM did not 
increase over this period, remaining significantly low, contradicts this supposition.  
The girls with CF were depleted in FFM and both boys and girls with CF show 
downward centile crossing compared to the controls.  The fact that both boys and 
girls are not sustaining FFMI SDS over time is likely to be associated with declining 
lung function even at this young age (10;116) although this is only apparent at this 
time in the girls of this study.  The literature reports declining lung function in both 
sexes (10;116), and it is likely that other factors also impact on lung function.  The 
boys in this study perform more vigorous exercise than the girls and this may either 
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contribute to or be in response to their better lung function.  The pattern of change in 
FFMI can be seen graphically in Figure 7.3; the graph for boys shows that most are 
showing a reduction or staying the same, only 4 show a good positive change.  
However, the age range of the boys is lower than that of the girls and the graph for 
girls indicates that many have declining or the same SDS till around age 11 and 
thereafter those with declining and those with improving SDS are about equal.  Of 
the 7 girls with increasing FFMI SDS after age 11, 6 were classed at Tanner stage 2 
or 3, of the 7 remaining stable or declining in FFM, 5 were Tanner stage 1 and 2 
stage 2 at baseline.  These findings are in accord with reports of normal growth 
patterns with increases in FFM, in particular MM in the later stages of puberty in 
girls (228).  Despite the children with CF not maintaining FFMI SDS this is not due 
to declining MM.      
      
In this study, conditional change in body composition was significantly associated 
with activity level at 2 years in CF boys, the most active having a difference of 0.68 
FMI and 0.94 FFMI SDS compared to the least active group.  Conditional SDS for 
FMI were negatively and for FFMI positively associated with activity level.   
Conditional change in body composition in girls was not associated with activity 
level in girls which may, in part, be due to the girls exercising at lower levels than 
boys.  Mothers of boys with CF rated 48% as having greater physical activity than 
peers whereas only 29% of girls with CF were rated as higher. Indeed, the CF girls 
were also less active than control girls who maintain the time spent in vigorous 
activity from baseline to 2 years whereas the girls with CF had a mean reduction of 1 
hour 22 minutes per week.  In addition, the fact that the girls have poorer lung 
function may be a contributory factor to a reduction of vigorous physical activity.  
An objective measure of physical activity would be more accurate than parental 
assessment. 
    
It is useful to identify any baseline measurement that predicts change so that 
treatment may be targeted appropriately.  In addition, change over a period of time 
may predict future outcomes and be useful for clinicians.  Original height and change 
in height above that expected are positive predictors of conditional change in MMI 
SDS in boys and girls. This is not surprising since the growth spurt experienced in 
mid-puberty is accompanied by a period of peak bone accretion.  Typically children 
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with CF have delayed puberty which may, in some part, account for any deficit in 
MM, although surprisingly, the girls with CF in this study report similar numbers at 
Tanner stage 1 (26.3%) to control girls (28.6%) at aged 8-14 years.  However, the 
percentage of girls in Tanner stage 3 and above is CF 32.3% and controls 40.8%, 
showing that there are more control girls in the mid-pubertal stage, a period during 
which peak growth occurs in girls (228). 
 
For boys with CF, baseline FFMI SDS predicted change above the expected in FFMI 
SDS; those with the lowest baseline score showing most ‘catch-up’ growth (or least 
decline).  In addition, a 1 SDS change in FEV1 above that expected for the group was 
associated with a 0.27 SDS increase above the expected for FMI SDS.  There were 
no predictors of conditional change in FFMI SDS despite FFM SDS in girls 
decreasing compared to the controls, however, a lower MMI SDS at baseline was 
associated with ‘catch-up’ (or less decline) in MM.  The fact that low FFM at 
baseline in boys predicts the greatest ‘catch-up’ of SDS is encouraging since it is 
predominantly FFM that is acquired during normal growth and maturation in boys.  
Although girls lowest in FM did not show the most ‘catch-up’, those lowest in MM 
did show most ‘catch-up’. 
 
When using SDS in children who are tracking a centile there would be little change 
in scores and this may in part explain the lack of predictors of absolute change in 
body composition variables in the control boys.  However, predictors of change in 
MMI SDS in control girls were similar to predictors of change in MMI SDS in girls 
with CF (although CF analyses were based on conditional change), those who were 
tallest at baseline had the greatest increase in MMI SDS and those with lowest MMI 
SDS at baseline had the greatest increase.  Unlike the girls with CF, the higher the 
FMI SDS at baseline the higher the change in MMI SDS.  It is likely that high FM is 
acting as a proxy for puberty since the post pubertal females are likely to have the 
more positive change in FM.  Conversely, low FFMI SDS at baseline is associated 
with lowest change in FFM in control girls.  Separate general linear models to 
examine the effect of having CF on change in body composition revealed that the CF 
girls are significantly different from the control girls in respect of FFM but for boys 
the only factor that approached significance was BMI SDS despite their reduction in 
FFM. 
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7.7.2 Spirometry 
 
Gender differences in lung function in CF are a moot point with some studies 
reporting no difference (13;121;229) and others, greater decline in either males 
(67;111) or females (10;39).  In this study girls, even at a young age had poorer lung 
function than boys and it deteriorated over two years.    This may be a reflection of 
their sub-optimal body composition and is not surprising given the poorer prognosis 
in females and may, in some part be related to girls being less active than boys (121).   
 
In a clinical situation it is difficult to calculate conditional change and absolute 
change is more likely to be considered.  Using absolute change the only factor 
predicting FEV1 SDS is change in FMI SDS in boys only with a 1 SDS change in 
FMI being associated with a 0.7 change in FEV1 SDS.  However, when conditional 
change in FEV1 SDS is considered, that is change after removing the effect of the 
baseline measurement, a large change in activity of 10 hours per week is associated 
with a 0.7 increase in FEV1 SDS in addition to the association with FM.  There is a 
weak association between conditional change in FEV1 SDS and conditional change 
in MMI SDS in girls.  There are several reports of an association between FFM and 
lung function in the literature (65;230) and in particular bone (36;119) but only 
Ahmed et al (111) has found a relationship between FM and FEV1 in boys, however, 
it is not clear whether this is a relationship between change in FM and change in lung 
function and only a crude prediction technique (SFT) had been used.   There may be 
several explanations for the fact that in this study a relationship between change in 
FM and change in lung function was found in boys.  I have used a ‘criterion’ 
technique whereas many studies use inappropriate techniques to predict FFM such as 
SFT (121;231), the age range is narrow, the sexes are analysed separately and an 
adjustment for short stature has been made.   The differing findings dependent on 
whether absolute or conditional change are used are important when considering the 
outcome since a 1 SDS change in FEV1 has a different impact dependent on the 
baseline value. In this chapter I have investigated the relationship between lung 
function and body composition but it is impossible to say to what degree one is a 
result of, or influences the other.  A randomized controlled trial of a treatment that 
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either impacts on body composition or lung function would be necessary to 
investigate the relationship further. However, simple regression analyses to 
investigate whether either baseline body composition predicts change in FEV1 or 
whether baseline FEV1 predicts change in body composition revealed that only 
baseline FEV1 SDS predicted change in FFMI SDS such that a 1 SDS higher FEV1 
predicted a 0.18 higher FFMI SDS at 2 years in this group of boys with CF.  This of 
course does not prove cause and effect but is interesting in the debate about the 
relationship between lung function and body composition.  In summary, in this group 
of boys with CF increased change in FM predicted increased change in lung function 
and baseline lung function predicted change in MM.  Since those boys who were 
exercising the most at 2 years had better FFM it is possible that those with good lung 
function are more likely to exercise which is likely to impact positively on FFM. 
 
7.8 Study limitations 
 
 
Ideally, conditional change in FEV1 SDS would be calculated by generating a 
regression equation in the healthy children.  Unfortunately, the control children did 
not undergo lung spirometry, however, the conditional change calculated in the CF 
group represents change that is not associated with the baseline FEV1.   
 
Children with CF can become ill and quickly change in their appetite and exercise 
ability.  When I asked about the typical amount of time spent in vigorous physical 
activity it is likely that, to some degree, the answer will be shaped by the child’s 
current medical condition.  I have examined change over 2 years by measuring the 
children at baseline and 2 years and therefore these measurements represent a 
‘snapshot’ in time, with some children fluctuating in body composition, lung 
function and activity level and others remaining more stable.  Without more frequent 
measurements which may be onerous to the child and family it is not possible to 
define the pattern of body composition in the interim.  
 
There are many factors that impact on growth and body composition in children with 
CF.  No account of nutritional intake, cortico-steroid use, lung infections and hospital 
admissions have been accounted for in this study.  However, obtaining accurate 
  
174 
 
records of clinical details was difficult in some of these children who are managed 
predominantly by their local hospital paediatrician.  The use of FEV1 allows for an 
objective measure of ‘health’ although in some children, particularly the very young 
the results are dependent on the child’s motivation.  However, the use of FEV1 as a 
clinical indicator is typical of many studies and allows for comparison. 
 
7.9 Summary 
 
 
In this chapter I have investigated change in body composition and lung function in 
children with CF over a 2 year period.   
 Both boys and girls were downward centile crossing compared to control 
children in respect of FFM.   
 There is an indication that FFM is increasing in some of the older girls in the 
later stages of puberty but this needs to be confirmed with larger numbers as 
the children become older. 
 Boys who are low in FFM and girls who are low in MM at baseline show the 
most ‘catch-up’ (or least decline) in SDS.  FFM in boys and MM in girls are 
the tissues that are predominantly acquired during puberty. 
 Change above that expected for FM in boys and MM in girls was associated 
positively with a greater conditional change in lung function (more than the 
rest of the group).  If absolute change is considered, only change in FM in 
boys is related to change in lung function which is contrary to the literature. 
 Level of activity at baseline was not associated with later body composition 
but in boys with CF those rated most active at 2 years had a lower than 
expected gain in FM and a gain in FFM similar to controls whereas the least 
active at 2 years had a greater than expected gain in FM and lower than 
expected FFM. 
 Baseline FEV1 predicts change in FFMI SDS in boys. 
 Lung function is poorer in girls and may reflect their sub-optimal body 
composition which is not surprising given the poorer prognosis in females.   
 The fact that the girls exercise less than the boys may be one explanation for 
their deteriorating lung function or alternatively poorer lung function may be 
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affecting their ability to exercise.  It is also likely that sub-optimal body 
composition has an impact on lung function and exercise ability. 
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Chapter 8.  An assessment of clinical tools for measuring 
body composition in children with cystic fibrosis using 
standard deviation scores 
 
 
8.1 Introduction 
 
 
In Chapter 3 I discussed body composition techniques and the advantages and 
disadvantages of each technique.  Only cadaver analysis may be considered a gold 
standard for body composition measurement and all in-vivo techniques do not 
measure body composition directly but predict it from the measurement of other 
body properties.  In vivo techniques therefore suffer from 2 forms of error, 
methodological error in collecting the data and error from the theoretical assumptions 
used to convert the data to body composition components (142).  The simple 
techniques make different assumptions which may affect their suitability in different 
conditions and therefore no one technique is appropriate for all subjects at all times. 
The 4CM is considered a criterion method because the assumptions made are 
minimal, merely that there is a constant relationship between osseous and non-
osseous mineral.  In this chapter I will assess the accuracy of the simple techniques 
compared to the 4CM using SDS for each technique derived from the same reference 
population when measuring children with CF. 
 
Comparison of my data with those of previous studies is complicated by the various 
techniques used to assess body composition.  Although all techniques suffer from 
assumptions about the nature of components of body composition, the simple 
prediction and 2CM methods rely heavily on assumptions about the nature of the 
FFM which, in children, is constantly changing with maturation and growth.  
Hydration, for example, which is highly influential on the outcome in the simpler 
models, is not constant across age and sex and does not change linearly from birth to 
adulthood.  In addition, error is introduced if published constants are used to convert, 
for example, TBW to FFM, since in this example, the hydration factor is the mean 
value by age and sex that has been derived from healthy populations and therefore 
  
177 
 
assumes that the individual has an average hydration.  Comparison between 
techniques is important for research purposes but also clinically because it is helpful 
to know whether the techniques are suitable in a given patient group or are 
interchangeable.  
 
Using the same methods as those used in this study we have recently published 
reference data on body composition of 533 children and young people aged 4 to 22 
which allows for the calculation of SDS for the 4CM and simpler techniques.  In this 
chapter I will address the question of whether the same result is achieved using SDS 
regardless of the technique used and in addition, to compare longitudinal change in 
SDS by the different techniques. 
 
I will also present the findings of a ‘wisdom of crowds’ (218) approach which 
postulates that by aggregating several independent predictions the resultant 
prediction will be more accurate and precise.  If this is the case and if the prediction 
is comparable to, or better than that of, for example, a DXA scan it would allow 
much simpler, cheaper assessments of the body composition of children with CF and 
thereby aid clinical assessment.  Even with less accuracy the approach may be useful 
when more sophisticated equipment is not available.  
 
8.2 Study design 
 
 
This is a cross-sectional study comparing the outcome of simple body composition 
techniques with that of the 4CM in SDS for all children recruited to the study and for 
all time-points.  In addition, the longitudinal measurements by different techniques 
are compared in the same cohort as that presented in Chapter 7.  
 
8.3 Recruitment and exclusion criteria 
 
 
Children with CF were recruited from patients at Great Ormond Street Hospital for 
Children; details can be found in Chapter 4.  In addition, for the cross-sectional 
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analyses a further 27 adolescents with CF who were part of another study using the 
same techniques were included to extend the age range.  
 
8.4 Methods 
 
 
Measures of anthropometry and BMC, TBW and densitometry for 4CM were 
performed as described previously.   
 
8.5 Statistical analyses 
 
 
Data for males and females and for every available time-point were pooled for purposes 
of the analysis.  The accuracy of the simpler methods was assessed using the criterion 
4CM as the reference method for adiposity (4C FM SDS) and leanness (4C FFM SDS).  
DXA FM, SFT and BMI SDS were used as simple measures of adiposity and DXA 
FFM, TBW and BIA (height
2
/Z) SDS were used as simple measures of leanness. 
 
8.5.1 Size adjustment and standard deviation score calculation 
 
Characteristics of all the children were compared to 1990 UK reference data to 
generate SDS for weight, height, and BMI.  SDS compared to our contemporary 
reference population for body composition variables were calculated for; (i) absolute 
values of 4C FM, 4C FFM, DXA FM, DXA FFM, DXA limb FM, DXA limb FFM, 
DXA trunk FM, DXA trunk FFM, TBW, BIA and SFT and (ii) size adjusted 
(described in Chapter 4) 4C FMI, 4C FFMI, DXA FMI, DXA FFMI, DXA limb 
FMI, DXA limb FFMI, DXA trunk FMI and DXA trunk FFMI.  All SDS were 
calculated using the lmsGrowth program©(210). 
Significance of the mean value from zero was tested using independent t-tests, and 
paired t-tests were used to compare the mean difference of the simpler methods with 
that of the 4CM.  
  
179 
 
 
8.5.2 Comparison of the simpler body composition techniques and 
the 4-component model  
 
The method of Bland and Altman (217) was used to assess agreement between 
absolute values for FM by DXA (whole body and regional), SFT and BMI SDS with 
4C FM SDS and for agreement between the absolute values for FFM by DXA 
(whole body and regional), TBW and BIA SDS with 4C FFM SDS.  In addition, 
height adjusted FMI by DXA (whole body and regional) was assessed for agreement 
with 4C FMI and FFMI by DXA (whole body and regional) was assessed for 
agreement with 4C FFMI SDS.    The mean difference between techniques (bias; 
simple method - 4CM) and the ± 2 SD of the difference between techniques (limits 
of agreement) were calculated.  The bias was then tested for significance from zero 
by using an independent t- test.  The extent to which the magnitude of the bias was 
related to the magnitude of the variable was calculated as the correlation between the 
difference and the mean of the measured values.  Correlations were performed 
unadjusted, adjusted for age and adjusted for age and sex.  All analyses were 
performed using Statistical Package for Social Sciences 18.0 (SPSS Inc., Chicago) 
and p<0.05 was considered significant. 
 
8.5.3 Predictors of bias 
 
Backward regression analyses were used to identify significant predictors of the bias 
in FM(I) and FFM(I) SDS.  Analyses were performed with age, sex and BMI SDS as 
explanatory variables with sex coded as male = 1 and female = 2. 
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8.5.4 Calculation of a correction factor for bio-electrical impedance 
 
Preliminary analysis suggested that a correction factor could be applied to the BIA 
SDS to improve accuracy (see 8.6.3).  I calculated a correction factor in 2 ways; 
firstly using regression analysis to investigate the relationship between bias in BIA 
(compared to 4CM) and BIA SDS in the whole group of BIA measurements (n=141) 
and using the value for the slope as the predicted average of the  group.  Each 
individual BIA SDS was then corrected as follows; average corrected BIA SDS = 
actual BIA SDS - predicted average bias in BIA SDS.  Secondly, the relationship 
between bias in BIA SDS (compared to 4CM) and BIA SDS was investigated taking 
into consideration possible significant predictors of bias.  I used backward linear 
regression with independent variables: age, sex (male=1, female=2), puberty (pre 
pubertal=1, post pubertal =2) and BMI SDS in a subset of measurements that were 
not used in the longitudinal analyses (n=60).  The resultant equation was used to 
correct each individual’s BIA SDS as follows; individual corrected BIA SDS = 
actual BIA SDS – predicted individual bias in BIA SDS. 
.   
8.5.5 Longitudinal comparison 
 
The ability of the simpler techniques to assess longitudinal change was compared to 
change assessed by the 4CM using SDS that have not been adjusted for height.  
Unadjusted (non-indexed) variables were chosen because all simple techniques apart 
from DXA do not generate FM or FFM SDS, rather SDS of that particular technique 
for example TBW SDS or SFT SDS and therefore it would be inappropriate to adjust 
for height.  Two-year change in anthropometric and body composition SDS were 
compared to zero change using independent t-tests.  Bland-Altman analyses were 
used to compare the bias in change (change by simple technique – change by 4CM) 
of body composition variables with limits of agreement of ±2SD.  The degree to 
which the magnitude of the bias was related to the magnitude of the variable was 
assessed with correlation analyses. 
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8.5.6 Categorisation of ‘abnormal’ standard deviation scores 
 
A ‘normal’ body composition SDS was classed as an SDS between -2 and +2, since 
these cut-offs are commonly used in clinical practice to define ‘normality’.  The 
ability of each technique to categorise ‘normal’ and ‘abnormal’ body composition 
was assessed by cross-tabulation of the simple technique with the 4CM and 
calculation of Cohen’s kappa coefficient (κ) and % agreement.  Whilst % agreement 
is a measure in absolute terms, Cohen’s kappa also takes into account the probability 
of agreement occurring by chance, a value of 1 indicating perfect agreement. 
 
8.5.7 ‘Wisdom of crowds’ approach to determine whether aggregate 
predictions improve accuracy.   
 
The ‘wisdom of crowds’ approach utilises the simplest, readily available prediction 
techniques and may be useful when more sophisticated techniques are not available.  
This approach is based on the theory that using many predictions will give an answer 
closer to the truth than using one or two predictions (a full explanation may be found 
in 4.6.8).  To test this hypothesis in this particular population I used 12 different 
prediction equations based on height, weight, SFT and BIA to calculate FM for each 
child and then aggregated them to compare with the 4CM.  Values of TBW or body 
density from some equations were converted to FFM using our published data on 
density and hydration (184).  FM was calculated as the difference between FFM and 
weight and vice versa.   Only equations that spanned at least 6 of the 6-17yrs of those 
subjects in this study were selected although most covered the whole range.  Only 
one equation was specifically derived for children with CF (Johnston).  Only children 
with a value for FM from the 12 separate equations were used in the analysis, the 
number being reduced by lack of BIA data in several and the inability to calculate 
some predictions in the younger children for whom the equations were not 
appropriate. 
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8.6 Results 
 
 
8.6.1 Subjects 
 
Data from all children measured from 2001 to 2011 in this study and another of older 
children with CF measured using the same techniques, was included in the analysis.  
Of the 127 children enrolled, 81 children had subsequent re-measurements of 
between 1 and 5 times.  28 measurements were not included due to inadequate data 
or failed 4CM.   Characteristics of the children are shown in Table 8.1, the age range 
was 6.7 to 17 years and the mean value for the group by sex indicates that they are 
both short and light for their age.  Girls with CF had significantly low values for all 
body composition variables by all methods apart from having significantly high 
mean DXA trunk FFMI.  FMI and FFMI SDS by 4CM were not different from zero 
in boys with CF although 4C FM and FFM SDS (unadjusted for height) and many of 
the simpler techniques suggest they had a depletion of both FM and FFM with the 
exception of higher trunk FMI and FFMI SDS by DXA. 
 
8.6.2 Accuracy of simpler body composition techniques compared to 
the 4-component model 
 
The simpler body composition techniques were compared to 4C FM and FFM in 
terms of mean bias and limits of agreement in individuals.  Table 8.2 and Figure 8.1 
(measures of ‘fatness’) and Figure 8.2 (measures of leanness) summarise the mean 
bias and limits of agreement for each method.  Graphs showing the individual biases 
may be found in Appendix 12.  
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Table 8.1. Anthropometry and body composition standard deviation scores by sex 
 Boys Girls 
Measurement 
method SDS 
1 N Mean SD P
Ref  
P
4CM  
N Mean SD P
Ref 
 P
4CM 
 
Age (y) 124 11.8 2.68   142 11.9 2.63   
Weight  124 -0.23 1.10 0.023  142 -0.57 1.18 <0.001  
Height  124 -0.52 1.08 <0.001  142 -0.57 1.14 <0.001  
Measure of ‘fatness’ 
BMI 124 0.10 1.07 0.324 <0.001 142 -0.32 1.09 0.001 <0.001 
4C FM  124 -0.32 1.00 0.001  142 -0.75 1.09 <0.001  
4C FMI  124 -0.09 1.18 0.108  142 -0.57 1.05 <0.001  
DXA FM  124 -0.29 0.92 0.001 0.394 142 -0.73 0.95    <0.001 0.521 
DXA FMI  124 -0.05 0.90 <0.001 0.264 142 -0.46 0.93 <0.001 0.307 
DXA limb FM 124 -0.58 1.83 0.001 0.033 142 -1.45 1.91 <0.001 <0.001 
DXA limb FMI 124 -0.36 1.81 0.027 <0.001 142 -1.20 1.82 <0.001 <0.001 
DXA trunk FM 124 0.02 0.91 0.983 <0.001 142 -0.42 0.95 <0.001 <0.001 
DXA trunk FMI 124 0.14 0.89 0.081 <0.001 142 -0.28 0.92 <0.001 <0.001 
Bicep SFT  123 -0.02 0.86 0.818 <0.001 142 -0.23 0.85 0.002 <0.001 
Tricep SFT  124 -0.02 0.95 0.829 <0.001 141 -0.46 0.96 <0.001 <0.001 
Subscapular SFT 124 -0.05 0.98 0.539 <0.001 142 -0.28 1.05 0.002 <0.001 
Supra-iliac SFT 123 0.07 0.98 0.464 <0.001 134 -0.31 1.07 0.001 <0.001 
Sum 4 SFT 122 -0.01 0.85 0.865 <0.001 133 -0.32 0.87 <0.001 <0.001 
1
 Standard deviation score except for age, P
Ref
; independent t-test for difference from zero, CF compared to reference data (54;155;209),  
P
4CM
 ;paired t-test simple technique compared to 4-component model, BMI; body mass index, 4C; 4-component, FM; fat mass, FMI; fat 
mass index (FM/height
2
), DXA; dual-energy X-ray absorptiometry, SFT; skinfold thickness.  Table continues on next page. 
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Table 8.1 continued. Anthropometry and body composition standard deviation scores by sex 
 
 
 
 
 Boys 
 
Girls 
Measurement 
method SDS 
1 N Mean SD P
Ref 
P
4CM 
N Mean SD P
Ref
 P
4CM
 
Measure of ‘leanness’ 
4C FFM  124 -0.44 1.09 <0.001  142 -0.83 1.21 <0.001  
4C FFMI  124 0.07 1.13 0.482  142 -0.39 1.00 <0.001  
DXA FFM  124 -0.85 1.10 0.527 <0.001 142 -1.36 1.16 <0.001 <0.001 
DXA FFMI  124 -0.09 1.18 0.406 <0.001 142 -0.57 1.05 <0.001 <0.001 
DXA limb FFM 124 -0.85 1.10 <0.001 <0.001 142 -1.36 1.16 <0.001 <0.001 
DXA limb FFMI 124 -0.70 1.06 <0.001 <0.001 142 -1.21 1.11 <0.001 <0.001 
DXA trunk FFM 124 -0.09 1.14 0.374 <0.001 142 -0.40 1.09 <0.001 <0.001 
DXA trunk FFMI 124 0.65 1.21 <0.001 <0.001 142 0.28 0.94 0.001 <0.001 
TBW  124 -0.48 1.09 <0.001 0.075 142 -0.84 1.13 <0.001 0.580 
BIA  65 -0.44 1.05 0.001 0.001 76 -1.16 1.21 <0.001 <0.001 
1
 Standard deviation score except for age, P
Ref
; independent t-test for difference from zero, CF compared to reference data, P
4CM
 ;paired 
t-test simple technique compared to 4-component model, 4C; 4-component, FFM; fat-free mass, FFMI; fat-free mass index 
(FFM/height
2
), DXA; dual-energy X-ray absorptiometry, TBW; total body water, BIA; bio-electrical impedance. 
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Table 8.2.  Bland-Altman analysis of mean bias in fat mass and fat-free mass standard deviation scores by simple body composition 
techniques compared to the 4-component model. 
Measurement method SDS N 
Mean 
bias
1 
95% Limits of 
agreement 
P
bias 
R P
correlation 
Measure of ‘fatness’ 
DXA fat mass 266 0.15 ±0.71 <0.001 -0.279 <0.001 
DXA fat mass index 266 0.13 ±0.71 <0.001 -0.251 <0.001 
DXA limb fat mass 266 0.02 ±0.74 0.295 -0.294 <0.001 
DXA limb fat mass index 266 -0.001 ±0.80 0.958 -0.233 <0.001 
DXA trunk fat mass 266 0.16 ±0.37 <0.001 -0.282 <0.001 
DXA trunk fat mass index 266 0.16 ±0.42 <0.001 -0.228 <0.001 
Bicep skinfold 265 0.42 ±1.35 <0.001 -0.331 <0.001 
Tricep skinfold 265 0.29 ±1.33 <0.001 -0.142 0.021 
Subscapular skinfold 266 0.37 ±1.32 <0.001 -0.072 0.245 
Supra-iliac skinfold 257 0.42 ±1.39 <0.001 0.001 0.982 
Sum 4 skinfold 255 0.38 ±1.04 <0.001 -0.350 <0.001 
BMI 266 0.42 ±1.42 <0.001 0.049 0.429 
 
1
 Bias is the difference (simple technique – 4-component model (4CM)), 95% limits of agreement ;  ±2SD, DXA; dual-energy X-ray  
absorptiometry, BMI; body mass index, P
bias
 ;independent t-test compared to zero, R; Pearson’s correlation, Pcorrelation ; paired sample t-test 
between the bias and the mean of simple technique and 4CM. 
 
 
  
186 
 
 
 
 
 
Table 8.2 continued.  Bland-Altman analysis of mean bias in fat mass and fat-free mass standard deviation scores by simple body 
composition techniques compared to the 4-component model. 
 
Measurement method SDS N 
Mean 
bias
1 
95% Limits of 
agreement 
P
bias 
R P
correlation 
Measure of ‘leanness’ 
DXA fat-free mass 266 -0.11 ±0.67 0.002 0.209 0.001 
DXA fat-free mass index 266 -0.17 ±0.88 <0.001 0.114 0.064 
DXA limb fat-free mass 266 -0.47 ±0.80 <0.001 0.096 0.121 
DXA limb fat-free mass index 266 -0.80 ±1.26 <0.001 0.049 0.424 
DXA trunk fat-free mass 266 0.20 ±0.39 <0.001 0.004 0.947 
DXA trunk fat-free mass index 266 0.31 ±0.63 <0.001 -0.002 0.977 
Total body water 266 -0.02 ±0.46 0.111 0.014 0.819 
Bio-electrical impedance 141 -0.24 ±0.92 <0.001 0.003 0.975 
Corrected bio-electrical impedance
2 
141 0.41 ±0.92 <0.001 0.003 0.975 
Corrected bio-electrical impedance
3 
81 0.001 ±0.80 0.986 -0.055 0.629 
Combined DXA and BIA  141 -0.07 ±0.53 0.560 -0.082 0.337 
1
 Bias is the difference (simple technique – 4-component model (4CM)), 95% limits of agreement; ±2SD, DXA; dual-energy  
X-ray absorptiometry, BMI; body mass index, 
2
Corrected BIA SDS; BIA SDS – predicted average bias of the group calculated by regressing BIA 
SDS on bias BIA SDS, 
3
Corrected BIA SDS; BIA SDS – predicted bias calculated by regressing BIA SDS on bias BIA SDS adjusting for age and 
BMI SDS, P
bias
; independent t-test compared to zero, R; Pearson’s correlation, Pcorrelation ; paired sample t-test between the bias and the 
mean of simple technique and 4CM.  
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Figure 8.1.  Bias and limits of agreement (±2SD) for ‘fatness’ by simple techniques  compared to the 4–component model(4CM;(simple 
technique SDS – 4CM FM SDS).  All values are SDS, DXA; dual-energy X-ray absorptiometry, BMI; body mass index.  Asterisks denote 
biases that were significantly different from the 4CM; * p<0.001. 
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Figure 8.2.  Bias and limits of agreement (±2SD) for ‘leanness’ by simple techniques compared to the 4-component model (4CM; 
simple technique SDS – 4CM FFM SDS).  All values are SDS, DXA; dual-energy X-ray absorptiometry, BIA; bio-electrical impedance.  
Asterisks denote biases that were significantly different from the 4CM, * p<0.005. 
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8.6.2.1 Measures of ‘fatness’ 
 
Compared to 4C FM SDS, DXA provided the most accurate measurement with 
lowest limits of agreement with a mean whole body bias of 0.15 (p<0.001) and limits 
of agreement of ±0.71.  However, although DXA trunk showed a similar bias 
(0.16±0.37, P<0.001), DXA limb FM SDS showed insignificant bias from the 4CM 
(0.02) with limits of agreement of ±0.74.  Children with CF tend to be short for their 
age and therefore the relationship between height-adjusted DXA and 4C FMI SDS 
was also examined and the results were similar. 
 
BMI significantly overestimated FM SDS with wide limits of agreement (0.42±1.42. 
p<0.001).  All SFT SDS showed a significant bias and wide limits of agreement, 
(0.29-0.42±1.32-1.39).  The mean of 4 SFT SDS improved the limits of agreement 
slightly but still showed a large significant bias (0.38±1.04). 
 
8.6.2.2 Measures of ‘leanness’ 
 
Measurement of FFM SDS by DXA showed a small significant bias, underestimating 
by, on average 0.11 SDS with limits of agreement of ±0.67.  Regional DXA FFM 
SDS gave a greater significant bias which was positive for trunk FFM SDS (mean 
bias ±2SD, 0.20±0.39) and negative for limb FFM SDS (-0.47±0.80).  Adjusting 
DXA FFM for height compared to 4C FFMI SDS increased the bias and limits of 
agreement. 
 
Compared to 4C FFM, TBW SDS provided the most accurate and precise value of 
FFM SDS, with an insignificant bias and narrow limits of agreement (-0.02±0.46).   
When compared to the 4CM, BIA SDS significantly underestimated FFM SDS by 
0.24 SDS and with limits of agreement of ±0.92.  
 
Bland-Altman correlations were used to test whether the bias for each technique is 
related to the magnitude of the mean FM and FFM (Table 8.2).  For DXA FM, bicep 
SFT, sum of 4 SFT and DXA FFM there was a highly significant correlation 
(p<0.001).  The correlation was less but significant for tricep SFT.  For all measures 
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of lean except DXA whole body FFM there was no correlation between the 
magnitude of FFM and the bias.  When age and sex were accounted for there was no 
difference in the findings (Appendix 13).  
 
 
8.6.3 Predictors of the bias in fat mass and fat-free mass standard 
deviation scores 
 
 
Multiple regression analyses were used to identify significant predictors of the bias 
in FM and FFM SDS (Table 8.3).  Possible predictors considered were age, gender, 
pubertal stage and BMI.  Pubertal stage (pre-pubertal v pubertal) was not a 
significant factor of bias for any technique. The predictive value of the models in 
explaining the bias was generally low with the adjusted R
2
 not exceeding 0.19 except 
in the case of DXA FMI and DXA limb FM where the predictive value was 72% and 
68% respectively.  There was no single variable that was consistently the most 
significant predictor of bias across all measurement techniques.  Age was 
significantly positively associated with DXA FMI, limb FM and BIA biases and 
negatively associated with bicep and tricep SFT and DXA whole body and trunk 
FFMI biases.  The association of gender with bias was variable indicating no 
consistent trend for a bias in either FM or FFM in either sex.  BMI showed a 
significant positive association with DXA whole body FMI, limb FM and negative 
association with bicep and tricep SFT and DXA trunk FFM(I). 
   
BIA is a readily available simple technique that, although biased compared to 4C 
FFM SDS, displays no relationship in the data between the magnitude of the bias and 
magnitude of SDS.  This allows for the calculation of a correction factor which may 
be calculated by adjusting each individual by the mean bias for the group or, 
considering the fact that age is a significant predictor of bias, taking into account 
possible predictors.  Regression analysis between bias in BIA (compared to 4CM) 
and BIA SDS in the whole group of BIA measurements (n=141) gave a value for the 
slope of -0.173 which was used as the mean value correction factor for each 
individual’s BIA SDS.  When the corrected BIA SDS was compared to 4C FFM SDS 
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there was an increase in the bias compared to uncorrected BIA SDS.  Secondly, the 
relationship between bias in BIA SDS and BIA SDS was investigated taking into 
consideration possible significant predictors of bias in 61 children whose data was 
not included in the longitudinal analysis.  Only age and BMI SDS were significant 
and included in the final equation for prediction of bias which was tested in the 
remaining 81 measurements.  The standard error of the estimate was calculated for 
the model to indicate accuracy in individuals.  The resultant equation was; 
 
Predicted bias in BIA SDS = -0.783 + 0.155(BIA SDS) + 0.058(age) – 0.176 (BMI 
SDS)         Equation 8.1 
 
This model has a standard error of the estimate of 0.44 SDS and explains only 20% 
of the variation in bias in BIA SDS.  Using the above equation a correction was made 
in the remaining 81 measurements (Table 8.2) and there was no significant bias 
compared to the 4CM for the corrected BIA SDS values.  The characteristics of the 
group with no BIA data, those used to generate the equation and those used to test 
the equation can be found in Appendix 14. 
 
Mindful of the ‘wisdom of crowds’ approach I was interested to see if combining 
DXA and corrected BIA would give a lower bias and limits of agreement than for 
each technique separately and therefore I calculated the mean SDS (DXA + BIA)/2 
and compared that to the 4CM (Table 8.2).  The bias of the combined techniques 
remained similar to that of corrected BIA and improved compared to the DXA bias 
but more importantly the limits of agreement were reduced to ±0.53 in the combined 
SDS as opposed to DXA (±0.67) and BIA (±0.80) separately. 
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Table 8.3.  Predictors of bias for different simple body composition measurements of (a) fat mass SDS and (b) fat-free mass SDS compared to 
the 4-component model. 
(a) Bias compared to 4-component fat mass 
Measurement 
method SDS 
Age Sex BMI SDS  
B 95%CI P B 95%CI P B 95%CI P Adjusted R
2 
Measure of ‘fatness’ 
DXA fat mass 0.005 
-0.011, 
-0.022 
0.512 -0.011 
-0.099, 
0.077 
0.809 -0.023 
-0.063, 
0.017 
0.261 -0.004 
DXA fat mass index 0.035 
0.013, 
0.058 
0.002 -0.115 
-0.237, 
0.008 
0.066 0.714 
0.658, 
0.770 
P<0.001 0.718 
DXA limb fat mass 0.039 
0.015, 
0.064 
0.002 -0.145 
-0.278, 
-0.012 
0.033 0.713 
0.652, 
0.773 
P<0.001 0.684 
DXA limb fat mass index -0.013 
-0.031, 
0.005 
0.162 0.063 
-0.035, 
0.161 
0.208 -0.031 
-0.076, 
0.013 
0.168 0.011 
DXA trunk fat mass 0.007 
-0.003, 
0.016 
0.179 -0.004 
-0.056, 
0.047 
0.870 -0.020 
-0.043, 
0.004 
0.101 0.008 
DXA trunk fat mass index 0.007 
-0.003, 
0.016 
0.168 0.031 
-0.109, 
0.173 
0.241 -0.008 
-0.031, 
0.016 
0.533 0.005 
Bicep skinfold -0.034 
-0.062, 
-0.006 
0.017 0.117 
-0.032, 
0.267 
0.124 -0.256 
-0.324, 
-0.187 
P<0.001 0.191 
Tricep skinfold -0.035 
-0.064, 
-0.005 
0.022 -0.072 
-0.231, 
0.087 
0.373 -0.161 
-0.233, 
-0.088 
P<0.001 0.068 
Subscapular skinfold -0.029 
-0.059, 
0.001 
0.058 0.190 
0.029, 
0.350 
0.021 -0.043 
-0.116, 
0.031 
0.255 0.029 
Supra-iliac skinfold -0.003 
-0.036, 
0.029 
0.842 0.026 
-0.148, 
0.200 
0.771 -0.059 
-0.139, 
0.020 
0.144 -0.002 
Sum 4 skinfold -0.023 
-0.046, 
0.001 
0.061 0.074 
-0.053, 
0.200 
0.252 -0.122 
-0.179, 
-0.064 
P<0.001 0.073 
BMI -0.046 
-0.096, 
0.003 
0.065 -0.410 
-0.674, 
-0.152 
0.002    0.041 
Each line gives the results for a different multiple regression model. Sex coded as male=1, female=2 
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Table 8.3 continued 
(b)Bias compared to 4-component fat-free mass 
 
Measurement 
method SDS 
Age Sex BMI SDS  
B 95%CI P B 95%CI P B 95%CI P Adjusted R
2 
Measure of ‘leanness’ 
DXA fat-free mass 0.005 
-0.010, 
0.021 
0.492 -0.025 
-0.108, 
0.058 
0.549 0.003 
-0.035, 
0.041 
0.873 -0.008 
DXA fat-free mass index -0.024 
-0.044, 
-0.004 
0.019 -0.020 
-0.127, 
0.088 
0.718 0.001 
-0.042, 
0.056 
0.767 0.012 
DXA limb fat-free mass 0.004 
-0.014, 
0.022 
0.663 -0.102 
-0.201, 
-0.004 
0.041 0.028 
-0.017, 
0.073 
0.225 0.015 
DXA limb fat-free mass index -0.002 
-0.031, 
0.028 
0.911 -0.038 
-0.195, 
0.119 
0.635 0.017 
-0.055, 
0.089 
0.636 -0.009 
DXA trunk fat-free mass -0.003 
-0.012, 
0.005 
0.444 0.016 
-0.030, 
0.063 
0.488 -0.047 
-0.068, 
-0.026 
<0.001 0.064 
DXA trunk fat-free mass index -0.025 
-0.039, 
-0.011 
<0.001 0.014 
-0.059, 
0.088 
0.699 -0.079 
-0.113, 
-0.045 
<0.001 0.098 
Total body water 0.009 
-0.002, 
0.019 
0.115 0.023 
-0.034, 
0.080 
0.435 -0.003 
-0.029, 
0.023 
0.803 0.002 
Bio-electrical impedance 0.060 
0.033, 
0.088 
<0.001 -0.091 
-0.238, 
0.056 
0.221 -0.037 
-0.104, 
0.030 
0.278 0.122 
 
 
Each line gives the results for a different multiple regression model. Sex coded as male=1, female=2. 
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8.6.4 Comparison of longitudinal change in body composition by the 
simpler techniques compared to change assessed by the 4-component 
model 
 
The group mean increased by (mean±SD); 0.20±0.67, (p=0.016) SDS for 4C FM and 
decreased by 0.13±0.50, (p=0.048) SDS for 4C FFM in the 2 year period (Table 
8.4).  The increase in SDS for 4C FM was replicated most closely by DXA trunk FM 
(0.17±0.53, p= 0.01) and the decrease in FFM SDS by 4CM was also identified by 
whole body and regional DXA FFM SDS and TBW SDS.   
  
To investigate the difference between the simpler techniques and the 4CM for 
quantifying change in SDS a Bland-Altman analysis was preformed (Table 8.5 and 
Figures 8.3 and 8.4) with bias (change by simple technique SDS – change by 4C 
SDS), mean ([simple technique SDS + 4C]/2) and limits of agreement of ±2SD.   
 
BMI, bicep SFT and uncorrected BIA SDS were the only techniques showing a 
significant bias for measuring change compared to the 4CM.  Corrected BIA SDS 
had insignificant bias.  Limits of agreement for measuring change with DXA were 
wide; 1SDS for FM and 0.6 SDS for FFM, although combining DXA and corrected 
BIA SDS improved the limits of agreement compared to DXA on its own from 0.6 
SDS to 0.3 SDS.  The magnitude of the bias was significantly inversely related to 
change in FM for BMI and DXA FM and there was a positive relationship between 
the bias and the magnitude of change in TBW SDS.   
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Table 8.4. Baseline measurements and change in longitudinal measurements using standard deviation scores 
 
Measurement method SDS
1 
 Baseline Two year change 
N Mean SD Mean SD Range P
change-zero 
Age (y) 69 9.34 1.55 2.08 0.13 1.84 2.50 <0.001 
Weight  69 -0.33 1.06 -0.02 0.45 -1.41 1.24 0.677 
Height 69 -0.55 1.07 0.08 0.38 -1.15 0.96 0.106 
Measures of ‘fatness’ 
4CM fat mass  69 -0.64 0.99 0.20 0.67 -1.53 1.98 0.016 
DXA fat mass  69 -0.49 0.92 0.13 0.54 -1.19 1.33 0.058 
DXA limb fat mass  69 -0.60 0.91 0.14 0.54 -0.95 1.28 0.033 
DXA trunk fat mass  69 -0.35 0.92 0.17 0.53 -1.20 1.27 0.010 
Bicep skinfold thickness  69 -0.09 0.78 0.03 0.74 -1.90 2.10 0.723 
Tricep skinfold thickness  68 -0.30 0.99 0.14 0.68 -1.40 1.60 0.104 
Subscapular skinfold thickness  69 -0.21 0.95 0.07 0.81 -1.70 2.70 0.467 
Supra-iliac skinfold thickness  66 -0.28 1.04 0.26 0.70 -1.50 2.60 0.003 
Sum 4 skinfold thickness  65 -0.24 0.33 0.15 0.61 -1.30 1.55 0.193 
BMI 69 -0.01 0.94 -0.09 0.54 -1.37 1.23 0.157 
Measures of ‘leanness’ 
4C fat-free mass  69 -0.50 1.08 -0.13 0.50 -1.21 1.01 0.048 
DXA fat-free mass  69 -0.61 1.13 -0.15 0.55 -1.78 1.38 0.039 
DXA limb fat-free mass  69 -1.01 1.11 -0.08 0.50 -1.46 1.08 0.166 
DXA trunk fat-free mass  69 -0.07 1.10 -0.17 0.61 -1.93 1.44 0.027 
Total body water  69 -0.56 1.16 -0.09 0.60 -1.25 1.89 0.029 
Bio-electrical impedance  32 -0.77 1.08 0.13 0.55 -0.92 1.32 0.193 
Corrected bio-electrical impedance 32 -0.38 1.01 0.03 0.51 -1.01 1.15 0.739 
1
 Standard deviation score apart from age, 4CM; 4-component model, DXA; dual-energy X-ray absorptiometry, BMI; body mass index,  
P
change - zero
; paired t-test of change compared to zero, corrected bio-electrical impedance is individual bias in BIA SDS corrected for age and BMI SDS. 
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Table 8.5.  Bias and limits of agreement of simpler methods compared to the 4-component model for change in fat mass and fat-free 
mass standard deviation scores. 
Measurement method SDS N Bias
1 95% Limits 
of agreement 
P
bias 
R P
correlation 
Measures of ‘fatness’ 
BMI  69 -0.29 ±0.94 <0.001 -0.317 0.008 
DXA fat mass  69 -0.08 ±1.00 0.214 -0.295 0.014 
DXA limb fat mass  69 -0.06 ±0.98 0.324 -0.294 0.014 
DXA trunk fat mass  69 -0.03 ±1.02 0.619 -0.304 0.011 
Bicep skinfold thickness  69 -0.17 ±1.32 0.037 0.118 0.336 
Tricep skinfold thickness  68 -0.06 ±1.32 0.473 0.002 0.989 
Subscapular skinfold thickness  69 -0.13 ±1.38 0.122 0.214 0.077 
Supra-iliac skinfold thickness  66 0.04 ±1.20 0.583 0.032 0.801 
Sum 4 skinfold thicknesses  65 -0.06 ±1.04 0.356 -0.160 0.204 
Measures of ‘leanness’ 
DXA fat-free mass  69 -0.02 ±0.60 0.578 0.162 0.183 
DXA limb fat-free mass  69 0.04 ±0.68 0.308 0.007 0.953 
DXA trunk fat-free mass  69 -0.04 ±0.70 0.360 0.325 0.006 
Total body water  69 0.04 ±0.62 0.351 0.271 0.024 
Bio-electrical impedance  32 0.19 ±0.72 0.005 0.260 0.151 
Corrected bio-electrical impedance
2 
32 0.07 ±0.68 0.283 0.027 0.884 
Combined DXA and BIA 32 0.03 ±0.34 0.283 -0.156 0.394 
1
 Bias is the difference (simple technique – 4-component model (4CM)), 95% limits of agreement; ±2SD, DXA; dual-energy X-ray absorptiometry, BMI; body 
mass index, BIA; bio-electrical impedance.  
2
Corrected BIA SDS; BIA SDS – predicted bias calculated by regressing BIA SDS on bias BIA SDS adjusting for age 
and BMI SDS. P
bias
; independent t-test compared to zero, R; Pearson’s correlation, Pcorrelation ; paired sample t-test between the bias and the mean of simple 
technique and 4CM.  
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Figure 8.3. Bias and limits of agreement (±2SD) for change in ‘fatness’ by simple techniques compared to the 4-component model 
(4CM; change by simple technique SDS – change by 4CM FM SDS).  All values are SDS, DXA; dual-energy X-ray absorptiometry, 
BMI; body mass index.  Asterisks denote biases that were significantly different from the 4CM, * p<0.05, ** p<0.001. 
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Figure 8.4 Bias and limits of agreement (±2SD) for change in ‘leanness’ by simple techniques compared to the 4-component model 
(4CM;change by simple technique SDS – change by 4CM FFM SDS).  All values are SDS, DXA; dual-energy X-ray absorptiometry, 
BIA; bio-electrical impedance. Asterisks denote biases that were significantly different from the 4CM, * p<0.005.
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8.6.5 Assessment of the ability of each technique to distinguish 
‘normal’ and ‘abnormal’ body composition in clinical practice. 
 
The ability of each simple technique to identify ‘normal’ and ‘abnormal’ body 
composition (normal defined as ±2 SDS 4C FM or 4C FFM) was examined by % 
agreement and Cohen’s Kappa coefficient (Table 8.6). DXA showed the highest 
agreement (96.2%) and kappa value (0.73) with 4C FM SDS.  Although agreement 
for SFT and BMI was high (91-94%) the kappa coefficient which takes account of 
chance agreement was much lower at 26-44%. 
 
Agreement of simple techniques with 4C FFM indicated that TBW had the highest 
agreement (97 %) and kappa value 83%.  Whole body DXA FFM and FFMI agreed 
with 4C FFM and FFMI SDS by approximately 96% with a kappa value of 76.5%.  
The ability of regional FFM to agree with 4C FFM was reduced with kappa values of 
0.57 for limb and 0.71 for trunk and reduced much further when size adjusted; limb 
0.33 and trunk 0.34.  Corrected BIA SDS had slightly better agreement with 4C FFM 
than unadjusted BIA (72 v 69%) and combined DXA and corrected BIA SDS a 
similar agreement to DXA on its own.  
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Table 8.6.  Cross-tabulation statistics for agreement in ‘abnormal’ scores assessed by simpler techniques compared to the 4-CM. 
Measurement method (SDS) N % agreement k se 
% abnormal 
by 4CM 
% abnormal 
by other 
technique 
Measure of ‘fatness’ 
DXA fat mass 266 96.2 0.73 0.08 8.6 6.4 
DXA fat mass index 266 96.6 0.69 0.10 6.8 4.9 
DXA limb fat mass 266 95.8 0.72 0.08 8.6 7.5 
DXA limb fat mass index 266 96.6 0.71 0.09 6.8 5.6 
DXA trunk fat mass 266 94.8 0.64 0.09 8.6 7.1 
DXA trunk fat mass index 266 95.8 0.65 0.10 6.8 5.6 
Bicep skinfold 265 92.4 0.26 0.11 8.6 1.9 
Tricep skinfold 265 91.3 0.37 0.10 8.7 6.0 
Subscapular skinfold 266 92.8 0.39 0.11 8.6 3.8 
Supra-iliac skinfold 257 93.8 0.44 0.11 8.2 3.5 
Sum 4 skinfold 255 93.0 0.29 0.12 8.2 2.0 
BMI 266 91.7 0.35 0.11 8.6 4.9 
Measure of ‘leanness’ 
DXA fat-free mass 266 94.8 0.76 0.06 11.3 14.3 
DXA fat-free mass index 266 97.0 0.77 0.08 6.0 8.3 
DXA limb fat-free mass 266 88.0 0.57 0.07 11.3 21.9 
DXA limb fat-free mass index 266 86.8 0.33 0.08 5.7 15.9 
DXA trunk fat-free mass 266 94.3 0.71 0.07 11.3 10.9 
DXA trunk fat-free mass index 266 94.7 0.34 0.13 6.0 2.3 
Total body water 266 96.6 0.83 0.05 11.3 11.7 
Bio-electrical impedance 141 92.2 0.69 0.09 13.5 15.6 
Corrected bio-electrical impedance 141 84.6 0.72 0.09 13.5 12.8 
Combined DXA and BIA 141 93.5 0.74 0.08 13.5 15.7 
DXA; dual energy X-ray absorptiometry, BIA; bio-electrical impedance, index is height
2 
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8.6.6 Accuracy of an aggregate prediction using the ‘wisdom of 
crowds’ approach. 
 
87 children (41 boys) had data that fitted the criteria for all 12 prediction equations 
(Table 8.7).  Characteristics of the children are presented in Table 8.8, they were 
significantly shorter than the UK reference data (p<0.05) and the girls were 
significantly lighter (p<0.01).  For the prediction of FM and FFM (since they are 
equal and opposite) the aggregate prediction had the third lowest bias (0.8 kg; 
p<0.001) and the second lowest limits of agreement (± 4.2 kg) (Table 8.9, Figure 
8.5).  The individual predictions range in bias from 0.5 to 7.2 kg and limits of 
agreement of ± 3.6 kg to ±15.5 kg.  For 8 of the prediction equations the magnitude 
of the bias was significantly related to the magnitude of FM, this was not the case for 
the aggregate prediction or 4 of the individual predictions. 
 
Figure 8.6 shows the bias in FM for individual children for the aggregate equation.  
Six children had a bias greater than 4 kg FM which for 5 children was between 47 
and 140% of their FM by 4CM. 
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Table 8.7. Equations for the prediction of body composition in children 
Raw data 
Predicted  
variable 
Age 
range y 
Equation Groupings 
Weight and height 
Morgenstern et al (232) TBW 0.25-13 0.0846 x 0.95F x (Ht x Wt)
0.65 
 
 TBW >13 0.0758 x 0.84F x (Ht x Wt)
0.69 
 
Mellits and Cheek (233) TBW 0.1-31 -1.927 + (0.465 x Wt) + (0.045 x Ht) Boys ≤132.7cm 
 TBW -21.933 + (0.406 x Wt) + (0.209 x Ht) Boys ≥ 132.7cm 
 TBW 0.076 + (0.507 x Wt) + (0.013 x Ht) Girls ≤ 132.7cm 
 TBW -10.313 + (0.252 x Wt) + (0.154 x Ht) Girls ≥ 132.7cm 
BMI 
Deurenberg et al (234) % Fat 7-20 1.4 + (1.51 x BMI) – (0.70 x age) – (3.6 x M)  
Pietriobelli et al (235) FM 5-19 -29.91 + (2.06 x BMI) Boys 
 FM -30.65 + (1.90 x BMI) + (0.53 x age) Girls 
Skinfold thickness 
Slaughter et al (165) % Fat 8-29 (1.21 x SF2) – (0.008 x SF22) – 1.7 Boys SF2 <35 mm 
 % Fat (1.33 x SF2) – (0.013 x SF2) – 2.5 Girls SF2 <35 mm 
 % Fat (0.783 x SF2) – 1.7 Boys SF2 >35 mm 
 % Fat (0.546 x SF2) + 9.7 Girls SF2 >35 mm 
Johnston et al (164) BD 8-14 1.279 – (0.121 x log SF4) Boys with CF 
 BD 1.120 – (0.030 x log SF4) Girls with CF 
Deurenberg et al (236) BD Mean 11 1.1133 – (0.0561 x log SF4) + (1.7 x age x 10-3) Boys 
 BD Mean 10.5 1.1187 – (0.063 x log SF4) + (1.9 x age x 10-3) Girls 
F; female = 1, male = 0, M; female = 0, male = 1, Wt; weight, Ht; height, TBW; total body water (L), BD; body density (g/cm
3
), SF2; 
sum of tricep and subscapular skinfold thicknesses (mm), log is log to base 10, SF4; sum of bicep, tricep, subscapular and suprailiac 
skinfold thicknesses (mm),FM; fat mass, FFM; fat-free mass. Table continues on next page. 
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Table 8.7 continued.  Equations for the prediction of body composition in children 
 
 
 
 
 
Raw data 
Predicted  
variable 
Age 
range y 
Equation Groupings 
Ht
2
/Z 
Horlick et al (237) TBW 4-18 0.725 + (0.475 x Ht
2
/Z) + (0.14 x Wt)  
Houtkooper et al (90) FFM 10-19 (0.61 x Ht
2
/Z) + (0.25 x Wt) + 1.31  
Schaefer et al (238) FFM 3-19 (0.65 x Ht
2
/Z) + (0.68 x age) + 0.15  
Deurenberg et al (91) FFM 7-15 (0.406 x Ht
2
/Z) + (0.36 x Wt) + [5.58 Ht (m)] + (0.56 x M) - 6.48   
Cordain et al (239) FFM 9-14 6.86 + (0.81 x Ht
2
/Z)  
F; female = 1, male = 0, M; female = 0, male = 1, Wt; weight, Ht; height, TBW; total body water (L), BD; body density (g/cm
3
), SF2; 
sum of tricep and subscapular skinfold thicknesses (mm), log is log to base 10, SF4; sum of bicep, tricep, subscapular and suprailiac 
skinfold thicknesses (mm),FM; fat mass, FFM; fat-free mass, Z; impedance (ohms). 
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Table 8.8.  Characteristics of children whose data was used for the aggregate prediction 
 
 Boys n=41 Girls n=46 
 Mean SD Range Mean SD Range 
Age (y) 12.8 1.91 10.1 16.0 12.68 1.76 10.0 15.7 
Weight (kg) 44.0 12.2 25.8 86.6 40.8 10.1 22.2 61.4 
Height (m) 1.52 0.14 1.29 1.83 1.48 0.11 1.21 1.68 
BMI (kg/height
2
) 18.6 2.28 13.9 25.9 18.4 2.68 13.2 24.5 
Weight SDS -0.02 0.98 -1.89 2.07 -0.56
**
 1.31 -4.45 1.42 
Height SDS -0.39
*
 1.15 -2.53 1.97 -0.72
***
 1.29 -3.64 1.46 
BMI SDS 0.18 0.87 -1.92 1.90 -0.21 1.14 -3.78 1.57 
Bicep skinfold (mm) 6.6 3.3 3.2 21.2 8.6 3.4 3.9 18.9 
Tricep skinfold (mm) 10.5 3.7 4.7 18.8 13.4 4.6 6.1 24.5 
Subscapular skinfold (mm) 7.4 2.6 4.0 17.9 10.5 6.3 4.6 31.6 
Supra-iliac skinfold (mm) 12.1 6.8 5.2 34.3 15.9 8.2 5.5 33.7 
Resistance (ohms) 695 82 539 867 800 88 584 1065 
Total body water (l) 26.5 7.0 16.0 40.4 22.6 4.65 14.2 31.2 
4-component fat mass (kg) 8.33 4.68 3.21 28.7 10.3 4.90 3.18 21.9 
4-component fat-free mass (kg) 35.7 9.83 21.8 57.9 30.5 6.35 19.0 43.0 
 
*
P<0.05, 
**
P<0.01, 
***
P<0.001, one sample t-test compared to zero, child with CF compared to reference data. 
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Table 8.9.  Bland-Altman statistics for bias and limits of agreement for individual or aggregate equations and reference 4-component fat 
mass. 
 
 
Equation Bias
1 Limits of 
agreement 
P R P
correlation 
Deurenberg et al, BIA 7.17 ± 8.91 <0.001 0.372 <0.001 
Johnston et al -5.84 ±15.47 <0.001 0.488 <0.001 
Horlick et al 4.66 ± 6.62 <0.001 0.233 0.030 
Schaefer et al 4.19 ± 6.44 <0.001 0.514 <0.001 
Morgenstern et al -3.14 ± 8.98 <0.001 -0.140 0.196 
Houtkooper et al 2.33 ± 5.28 <0.001 0.013 0.908 
Cordain et al 1.22 ± 6.95 0.001 0.500 <0.001 
Deurenberg et al, BMI -1.22 ± 5.00 <0.001 -0.599 <0.001 
Deurenberg et al, SFT 0.91 ± 7.11 0.002 0.049 0.654 
Slaughter et al -0.89 ± 3.56 <0.001 -0.219 0.041 
Aggregate  0.77 ± 4.17 0.001 -0.168 0.120 
Mellitis and Cheek -0.60 ± 5.61 0.049 -0.029 0.788 
Pietrobelli et al 0.46 ± 5.82 0.143 0.150 0.165 
 
1
Difference (prediction equation – 4-component model (4CM)), bias in fat-free mass is equal and opposite.   
Limits of agreement; ±2SD, P; one-sample t-test of bias compared to zero, R; correlation between the mean value  
(4CM and individual prediction equation) and the bias. 
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Figure 8.5.  Bland-Altman analysis showing mean bias (predicted – 4CM) and limits of agreement (±2SD) in fat mass and fat-free mass in 107 
children with CF compared to the 4-component model.  The bias in fat-free mass is equal and opposite to that of fat mass.  The graph compares 12 
individual predictions and an aggregate average of the 12 equations to the 4-component model.  BIA; bio-electrical impedance, BMI; body mass 
index, SFT; skinfold thickness.  Asterisks denote biases that were significantly different from the 4CM, * p<0.05, ** p<0.005. 
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Figure 8.6  Individual bias and limits of agreement (±2SD) for fat mass(FM)  by the aggregate prediction  compared to the 4-
component model (4C FM;(aggregate FM – 4CM FM ).   
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8.7 Discussion 
 
 
The 4CM is the ‘criterion’ in vivo method for the assessment of body composition in 
children but is not widely available due to high cost, the need for skilled technicians and 
lack of portability of the equipment. Other simpler techniques, which are available in the 
hospital setting are therefore the methods of choice for clinical assessment.  It is 
important that these techniques are assessed against a criterion method in order to 
identify the most appropriate for assessing body composition in children with CF and to 
determine to what extent they are interchangeable.  This is important because not all 
techniques may be available at every assessment or suitable for all patients on all 
occasions. 
 
DXA may be available in most hospitals but its use in children tends to be in specialist 
paediatric centres since interpretation of the data obtained is complicated by body size 
and maturity (213).  Several studies in adults and children have assessed absolute values 
for FM and FFM against the 4CM and found relatively poor agreement in terms of mean 
bias and limits of agreement (102;167;198;199;226;240-244) with age, gender, size, 
pubertal status and disease state as possible factors influencing the bias.  A recent study 
from our centre (245) found that when using DXA to assess body composition in obese 
children the bias was negligible but the limits of agreement wide for FM (±3.2 kg) and 
FFM (±3 kg).  These findings suggest that the use of DXA for individual assessment and 
longitudinal change has limitations. 
 
The use of body composition measurements in clinical practice is hampered by lack of 
reference data, particularly in children.  Several datasets have been generated for 
techniques such as SFT, BIA and DXA (246-252) but none have generated reference 
data in the same population using several different techniques. This issue was recently 
addressed at our centre by measuring 533 children, adolescents and young adults to 
generate reference curves from which SDS can be calculated for 4C FM and FFM and 
many of the simpler methods (155). Using this data I have compared SDS for BMI, SFT 
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and DXA FM to 4C FM and BIA, TBW and DXA FFM to 4C FFM.  These comparisons 
identify the best simple technique to use to assess FM and FFM in children with CF 
aged 6 -17 years. 
 
It is conceivable that there may be occasions when only simple bedside techniques such 
as anthropometry, SFT and BIA are available due to lack of resources.  Prediction of FM 
or FFM from a single prediction technique, particularly in children and patients, is likely 
to be inaccurate and imprecise.  However, an aggregate prediction in a ‘wisdom of 
crowds’ approach has been shown to improve accuracy and precision (253) when 
assessing body composition in healthy children and adolescents.    
 
There are 4 aspects to my analysis: (1) cross sectional comparison of simple techniques 
and the 4CM, (2) longitudinal comparison, (3) a comparison of the classification of 
‘abnormal’ scores by simple techniques and the 4CM and (4) whether an aggregate 
prediction is more accurate and precise than individual predictions.  These analyses aim 
to identify which techniques can be used to measure CF children’s body composition 
and monitor change adequately and the extent to which they may be interchangeable.  
The ability of a technique to classify patients as ‘normal’ or ‘abnormal’ for FM and FFM 
is an important factor when designing treatment and dietary regimens and therefore 
these analyses aim to quantify this for all simple techniques.  Finally, it must be 
acknowledged that many of the options may not be available for all patients at all times 
and therefore I have included an assessment of a method using the simplest bedside 
techniques.   
 
8.7.1 Cross sectional comparison of simple techniques compared to the 
4-component model and classification of patients 
 
I found DXA to be a more accurate predictor of 4C FM than BMI or SFT.  Bias in DXA 
whole body and regional FM was small (<0.16 SDS) and limits of agreement ranged 
from ±0.4 (trunk) to ±0.7 (limbs).  The best predictor of 4C FFM was TBW which is 
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unlikely to be used clinically due to its high cost and lengthy analysis time.  DXA whole 
body and trunk FFM bias was small (<0.2 SDS) and DXA limb FFM underestimated by 
on average, 0.5 SDS.  Limits of agreement ranged from 0.4 to 0.8.  Although whole 
body FM and FFM did not show the lowest limits of agreement compared to regional 
DXA, it would be wise to use whole body scans in clinical practice because the accuracy 
of regional scans will be affected by the positioning of the ‘regions of interest’ by the 
operator. Whereas the region of interest is chosen by the operator for regional scans in 
whole body scans it is standardised. In addition, the bias in whole body FM and FFM 
were not affected by age, sex or BMI SDS in this group of children. 
 
 For assessing FFM, corrected BIA showed no bias but wider limits of agreement than 
DXA whole body.  However, a combination of DXA whole body FFM and BIA SDS 
gave no bias and narrower limits of agreement (0.53 SDS) than most of the other single 
techniques.  Since BIA is a cheap, easy technique which could be performed in the same 
room as the DXA it would seem prudent to combine both techniques for the assessment 
of FFM.  A database to calculate the corrected BIA and combined SDS could be 
provided in Excel format although the correction factor would need to be tested in other 
populations before being applied to other groups children with CF of the age range in 
this study.   
 
Whole body DXA showed good agreement with 4CM for categorising patients as 
‘normal’ and abnormal’ with regards to FM and FFM (73% and 76% respectively) and 
DXA FFM combined with BIA SDS was similar.  The use of DXA (with or without 
BIA) in clinical practice as a predictor of 4C FM and FFM SDS and in the identification 
of CF children with abnormal body composition is supported by these findings.  
However, it is important to note that the limits of agreement were wide with 95% of 
values from DXA whole body falling within a 1.5 or 1.3 SD band of those obtained by 
4C FM and FFM respectively.  This suggests that DXA cannot be considered to be 
interchangeable with the 4CM and that the results should be used in conjunction with 
other clinical indicators.  If BIA is used in combination with whole body DXA FFM, 
95% of values fall within a narrower band of 0.5 SDS.    DXA was also less accurate in 
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patients with low FM.  The finding that the bias and magnitude were correlated for both 
whole body and regional FM and whole body FFM is in accord with previous research 
demonstrating that size affects the measurement of soft tissue from DXA (102;196;254). 
 
Analysis using indexed (height adjusted) DXA variables compared to 4C FMI and FFMI 
did not improve the results although there was an unexpected finding for trunk FFMI.  In 
both boys and girl it appears that there is a depletion of FFM by 4CM and DXA whole 
body (Table 6.1) that is not replicated in the trunk if a height adjustment is made.  On 
the contrary, there is a positive mean value of 0.65 for boys and 0.28 for girls. One 
possible explanation is that although these CF children are short for their age the 
shortness may be disproportionate in the limbs and trunk and therefore height
2
 would not 
be the most appropriate power for both trunk and limbs.  Data on sitting height is not 
available for baseline and some of year 2 measurements although 127 subsequent 
measurements of this group of children indicate a mean (SD) for standing height SDS of 
-0.57 (1.07) and sitting height SDS of   -0.67 (1.11), p=0.452.  Another explanation is 
that this finding is a reflection of increased density in the trunk area which may be due to 
enlarged organs or may be as a result of bowel dysfunction or methodological issues 
with DXA instrumentation as discussed in Chapter 6.  Height adjusting regional FFM by 
DXA reduces agreement on classification of patients by about a half compared to 
unadjusted and therefore the use of trunk FFM SDS for clinical assessment cannot be 
recommended.   
 
DXA may not always be available in clinical practice and therefore the ability of BMI 
and SFT to predict 4C FM and BIA to predict 4C FFM is an important consideration.  
BMI and SFT provided much less agreement with 4C FM than DXA whole body FM, 
demonstrating large positive biases and wide limits of agreement.  Tricep SFT provided 
a slightly better ranking of 4C FM than the other 3 SFT or BMI although the limits of 
agreement were similar.    Agreement with 4CM to categorise patients as ‘abnormal’ 
was also poor.  It is therefore not advisable to use SFT or BMI as an indicator of FM, 
even as a crude method to monitor an individual child with CF longitudinally. However, 
corrected BIA showed no bias (and good agreement for classification of patients) and 
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therefore when DXA is not available BIA, which is a cheap readily available 
technology, can be used to assess FFM, although it should be noted that limits of 
agreement are wide at ±0.8 SDS.  As previously discussed combining DXA and 
corrected BIA SDS improved accuracy and precision compared to DXA on its own.  
However, this data is obtained from a single frequency, standing BIA machine and 
caution should be taken if using a different make, model, multi-frequency or supine 
measurement machine. 
 
All techniques demonstrated an over-estimation of FM compared to 4C FM whereas 
bias in FFM estimation was variable.       
 
8.7.2 Longitudinal comparison of simple techniques compared to the 4-
component model 
 
Change in DXA whole body and regional FM and FFM SDS did not show any 
significant bias compared to change in the 4CM SDS although bias in DXA FM (whole 
body and regional) was greater in those with the least change and bias in change of DXA 
trunk FFM greatest in those with the most change.  Limits of agreement were about 1 
SDS for change in FM and slightly smaller for FFM.  The use of DXA whole body scans 
is recommended for clinical practice to reduce operator error.  Combining DXA FFM 
and BIA SDS not only improves the cross sectional outcome but also reduces the limits 
of agreement for longitudinal change by half.  The use of DXA whole body FM and 
FFM with or without corrected BIA in clinical practice to measure body composition 
and monitor change is supported by these findings.  However, it is important to note that 
the limits of agreement for bias in change in DXA whole body FM and FFM are wide 
with 95% of values from DXA falling within a 2.0 or 1.2 SD band of those obtained by 
4C FM and FFM respectively.  For FFM this is reduced by combining BIA with DXA 
whole body FFM (0.7 SD).  Corrected BIA SDS had an insignificant bias compared to 
change in 4C FFM with limits of agreement close to those of DXA and therefore would 
be a good alternative to assess FFM when DXA is not available.  The limits of 
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agreement suggest that these techniques should not be used interchangeably however; 
using the same technique over time will best monitor change in body composition. 
  
8.7.3 ‘Wisdom of crowds’ aggregate prediction from several simple 
prediction techniques 
 
As hypothesised by the ‘wisdom of crowds’ theory the aggregate prediction had greater 
accuracy than the majority of individual prediction equations in estimating FM and FFM 
in this group of children with CF.  Accuracy was better than all but 2 individual 
prediction equations and precision better than all but 1 individual prediction equation.  
Most of the individual prediction equations produced values where the magnitude of the 
bias was related to the magnitude of FM or FFM. This was not the case for the aggregate 
prediction.  Although mean bias in the aggregate prediction compared to 4C FM and 
FFM was one of the lowest (0.77 kg), individual bias was as much as 4 kg which, for 6 
children was between 50 and 139% of their 4C FM or FFM.  Clearly, where better 
techniques are available these should be used, but where they are not feasible this 
approach has some merit for assessing groups.   
 
The ‘wisdom of crowds’ approach minimises the risk of selecting an equation with a 
high bias given that it is not possible to know which equation will perform best in any 
given group.  Although 2 equations were marginally better than the aggregate for 
agreeing with the 4CM this may not be the case in another population of children with 
CF.  In addition the aggregate prediction had narrower limits of agreement than 11 of the 
12 individual prediction equations.  It should be noted that all but 1 of the equations used 
were generated in healthy populations and therefore further work to generate more CF 
specific equations, using several bedside techniques, would be helpful to determine 
whether accuracy and precision may be improved.    
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8.8 Study limitations 
 
There are some limitations to this study.  Firstly, it should be considered whether the fact 
that DXA is compared on its own to the 4CM which utilises DXA BMC measurement 
may influence the result.  I have previously addressed this issue (102) by analysing data 
from both 4CM and the 3CM which does not utilise any DXA measures.  The results 
remained unchanged.  Secondly, no attempt has been made to relate these findings to 
clinical outcome so although, for example, SFT are not good at assessing absolute FM 
they may be useful clinically to monitor health.  Thirdly, these analyses have utilised 
standardised scores, and the question of whether there is bias in absolute FM and FFM 
kg has not been addressed.  Fourthly, I used standing BIA apparatus and the findings 
may be different where impedance is measured lying down.  Finally, prediction 
equations generated with data from children with CF rather than healthy children may 
improve the outcome of an aggregate prediction. 
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8.9 Summary 
 
 
 Techniques cannot be used interchangeably.   
 Standardised FM and FFM measurements from DXA compare most favourably 
with those derived from the 4CM and are the most useful clinically for 
measuring body composition and monitoring change.   
 Regional DXA may be affected by operator error whereas whole body DXA is 
standardized and therefore whole body scans are recommended for clinical 
practice.  
 BIA may reasonably be used to provide a FFM SDS in place of DXA if a 
correction factor is applied.  Assessment of FFM is improved by combining 
corrected BIA with DXA FFM in terms of agreement with the 4CM in this group 
of children.   
 Despite the short stature of these CF children, agreement with 4CM is not 
improved by height adjusting DXA SDS.   
 BMI and SFT should not be used for assessing individuals due to lack of 
accuracy.  
 Monitoring change in body composition is appropriate with DXA, BIA or a 
combination of the 2, although the separate techniques are not interchangeable 
over time. 
 When only simple bedside techniques are available the use of an aggregate 
prediction based on a healthy population may be informative when comparing 
groups but not individuals.  It is likely that the generation of several prediction 
equations based on data from children with CF and aggregated will improve the 
outcome.   
 Ultimately, the most appropriate measure should be determined by its predictive 
value for clinical outcome.
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Chapter 9.  Conclusion 
 
 
This chapter will summarise the findings, describe possible future research, outline 
the limitations of the thesis and relate the findings to clinical practice. 
 
9.1 Summary of the findings 
 
 
This thesis had 3 aims; 
4. To investigate the effect of CF on body composition in young children with 
CF and whether this changes with growth and maturity.  In addition, to 
investigate whether the type of comparison (pair-, group-match or compared 
to a reference population) affects the outcome of the analysis. 
5. To investigate the relationship between body composition and clinical status 
assessed by FEV1. 
6. To investigate simple body composition techniques to define which would be 
most appropriate in clinical practice where 4CM is not available. 
 
9.1.1 Effect of cystic fibrosis on body composition 
 
Even at baseline (Chapters 5 and 6), abnormal body composition was apparent with 
clear sex differences indicating that abnormalities in females may be established 
much earlier than previously considered.  The deficit of FM and MM found in this 
group of girls with CF was not related to pubertal status.  Two girls had hidden 
depletion of FFM which is likely to impact greatly on the course of the disease and 
response to treatment.  Both girls and boys with CF were short but boys had similar 
body composition to control boys apart from more FFM once adjustment for stature 
was made.  However, 3 boys were obese which may present problems for the future 
management of these patients.  Only by performing body composition measurements 
was it possible to identify those boys with high BMI and high FM or FFM and those 
girls with ‘normal’ BMI and low FFM indicating that, without these measurements a 
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detrimental body composition may not be identified clinically.  The consistent 
finding was that the children with CF have, on average, larger waist circumference 
than both the reference data and controls which appears from regional DXA 
measurements to be a reflection of increased FFM rather than increased FM, 
suggesting that waist measurements will not be helpful as a measure of adiposity in 
this group.   
 
Longitudinal analysis (Chapter 7) indicated deterioration in FFM in both sexes 
although there was an indication of improving FFM in the older girls.  Boys lowest 
in FFM at baseline and girls lowest in MM at baseline showed the greatest ‘catch-up’ 
(or least decline) in these tissues over 2 years. Clinically, BMD SDS is monitored 
and in children this is size adjusted as BMAD SDS which, for the children in this 
study remained stable at 0.2 in boys and -0.4 in girls.  I also investigated the role of 
physical activity on body composition and although there was no relationship 
between baseline activity and body composition at 2 years, the most active boys at 2 
years had less than expected gains in FM and FFM gains similar to controls.  
However, it must be emphasised the assessment of activity in this study was crude 
and a causal relationship between activity and body composition could only be 
defined with an intervention study.  
 
None of these effects would have been detected using simple anthropometric 
measurements. 
 
Different types of analysis were used to compare the children with CF to a healthy 
control group; matched-pair and group comparisons were made with absolute values 
of components of body composition and also SDS calculated from a large reference 
population.  In addition, these SDS indicate how both the children with CF and the 
controls compare to the large reference population.  I found that the conclusions 
differed depending on the type of analysis and this may, in part, explain the differing 
conclusions of previous studies.  
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9.1.2 The relationship between body composition and spirometry as 
a marker for clinical status.  
 
I found that FM in girls was related to FEV1 at baseline but not at 2 years despite 
declining lung function.  No relationship between body composition and spirometry 
was found in boys at baseline although at 2 years FFM was related to FEV1 and in 
girls whole body BMC was related to FEV1 in accord with many previous studies.  
These findings are presented in Chapters 5 and 6.  In Chapter 7 I showed how a 
greater than expected increase in FM in boys was associated with greater increase in 
FEV1 over 2 years and that baseline FEV1 in boys predicted change in FFMI SDS 
such that a 1 SDS higher FEV1 at baseline predicted an additional 0.18 SDS change 
in FFMI over 2 years.  These findings suggest that, in boys, improving lung function 
is associated with greater than expected gains in FM over the same period, and that 
baseline lung function predicts greater than expected subsequent gain in FFM.  
However, the relationship between body composition and lung function is clearly 
complex and it is impossible to define cause and effect with an observational study.  
A randomised controlled intervention trial to improve either body composition or 
lung function would be necessary.   
 
This study indicated that BMI SDS was only related to FEV1 when there was a 
severe depletion of FM in girls at baseline but it did not relate to change in FEV1 
over the 2 years and in addition, does not accurately reflect either obesity or 
depletion of FFM.  This highlights the importance of using body composition 
measurements in clinical practice if the patient is to receive the most appropriate 
treatment.   
 
9.1.3 Simple body composition techniques for use in clinical practice 
where 4-component model is not available 
 
When deciding which body composition technique to use in clinical practice there 
are practical considerations such as cost, availability, ease of use and patient 
acceptance and also consideration of the quality of the data derived from the 
technique and the applicability to the question being asked.  For example, SFT are 
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not appropriate to measure FM in the group of children measured for this thesis but 
SFT may be useful to monitor overall health in these children.  In addition, a 
technique which has wide limits of agreement may not be suitable to assess and 
monitor individuals over time but may be useful in large epidemiological studies. 
 
I found that FM and FFM SDS derived from whole body DXA gave results closest to 
the criterion method and that assessment of FFM is improved by combining adjusted 
BIA with DXA in this group of children.  However, the equation generated to 
calculate adjusted BIA values in this study would need to be tested in other similar 
aged CF populations before its use could be recommended generally.  BMI and SFT 
are not accurate enough to assess individuals.  Monitoring change in body 
composition is best achieved with DXA, BIA or a combination of both although 
separate techniques are not interchangeable over time.  Simple bedside techniques 
may be informative when comparing groups if an aggregate prediction (of several 
predictions) is used.                                                                                                                                            
                                                                                                                                        
9.2 Future Research 
 
 
From the work in this thesis I have identified possible areas of future research: 
 
1. In the light of the findings of altered body composition in this group of 
children there is a need to establish how body composition measurements can 
be used clinically, for example:  
a. Continued longitudinal follow-up of this cohort into adult life may 
identify whether baseline or change in body composition predicts later 
prognosis. 
b. Could body composition measurements be used as a basis for 
nutritional advice, for example, is it better to base calculation of 
energy requirement on FFM rather than weight?  A randomised 
controlled trial of current (based on weight) versus new management 
(based on FFM) may be helpful. 
c. Whether nutritional interventions lead to greater gains in FM or FFM 
and whether gains in FM or gains in FFM have different outcomes. 
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d. Randomised controlled trials of the impact of interventions on lung 
function or body composition to better understand the relationship 
between the two. 
e. Using data from the 4CM to investigate the relationship between PM 
and lung infection. 
 
2. Continued longitudinal follow-up of the cohort will also allow for the 
investigation of sex differences, not only in body composition but also 
activity using activity monitors and measures of behaviour and attitude to 
illuminate whether there are other, non-biological factors that contribute to 
sex differences.  This information could then be used to design sex specific 
management. 
 
3. Study of the generalisability of the equation generated to adjust raw values of 
impedance from BIA by comparing with deuterium dilution in another group 
of CF patients aged 6-17 years.  
 
4. This thesis highlights some of the issues related to different measurement 
techniques and study design which may explain inconsistencies of previous 
research.  Greater attention to these issues in future studies with more 
consistency in methods and study design would be an advantage. 
 
 
9.3 Limitations 
 
 
Methodological limitations have been discussed in each chapter and are summarised 
here; 
 Spirometry is commonly used as a clinical outcome measure but may not 
capture a complete picture of the health of the patient.  Ideally other clinical 
factors would be incorporated into the analysis although obtaining accurate 
records of all possible variables is difficult in this group of children where 
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some are managed at a local hospital and attend Great Ormond Street 
Hospital for Children once a year. 
 
 I did not measure FEV1 in the control children, however the reference data 
for lung function used in this study is from a large reference population and 
therefore should accurately depict the lung health of CF children in this study.  
However, it must be acknowledged that spirometry outcome is affected by 
motivation, particularly in the young. 
 
 Consistent body volume measurements using ADP are more difficult to 
achieve due to erratic breathing in some of the children with CF.  I therefore 
made multiple measurements in order to achieve consistency.  Measured lung 
volumes whilst in the equipment are difficult to perform particularly in 
children and more so in children with CF.  I therefore used predicted lung 
volumes in all the children.  However, a previous study of children with CF 
using ADP found that there was no significant difference in FFM calculated 
using measured as opposed to predicted lung volume. 
 
  The use of questionnaires to assess activity could be challenged since they 
may be affected by differing parental expectations between parents of 
children with CF and parents of healthy children. 
   
 Children with CF have large changes in appetite and activity depending on 
how well they are.  Measurement of body composition gives a ‘snap shot’ of 
that period and it is possible that there are changes occurring within the 2 
year period that have been missed.  However, treatment regimens for patients 
with CF are onerous and many take part in several research projects and 
therefore to increase the frequency of measurements would be unacceptable.  
 
 Although I have found statistically significant differences between children 
with CF and controls and between different techniques this does not 
necessarily equate to clinical relevance.  The -2 SDS cut-off for ‘abnormal’ is 
arbitrary and should only be regarded as a guide to be used in conjunction 
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with other clinical factors.  Regarding techniques, the most appropriate 
measure should ideally be determined by its predictive value for clinical 
outcome; SFT may not be good to monitor FM but may be useful clinically to 
monitor health.  
 
 Observational studies such as mine cannot define cause and effect.  Only a 
randomised controlled trial of an intervention to improve body composition 
or improve lung function would make the picture clearer.  However, due to 
the multiple factors which impact on overall disease severity in this group 
and the way that each is likely to impact upon and be affected by other 
factors, a clear answer is unlikely.    
 
 SDS used in this study to compare techniques are, as yet, not generally 
available and will not be appropriate for all ethnic groups, all makes of DXA 
and supine BIA machines.  
 
 This study was unable to investigate the important contribution of diet on 
body composition.  
 
 
 
9.4 Implications of this research for clinical practice 
 
 
The body composition of children with CF is an important factor influencing 
prognosis.  Simple anthropometric techniques are internationally recommended to 
monitor the growth and nutritional status in these children.  However, my findings 
suggest that these are not able to detect abnormal body composition. Using more 
detailed measurement techniques, abnormal body composition is apparent during 
mid-childhood, with gender differences that are in accord with our knowledge about 
prognosis.  However, these findings would not be apparent unless an appropriate 
method is used, for example using simple anthropometry does not identify hidden 
depletion of FFM and ‘obesity’ and BMI is not a good predictor of FEV1 in this 
group of children. 
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A very important aspect of this study is the information on which techniques are 
likely to be most appropriate for clinical use finding that DXA or a combination of 
DXA and BIA give results closest to the criterion method.  However, the equation 
for adjusting BIA SDS would need to be tested in another population of children 
with CF before it could be recommended for other groups of CF patients. 
 
The findings in this thesis support the concept that the measurement of body 
composition in children with CF is important for both research and clinical practice 
however, it must be emphasised that appropriate techniques should be used. 
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Appendices 
Appendix 1. Ethical approval 
 
Institute of Child Health/Great  Ormond Street  Hospital Ethics 
Committee 
The Institute of Child Health 
30 Guilford Street 
London 
WC1N 1EH 
Telephone: 020 7599 4130 
Facsimile: 
16 September 2008 
Dr M S Fewtrell 
Reader in Childhood Nutrition, Hon Consultant 
Paediatrician Childhood Nutrition Research Centre, 
UCL Institute of Child Health 30, Guilford St 
London 
WC1N 1EH 
Dear Dr Fewtrell 
Full title of study: Body composition and bone health in children with cystic 
fibrosis compared to healthy children; a longitudinal matched pairs 
study. 
REC reference number: 08/H0713/66 
Thank you for your letter of 01 August 2008, responding to the 
Committee's request for further information on the above research and 
submitting revised documentation. 
The further information has been considered on behalf of the Committee by the 
Vice-Chair. Confirmation of ethical opinion 
On behalf of the Committee, 1 am pleased to confirm a favourable ethical 
opinion for the above research on the basis described in the application form, 
protocol and supporting documentation as revised, subject to the conditions 
specified below. 
Ethical review of research sites 
The Committee has designated this study as exempt from site-specific 
assessment (SSA). The favourable opinion for the study applies to all sites 
involved in the research. There is no requirement for other Local Research 
Ethics Committees to be informed or SSA to be carried out at each site. 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. 
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Management permission or approval must be obtained from each host 
organisation prior to the start of the study at the site concerned.  
Management permission at NHS sites ("R&D approval") should be 
obtained from the relevant care organisation(s) in accordance with NHS 
research governance arrangements. Guidance on applying for NHS 
permission is available in the Integrated Research Application System or 
at http://www.rdforum.nhs.uk. 
This Research Ethics Committee is an advisory committee to London Strategic Health Authority 
The National Research Ethics Service (NRES) represents the NRES Directorate within 
the National Patient Safety Agency and Research Ethics Committees in England 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
Document , Version Date. 
Application 1 05 June 2008 
Investigator CV 1 04 February 2008 
Protocol 1 01 May 2008 
Covering Letter 1 27 June 2008 
Compensation Arrangements 1 06 June 2008 
Letter of invitation to participant 1 26 June 2008 
Participant Information Sheet: CF parent information sheet 2 26 July 2008 
Participant Information Sheet: Control over 12 yrs participant 
information sheet 
2 26 July 2008 
Participant Information Sheet: CF over 12 yrs participant information 
sheet 
2 26 July 2008 
Participant Information Sheet: Control child information sheet 2 26 July 2008 
Participant Information Sheet: CF child information sheet 2 26 July 2008 
Participant Information Sheet: Control parent information sheet 2 26 July 2008 
Participant Consent Form: Assent 1 02 May 2008 
Participant Consent Form: Parent 1 02 May 2008 
Participant Consent Form: Participant 1 02 May 2008 
Response to Request for Further Information 1 01 August 2008 
CV Jane Williams   
Original Ethics Approval Letter 1 26 March 2008 
Certificate for Participants 1  
Data Protection Form 1  
 
Statement of compliance 
The Committee is constituted in accordance with the Governance 
Arrangements for Research Ethics Committees (July 2001) and complies fully 
with the Standard Operating Procedures for Research Ethics Committees in 
the UK. 
 
After ethical review 
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Now that you have completed the application process please visit the 
National Research Ethics Website > After Review 
You are invited to give your view of the service that you have received from 
the National Research Ethics Service and the application procedure. If you 
wish to make your views known please use the feedback form available on 
the website. 
The attached document "After ethical review — guidance for researchers" 
gives detailed guidance on reporting requirements for studies with a 
favourable opinion, including: 
 Notifying substantial amendments 
 Progress and safety reports 
 Notifying the end of the study 
The NRES website also provides guidance on these topics, which is updated in 
the light of changes in reporting requirements or procedures. 
We would also like to inform you that we consult regularly with stakeholders to 
improve our service. If you would like to join our Reference Group please email 
referencedroup nres.npsa.nhs.uk. 
081H0713/66  Please quote this number on all correspondence 
With the Committee's best wishes for the success of 
this project Yours sincerely 
 rDr Victor Larcher 
Chair 
Email: Tom.Lucas@ich.ucl.ac.uk 
Copy to: Dr Tracey Assari 
R&D office for GOSH/1CH 
 
 
 
 
 
 
 
 
 230 
 
 
Appendix 2.1. Child with CF information sheet 
 
 
 
  
MRC Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street 
London WC1N 1EH 
Tel 020 7905 2389 
 
Title of project 
Body composition and bone mineralisation in children with Cystic Fibrosis 
compared to healthy children. 
 
 
Children’s Information Sheet ( 6 to 11 yrs). 
You are being asked to take part in a research study.  Take time to decide if 
you want to say YES or NO to this.  Please read this information, or ask 
someone to read it to you.  Don’t worry if you don’t understand it straight 
away.  Your parents have also been told about this, and you can ask them to 
help you understand.  You can find more general information about research 
on the Great Ormond Street Hospital website: 
 
(http://www.gosh.nhs.uk/gosh_families/research) 
 
 
Why have I been asked to take part? 
You have cystic fibrosis which means that you are not able to use all the food 
you eat to grow.  We would like to measure you to find out how well you are 
growing. 
 
 
Do I have to take part? 
No, it is up to you to decide whether or not you want to take part.  Even if you 
decide to take part, you can change your mind at any time and you don’t 
have to give us a reason.  If you decide not to take part it will not make any 
difference to your treatment. 
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What do I have to do? 
You will be asked to come to the X-ray department at GOSH with your 
parents.  It will take about 1 ½ hours and we will arrange a time when you are 
coming to the hospital for a routine appointment or are staying on the ward.  
None of the measurements are dangerous or hurt: 
 
We will measure your size and shape with a tape measure.  
We will ask you to lie on a bed with a camera over the top which takes a 
picture of your bones.  You need to keep still for a few minutes while it takes 
a picture.  You will get a copy of the picture of your skeleton to take home. 
We will also take a picture of your arm and leg using another machine. 
We will measure the strength of your arm and leg using sound waves and 
some slippery gel. 
We will give you some cotton wool to put in your mouth to get wet and then 
give you a drink of special water.  This will help us to measure how much 
water you have in your body. 
We will ask you to sit in an egg shaped pod for a few minutes whilst wearing 
your swimming costume.  There is no water, just air blowing gently around 
you. 
We will ask you to stand on a weighing scale whilst you hold onto two 
handles. 
We will ask you some questions about how healthy you are and what you 
eat.   
We will ask you to wear an activity monitor on a belt around your waist so 
that we can measure how much you move about. 
 
Photos of the machines are shown at the end of this leaflet.  You will need to 
wear loose clothes without any metal – but you will not have to undress.  
Your parent or guardian will be with you all the time. 
 
 
Is there anything dangerous? 
None of the measurements are dangerous and none of them hurt.  If you 
don’t want to do one of the tests you can tell us. 
 
Who will know about me taking part? 
Only the people doing the research and your doctors at the hospital will know 
about you doing the measurements.   
 
Who do I speak to if I have any problems? 
You can speak to your parents who also have information about the study.  
You can also contact one of the researchers- their details are at the end of 
this leaflet.  No one will be told that you have called and you do not have to 
give your name if you want to ask a question or talk about the tests. 
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Details of how to contact the researchers: 
Jane Williams      Dr Mary Fewtrell 
Research Nurse     Chief Investigator  
Childhood Nutrition Research Centre  Childhood Nutrition Research 
Centre 
Institute of Child Health    Institute of Child Health  
30 Guilford Street      30 Guilford Street 
London WC1N 1EH     London WC1N 1EH 
Tel: 0207 905 2389     Tel: 0207 905 2743 
Email; jane.williams@ich.ucl.ac.uk   Email; m.fewtrell@ich.ucl.ac.uk 
 
Thank-you for reading this information sheet! 
 
a) Measuring your head 
 
b) Taking a picture of your bones 
 
 
 
 
  
 
 
 
 
 
 
                                                                          
b) You will be given a copy to keep 
 
 
c) Taking another picture of your bones 
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d) How strong are your bones? 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
  f) The Bodpod to measure your size and weight 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  g) Measuring your muscles 
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Appendix 2.2. Control child information sheet 
 
 
 
 
  
MRC Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street 
London WC1N 1EH 
Tel 020 7905 2389 
 
Title of project 
Body composition and bone mineralisation in children with Cystic Fibrosis 
compared to healthy children. 
 
 
Children’s Information Sheet ( 6 to 11 yrs). 
You are being invited to take part in a research study.  Take time to decide if 
you want to say YES or NO to this.  Please read this information, or ask 
someone to read it to you.  Don’t worry if you don’t understand it straight 
away.  Your parents have also been told about this, and you can ask them to 
help you understand.  You can find more general information about research 
on the Great Ormond Street Hospital website: 
 
(http://www.gosh.nhs.uk/gosh_families/research) 
 
 
Why have I been asked to take part? 
 
We are measuring children with cystic fibrosis, an illness which means they 
are not able to use all the food they eat to grow.  To find out how well they 
are growing we need to measure children who do not have any illness so we 
can see the difference.  We are asking you to take part because you are 
healthy. 
 
 
Do I have to take part? 
No, it is up to you to decide whether or not you want to take part.  Even if you 
decide to take part, you can still leave the study at any time and you don’t 
have to give us a reason. 
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What do I have to do? 
You will be asked to come to the X-ray department at GOSH with your 
parents.  It will take about 1 ½ hours and we will arrange a time that is best 
for you and your parents.  None of the measurements are dangerous or hurt: 
 
We will measure your size and shape using a tape measure.  
We will ask you to lie on a bed with a camera over the top which takes a 
picture of your bones.  You need to keep still for a few minutes while it takes 
a picture.  You will get a copy of the picture of your skeleton to take home. 
We will also take a picture of your arm and leg using another machine. 
We will measure the strength of your arm and leg using sound waves and 
slippery gel. 
We will give you some cotton wool to put in your mouth to get wet and then 
give you a drink of special water.  This will help us to measure how much 
water you have in your body. 
We will ask you to sit in an egg shaped pod for a few minutes whilst wearing 
your swimming costume.  There is no water, just air blowing gently around 
you. 
We will ask you to stand on a weighing scale whilst you hold onto two 
handles. 
We will ask you some questions about how healthy you are and what you 
eat.   
We will ask you to wear an activity monitor on a belt around your waist so 
that we can measure how much you move about. 
 
Photos of the machines are shown at the end of this leaflet.  You will need to 
wear loose clothes without any metal – but you will not have to undress.  
Your parent or guardian will be with you all the time. 
 
 
Is there anything dangerous? 
None of the measurements are dangerous and none of them hurt.  If you 
don’t want to do one of the tests you can tell us. 
 
Who will know about me taking part? 
Only the people doing the research will know about you doing the 
measurements.   
 
Who do I speak to if I have any problems? 
You can speak to your parents who also have information about the study.  
You can also contact one of the researchers- their details are at the end of 
this leaflet.  No one will be told that you have called and you do not have to 
give your name if you want to ask a question or talk about the tests. 
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Details of how to contact the researchers: 
Jane Williams      Dr Mary Fewtrell 
Research Nurse     Chief Investigator  
Childhood Nutrition Research Centre  Childhood Nutrition Research 
Centre 
Institute of Child Health    Institute of Child Health  
30 Guilford Street      30 Guilford Street 
London WC1N 1EH     London WC1N 1EH 
Tel: 0207 905 2389     Tel: 0207 905 2743 
Email; jane.williams@ich.ucl.ac.uk   Email; m.fewtrell@ich.ucl.ac.uk 
 
Thank-you for reading this information sheet! 
 
a) Measuring your head 
 
b) Taking a picture of your bones 
 
 
 
 
  
 
 
 
 
 
 
                                                                         
b) You will be given a copy to keep 
 
 
c) Taking another picture of your bones 
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d) How strong are your bones? 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
  f) The Bodpod to measure your size and weight 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   g) Measuring your muscles 
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Appendix 2.3. Child with CF over 12 y information sheet 
 
 
 
 
 
  
MRC Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street 
London WC1N 1EH 
Tel 020 7905 2389 
 
Title of project 
Body composition and bone mineralisation in children and with Cystic 
Fibrosis compared to healthy children. 
 
Participant Information Sheet (12 yrs and older). 
You are being invited to take part in a research study.  Before you decide 
whether to take part or not, it is important you understand why the research is 
being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  You can find 
more general information about research on the Great Ormond Street 
Hospital website: 
 
(http://www.gosh.nhs.uk/gosh_families/research) 
 
 
What is the aim of the study? 
The aim of this study is to measure the amount of fat, muscle and bone in 
children with cystic fibrosis (CF) and to see if these measurements relate to 
how well the children are. 
 
 
Why is the study being done? 
Some children with CF may develop problems with growth, due to problems 
with the absorption of food.  This may lead to differences in the proportions of 
fat and muscle in the body, and also with the amount of mineral in their 
bones.  Until recently, it has been difficult to accurately measure the amounts 
of fat, muscle and bone in children, but we can now do this using some 
simple measurements that are available at GOSH. 
 
How is the study to be done? 
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We are inviting all children aged 6-17 years with CF who attend GOSH to 
participate.  If you are willing to take part in the study, we will arrange an 
appointment at a time which is convenient for you (if possible, at the same 
time as your outpatient appointment).  If you agree we will contact you again 
every 2 years to repeat the measurements.  You can decide on each 
occasion whether to take part.  The study will take about 1 ½ hours and will 
take place in Great Ormond Street Hospital.  We will reimburse any travelling 
expenses.   
 
At the appointment we will ask you to do the following: 
After the study has been explained to you (and we have answered all your 
questions) we would like you or your parent to sign a consent form.  This will 
give us permission to include you in the study and to obtain information about 
genotype (your genetic code) and clinical details from the hospital notes.   
We will measure your standing and sitting height and weight, waist, hip, 
head, arm and leg circumference and limb length, and skin-folds (by pressing 
the fat gently on the arm, shoulder and abdomen).  You will not be asked to 
undress completely.  
We will ask you to lie on a bed with a machine above (DXA  
scan) that measures bone using very low dose X-rays (much less than the 
daily background radiation we are all exposed to).  This will also take a 
picture of your skeleton, which you can keep. The scans take a few minutes 
each, and are performed with you wearing light indoor clothing (such as 
shorts and a t-shirt) that do not contain metal.  These scans give a 
measurement of the size and amount of mineral in the bones, as well as the 
proportions of fat and muscle.  If there is any possibility that the person 
being scanned is pregnant, the scan will not be performed. 
We will measure the strength of the bones in your wrist and lower leg using 
an ultrasound machine.  The measurements take a few minutes, are 
completely painless and do not use X-rays. 
We will measure the shape, size and bone mineral content of your tibia 
(lower leg bone) and radius (lower arm bone) using a pQCT machine.  This 
uses a very low dose of X-rays (much less than the daily background 
radiation we are all exposed to). 
We will measure the amount of water in your body.  This measurement 
involves drinking some water containing heavy oxygen molecules (18-
oxygen).  These molecules are not radioactive, they simply weigh more than 
most oxygen molecules and they occur naturally in all of us.  Before and 4 
hours after the drink you will be asked to provide a saliva sample using an 
absorbent cotton wool swab. 
We will measure the volume of your body.  This measurement involves you 
sitting still inside a chamber (with a clear window) called a BodPod for about 
2 minutes whilst room air is gently blown around you.  This measurement will 
be repeated a second and possibly third time.  The test is performed with you 
wearing a swimming costume and a polyester swimming hat (which we will 
provide). 
We will perform a measurement of bioelectrical impedance using a low level 
of electrical current (that is undetectable), passed between electrodes in 
contact with your hands and feet.  The test is harmless and painless and 
gives a measure of body water. 
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We will ask you some questions about general health, including any 
medicines being taken, and use a short questionnaire to measure calcium 
intake and activity level.  To avoid undressing we will give you a leaflet to 
complete in private, that shows pictures of the different stages of pubertal 
development and ask you to indicate which is closest to you. 
 
All the things we have asked you to do will take about 1 ½ hours.  None of 
the tests will hurt. 
  
j) To measure the amount of activity that you do, we will ask you to wear an 
activity monitor on a belt during the daytime for 7 days (5 week days 
and 2 week-end days).  This machine can be posted back to us when 
the measurements are finished. 
 
Are there any risks and discomforts? 
All of the tests are painless and harmless.  DXA and pQCT scans involve a 
tiny amount of radiation, which is less than half of a day’s background 
radiation in the United Kingdom (to which we are all exposed), and less than 
one tenth of the radiation from a flight across the Atlantic.  
 
What are the potential benefits? 
The study could identify any abnormalities of bone density or in the 
proportions of fat and lean tissue.  Where possible, these would be treated.  
Most people find the tests interesting and educational and everyone will be 
given a printout of his/her skeleton to take home.  
 
Who will have access to the research records? 
Only the researchers will have access to the data collected during this study.   
 
Do I have to take part in this study? 
No. If you decide, now or at a later stage, that you do not wish to take part in 
the study, that is entirely your right and it will not affect your clinical care. 
 
What will happen to the results of the research study? 
The results of this research will be published in a medical journal and 
presented at scientific meetings.  The clinical team will receive the results of 
the bone density scan. 
 
 
What if something goes wrong? 
The research project has been approved by an Independent Research Ethics 
Committee which believes that it is of minimal risk to you.  However, any 
research can carry unforeseen risks and we want you to be informed of your 
rights in the unlikely event that any harm should occur as a result of taking 
part in this project. 
 
This research is covered by a no-fault compensation scheme which may 
apply 
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in the event of any significant harm resulting from  involvement in the project.  
Under this scheme it would not be necessary for you to prove fault.  You also 
have the right to claim damages in a court of law.  This would require you to 
prove fault on the part of the Hospital/Institute and/or any manufacturer 
involved. 
 
Who do I speak to if problems arise? 
If you have any complaints about the way in which this research project has 
been, or is being conducted, please, in the first instance, discuss them with 
the researcher.  If the problems are not resolved, or you wish to comment in 
any other way, please contact Mrs Jane Clist by post at the Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London 
WC1N 1EH, or, if urgent, by telephone on 020 7905 2201. 
 
 
Details of how to contact the researchers: 
Jane Williams 
Research Nurse 
Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2743 
Email; jane.williams@ich.ucl.ac.uk 
 
Dr Mary Fewtrell 
Chief Investigator 
Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2389 
Email; m.fewtrell@ich.ucl.ac.uk 
 
 
 
Thank-you for reading this information sheet! 
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Appendix 2.4. Control over 12y information sheet 
 
 
 
  
MRC Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street 
London WC1N 1EH 
Tel 020 7905 2389 
 
Title of project 
Body composition and bone mineralisation in children with cystic fibrosis 
compared to healthy children. 
 
 
Participant Information Sheet (12 yrs and older). 
You are being invited to take part in a research study.  Before you decide 
whether to take part or not, it is important to understand why the research is 
being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  You can find 
more general information about research on the Great Ormond Street 
Hospital website: 
 
(http://www.gosh.nhs.uk/gosh_families/research) 
 
 
What is the aim of the study? 
The aim of this study is to measure the amount of fat, muscle and bone in 
children with cystic fibrosis (CF) and to see if these measurements relate to 
how well the children are.  In order to do this we need to measure healthy 
children as a comparison. 
 
 
Why is the study being done? 
Some children with CF may develop problems with growth, due to problems 
with the absorption of food.  This may lead to differences in the proportions of 
fat and muscle in the body, and also with the amount of mineral in their 
bones.  Until recently, it has been difficult to accurately measure the amounts 
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of fat, muscle and bone in children, but we can now do this using some 
simple measurements that are available at GOSH. 
 
How is the study to be done? 
We are inviting healthy, full term children aged 8-19 years to participate.  If 
you are willing to take part in the study, we will arrange an appointment at a 
time which is convenient for you.  If you agree we will contact you again 
every 2 years until the age of 19 years to repeat the measurements.  You can 
decide on each occasion whether to take part.  The study will take about 1 ½ 
hours and will take place in Great Ormond Street Hospital.  We will reimburse 
any travelling expenses.  
 
At the appointment we will ask you to do the following: 
After the study has been explained to you (and we have answered all your 
questions) we would like you or your parent to sign a consent form.  This will 
give us permission to include you in the study. 
We will measure your standing and sitting height and weight, waist, hip, 
head, arm and leg circumference and limb length, and skin-folds (by pressing 
the fat gently on the arm, shoulder and abdomen).  You will not be asked to 
undress completely.  
We will ask you to lie on a bed with a machine above (DXA  
scan) that measures bone using very low dose X-rays (much less than the 
daily background radiation we are all exposed to).  This will also take a 
picture of your skeleton, which you can keep. The scans take a few minutes 
each, and are performed with you wearing light indoor clothing (such as 
shorts and a t-shirt) that does not contain metal.  These scans give a 
measurement of the size and amount of mineral in the bones, as well as the 
proportions of fat and muscle.  If there is any possibility that the person 
being scanned is pregnant, the scan will not be performed. 
We will measure the strength of the bones in your wrist and lower leg using 
an ultrasound machine.  The measurements take a few minutes, are 
completely painless and do not use X-rays. 
We will measure the shape, size and bone mineral content of your tibia 
(lower leg bone) and radius (lower arm bone) using a pQCT machine.  This 
uses a very low dose of X-rays (much less than the daily background 
radiation we are all exposed to). 
We will measure the amount of water in your body.  This measurement 
involves drinking some water containing heavy hydrogen molecules 
(deuterium).  These molecules are not radioactive, they simply weigh more 
than most hydrogen molecules and they occur naturally in all of us.  Before 
and 4 hours after the drink you will be asked to provide a saliva sample using 
an absorbent cotton wool swab. 
We will measure the volume of your body.  This measurement involves you 
sitting still inside a chamber (with a clear window) called a BodPod for about 
2 minutes whilst room air is gently blown around you.  This measurement will 
be repeated a second and possibly third time.  The test is performed with you 
wearing a swimming costume and a polyester swimming hat (which we will 
provide). 
We will perform a measurement of bioelectrical impedance using a low level 
of electrical current (that is undetectable), passed between electrodes in 
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contact with your hands and feet.  The test is harmless and painless and 
gives a measure of body water. 
We will ask you some questions about general health, including any 
medicines being taken, and use a short questionnaire to measure your 
calcium intake and activity level.  To avoid undressing we will give you a 
leaflet to complete in private, that shows pictures of the different stages of 
pubertal development and ask you to indicate which is closest to you. 
 
All the things we have asked you to do will take about 1 ½ hours.  None of 
the tests will hurt you. 
  
j) To measure the amount of activity that you do, we will ask you to wear an 
activity monitor on a belt during the daytime for 7 days (5 week days 
and 2 week-end days).  This machine can be posted back to us when 
the measurements are finished. 
 
Are there any risks and discomforts? 
All of the tests are painless and will not harm you.  DXA and pQCT scans 
involve a tiny amount of radiation, which is less than half of a day’s 
background radiation in the United Kingdom (to which we are all exposed), 
and less than one tenth of the radiation from a flight across the Atlantic.  
 
What are the potential benefits? 
The tests that we will use are mainly a research tool.  However, if we identify 
any problems, we will, with your permission, contact your GP so that further 
investigations or treatment can be arranged if appropriate. 
 
Who will have access to the research records? 
Only the researchers will have access to the data collected during this study.   
 
Do I have to take part in this study? 
No. If you decide, now or at a later stage, that you do not wish to take part in 
the study, that is entirely your right and it will not prejudice any present or 
future treatment. 
 
What will happen to the results of the research study? 
The results of this research will be published in a medical journal and 
presented at scientific meetings.  The clinical team will receive the results of 
the bone density scan. 
 
 
What if something goes wrong? 
The research project has been approved by an Independent Research Ethics 
Committee which believes that it is of minimal risk to you.  However, any 
research can carry unforeseen risks and we want you to be informed of your 
rights in the unlikely event that any harm should occur as a result of taking 
part in this project. 
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This research is covered by a no-fault compensation scheme which may 
apply 
in the event of any significant harm resulting to you from  involvement in the 
project.  Under this scheme it would not be necessary for you to prove fault.  
You also have the right to claim damages in a court of law.  This would 
require you to prove fault on the part of the Hospital/Institute and/or any 
manufacturer involved. 
 
Who do I speak to if problems arise? 
If you have any complaints about the way in which this research project has 
been, or is being conducted, please, in the first instance, discuss them with 
the researcher.  If the problems are not resolved, or you wish to comment in 
any other way, please contact Mrs Jane Clist by post at the Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London 
WC1N 1EH, or, if urgent, by telephone on 020 7905 2201. 
 
Details of how to contact the researchers: 
Jane Williams 
Research Nurse 
Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2743 
Email; jane.williams@ich.ucl.ac.uk 
 
Dr Mary Fewtrell 
Chief Investigator 
Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2389 
Email; m.fewtrell@ich.ucl.ac.uk 
 
 
 
Thank-you for reading this information sheet! 
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Appendix 2.5. Parent of child with CF information sheet 
 
 
 
   
 
 
  
MRC Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street 
London WC1N 1EH 
Tel 020 7905 2389 
 
Title of project 
Body composition and bone mineralisation in children with Cystic Fibrosis 
compared to healthy children. 
 
Parent Information Sheet 
Your child is being invited to take part in a research study.  Before you decide 
whether he/she should take part or not, it is important to understand why the 
research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.  You 
can find more general information about research on the Great Ormond 
Street Hospital website: 
 
(http://www.gosh.nhs.uk/gosh_families/research) 
 
 
What is the aim of the study? 
The aim of this study is to measure the amount of fat, muscle and bone in 
children with cystic fibrosis (CF) and to see if these measurements relate to 
how well the children are. 
 
 
Why is the study being done? 
Some children with CF may develop problems with growth, due to problems 
with the absorption of food.  This may lead to differences in the proportions of 
fat and muscle in the body, and also with the amount of mineral in their 
bones.  Until recently, it has been difficult to accurately measure the amounts 
of fat, muscle and bone in children, but we can now do this using some 
simple measurements that are available at GOSH. 
 
How is the study to be done? 
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We are inviting all children aged 6-17 years with CF who attend GOSH to 
participate.  If you are willing to take part in the study, we will arrange an 
appointment at a time which is convenient for you (if possible, at the same 
time as your outpatient appointment).  If you and your child agree we will 
contact you again, every 2 years to repeat the measurements.  You can 
decide on each occasion whether to take part.  The study will take about 1 ½ 
hours and will take place in Great Ormond Street Hospital.  We will reimburse 
any travelling expenses.   
 
At the appointment we will ask you to do the following: 
After the study has been explained to you (and we have answered all your 
questions) we would like you to sign a consent form.  This will give us 
permission to include your child in the study and to obtain information about 
genotype (the genetic code) and clinical details from the hospital notes.  We 
will also ask for your permission to contact you again in two years time. 
We will measure your child’s height, sitting height and weight, waist, hip, 
head, arm and leg circumference and limb length, and skin-folds (by pressing 
the fat gently on the arm, shoulder and abdomen).  Children will not be asked 
to undress completely.  
We will ask your child to lie on a bed with a machine above them (DXA  
scan) that measures bone using very low dose X-rays (much less than the 
daily background radiation we are all exposed to).  This will also take a 
picture of your child’s skeleton, which you can keep. The scans take a few 
minutes each, and are performed with your child wearing light indoor clothing 
(such as shorts and a t-shirt).  These scans give a measurement of the size 
and amount of mineral in the bones, as well as the proportions of fat and 
muscle.  If there is any possibility that the person being scanned is 
pregnant, the scan will not be performed. 
We will measure the strength of the bones in your child’s wrist and lower leg 
using an ultrasound machine.  The measurements take a few minutes, are 
completely painless and do not use X-rays. 
We will measure the shape, size and bone mineral content of the tibia (lower 
leg bone) and radius (lower arm bone) using a pQCT machine.  This uses a 
very low dose of X-rays (much less than the daily background radiation we 
are all exposed to). 
We will measure the amount of water in the body.  This measurement 
involves drinking some water containing heavy oxygen molecules (18-
oxygen).  These molecules are not radioactive, they simply weigh more than 
most oxyogen molecules and they occur naturally in all of us.  Before and 4 
hours after the drink your child will be asked to provide a saliva sample using 
an absorbent cotton wool swab. 
We will measure the volume of the body.  This measurement involves your 
child sitting still inside a chamber (with a clear window) called a BodPod for 
about 2 minutes whilst room air is gently blown around them.  This 
measurement will be repeated a second and possibly a third time.  The test is 
performed with the child wearing a swimming costume and a polyester 
swimming hat (which we will provide). 
We will perform a measurement of bioelectrical impedance using a low level 
of electrical current (that is undetectable), passed between electrodes in 
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contact with the hands and feet.  The test is harmless and painless and gives 
a measure of body water. 
We will ask you and your child some questions about general health, 
including any medicines being taken, and use a short questionnaire to 
measure his or her calcium intake and activity level.  For older children 
(above about 9 years of age) we also need to know if any pubertal 
development has taken place as this affects the growth and mineral content 
of bones.  To avoid any undressing, we will show your child some pictures of 
the different stages of pubertal development (in private) and ask him or her to 
pick the one which is closest to them. 
 
All the things we have asked your child to do will take about 1 ½ hours.  
None of the tests will hurt your child. 
  
j) To measure the amount of activity that your child does, we will ask him or 
her to wear an activity monitor on a belt during the daytime for 7 days (5 
week days and 2 week-end days).  This machine can be posted back to us 
when the measurements are finished. 
 
Are there any risks and discomforts? 
All of the tests are painless and will not harm your child.  DXA and pQCT 
scans involve a tiny amount of radiation, which is less than half of a day’s 
background radiation in the United Kingdom (to which we are all exposed), 
and less than one tenth of the radiation from a flight across the Atlantic.  
 
What are the potential benefits? 
The study could identify any abnormalities of bone density or in the 
proportions of fat and lean tissue.  Where possible, these would be treated.  
Most children find the tests interesting and educational and each child will be 
given a printout of his/her skeleton to take home.  
 
Who will have access to the research records? 
Only the researchers will have access to the data collected during this study.   
 
Does my child have to take part in this study? 
No. If you decide, now or at a later stage, that you do not wish to take part in 
the study, that is entirely your right and it will not affect your child's clinical 
care. 
 
What will happen to the results of the research study? 
The results of this research will be published in a medical journal and 
presented at scientific meetings.  The clinical team will receive the results of 
the bone density scan. 
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What if something goes wrong? 
The research project has been approved by an Independent Research Ethics 
Committee which believes that it is of minimal risk to your child.  However, 
any research can carry unforeseen risks and we want you to be informed of 
your rights in the unlikely event that any harm should occur as a result of 
taking part in this project. 
 
This research is covered by a no-fault compensation scheme which may 
apply 
in the event of any significant harm resulting to your child from  involvement 
in the project.  Under this scheme it would not be necessary for you to prove 
fault.  You also have the right to claim damages in a court of law.  This would 
require you to prove fault on the part of the Hospital/Institute and/or any 
manufacturer involved. 
 
Who do I speak to if problems arise? 
If you have any complaints about the way in which this research project has 
been, or is being conducted, please, in the first instance, discuss them with 
the researcher.  If the problems are not resolved, or you wish to comment in 
any other way, please contact Mrs Jane Clist at the Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London 
WC1N 1EH, or, if urgent, by telephone on 020 7905 2201. 
 
Details of how to contact the researchers: 
Jane Williams 
Research Nurse 
Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2743 
Email; jane.williams@ich.ucl.ac.uk 
 
Dr Mary Fewtrell 
Chief Investigator 
Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2389 
Email; m.fewtrell@ich.ucl.ac.uk 
 
 
 
Thank-you for reading this information sheet! 
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Appendix 2.6. Parent of control child information sheet 
 
 
 
  
MRC Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street 
London WC1N 1EH 
Tel 020 7905 2389 
 
Title of project 
Body composition and bone mineralisation in children with Cystic Fibrosis 
compared to healthy children. 
 
 
Parent Information Sheet 
Your child is being invited to take part in a research study.  Before you decide 
whether he/she should take part or not, it is important to understand why the 
research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.  You 
can find more general information about research on the Great Ormond 
Street Hospital website: 
 
(http://www.gosh.nhs.uk/gosh_families/research) 
 
 
What is the aim of the study? 
The aim of this study is to measure the amount of fat, muscle and bone in 
children with cystic fibrosis (CF) and to see if these measurements relate to 
how well the children are.  In order to do this we need to measure healthy 
children as a comparison. 
 
 
Why is the study being done? 
Some children with CF may develop problems with growth, due to problems 
with the absorption of food.  This may lead to differences in the proportions of 
fat and muscle in the body, and also with the amount of mineral in their 
bones.  Until recently, it has been difficult to accurately measure the amounts 
of fat, muscle and bone in children, but we can now do this using some 
simple measurements that are available at GOSH. 
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How is the study to be done? 
We are inviting healthy, full term children aged 8-19 years to participate.  If 
you are willing to take part in the study, we will arrange an appointment at a 
time which is convenient for you.  If you and your child agree we will contact 
you again, every 2 years until your child is 19 years old to repeat the 
measurements.  You can decide on each occasion whether to take part.  The 
study will take about 1 ½ hours and will take place in Great Ormond Street 
Hospital.  We will reimburse any travelling expenses.  
 
At the appointment we will ask you to do the following: 
After the study has been explained to you (and we have answered all your 
questions) we would like you to sign a consent form.  This will give us 
permission to include your child in the study and to contact you again in two 
years time. 
We will measure your child’s height, sitting height and weight, waist, hip, 
head, arm and leg circumference and limb length, and skin-folds (by pressing 
the fat gently on the arm, shoulder and abdomen).  Children will not be asked 
to undress completely.  
We will ask your child to lie on a bed with a machine above them (DXA  
scan) that measures bone using very low dose X-rays (much less than the 
daily background radiation we are all exposed to).  This will also take a 
picture of your child’s skeleton, which you can keep. The scans take a few 
minutes each, and are performed with your child wearing light indoor clothing 
(such as shorts and a t-shirt).  These scans give a measurement of the size 
and amount of mineral in the bones, as well as the proportions of fat and 
muscle.  If there is any possibility that the person being scanned is 
pregnant, the scan will not be performed. 
We will measure the strength of the bones in your child’s wrist and lower leg 
using an ultrasound machine.  The measurements take a few minutes, are 
completely painless and do not use X-rays. 
We will measure the shape, size and bone mineral content of the tibia (lower 
leg bone) and radius (lower arm bone) using a pQCT machine.  This uses a 
very low dose of X-rays (much less than the daily background radiation we 
are all exposed to). 
We will measure the amount of water in the body.  This measurement 
involves drinking some water containing heavy hydrogen molecules 
(deuterium).  These molecules are not radioactive, they simply weigh more 
than most hydrogen molecules and they occur naturally in all of us.  Before 
and 4 hours after the drink your child will be asked to provide a saliva sample 
using an absorbent cotton wool swab. 
We will measure the volume of the body.  This measurement involves your 
child sitting still inside a chamber (with a clear window) called a BodPod for 
about 2 minutes whilst room air is gently blown around them.  This 
measurement will be repeated a second and possibly a third time.  The test is 
performed with the child wearing a swimming costume and a polyester 
swimming hat (which we will provide). 
We will perform a measurement of bioelectrical impedance using a low level 
of electrical current (that is undetectable), passed between electrodes in 
contact with the hands and feet.  The test is harmless and painless and gives 
a measure of body water. 
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We will ask you and your child some questions about general health, 
including any medicines being taken, and use a short questionnaire to 
measure his or her calcium intake and activity level.  For older children 
(above about 9 years of age) we also need to know if any pubertal 
development has taken place as this affects the growth and mineral content 
of bones.  To avoid any undressing, we will show your child (in private) some 
pictures of the different stages of pubertal development and ask him or her to 
pick the one which is closest to them.  
 
 
All the things we have asked your child to do will take about 1 ½ hours.  
None of the tests will hurt your child. 
  
j) To measure the amount of activity that your child does, we will ask him or 
her to wear an activity monitor on a belt during the daytime for 7 days (5 
week days and 2 week-end days).  This machine can be posted back to us 
when the measurements are finished. 
 
Are there any risks and discomforts? 
All of the tests are painless and will not harm your child.  DXA and pQCT 
scans involve a tiny amount of radiation, which is less than half of a day’s 
background radiation in the United Kingdom (to which we are all exposed), 
and less than one tenth of the radiation from a flight across the Atlantic.  
 
What are the potential benefits? 
The tests that we will use are mainly a research tool.  However, if we identify 
any problems, we will, with your permission, contact your child’s GP so that 
further investigations or treatment can be arranged if appropriate. 
 
Who will have access to the research records? 
Only the researchers will have access to the data collected during this study.   
 
Does my child have to take part in this study? 
No. If you decide, now or at a later stage, that you do not wish to take part in 
the study, that is entirely your right and it will not prejudice any present or 
future treatment. 
 
What will happen to the results of the research study? 
The results of this research will be published in a medical journal and 
presented at scientific meetings.  The clinical team will receive the results of 
the bone density scan. 
 
 
What if something goes wrong? 
The research project has been approved by an Independent Research Ethics 
Committee which believes that it is of minimal risk to your child.  However, 
any research can carry unforeseen risks and we want you to be informed of 
your rights in the unlikely event that any harm should occur as a result of 
taking part in this project. 
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This research is covered by a no-fault compensation scheme which may 
apply 
in the event of any significant harm resulting to your child from  involvement 
in the project.  Under this scheme it would not be necessary for you to prove 
fault.  You also have the right to claim damages in a court of law.  This would 
require you to prove fault on the part of the Hospital/Institute and/or any 
manufacturer involved. 
 
Who do I speak to if problems arise? 
If you have any complaints about the way in which this research project has 
been, or is being conducted, please, in the first instance, discuss them with 
the researcher.  If the problems are not resolved, or you wish to comment in 
any other way, please contact Mrs Jane Clist at the Research and 
Development Office, Institute of Child Health, 30 Guilford Street, London 
WC1N 1EH, or, if urgent, by telephone on 020 7905 2201. 
 
Details of how to contact the researchers: 
Jane Williams 
Research Nurse 
Childhood Nutrition Research Centre 
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2743 
Email; jane.williams@ich.ucl.ac.uk 
 
Dr Mary Fewtrell 
Chief Investigator 
Childhood Nutrition Research Centre  
Institute of Child Health 
30 Guilford Street  
London WC1N 1EH 
Tel: 0207 905 2389 
Email; m.fewtrell@ich.ucl.ac.uk 
 
 
 
Thank-you for reading this information sheet! 
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Appendix 3. Appointment letter 
 
UCL INSTITUTE OF CHILD HEALTH 
      
      
 
Name and address 
27 August 2013 
 
Dear ........., 
Appointment for body composition study on Tuesday 14
th
 April at 11.30am. 
Thank you for volunteering to take part in the study of body composition at Great 
Ormond Street Hospital.  If you enter the main entrance of the hospital in Gt Ormond 
Street I will meet you at the X ray reception which is situated on the same level and 
in the Variety Club Building.  Tell X ray reception that you are booked in for a 
DEXA scan. 
 
If you have any problems attending this appointment please call and leave me a 
message, tel: 020 7905 2743 and I will organise another date.  If you need to contact 
me on the day, then ring the hospital switchboard, tel: 020 7405 9200 and ask them 
for extension 2309 or 0559. 
 
The bone density scan can be performed whilst wearing light clothing providing 
there are no metal zips, buttons, bra hooks etc.  In order to do an accurate 
measurement of body volume in the Bodpod, it is necessary to wear a close fitting 
swimming costume.  Loose fitting shorts will affect the measurement and are not 
acceptable but tight fitting shorts are acceptable.  If you think you may have a 
problem let me know before the appointment.  
 
Please keep your travel tickets for re-imbursement on the day.  The nearest 
underground stations are Russell Sq and Holborn. 
 
Please call me if you have any questions at all.  
 
Yours sincerely, 
 
 
 
 
Jane Williams 
Research Nurse  
Tel: 020 7905 2743 
Email: jane.williams@ich.ucl.ac.uk 
 
Enc;  Map and Information sheet 
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Appendix 4.1. Child assent form 
 
 
 
ASSENT FORM 
Title of the Research project:  
 
Body composition and bone health in children with cystic fibrosis 
 
Sponsor Protocol No:   02NT01        
Investigator: Dr Mary Fewtrell 
Contact details:  : 0207 905 2389/2251 : m.fewtrell@ich.ucl.ac.uk 
 
Subject Identification No for this trial: ________________ 
 
       Please initial box            
       to indicate agreement: 
 
 
1 
 
I  have read and understand the information sheet dated 02/05/08 (version 1) for the above study 
and have had the chance to ask questions. 
      
 
2 
 
I understand that taking part is voluntary and that I can decide not to take part at any time. 
 
 
3 
 
I agree to take part in the above study. 
 
 
 
 
 
 
   
                         
 
__________________________________         ___________                    ______________ 
Name of young person               Date    Signature 
 
 
_________________________________          ___________                   ______________ 
Name of Person taking consent              Date   Signature 
(if different from Investigator) 
 
__________________________________          ___________            ______________ 
Investigator                Date   Signature 
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Appendix 4.2. Participant consent form 
 
 
PARTICIPANT CONSENT FORM 
Title of the Research project:  
 
Body composition and bone health in children with cystic fibrosis 
 
Sponsor Protocol No:   02NT01        
Investigator: Dr Mary Fewtrell 
Contact details:  :0207 905 2389/2251 : m.fewtrell@ich.ucl.ac.uk 
 
Subject Identification No for this trial: ________________ 
        
         Please initial box            
        to indicate agreement: 
 
 
1 
 
I confirm that I have read and understand the information sheet dated 02/05/08 (version 1) for the 
above study. I have had the opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
 
 
2 
 
I understand that my participation is voluntary and that I am free to withdraw at  
any time, without giving any reason, without my medical care or legal rights being affected. 
 
 
3 
 
I understand that relevant sections of any of my Medical Notes and data collected during the study, 
may be looked at, by employees from Regulatory Authorities or from Great Ormond Street 
Hospital/ Institute of Child Health, where it is relevant to my taking part in this research.  I give 
permission for these individuals to have access to my records.  
 
4 I agree to my GP being informed of any sub-optimal results noted as a result of participating in 
this study. 
 
 
5 
 
I agree to take part in the above study and  I understand that I may be contacted in the  
future regarding re-measurement.  I will be able to decide at that time whether to take  
part and give consent. 
  
 
   
                          
 
 
__________________________________         ___________                    ______________ 
Name of Participant                Date    Signature 
 
 
_________________________________          ___________                   ______________ 
Name of Person taking consent              Date   Signature 
(if different from Investigator) 
 
__________________________________          ___________            ______________ 
Investigator                Date   Signature 
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Appendix 4.3. Parent consent form 
 
PARENT/GUARDIAN CONSENT FORM 
Title of the Research project:  
Body composition and bone health in children with cystic fibrosis 
 
Sponsor Protocol No:   02NT01      Investigator: Dr Mary Fewtrell 
Contact details:  :0207 905 2389/2251 : m.fewtrell@ich.ucl.ac.uk 
 
Subject Identification No for this trial: ________________ 
        
         Please initial box            
        to indicate agreement: 
 
 
1 
 
I confirm that I have read and understand the information sheet dated 02/05/08 (version 1) for the 
above study. I have had the opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
 
 
2 
 
I understand that my child’s participation is voluntary and that he/she is free to withdraw at  
any time, without giving any reason, without his/her medical care or legal rights being  
affected. 
 
 
3 
 
I understand that relevant sections of any of my child’s Medical Notes and data collected during the 
study, may be looked at, by employees from Regulatory Authorities or from Great Ormond Street 
Hospital/ Institute of Child Health, where it is relevant to my child’s taking part in this research.  I 
give permission for these individuals to have access to my child’s records.  
 
4 I agree to my child’s GP being informed of any sub-optimal results noted as a result of participating 
in this study. 
 
 
5 
 
I agree to my child taking part in the above study and I understand that I may be contacted   in the 
future regarding re-measurement.  I will be able to decide at that time whether to take  
part and give consent. 
 
 
   
                      
__________________________________ 
Name of Child                                         
 
 
__________________________________         ___________                    ______________ 
Name of Parent/Guardian              Date    Signature 
 
 
_________________________________          ___________                   ______________ 
Name of Person taking consent              Date   Signature 
(if different from Investigator) 
 
__________________________________          ___________            ______________ 
Investigator                Date   Signature 
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Appendix 5.1. Questionnaires for children with CF 
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Appendix 5.2. Questionnaire for control children 
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Appendix 6. Saliva collection information 
INSTRUCTIONS FOR TAKING SALIVA SAMPLE 
Study No.  
 
Date 
 
We need you to take a sample of saliva after you get home and post it back to us in 
the envelope provided. 
 
…………. hours after your special drink, at …….……..pm we would like you to do 
another saliva sample in the same way you did the first.  Do not eat, drink or clean 
your teeth for 30 minutes before taking the sample.  Move the swab around your 
mouth until it is very wet without chewing on it.   
 
It is very important that you take the sample at this time but if it is not possible it is 
better that you tell us the time it was taken. 
 
Record time sample taken here……………….. 
 
We also need to know how much you drank in the period between the special drink 
and the saliva sample you have done at home. 
 
Record the amount of drink you have had: 
       ………………..cups 
        
………………..mugs 
        
………………..small glasses 
        
………………..large glasses 
        
………………..cans (330ml) 
        
………………..bottles (500ml) 
 
 
Place the cotton swab in the tube and replace the lid firmly.  Put the tube in the 
plastic bag and seal carefully. 
 
Please return this sheet and the sample in the envelope provided as soon as possible. 
THANK YOU FOR TAKING PART IN THIS STUDY 
 
Jane Williams 
Research Nurse 
MRC Childhood Nutrition Research Centre 
Institute of Child Health 
30, Guilford Street 
London WC1N 1EH 
020 7905 2743 
jane.williams@ich.ucl.ac.uk 
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Appendix 7. Certificate 
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Appendix 8.1. Boys puberty questionnaire 
 
 
 278 
 
 
Appendix 8.2. Girls puberty questionnaire 
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Appendix 9. Comparison between children with CF that 
have dropped-out and those remaining in study after 2 
years 
 
 
 
 
 Drop-outs Remaining in study 
 Boys Girls Boys Girls 
 Mean SD P Mean SD P Mean SD Mean SD 
Age 8.85 1.76 NS 9.99 2.15 NS 8.99 1.32 9.36 1.50 
Height SDS -0.07 0.80 NS -0.78 1.45 NS -0.55 1.02 -0.62 1.09 
Weight SDS 0.62 1.30 NS -0.87 0.97 NS -0.21 1.05 -0.58 1.06 
BMI SDS 0.83 1.68 NS -0.57 0.46 NS 0.18 0.94 -0.35 1.09 
FEV1 SDS -0.73 2.06 NS -2.36 1.29 NS -0.21 1.46 -1.64 1.49 
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Appendix 10. Regression of factors impacting on waist 
circumference. 
 
Regression analysis of effect of body composition, age, sex and height on waist 
circumference with sex as male = 0, female =1. 
 
Children with CF; 
 
Waist circumference = 67.518 +1.224 (FM) + 0.838 (FFM) + 0.625 (age) – 2.303 
(female) – 28.408 (height) 
 
Adjusted R
2
 = 0.858 
 
Controls; 
Waist circumference = 61.405 + 1.260(FM) + 0.690(FFM) – 0.254 (age) – 
1.249(female) – 18.029(height) 
 
Adjusted R
2
 = 0.913 
 
 
Partial correlations of the relationship between waist circumference and fat 
mass or fat-free mass or age or sex or height each adjusted for the others. 
 
 CF Controls 
Partial correlation  
(adjusted for all other 
factors)  
R P R P 
Waist circumference and fat 
mass 
0.817 <0.001 0.901 <0.001 
Waist circumference and fat-
free mass 
0.533 <0.001 0.604 <0.001 
Waist circumference and age 0.254 0.022 -0.096 0.392 
Waist circumference and sex -0.415 <0.001 -0.262 0.018 
Waist circumference and 
height 
-0.414 <0.001 -0.301 0.006 
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Appendix 11. Regression analyses for the relationship 
between baseline FEV1 and change in body composition and 
baseline body composition and change in FEV1.   
 
  Boys Girls 
IV DV B SEM P B SEM P 
Baseline 
FMI SDS 
Change 
FEV1 SDS 
-0.28 0.17 0.120 0.01 0.19 0.950 
Baseline 
FFMI SDS 
Change 
FEV1 SDS 
0.17 0.16 0.191 0.24 0.17 0.181 
Baseline  
FEV1 
Change 
FMI SDS 
-0.12 0.08 0.141 -0.05 0.08 0.589 
Baseline  
FEV1 
Change 
FFMI SDS 
0.18 0.07 0.023 -0.01 0.06 0.851 
 
Baseline 
FMI SDS 
Conditional 
change FEV1 SDS 
-0.25 0.17 0.149 0.08 0.18 0.662 
Baseline 
FFMI SDS 
Conditional 
change FEV1 SDS 
0.18 0.16 0.258 0.22 0.16 0.170 
Baseline  
FEV1 SDS 
Conditional change 
FMI SDS 
-0.11 0.07 0.146 -0.02 0.09 0.827 
Baseline  
FEV1 SDS 
Conditional  
change FFMI SDS 
0.18 0.07 0.020 -0.01 0.06 0.557 
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Appendix 12. Bland-Altman analyses for simpler body composition techniques compared to the 4-
component model. 
 
Figure 1 (a-c) shows the results of the Bland-Altman analysis for DXA (whole body and regional), SFTs and BMI for predicting 4C FM SDS, 
and for DXA (whole body and regional) FMI for predicting 4C FMI SDS.  Using the same analyses, Figure 2 (a-b) shows the assessment for 
DXA, TBW and BIA to predict 4C FFM SDS and height adjusted DXA FFMI to predict 4C FFMI SDS.   
 
Graphs are on following pages.
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Figure 1a.  Bland-Altman analyses of agreement between the 4-component model and dual-energy X-ray absorptiometry, skinfold thicknesses and body mass 
index in the assessment of fat mass and fat mass index. 
 
    DXA FM                                                 DXA FMI          
                                        
 
 
 
 
 
 
 
 
 
 
 
                                                                                  
   
DXA limb FM     DXA limb FMI 
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Figure 1b.  Bland-Altman analyses of agreement between the 4-component model and dual-energy X-ray absorptiometry, skinfold thicknesses 
and body mass index in the assessment of fat mass and fat mass index. 
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Figure 1c.  Bland-Altman analyses of agreement between the 4-component model and dual-energy X-ray absorptiometry, skinfold thicknesses 
and body mass index in the assessment of fat mass and fat mass index. 
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Figure 2a.  Bland-Altman analyses of agreement between the 4-component model and dual-energy X-ray absorptiometry, total body water and 
bio-electrical impedance in the assessment of fat-free mass and fat-free mass index. 
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Figure 2a.  Bland-Altman analyses of agreement between the 4-component model and dual-energy X-ray absorptiometry, total body water and 
bio-electrical impedance in the assessment of fat-free mass and fat-free mass index. 
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Appendix 13. Bland Altman correlations, unadjusted and adjusted for age, and age and sex 
 
 
 
 
 
 
 
 
 
 
 
 
    
    
    
    
    
    
    
    
    
    
    
 
 
 
2  Pearson’s correlation between the bias in individuals and the mean values (unadjusted and adjusted for age and for age and sex).
 R 
unadjusted 
P R 
adjusted 
for age 
P R 
Adjusted for 
age and sex 
P
2 
 
SDS 
Measure of ‘fatness’ 
DXA fat mass -0.279 P<0.001 -0.281 P<0.001 -0.288 P<0.001 
DXA fat mass index -0.251 P<0.001 -0.251 P<0.001 -0.232 P<0.001 
DXA limb fat mass -0.294 P<0.001 -0.294 P<0.001 -0.303 P<0.001 
DXA limb fat mass index -0.233 P<0.001 -0.235 P<0.001 -0.220 P<0.001 
DXA trunk fat mass -0.282 P<0.001 -0.287 P<0.001 -0.292 P<0.001 
DXA trunk fat mass index -0.228 P<0.001 -0.230 P<0.001 -0.218 P<0.001 
Bicep skinfold -0.331 P<0.001 -0.334 P<0.001 -0.314 P<0.001 
Tricep skinfold -0.142 0.021 -0.145 0.018 -0.150 0.015 
Subscapular skinfold -0.072 0.245 -0.074 0.229 -0.049 0.424 
Supra-iliac skinfold 0.001 0.982 0.001 0.982 0.009 0.886 
Sum 4 skinfold -0.350 P<0.001 -0.354 P<0.001 -0.339 P<0.001 
BMI 0.049 0.429 0.039 0.531 0.042 0.492 
Measure of ‘leanness’ 
DXA fat-free mass 0.209 0.001 0.217 P<0.001 0.214 P<0.001 
DXA fat-free mass index 0.114 0.064 0.093 0.132 0.089 0.149 
DXA limb fat-free mass 0.096 0.121 0.098 0.112 0.072 0.244 
DXA limb fat-free mass index 0.049 0.424 0.048 0.435 0.041 0.507 
DXA trunk fat-free mass  0.004 0.947 0.003 0.966 0.017 0.788 
DXA trunk fat-free mass index -0.002 0.977 -0.036 0.559 -0.022 0.723 
Total body water 0.014 0.819 0.025 0.681 0.035 0.577 
Bio-electrical impedance 0.003 0.975 0.019 0.826 0.004 0.967 
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Appendix 14. Characteristics of children used and not used in 
generation of a regression equation to correct for bias in bio-
electrical impedance standard deviation scores. 
 
 
 N Mean 
age y 
SD Range 
y  
Males Females 
Included in the regression model 61 12.6 2.8 7.0-
17.0 
29 32 
Excluded from the equation model 
(longitudinal subjects) 
81 10.7 2.4 6.7-
16.6 
36 45 
No bio-electrical impedance data 124 12.2 2.5 6.9-
16.5 
59 65 
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Evaluation of Lunar Prodigy dual-energy X-ray absorptiometry for
assessing body composition in healthy persons and patients by
comparison with the criterion 4-component model1–3
Jane E Williams, Jonathan CK Wells, Catherine M Wilson, Dalia Haroun, Alan Lucas, and Mary S Fewtrell
ABSTRACT
Background: Dual-energy X-ray absorptiometry (DXA) is widely
used to assess body composition in research and clinical practice.
Several studies have evaluated its accuracy in healthy persons; how-
ever, little attention has been directed to the same issue in patients.
Objective: The objective was to compare the accuracy of the Lunar
Prodigy DXA for body-composition analysis with that of the refer-
ence 4-component (4C) model in healthy subjects and in patients
with 1 of 3 disease states.
Design: A total of 215 subjects aged 5.0–21.3 y (n  122 healthy
nonobese subjects, n  55 obese patients, n  26 cystic fibrosis
patients, and n  12 patients with glycogen storage disease). Fat
mass (FM), fat-free mass (FFM), and weight were measured by DXA
and the 4C model.
Results: The accuracy of DXA-measured body-composition out-
comes differed significantly between groups. Factors independently
predicting bias in weight, FM, FFM, and percentage body fat in
multivariate models included age, sex, size, and disease state. Biases
in FFM were not mirrored by equivalent opposite biases in FM
because of confounding biases in weight.
Conclusions: The bias of DXA varies according to the sex, size,
fatness, and disease state of the subjects, which indicates that DXA
is unreliable for patient case-control studies and for longitudinal
studies of persons who undergo significant changes in nutritional
status between measurements. A single correction factor cannot
adjust for inconsistent biases. Am J Clin Nutr 2006;83:
1047–54.
KEY WORDS Body composition, fat mass, fat-free mass,
dual-energy X-ray absorptiometry, DXA, obesity, clinical practice
INTRODUCTION
Assessment of body composition is increasingly used to direct
the clinical management of patients. First, an abnormal body
composition (eg, high or low amounts of body fat) is often a
major symptom of diseases such as obesity, with changes in body
components reflecting the relative success of treatment. Second,
the association of body composition with the risk of diseases,
such as coronary heart disease, broadens its clinical significance.
Third, body composition can also be used as the basis of require-
ments for fluids, nutrition, and dosages of drugs and dialysis.
Despite increasing awareness of the value of such information,
its measurement in routine practice has remained constrained by
the lack of appropriate technology.
Dual-energy X-ray absorptiometry (DXA), first developed for
assessment of bone mass, provides information on total fat mass
(FM) and fat-free mass (FFM) and their distribution in the trunk
and upper and lower limbs (1). Over the past decade, DXA has
been increasingly used to assess body composition in research
and clinical practice, including applications to direct treatment
(2–4). Its rapid uptake can be attributed to its ease of use, avail-
ability, and low radiation exposure. However, although the pre-
cision of the technique for body-composition outcomes is well-
established, insufficient attention has been paid to accuracy.
Many validation studies have used as the reference method a
technique that itself has unknown accuracy, thereby limiting
confidence in the findings.
In the absence of chemical analysis of body composition, the
ideal reference method is a multicomponent model of body com-
position, which minimizes the need for theoretical assumptions
of biological constancy in tissues (5). A recent study evaluated
Hologic Inc (Waltham, MA) DXA instrumentation against the
4-component (4C) model for estimating FM in a group of girls
and adolescent females. A large bias and large limits of agree-
ment were found between the 2 methods that could not be attrib-
uted to age, ethnicity, or fatness, but that could cause a person’s
FM to be under- or overestimated by 28% (6). These authors
proposed that the bias could be addressed by a correction factor.
The latter study highlights important issues; however, further
work is still required. First, the results may not apply to other
manufacturer’s instrumentation, because instruments differ in
the way in which tissue masses are quantified. Second, many
clinical applications involve extremes of body size and compo-
sition; however, the validity of DXA over a wide range of body
sizes and health states has yet to be investigated. The aim of this
study was to evaluate the level of agreement between DXA and
the 4C model reference method when estimating FM, FFM, and
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Health, London, United Kingdom (JEW, JCKW, DH, AL, and MSF), and the
Radiology Department, Great Ormond Street Hospital, London, United
Kingdom (CMW).
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weight in a diverse group of healthy and unhealthy adults and
children to determine whether biases are consistent between
these groups.
SUBJECTS AND METHODS
Subjects
A total of 215 subjects aged 5.0–21.3 y were recruited into
studies of body composition in healthy subjects, adults born
preterm, and patient groups from Great Ormond Street Chil-
dren’s Hospital and the National Hospital for Neurology and
Neurosurgery. The sample consisted of nonobese adults (n 
70), obese adults (n 16), healthy nonobese children (n 52),
obese children (n  39), children with cystic fibrosis (CF; n 
26), and children with glycogen storage disease (GSD; n 12).
Obesity was defined as a body mass index (BMI; in kg/m2) above
the 95th percentile according to UK 1990 reference data (7). Two
obese boys did not complete the protocol because it was not
possible to scan their whole body because of the inadequate size
of the scanning area. A separate analysis of data from obese men
was not possible because of small sample sizes (n  2). Mea-
surements were conducted over a 90-min visit to the study center
at Great Ormond Street Children’s Hospital after a light meal.
Ethical permission was obtained from the ethical committee of
the Institute of Child Health and The National Hospital. Written
consent was obtained from adults and parents. Written assent was
obtained from children aged 11 y, and verbal assent was ob-
tained from children aged11 y.
Dual-energy X-ray absorptiometry
Bone mineral content (BMC), FM, and FFM were determined
by using a Lunar Prodigy whole-body scanner (GE Medical
Systems, Madison, WI) in conjunction with Encore 2002 soft-
ware. The instrument automatically alters scan depth depending
on the thickness of the subject, as estimated from age, height, and
weight. All scans were performed while the subjects were wear-
ing light indoor clothing and no removable metal objects. The
typical scan time was 5 min, depending on height. The radiation
exposure per whole-body scan is estimated to be 2Sv, which is
lower than the daily background level. All scans were performed
by one operator (CMW). The precision of soft tissue analysis for
a Lunar DPX-L instrument (regarded by the manufacturers to be
similar to the Lunar Prodigy), established by repeat measure-
ments of humans on 4 successive days, has been reported as 1%
for FFM and 2% for FM (8).
Body volume
Body volume (BV) was measured by using Bod Pod Instru-
mentation (Life Measurement Instruments, Concord, CA) ac-
cording to the manufacturer’s instructions as previously de-
scribed (9). Measurements were made while the subjects wore a
close-fitting swimming costume and hat. The raw volume values
that appear transiently on the screen were recorded, and an ad-
justment for thoracic gas volume and surface area artifact was
made to obtain actual BV as described previously (10). To im-
prove precision, the procedure was repeated until 2 values for raw
density of within 0.007 kg/L were obtained (11). When it was not
possible to achieve 2 such measurements, because of breathing
irregularities in 3 of the children with CF, the mean of all raw
volume values was used after values2 SD were discarded. All
measurements were made by 1 of 3 operators (JEW, CMW, or
DH).
Anthropometric measurements
Body weight was measured as an integral stage of the Bod Pod
procedure to within 0.01 kg. Accuracy was confirmed by the use
of 2 solid weights of known mass. Height was measured to within
0.1 cm with a wall-mounted digital display stadiometer (Holtain,
Dyfed, United Kingdom). BMI was calculated as weight (kg)
divided by the square of height (m). Data on weight, height, and
BMI were converted to SD scores (SDS) with the use of UK 1990
reference data (7, 12).
Deuterium dilution
Total body water (TBW) was assessed by deuterium (2H-
labeled water) dilution with the use of a dose equivalent to 0.05 g
2H2O/kg body weight. Doses were made up with water to100
mL for young children and to 150 mL for older children and
adults. Saliva samples were taken before the dose was adminis-
tered and either 4 (for persons of normal body fatness) or 5 (for
obese subjects) h after the dose was administered. Absorbent
salivettes (Sarstedt, Rommelsdorf, Germany) were used to col-
lect the saliva30 min after the last ingestion of food or drink.
Deuterium samples were analyzed by Iso-Analytical Ltd
(Sandbach, United Kingdom) by using the equilibration method
of Scrimgeour et al (13). Briefly, 0.3 mL liquid, along with a vial
of 5% platinum on alumina powder (Sigma-Aldrich, Poole,
United Kingdom), was placed in a septum sealed container
(Labco, High Wycombe, United Kingdom) and flushed for 2 min
with hydrogen. Low-enrichment and high-enrichment standard
waters were similarly prepared to normalize data against
SMOW-SLAP (Standard Mean Ocean Water/Standard Light
Arctic Precipitation) standards. Samples were equilibrated at
room temperature for 3 d before analysis. The head spaces in the
containers were then analyzed for deuterium enrichment with a
continuous-flow isotope ratio mass spectrometer (Geo20-20;
Europa Scientific, Crewe, United Kingdom). The accuracy of the
analyses was checked by measuring an intermediate water stan-
dard within each batch of samples. All samples were prepared
and analyzed in duplicate. The mean SD of deuterium analyses
by the equilibration technique in the laboratory is2.5‰.
2H dilution space was assumed to overestimate TBW by a
factor of 1.044 (14), and a correction was made for fluid intake
during the equilibrium period to derive actual body water.
Four-component model
The 4C model uses values of BMC, body weight (BW), BV,
and TBW to derive values for mineral, water, fat, and protein as
described previously (5). Assumed densities of the 4 components
were accounted for when calculating fat mass from the measure-
ments.
FM (kg)  [(2.747  BV)  (0.710  TBW)]
 [(1.460  BMC)  (2.050  BW)] (1)
FFM was calculated as the difference between weight and FM.
We previously propagated error for FFM and FM on the basis of
precision of the raw measurements and obtained values of 0.5 kg
FM or FFM in children (15) and adults (5).
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Statistical analysis
Comparisons for anthropometric and body-composition vari-
ables between groups were made by using analysis of variance
(ANOVA). Data for males and females were pooled, unless a
significant interaction between group and sex was present. Pair-
wise post hoc comparisons between groups were made where
appropriate by using Tukey’s test.
The method of Bland and Altman (16) was used to assess
agreement between techniques. The mean difference between
techniques (bias) and the 2 SDs of the difference between
techniques (limits of agreement) were calculated. The bias was
then tested for significance from zero by using a paired t test. The
correlation between the bias and the mean of the measured values
was also determined. To express the bias as a percentage of the
mean, the bias of the individual natural log value multiplied by
100 was calculated (17, 18). We used analysis of covariance
(ANCOVA) to examine factors predicting bias in FM, FFM,
weight, and percentage body fat, including age, sex, disease state,
and either BMI SDS, FM, or percentage body fat as independent
variables. All analyses were performed by using the Statistical
Package for Social Sciences (version 11.0; SPSS Inc, Chicago,
IL), and a P value0.05 was considered significant.
RESULTS
Subject characteristics and body composition
The population encompassed a wide range of body sizes and
nutritional status. The characteristics of the adults (n  84) are
shown in Table 1. The young adults (19–22 y) of normal weight
were representative of the UK population in height and weight.
There were no significant differences in age and weight, height,
and BMI SDS between the sexes in the nonobese group. The
obese women were significantly shorter and, by definition,
heavier than the UK reference data.
Characteristics of the children (n 127) are shown in Table
2. The subjects were deliberately chosen to represent a range of
body sizes and shapes and, as expected, ANOVA showed sig-
nificant differences in weight, height, and BMI SDS between
groups. Compared with the UK reference data, the nonobese
boys were representative of the general population in terms of
height and weight SDS, but the nonobese girls were significantly
heavier than expected (P 0.05). The obese girls were signifi-
cantly taller (P  0.001), whereas the patient groups showed a
wide range of body sizes: the children with CF were significantly
shorter and the children with GSD were significantly shorter and
heavier.
The body-composition data for adults are shown in Table 3.
ANOVA showed significant differences between groups for all
variables, and post hoc testing indicated that these significant
differences were present between all groups for all variables
except the BMC and FFM of obese and nonobese women and the
density of FFM in the nonobese men and women.
Data for the children’s body composition are given in Table
4. ANOVA showed significant differences between groups
for all variables, except for the density of FFM (P  0.06).
Mean percentage fat varied widely between groups, averaging
42% in obese girls and 19% in nonobese boys. FFM also
varied widely between groups. Hydration was significantly
higher (1.6%; P  0.01) in the obese children than in the
nonobese children.
TABLE 1
Characteristics of the adults1
Nonobese men
(n 26)
Nonobese women
(n 44)
Obese women
(n 14)
Age (y) 20.4 0.45 20.3 0.40 20.4 0.41
Weight SDS 0.38 1.13 0.19 1.17 1.90 0.722,3
Height SDS 0.27 0.81 0.17 1.28 1.01 0.792,4
BMI SDS 0.27 1.14 0.13 0.96 2.35 0.542,3
1 All values are xSD. SDS, SD score relative to the 1990 UK reference
data (7, 12).
2 Significantly different from zero, P 0.001 (paired t test).
3,4 Significantly different from nonobese women (independent samples
t test): 3P 0.001, 4P 0.05.
TABLE 2
Characteristics of the children1
Group
Nonobese
(n 30 M, 22 F)
Obese
(n 11 M, 26 F)
CF
(n 12 M, 14 F)
GSD
(n 8 M, 4 F)
Age (y)2
Boys 10.3 3.82 12.6 2.66 9.47 0.67 9.87 2.90
Girls3 10.2 3.28 10.9 2.48 10.2 1.13 14.5 2.30
BMI SDS2,4
Boys 0.22 0.89 2.77 0.685 0.44 1.10 1.70 1.266
Girls 0.34 0.57 2.77 0.735 0.68 1.47 0.77 0.85
Weight SDS4,7 0.21 0.87 2.68 0.93 0.42 1.27 0.64 1.28
Height SDS4,7 0.03 0.91 0.81 1.015 0.58 1.056 0.75 1.038
1 All values are x  SD. CF, cystic fibrosis; GSD, glycogen storage disease; SDS, SD score relative to the 1990 UK reference data (7, 12).
2 Significant interaction between sex and group (P 0.05) in 2-factor ANOVA; therefore, the sexes were analyzed separately.
3 ANOVA for condition, P 0.03.
4 ANOVA for condition, P 0.001.
5,6,8 Significantly different from zero (paired t test): 5P 0.001, 6P 0.01, 8P 0.05.
7 No significant interaction between sex and group (P 0.05) in 2-factor ANOVA; therefore, the sexes were analyzed together.
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Comparison between DXA and the 4C model
Results of the Bland-Altman analyses are given in Table 5.
These results show the variable bias in FM, FFM, body weight,
and percentage fat in the different subject groups. DXA-
measured weight was significantly underestimated in obese
women and children, except the nonobese and obese boys, and
was significantly overestimated in nonobese men. FM was sig-
nificantly overestimated in all adults and obese boys and was
significantly underestimated in nonobese boys. However, the
bias in FFM did not mirror that in FM, as might have been
expected. This finding was accounted for by variable bias in
weight between groups. Correlation analyses showed that the
magnitude of the bias was related to the magnitude of the variable
in several categories (Table 5). DXA measurement significantly
underestimated percentage fat in nonobese boys, showed no sig-
nificant bias in nonobese girls and children with CF or GSD, and
overestimated it in obese children and all 3 categories of adults.
Factors predicting bias between DXA and the 4C model, by
ANCOVA, are shown in Table 6. FM bias was significantly
positively associated with both age and BMI SDS. FFM bias was
TABLE 3
Body composition of the adults1
Nonobese men
(n 26)
Nonobese women
(n 44)
Obese women
(n 14)
BW (kg) 66.9 8.83 57.3 9.14 78.1 9.52
BV (L) 63.0 8.84 55.6 9.32 78.3 9.97
TBW (L) 40.9 4.34 29.9 3.99 33.5 3.56
BMC by DXA (kg) 2.88 0.45 2.31 0.38 2.38 0.25
DXA body composition
FM (kg) 12.1 5.80 18.6 6.46 36.4 6.49
FFM (kg) 55.8 5.72 38.7 5.10 41.3 4.41
Percentage fat (%) 17.3 6.75 32.1 6.76 46.6 3.59
Weight (kg) 67.9 8.94 57.3 9.14 77.6 9.58
4-Component model
FM (kg) 10.8 5.27 17.4 5.81 34.8 6.55
FFM (kg) 56.2 5.94 39.9 5.37 43.3 4.55
Percentage fat (%) 15.6 6.26 29.9 6.05 44.4 3.9
HFFM (%) 72.8 1.39 74.7 1.60 77.2 1.07
DFFM (kg/L) 1.101 0.005 1.100 0.006 1.091 0.004
1 All values are x  SD. BW, body weight; BV, body volume; TBW, total body water; BMC, bone mineral content; DXA, dual-energy X-ray
absorptiometry; FM, fat mass; FFM, fat-free mass; HFFM, hydration of FFM; DFFM, density of FFM. Significant differences between groups for all variables
(P 0.001) by ANOVA and for all variables (P 0.05) except for BMC and FFM between nonobese and obese women and for DFFM between nonobese men
and women by post hoc Tukey’s test.
TABLE 4
Body composition of the children1
Group
Nonobese
(n 30 M, 22 F)
Obese
(n 11 M, 26 F)
CF
(n 12 M, 14 F)
GSD
(n 8 M, 4 F)
BW (kg)2 36.1 14.03 67.4 21.8 30.1 6.273,4 42.5 12.33
BV (L)2 34.6 13.33 67.4 22.2 28.9 6.463 41.7 12.23
TBW (L)2 21.0 8.293 29.7 8.60 17.9 2.513 21.9 5.683
BMC by DXA (kg)2 1.35 0.643 1.90 0.59 1.07 0.163 1.29 0.513
DXA body composition
FM (kg)2 7.76 4.613 29.2 12.0 6.45 3.603,4 13.7 6.303
FFM (kg)2 28.3 11.43 37.9 11.4 23.4 3.203 28.7 7.213
Percentage fat (%)2 21.5 7.843,4 42.6 6.40 20.3 7.333,4 31.0 8.133
DXA weight (kg)2 36.0 14.13 67.1 21.9 29.9 6.363 42.3 13.53
4-component model
FM (kg)2 8.05 4.363 28.6 12.2 6.42 3.743,4 13.7 5.593
FFM (kg)2 28.1 11.43 38.8 11.5 23.7 3.163 28.8 7.803
Percentage fat (%)2 22.0 7.023,4 41.4 7.25 20.0 7.543,4 31.5 6.703
HFFM (%)2 75.1 1.993 76.4 1.73 75.3 2.37 76.1 1.98
DFFM (kg/L) 1.091 0.008 1.089 0.006 1.089 0.007 1.086 0.009
1 All values are x  SD. CF, cystic fibrosis; GSD, glycogen storage disease; BW, body weight; BV, body volume; TBW, total body water; BMC, bone
mineral content; DXA, dual-energy X-ray absorptiometry; FM, fat mass; FFM, fat-free mass; HFFM, hydration of FFM; DFFM, density of FFM.
2 Significant difference across groups, P 0.001 (ANOVA).
3 Significantly different from the obese group, P 0.006 (post hoc Tukey’s test).
4 Significantly different from the GSD group, P 0.006 (post hoc Tukey’s test).
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significantly associated with age, sex, BMI SDS, and CF, and
there was a significant interaction between age and BMI SDS,
which indicated that BMI SDS was associated with decreased
bias with increasing age. Weight bias was significantly associ-
ated with age, sex, and BMI SDS. The use of an alternative
model, in which BMI SDS was replaced with FM or percentage
TABLE 5
Bland-Altman analysis of mean bias in fat mass (FM), fat-free mass (FFM), weight, and percentage fat measured by dual-energy X-ray absorptiometry
(DXA) compared with the 4-component model1
Absolute
bias2
Absolute 95%
limits of
agreement
Bias as a
percentage
of the mean3
95% limits of
agreement as a
percentage of the mean
P for
the bias
from zero4 r5
P for the
correlation
% %
FM
Adults
Nonobese men (n 26) 1.35 2.82 12.4 25.3  0.001 0.38 NS
Nonobese women (n 44) 1.21 2.29 6.19 14.8  0.001 0.58  0.01
Obese women (n 14) 1.58 3.50 4.60 11.0  0.01 0.04 NS
Children
Nonobese boys (n 30) 0.52 1.17 10.9 23.8  0.001 0.10 NS
Nonobese girls (n 22) 0.01 1.24 9.72 10.6 NS 0.46  0.05
Obese boys (n 11) 0.93 1.86 3.52 7.06  0.01 0.08 NS
Obese girls (n 17) 0.46 2.42 2.26 9.39 NS 0.24 NS
Boys with CF (n 12) 0.14 1.83 0.38 29.9 NS 0.53 NS
Girls with CF (n 14) 0.18 1.42 0.77 26.6 NS 0.48 NS
Boys and girls with GSD (n 12) 0.06 2.28 3.67 22.6 NS 0.63  0.05
FFM
Adults
Nonobese men (n 26) 0.37 2.71 0.62 4.88 NS 0.18 NS
Nonobese women (n 44) 1.19 2.38 2.96 6.06  0.01 0.23 NS
Obese women (n 14) 1.97 3.39 4.68 8.45  0.001 0.08 NS
Children
Nonobese boys (n 30) 0.56 1.51 2.06 4.67  0.001 0.19 NS
Nonobese girls (n 22) 0.34 1.38 0.99 4.99  0.05 0.56  0.01
Obese boys (n 11) 1.02 1.99 2.49 4.38  0.01 0.03 NS
Obese girls (n 17) 0.80 2.49 2.25 6.12  0.01 0.05 NS
Boys with CF (n 12) 0.04 1.76 0.28 7.13 NS 0.30 NS
Girls with CF (n 14) 0.53 1.20 2.20 5.14  0.01 0.40 NS
Boys and girls with GSD (n 12) 0.10 2.28 0.13 7.71 NS 0.51 NS
Weight
Adults
Nonobese men (n 26) 0.99 0.92 1.46 1.33  0.001 0.23 NS
Nonobese women (n 44) 0.02 0.50 0.04 0.88 NS 0.02 NS
Obese women (n 14) 0.39 0.78 0.52 1.01  0.01 0.16 NS
Children
Nonobese boys (n 30) 0.04 0.70 0.64 1.67 NS 0.61  0.01
Nonobese girls (n 22) 0.32 0.50 0.92 1.22  0.001 0.47  0.05
Obese boys (n 11) 0.09 0.89 0.19 1.10 NS 0.37 NS
Obese girls (n 17) 0.33 0.68 0.63 1.31  0.001 0.28 NS
Boys with CF (n 12) 0.18 0.51 0.67 2.43  0.05 0.21 NS
Girls with CF (n 14) 0.35 0.70 1.28 2.48  0.01 0.35 NS
Boys and girls with GSD (n 12) 0.17 0.41 0.44 1.16  0.05 0.06 NS
Percentage fat (%)
Adults
Nonobese men (n 26) 1.69 3.81 — —  0.001 0.26 NS
Nonobese women (n 44) 1.98 3.94 — —  0.001 0.25 NS
Obese women (n 14) 2.28 4.72 — —  0.05 0.16 NS
Children
Nonobese boys (n 30) 1.74 3.52 — —  0.001 0.09 NS
Nonobese girls (n 22) 0.03 3.51 — — NS 0.44  0.05
Obese boys (n 11) 1.41 2.59 — —  0.01 0.54 NS
Obese girls (n 17) 1.03 3.50 — —  0.01 0.52  0.01
Boys with CF (n 12) 0.18 5.54 — — NS 0.42 NS
Girls with CF (n 14) 0.65 4.55 — — NS 0.41 NS
Boys and girls with GSD (n 12) 0.53 5.59 — — NS 0.52 NS
1 CF, cystic fibrosis; GSD, glycogen storage disease. Differential bias by group is evaluated by using analysis of covariance in Table 6.
2 The mean value measured by DXA minus the mean value measured with the 4-component model.
3 The bias of the natural log values multiplied by 100.
4 Paired t test.
5 Pearson’s correlation between the bias in individuals and the mean values.
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fat, showed that weight bias was associated with age, sex, and
either FM or percentage fat. Bias in percentage fat was associated
with age, sex, BMI SDS, and CF, and there was a significant
interaction between age and sex, which indicated that the effect
of being female on percentage fat bias was greater with increas-
ing age. When waist circumference (as an alternative proxy for
depth of scan) was substituted for BMI SDS in the ANCOVA, the
results for all 4 body-composition biases were similar to those for
BMI SDS (data not shown).
Propagation of error analysis indicated that methodologic im-
precision was equivalent to 0.6 kg of bias. Biases of 0.6 kg
could be attributed to imprecision, but larger biases could be
attributed to the combination of imprecision and inaccuracy. For
biases1 kg, most of the bias could be attributed to the inaccu-
racy of one or other method.
DISCUSSION
DXA was designed for the measurement of bone mass and has
been shown to be both accurate and precise when used for this
purpose. However, this method is increasingly being used for the
measurement of body composition. Our study was the first to
examine the validity of DXA in groups differing in body size,
fatness, and (due to the effects of disease states) the chemical
composition of FFM. We showed that the bias of DXA varied
according to body size, body fatness, sex, and disease state.
These findings indicate that caution is necessary when DXA is
used to compare patients with control subjects or to assess
changes in body composition in persons whose relative weight
changes significantly between measurements.
Many studies have investigated the accuracy of DXA. Animal
carcass studies have shown systematic biases in younger age
groups, which required a correction factor to be generated (19)
and applied (20, 21). However, most studies in humans have used
reference methods that may not have been accurate. Two-
component techniques, such as hydrodensitometry, rely on as-
sumed constant properties of FM and FFM. We showed previ-
ously that this is not the case in healthy adults (5) or children (15),
and the issue is of even greater importance when measuring
patients in whom body-composition variability, especially FFM
composition, is most extreme.
Recently, several studies have assessed DXA in relation to the
4C model. These studies are summarized in Table 7, and they
highlight 2 issues: 1) the bias varies according to several factors,
including subject age and instrumentation, and 2) the vast ma-
jority of work has been conducted in healthy adults and children.
TABLE 6
Analysis of factors predicting for bias between dual-energy X-ray
absorptiometry and the 4-component (4C) model by analysis of
covariance1
Factor  Coefficient t P Adjusted r2
FM bias
Age 0.14 8.85  0.001 0.32
BMI SDS 0.21 4.01  0.001
FFM bias
Age2 0.099 6.18  0.001 0.29
Sex 0.74 4.8  0.001
BMI SDS 0.26 4.87  0.001
CF 0.51 2.02 0.05
Weight bias
Age3,4 0.041 7.05  0.001 0.45
Sex 0.55 9.76  0.001
BMI SDS5 0.049 2.5 0.013
Percentage fat bias
Age6 0.25 8.78  0.001 0.34
Sex 0.89 3.2 0.002
BMI SDS 0.43 4.49  0.001
CF 1.27 2.79 0.006
1 For each bias we performed general linear models that included the
following factors: age, sex (M  0, F  1), CF (healthy  0, CF  1), GSD
(healthy 0, GSD 1), and BMI SDS, FM, or percentage fat. The significant
factors (P 0.05) for each model are shown. Interactions between significant
factors for each model were then tested and are reported with the adjusted mean
values for significant categorical variables as follows: FFM bias (male,0.29;
female, 1.03; healthy, 0.4; CF, 0.91); weight bias (male, 0.17; female,
0.37); percentage fat bias (male, 0.50; female, 1.39; healthy, 0.31; CF, 1.58).
SDS, SD score relative to the 1990 UK reference data (7, 12); CF, cystic fibrosis;
GSD, glycogen storage disease; FM, fat mass; FFM, fat-free mass.
2 Significant interactionbetweenageandBMISDS(coefficient0.026,
P 0.021).
3 Significant interactionbetweenageandBMISDS(coefficient0.007,
P 0.04).
4 Significant interaction between sex and age (coefficient  0.06,
P  0.001).
5 Similar results were also obtained if BMI SDS was replaced with FM
(coefficient0.009, P 0.001) or percentage fat (coefficient0.015,
P 0.001).
6 Significant interaction between age and sex (coefficient  0.13,
P 0.03).
TABLE 7
Summary of studies that assessed dual-energy X-ray absorptiometry against a 4-component model
Reference Date Instrumentation
No. of
subjects Subjects
Percentage
fat bias Significance
Percentage fat
limits of agreement
%
Prior et al (22) 1997 QDR1000W1 172 Adults 0.4 No 5.8
Roemmich et al (23) 1997 QDR20001 47 Children 1.88 Yes 8.3
Wells et al (15) 1999 QDR1000W1 30 Children 0.2 No 6.5
Clasey et al (24) 1999 QDR20001 78 Adults 0.9 to4.5 Yes 7.8–10.5
Wong et al (6) 2002 QDR2000W1 141 9–17 y 3.9 Yes 3.4
Fuller et al (5) 1992 DPX2 28 Adults 1.36 Yes 4.95
Gately et al (25) 2003 Lunar2 30 Obese children 1.9 Yes 4.0
Van der Ploeg et al (26) 2003 DPX-L2 152 Adults 1.8 Yes 4.0
Sopher et al (27) 2004 DPX/DPX-L2 411 Children 1.01 Yes 8.9
1 Hologic Inc, Waltham, MA.
2 GE Medical Systems, Madison, WI.
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Demonstration of the validity of DXA in healthy subjects is not
sufficient justification for its application in patients, and our
findings are highly relevant to this issue.
Many factors may contribute to the differences between stud-
ies. First, DXA assumes a constant value for FFM hydration;
however, this may not apply to all categories of subjects and,
hence, may represent an inappropriate bias that introduces error
(22, 28-32). One study, however, suggested that the magnitude of
this bias is likely to be small (30). Second, subject size may
influence bias through the effect of tissue depth (29), with in-
creasing tissue depth associated with greater bias by DXA (33).
Third, some DXA instruments have no algorithms specific to
children. Fourth, accuracy may differ between pencil- and fan-
beam DXA instruments (34). Fifth, fat distribution may influ-
ence accuracy, because pixels containing bone (approximately
one-third of the total) extrapolate soft tissue composition from
adjacent regions, which may have a fat content different from the
region overlying the bone (29). Sixth, most of the head soft tissue
composition is not calculated. Seventh, DXA instruments vary in
the approach used to estimate the fat content of bone, which leads
to generic differences between manufacturers. Finally, it is pos-
sible that 4C models differ according to whether BV is measured
by underwater weighing or plethysmography, although most
studies have shown good agreement between these methods (35).
Note that our own findings apply only to Lunar Prodigy instru-
mentation.
The results of our study highlight variable bias in the mea-
surement of FM, FFM, and weight by DXA according to several
key characteristics of subjects. Clearly, variable bias between
patients and healthy subjects presents difficulties for case-
control studies. Bias in weight has particular relevance to longi-
tudinal studies because it may confound the estimation of
changes in body composition (36). The sex-difference in bias has
implications for studies intending to derive body composition
cutoffs for overweight and obesity (37, 38). The difference in
bias between obese and nonobese persons indicates that DXA
may be unsuitable for assessing changes in body composition
during weight loss, as was reported in several studies (24, 39).
However, body size and fatness did not fully account for the
variability in bias between groups: children with GSD, though
fatter than nonobese children, did not have biases similar to those
of obese children. Because the bias was inconsistent, it would be
difficult to derive a simple single correction factor, as has been
proposed by others working on more homogenous samples (6).
The magnitude of mean biases found in our study was2 kg
of FFM and FM in groups, equivalent to2% fat. In individuals,
the limits of agreement were3 kg of FFM and FM in adults and
2 kg in children, equivalent to 4–6% fat depending on age and
group. This range of bias is smaller than that reported by Wong
et al (6), but remains a serious issue because it is potentially of the
order of magnitude of difference that might be expected after
treatment in an individual or between groups. Factors including
size, age, sex, and disease state all showed an independent effect
in ANCOVA, which suggests that qualitatively different factors
contribute to DXA bias. Our data indicate that DXA has limita-
tions for measurement of body composition in clinical practice,
but our findings are also important in the context of research
studies. The literature contains increasing numbers of studies
using DXA to undertake clinical research intended to provide
evidence appropriate as the basis for clinical practice. Our find-
ings challenge the validity of this approach and suggest that other
approaches, such as multicomponent models, are preferable.
The main limitation of our study, which is common to all
studies comparing DXA with the 4C model, was that DXA pro-
vides data for both measurements. The measurement of BMC is
integral to DXA calculations of FFM and FM, and the same data
are also used in the 4C model. However, we believe that our study
is not adversely affected by this scenario. First, we calculated that
BMC would need to be measured with 30% error to induce a
2% error in percentage fat. Thus, we think it highly unlikely that
our finding of variable bias between category of subjects can be
entirely attributed to an effect of BMC error on both methods.
Second, we reran our Bland-Altman calculations using the
3-component model, which incorporates no data from DXA and
is therefore fully independent, and obtained similar results. We
chose the 4C model as the reference because only this method can
address the variability in mineralization that occurs within and
between groups. Although the results are limited to the groups
being studied, it is sufficient to highlight that the accuracy with
which DXA measures body composition varies depending on
several factors.
In conclusion, our study suggests that caution is required in the
applicationof this instrumentation in themeasurementofbodycom-
position in medical research and clinical practice. Our findings may
be particularly challenging for randomized controlled trials, in
which differences in body composition at follow-up may induce
inconsistent accuracy between 2 groups. We suggest that multicom-
ponentmodels remain thebest existingmethodforunderpinning the
evidence base for body-composition studies.
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Pediatric reference data for lean tissue properties: density and
hydration from age 5 to 20 y1–3
Jonathan CK Wells, Jane E Williams, Sirinuch Chomtho, Tegan Darch, Carlos Grijalva-Eternod, Kathy Kennedy,
Dalia Haroun, Catherine Wilson, Tim J Cole, and Mary S Fewtrell
ABSTRACT
Background: Hydrometry and densitometry are widely used to
assess pediatric body composition due to their ease of application.
The accuracy of these techniques depends on the validity of age-
and sex-specific constant values for lean tissue hydration or density.
Empirical data on these constants, and their variability between
individuals, are lacking.
Objectives: The objectives were to measure lean tissue hydration
and density in a large sample of children and adolescents and to
derive prediction equations.
Design: Body composition was measured in 533 healthy individuals
(91% white) aged 4–23 y by using the 4-component model. Age-
and sex-specific median values for hydration and density were ob-
tained by using the LMS (lambda, mu, sigma) method. Regression
analysis was used to generate prediction equations on the basis of
age, sex, and body mass index SD score (BMI SDS). Values were
compared with those in previously published predictions.
Results: Age-associated changes in density and hydration differed
between the sexes. Compared with our empirical values, use of
published values resulted in a mean bias of 2.1% fat (P ,
0.0001). Age, sex, and BMI SDS were all significant predictors of
lean tissue hydration and density. With adjustment for age and sex,
hydration was higher, and density lower, in higher–BMI SDS indi-
viduals.
Conclusions: The chemical maturation of lean tissue is not a linear
process and proceeds differently in males and females. Previously
published reference values are inaccurate and induce clinically sig-
nificant bias in percentage fat. New empirical reference values are
provided for use in pediatric hydrometry and densitometry.
Further research that extends to cover nonwhite ethnic groups is
needed. Am J Clin Nutr 2010;91:610–8.
INTRODUCTION
The gold standard for body-composition assessment at the
molecular level is cadaver dissection; hence, all in vivo mea-
surements in humans are restricted to the measurement of specific
physical parameters, such as body density, body water or po-
tassium content, or X-ray attenuation. Raw data on such variables
are converted to final body-composition values by using as-
sumptions concerning the biological, chemical, or physical prop-
erties of specific body components. Two useful body-composition
techniques, especially in children, are hydrometry [the mea-
surement of total body water (TBW)] and densitometry. In
hydrometry, TBW is converted to lean tissue (used here syn-
onymously with fat-free tissue) by using an assumed constant
value for lean tissue hydration (1). The same correction is re-
quired with the use of most bioelectrical impedance equations,
which usually predict TBW from the raw bioelectrical data (2). In
densitometry, the proportion of fat in weight (% fat) is calculated
on the basis of assumed constant densities of fat and lean tissues
(3). Although these techniques are regularly used for pediatric
body-composition assessment, their accuracy is dependent not
only on accuracy of the raw data but also on the accuracy of the
tissue property values assumed to be constant among individuals.
These issues are of particular importance when studying
children due to the well-established process of chemical matu-
ration that occurs before adulthood (4, 5). Whereas fat has rel-
atively uniform physical properties throughout the life course
(zero water content and a density of 0.9007 kg/L), lean tissue
decreases in water content and increases in density during growth
(5). At birth, lean tissue has been proposed to be’80% water, in
contrast to the adult value of ’73% (5). Lean tissue density
likewise increases from ’1.063 to ’1.10 kg/L over the same
period (5). For almost 3 decades, researchers have relied on 2
landmark publications for these tissue constants. In 1982 Fomon
et al (5) published a “reference child,” providing such data for
the period from birth to age 10 y. However, these data were
based on actual measurements only in infancy and at age 9 or
10 y, with most values in between being extrapolated. In 1989
Lohman (6) published similar reference data for the entire pe-
diatric age range, merging the data of Fomon et al with further
empirical data based on simultaneous measurements of TBW,
body density, and forearm bone mineral density in 292 in-
dividuals aged 8–30 y (7). Simulations for adolescents were also
reported by Haschke (8).
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Further data on these tissue properties have been reported for
narrow age ranges, and typically in small samples (7, 9–12),
although more comprehensive data for the first 2 y of life are
available (13). Currently, researchers cannot be confident of
selecting appropriate age- and sex-specific values, and there is
little understanding of other factors associated with individual
variability in these tissue properties. For example, we previously
reported an association between hydration and body mass index
(BMI) SD score (BMI SDS) in children (14).
We have recently obtained data on body composition in a large,
healthy sample of children and adolescents aged 4–23 y. Here, we
report reference data for the hydration and density of lean tissue
and develop prediction equations on the basis of age, sex, and
BMI SDS.
SUBJECTS AND METHODS
A total of 565 normal, healthy children and adolescents aged
4–23 y were recruited by using flyers and newspaper adver-
tisements in London and the southeast of England, starting in
2001. There were no exclusion criteria for BMI; hence, some
individuals were categorized as overweight or obese, but they
were not recruited directly from obesity weight-loss clinics and
had no disease that might have adversely affected growth
and development. The lower age limit of 4 y was chosen on
the basis of our previous work, in that younger children are
unlikely to satisfy the protocol for air-displacement plethys-
mography. Data collection was extended to young adults to
cover the entire pediatric age range. Ethical approval was granted
by the Ethical Committee of the University College London
Institute of Child Health and Great Ormond Street Hospital. All
individuals attended our body-composition investigation suite
located at Great Ormond Street Hospital for a 2-h measurement
session.
Weight and height were measured by using standard protocols.
Body weight (BW) was measured in duplicate as part of the air-
displacement plethysmography protocol (see below). Height was
measured by using a wall-mounted stadiometer (Holtain, Dyfed,
United Kingdom). BMI was calculated as weight (kg) divided
by the square of height (m). Anthropometric data were con-
verted to SDS format by using UK reference data (15, 16).
Obesity was defined as a BMI .95th centile (SDS .1.64), and
overweight was defined as a BMI .85th centile (SDS .1.04)
(16). Pubertal development was assessed by Tanner staging by
self-assessment on the basis of line drawings. Skinfold thickness
measurements were performed in triplicate at the biceps, triceps,
subscapular, and suprailiac sites, and the mean of the 3 values
was used.
Measurements of TBW by deuterium dilution, bone mineral
content (BMC) by dual-energy X-ray absorptiometry (DXA;
Lunar Prodigy; GE Medical Systems, Madison, WI), and body
volume (BV; in duplicate) by air-displacement plethysmography
(Bodpod; Life Measurements, Concord, CA) were obtained as
described previously (17). The deuterium dilution space was
converted to TBW assuming the degree of overestimation at-
tributable to proton exchange to be 1.044 (18). Lung volume was
predicted rather than measured in the plethysmography mea-
surements, because we have found a large proportion of children
are unable to complete the lung volume measurement protocol.
The 4-component (4C)model was used to calculate lean mass and
fat mass (FM), as described previously (10, 19), using the fol-
lowing equation:
FM ¼ ð2:7473BVÞ2 ð0:7103TBWÞ
þ ð1:4603BMCÞ2 ð2:0503BWÞ ð1Þ
The precision of TBW in our laboratory is 1% (10). The
precision of BV from duplicate measurements and BMC is 0.24 L
and 1.1%, respectively (20). Hydration was calculated as (TBW/
lean mass) · 100%. Density was calculated as [(mass of water +
mass of mineral + mass of protein)/(volume of water + volume
of mineral + volume of protein)] with the use of values for the
density of water at 36C, mineral, and protein of 0.99371,
3.0375, and 1.34 kg/L, respectively (17).
Sex-specific values by year of age were obtained for hydration
and density by using Cole’s LMS (lambda, mu, sigma) method
(LMS Chart Maker; Medical Research Council, London, United
Kingdom) (21). This statistical approach, widely used to con-
struct reference data for traits that incorporate the effects of
growth, provides 3 outputs: 1) a smoothed median (M or mu)
curve, which represents how the outcome varies in relation to
age; 2) the CV (S or sigma), which models the scatter of values
around the mean and adjusts for any nonuniform dispersion;
and 3) the skewness (L or lambda), which is addressed by using
age-specific Box-Cox transformation (L) to achieve a normal
distribution. Goodness-of-fit was assessed by comparing con-
secutive models and adding complexity only if a significant
improvement to the fit (reduced deviance) was obtained. Be-
cause the precision of the M curve at any age depends on data
points at younger and older ages, precision is lower at the ex-
tremes of the age range. We therefore fitted the data for all ages
(4–23 y) and derived M values for the age range of 5–20 y.
Derived values for the density of lean tissue (DL) were com-
bined with an assumed constant density of fat (DF: 0.9007 kg/L)
to generate age-specific constants for application in the generic
equation proposed by Siri (3), as undertaken previously by
Lohman (6):
% Fat ¼ ðC1=BD 2 C2Þ3 100 ð2Þ
where BD is body density, C1 is calculated as (DL · DF)/(DL 2
DF), and C2 is calculated as DF/(DL 2 DF) (6).
Multiple regressionanalysiswasundertaken toderivepredictive
equations for hydrationanddensity of lean tissue.The independent
variables comprised age, age squared, sex, and BMI SDS. These
values are readily obtainable in community or clinical studies. Our
aim was to derive appropriate equations and to identify the pro-
portion of variance accounted for by the predictors. We also
compared the utility of sex-specific equations with sex-combined
equations. The association of BMI with hydration and density was
assessed by using partial correlations adjusted for age and sex.
Residual values for hydration and density were calculated as
the measured value minus the average (LMS-derived) value for
the appropriate year age group. Correlation analysis was then
used to investigate possible associations between the residual
values and BMI SDS or skinfold thicknesses. The effect of
obesity (categorized as yes/no) on hydration and density after
adjustment for age, sex, and ethnicity was also tested for.
The method of Bland and Altman was used to compare our
empirical values of % fat with those that were calculated by using
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densitometry in association with the Lohman values for the
pediatric version of Siri’s equation (3, 6, 22). We also calculated
the proportion of our sample that would be incorrectly catego-
rized as obese on the basis of % fat [using cutoffs of 20% fat for
males and 30% for females (23)] if using the Lohman density
values and our own empirical values as the reference. All
analyses were conducted with the use of Data Desk version 6.1
(Data Description Inc, Ithaca, NY).
Finally, we evaluated the agreement between hydrometry and
densitometry used as 2-component techniques (ie, by using data
on TBWor density in combination with our new reference values
for hydration or density, respectively) and DXA. Age- and sex-
specific values for lean tissue hydration and density were used to
convert TBW to lean mass and density to % fat. Bland-Altman
analysis was then used to compare agreement in lean mass and %
fat between DXA and hydrometry or DXA and densitometry. The
DXA lean mass value as used here included both bone and lean
soft tissue. Correlations were also calculated to assess the as-
sociation between bias and the magnitude of lean mass or % fat.
RESULTS
Valid data were obtained for 533 individuals. Data for 32
individuals were discarded in cases in which one or more of the
measurements was unsuccessful (n = 16; mostly very young
children) or if the modeling was unsuccessful (n = 16) indicated
by spurious body-composition data. As indicated in Figure 1,
a wide range of BMI SDS was apparent at all ages. There was no
significant correlation between BMI SDS and age in either sex.
Data on the anthropometric SDS values and the range of % fat
by sex are provided in Table 1. On average, our sample was
heavier, taller, and relatively heavier for their height than the UK
reference data of the early 1990s (P , 0.005 in all cases). Fe-
males had significantly greater % fat than males by the 4C
model (P, 0.0001, adjusted for age). The prevalence of obesity
was 11.5% and 14.7% in males and females, respectively, and
was uncorrelated with age. The numbers by pubertal stage were
as follows: males: 98, 60, 28, 24, 50 (for pubertal stages 1–5,
respectively); females: 87, 48, 34, 22, 80 (for pubertal stages 1–
5, respectively); and 2 others not recorded. Age- and sex-specific
empirical mean (6SD) values for lean tissue properties, strati-
fied in 2-y age groups, are given in Table 2.
Our values for density and hydration with equivalent data from
other studies for each sex are compared in Figure 2. Density
increased with age in both sexes, but in different patterns.
Whereas the increase was relatively consistent in females, in
males the values plateaued between 10 and 15 y, and again from
18 y. Hydration decreased with age in both sexes, but again
differing by sex. The decrease in hydration in males lagged
behind that for females, until a sudden marked drop from ’
16 y. Overall, age changes in lean tissue properties were more
linear in females compared with males, but in both sexes the
trend was nonlinear. In comparison with previously reported
data, our hydration data fit fairly well for males but not for
females, in whom the simulations produced values ’2% too
high in mid-childhood. For density, our values are systemati-
cally higher than previously modeled values throughout child-
hood and adolescence. Our empirical % fat values compared
with those obtained by using values for body density in com-
bination with the Lohman values for lean tissue density are
shown in Figure 3. The mean bias was 22.1% (limits of agree-
ment 6 4.7%), which was significantly greater in females than
males (23.3 compared with 21.1%, P , 0.001). The bias in-
creased with age in males (r = 0.30, P , 0.0001) but not fe-
males (r = 0.11). By using cutoffs of 20% fat in males and 30%
fat in females, this error would result in 24 males and 17 fe-
males being incorrectly categorized as nonobese, lowering the
prevalence of obesity from 36.6% to 27.5% in males and from
33.4% to 27.2% in females.
FIGURE 1. BMI SD score (BMI SDS) in the whole sample, by sex.
TABLE 1
Summary statistics for anthropometric measurements and weight status by sex1
Males (n = 261) Females (n = 272)
Mean 6 SD Range Mean 6 SD Range
Weight SDS 0.31 6 1.08 22.42, 3.44 0.42 6 1.10 22.75, 3.46
Height SDS 0.21 6 0.96 22.09, 3.28 0.34 6 1.02 22.77, 3.42
BMI SDS 0.24 6 1.15 22.99, 3.49 0.31 6 1.15 23.33, 3.32
% Fat (4-component model)2 19.2 6 8.0 4.9, 45.5 27.0 6 8.0 11.7, 46.9
Overweight (%) 9.2 10.7
Obese (%) 11.5 14.8
1 SDS, SD score.
2 Significantly different between sexes, P , 0.0001 (multiple regression analysis to assess significance of female sex,
adjusted for age).
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The association between residual hydration or density (the
actual value minus the average value for that age-sex group) and
BMI SDS was weak but significant (hydration: r = 0.26, P ,
0.0001; density: r = 20.14, P = 0.002). With skinfold thickness,
with adjustment for age, the associations were weaker (hydra-
tion: r = 0.11, P = 0.007; density: r = 20.05, P = 0.2). Fitting
a squared BMI term increased the r2 values only slightly, in-
dicating that the effect of BMI SDS on lean tissue properties is
broadly consistent across the range of BMIs. Dividing the
sample into those above and below a BMI SDS of zero, dif-
ferences in density and hydration were greater at older ages,
especially in males (Figure 4). Mean (6SE) values for hydra-
tion were 1.0 6 0.2% (P , 0.0001) greater, and density was
0.0022 6 0.0007 kg/L (P , 0.002) lower in obese compared
with nonobese individuals.
Regression equations for density and hydration on age, sex,
and BMI SDS are given in Table 3. Age squared did not con-
tribute significantly, which indicated a linear association. The
sex-combined equation explained around half of the variance in
density but only a third of the variance in hydration. Given the
FIGURE 2. Comparison of our empirical values for lean tissue properties with those reported from the literature previously (5, 6, 8, 13) by using the mean
and SD of 2-y age groups. Density of lean tissue in males (A) and in females (B). Hydration of lean tissue in males (C) and in females (D).
TABLE 2
Age- and sex-specific values for the density and hydration of lean tissue
Age
Males (n = 261) Females (n = 272)
n Density Hydration n Density Hydration
kg/L % kg/L %
4–5.99 y 22 1.0826 6 0.0080 76.6 6 2.4 13 1.0821 6 0.0070 77.3 6 2.0
6–7.99 y 24 1.0865 6 0.0064 76.1 6 1.8 35 1.0899 6 0.0058 75.3 6 1.7
8–9.99 y 40 1.0887 6 0.0049 75.8 6 1.4 31 1.0905 6 0.0058 75.2 6 1.7
10–11.99 y 51 1.0917 6 0.0043 75.2 6 1.4 43 1.0926 6 0.0052 75.0 6 1.7
12–13.99 y 51 1.0914 6 0.0055 75.2 6 1.6 54 1.0951 6 0.0051 74.8 6 1.5
14–15.99 y 18 1.0923 6 0.0066 75.0 6 1.6 32 1.0996 6 0.0050 74.1 6 1.5
16–17.99 y 23 1.0992 6 0.0055 73.1 6 1.6 19 1.1021 6 0.0041 73.7 6 1.7
18–19.99 y 21 1.0995 6 0.0065 73.4 6 2.0 26 1.1034 6 0.0056 73.5 6 1.5
20–22.99 y 11 1.1013 6 0.0055 73.6 6 1.5 19 1.1037 6 0.0057 73.7 6 1.0
PEDIATRIC REFERENCE DATA FOR LEAN TISSUE PROPERTIES 613
 at University College London on February 21, 2010 
w
w
w
.ajcn.org
D
ow
nloaded from
 
sex differences in the age pattern of density and hydration, sex-
specific models were also fitted, with similar r2 values as those
for the sex-combined model. Ethnicity (black or Asian) was not
significant for hydration or density, except for black females in
whom the mean density of lean tissue was 0.0003 kg/L lower
than in white females (P, 0.0008). Excluding the effects of age
and sex, the correlations of BMI SDS with hydration and density
were 0.26 (P , 0.0001) and 20.15 (P , 0.001), respectively.
Age- and sex-specific constants on the basis of our data,
obtained from the M curve of the LMS method, are shown in
Table 4. These values are for hydration of lean tissue and the C1
and C2 constants for the densitometric equation predicting % fat
from body density. The values for adult males are similar to
Siri’s values of 4.95 for C1 and 4.50 for C2. However, for adult
females our values are slightly lower: 4.90 for C1 and 4.44 for
C2 at 20 y. The difference between our adult female equation
and that of Siri’s is 1.1% fat.
Agreement between DXA and hydrometry or densitometry as
2-component techniques is shown in Table 5. There was a sig-
nificant underestimation of lean mass by DXA relative to both
hydrometry and densitometry in females (P , 0.001) but not in
males. Likewise, there was a significant overestimation of % fat
by DXA relative to hydrometry and densitometry in females
(P , 0.001) but not in males. The limits of agreement were
approximately 63.1–3.4 kg of lean mass and 66.1–6.6% fat.
Bias was in most cases associated with the magnitude of lean
tissue or % fat.
DISCUSSION
This study provides the first comprehensive empirical data on
the density and hydration of lean tissue, and their variability,
across the majority of the growth period. These data will improve
the accuracy of hydrometry and densitometry when applied to the
FIGURE 3. Bland-Altman plot showing the bias in % fat obtained by
using body density from air-displacement plethysmography in combination
with the lean tissue density values of Lohman (6) in comparison with our
empirical 4-component (4C) values as the reference. The mean bias is shown
for each sex.
FIGURE 4. Mean (6SD) age changes in the properties of lean tissue, stratified according to BMI SD score (BMI SDS) above or below zero. Hydration of
lean tissue in males (A) and in females (B). Density of lean tissue in males (C) and in females (D).
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pediatric population. They also reveal important nonlinear pat-
terns of chemical maturation in children, which further differ
between the 2 sexes. Our empirical values were similar to those of
Lohman (6) for hydration in males but differed substantially for
hydration in females and for density in both sexes. These dif-
ferences generate mean errors of approximately21 to22.5% fat
in individuals of average fatness according to age, with an
overall mean bias of 22.1% for densitometry. Such errors are
clinically significant when, for example, categorizing obesity
according to adiposity [% fat: .20% in males, 30% in females
(23)] rather than BMI.
Maturational changes in hydration and density have been
attributed to a combination of factors. On the one hand, decreases
in the water content of lean tissue correspond to increases in
protein and mineral content (5) and hence to the ratio of ex-
tracellular solids to body water (24). However, this absolute
decrease in water content also incorporates a decline in the ratio
of extracellular to intracellular water, as cells increase in size and
thus in their relative water content (24). It has been generally
assumed that these changes occur fastest in early childhood, and
that the rate of change is slower after 2 y (5, 13). Our data,
however, suggest that chemical maturation continues at a faster
rate until’7 y of age and that less maturation takes place during
adolescence than previously assumed.
Our values for male adults aged 18–23 y are extremely similar
to those generally assumed, with amean hydration of 73.4–73.6%
TABLE 3
Regression equations for the prediction of lean tissue density and hydration by age, sex, and BMI SD score (BMI SDS)1
Density (·1000) Hydration
B SE t P r2 B SE t P r2
All
Constant 1074.8 0.97 1106 ,0.0001 0.52 77.59 0.28 281 ,0.0001 0.30
Age (y) 1.18 0.05 22.0 ,0.0001 20.19 0.01 212.7 ,0.0001
Female sex 2.79 0.48 5.8 ,0.0001 20.27 0.14 22.0 0.046
BMI SDS 20.90 0.21 24.3 ,0.0001 0.41 0.06 7.0 ,0.0001
Males
Constant 1078.2 1.04 1037 ,0.0001 0.44 77.71 0.30 261 ,0.0001 0.31
Age (y) 1.14 0.08 14.0 ,0.0001 20.23 0.02 29.7 ,0.0001
BMI SDS 21.09 0.30 23.6 0.0004 0.43 0.09 4.9 ,0.0001
Females
Constant 1079.8 0.98 1093 ,0.0001 0.53 76.69 0.28 277 ,0.0001 0.28
Age (y) 1.23 0.07 17.1 ,0.0001 20.17 0.02 28.2 ,0.0001
BMI SDS 20.70 0.28 22.4 0.015 0.42 0.08 5.3 ,0.0001
1 In each model, hydration or density was regressed on predictors that included age, BMI SDS, and female sex as specified.
TABLE 4
Median values for hydration, density, and constants (C1 and C2) for the pediatric version of Siri’s (3) equation, obtained
by using the LMS (lambda, mu, sigma) method1
Age
Males Females
Hydration Density C1 C2 Hydration Density C1 C2
% kg/L % kg/L
5 y 76.5 1.0827 5.36 4.95 76.7 1.0837 5.33 4.92
6 y 76.3 1.0844 5.32 4.90 76.1 1.0865 5.27 4.85
7 y 76.1 1.0861 5.28 4.86 75.5 1.0887 5.22 4.79
8 y 75.9 1.0877 5.24 4.82 75.2 1.0900 5.19 4.76
9 y 75.7 1.0889 5.21 4.79 75.1 1.0909 5.17 4.74
10 y 75.5 1.0900 5.19 4.76 75.0 1.0916 5.15 4.72
11 y 75.3 1.0911 5.16 4.73 75.0 1.0924 5.13 4.70
12 y 75.2 1.0917 5.15 4.72 74.9 1.0937 5.10 4.67
13 y 75.0 1.0920 5.14 4.71 74.6 1.0954 5.07 4.63
14 y 74.8 1.0927 5.13 4.69 74.4 1.0975 5.02 4.58
15 y 74.4 1.0942 5.09 4.66 74.1 1.0996 4.98 4.53
16 y 74.0 1.0960 5.05 4.61 73.8 1.1011 4.95 4.49
17 y 73.7 1.0978 5.02 4.57 73.7 1.1020 4.93 4.47
18 y 73.5 1.0991 4.99 4.54 73.6 1.1027 4.92 4.46
19 y 73.4 1.1000 4.97 4.52 73.6 1.1031 4.91 4.45
20 y 73.3 1.1006 4.96 4.51 73.6 1.1035 4.90 4.44
1 C1 is calculated as (DL · DF)/(DL 2 DF), and C2 is calculated as DF/(DL 2 DF); DL and DF represent density of lean
tissue and density of fat, respectively. % Fat is calculated as [(C1/BD) – C2] · 100, where BD is measured whole-body
density.
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and a density of 1.0995–1.1013 kg/L. Our female values are
similar for hydration (73.5–73.7%) but slightly greater for density
(1.1034–1.1037 kg/L). The average value from 9 cadaver studies
was 73.7%, although the range was quite high (68.6–80.8%) (25),
whereas the study by Fuller et al (19), using the 4C model, re-
ported mean (6SD) values of 73.86 2.1% (19). Our adult values
for density are likewise very close to the value of 1.10 kg/L
assumed by Siri (3) and Brozek et al (26) and to the mean
(6SD) provided by 8 cadaver studies of 1.099 6 0.015 kg/L
(27). From their modeling, Wang et al (27) predicted ’0.002–
0.004 kg/L greater density in women compared with men, and
our empirical data show very similar differences of 0.004 kg/L at
age 18–19.99 y and 0.002 kg/L at age 20–22.99 y. Consequently,
our data imply that there should be slightly different versions of
Siri’s equation for adult men and women to calculate body
composition from whole-body density.
Although in the past decade many body-composition re-
searchers have selected DXA for pediatric research studies,
significant bias has been shown in this technique, which further
varies between instruments, and in relation to sex and nutritional
status (28–30). Limits of agreement are also wide in individuals.
In the present study, hydration and density have been calibrated
against the 4C model, thus removing any average biases at each
age. By using this calibration, we found that DXA showed
significant disagreement with hydrometry and densitometry as
2-component techniques in females but not males, which is similar
to our previous evaluation of DXA by using the 4C model (29).
However, our study further shows that nutritional status, as
indexed by BMI SDS or skinfold thickness, accounts for some of
the between-individual variability in lean tissue properties after
adjustment for age and sex. This finding is consistent with
previous studies by us (14) and others (12) and is partly explained
from a theoretical perspective by the fact that hydration of the
cellular component of adipose tissue is greater than that of lean
tissue (25). In males, this effect of BMI is negligible until late
adolescence, but in females it is significant during pubertal de-
velopment from ’10 y old, although it temporarily lessens at
’14 y. Failure to take this effect into account will therefore
introduce bias in the final body-composition values in relation to
nutritional status, whether hydrometry or densitometry is used.
A correction factor could be applied on the basis of our linear
regression of hydration or density against BMI SDS, and in the
absence of such correction errors of 2–4% fat could arise.
The increase in hydration in obese compared with nonobese
individuals averaged ’1% after adjustment for age and sex, but
in other studies reached ’2% in extreme obesity (14). This
greater increase in hydration has been attributed to expansion of
the extracellular water pool (31). The density of lean tissue is
likewise reduced by ’0.015 kg/L in obese individuals, as we
have found previously (32). When high levels of accuracy are
required, 2-component techniques are inherently limited be-
cause of their assumption of constant values for lean tissue
composition, and multicomponent models are preferred in obese
individuals, in whom variability in lean tissue properties is also
greater.
Nevertheless, we have previously shown that around half of the
variability in hydration and density of lean tissue in the normal
weight range can be attributed to methodologic imprecision (10).
This is likely to account for the limited success (r2 values ranging
from 0.28 to 0.53) with which factors such as age, sex, and BMI
SDS accounted for density and hydration variance in our re-
gression models. From a theoretical perspective, a narrow range
of hydration variability is predicted in healthy individuals of
a given age because of limited capacity for variability in cellular
and extracellular hydration and in the ratio of extracellular
solids to TBW (25). Because mineral and protein content are
closely related, the scenario for hydration is broadly applicable
to density.
Disease can generate marked shifts in the extra- to intracellular
ratio and change hydration and density to a greater extent. In
pediatric survivors of acute lymphoblastic leukemia, we detected
a 1.8% increase in hydration and a 0.007-kg/L reduced density
relative to healthy control children (33), some of which may be
attributed to the greater adiposity of the patients. In healthy
individuals, however, these tissue properties have a limited range
of biological variability, and among the range of body-composition
techniques, hydrometry and densitometry remain relatively ac-
curate and perform well when compared against the gold-standard
TABLE 5
Bland-Altman analysis of the agreement between dual-energy X-ray absorptiometry and hydrometry or densitometry as
2-component techniques
Sex Bias1
Limits of
agreement2 P3 r4 P5
Hydrometry
Lean mass Male 20.16 63.44 0.1 20.25 ,0.001
Female 21.05 63.28 ,0.001 20.51 ,0.001
% Fat Male 0.1 66.6 0.6 0.31 ,0.001
Female 1.3 63.3 ,0.001 0.41 ,0.001
Densitometry
Lean mass Male 20.10 62.68 0.2 20.33 ,0.001
Female 21.08 63.11 ,0.001 20.51 ,0.001
% Fat Male 20.1 66.3 0.7 20.02 0.9
Female 1.6 66.1 ,0.001 0.08 0.1
1 Calculated as dual-energy X-ray absorptiometry value minus hydrometry or densitometry value.
2 Calculated as twice the SD of the bias.
3 Refers to significance of bias.
4 Correlation between bias and magnitude of lean mass or % fat.
5 Refers to significance of r.
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4C model (10, 34, 35). Furthermore, if the SD of hydration and
density in patients is similar to that in healthy children, as we
found in our study of leukemia survivors (33), a simple correction
factor might be used in subsequent evaluation of such patients on
the basis of 2-component methodologies.
Due to practical factors, we were not able to extend our study
to children aged ,4 y. Body density is rarely measured in young
children, but there are negligible difficulties in applying hy-
drometry across the entire human age range. Butte et al (13)
recently published reference values for hydration in the first 2 y
of life, although their multicomponent model calculations did
not match exactly with our own due to the difficulty of mea-
suring body density in very young age groups. The link between
the 2 data sets is not very smooth in females, but it remains
unclear if this is an effect of small sample size or methodologic
issues.
A further limitation is that we had limited capacity to in-
vestigate possible ethnic variability in lean tissue properties. Over
90% of our sample was white, and our nonwhite individuals were
distributed across a range of ethnic categorizations. Others have
previously reported differences in lean tissue hydration between
ethnic groups in adults (35), although the evidence for density is
inconsistent (35–38), but findings in children have generally been
negative (7, 12). Modeling suggests that some ethnic differences
in density may be too small for empirical detection (27), and our
sample was able to detect only a small difference in the density of
lean tissue in black females. This issue therefore requires further
investigation; however, the differences identified in adult studies
were relatively small, and neither hydrometry nor densitometry
are likely to be seriously compromised in accuracy by failing to
take ethnicity into account, unless relatively small differences
between ethnic groups are themselves the focus of study.
In conclusion, our study provides the first empirical reference
data on lean tissue properties for childhood and adolescence and
should improve the accuracy of hydrometry and densitometry in
relatively healthy members of the pediatric population. Nutri-
tional status accounts for variability in these properties over the
normal range of BMI, but the error resulting from this source is of
moderate magnitude until individuals are relatively obese. Two-
component techniques may be less appropriate in individuals
with obesity or more severe disease states, in whom multi-
component models remain the preferred approach for molecular
data on body composition.
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Body composition assessed by the 4-component model and
association with lung function in 6–12-y-old children with
cystic fibrosis1–3
Jane E Williams, Jonathan CK Wells, Christian Benden, Adam Jaffe, Ranjan Suri, Catherine M Wilson, and Mary S Fewtrell
ABSTRACT
Background: Malnutrition is an indicator of a poor prognosis in
patients with cystic fibrosis (CF). Previous body-composition (BC)
studies in children with CF used 2-component models (2CMs) to
assess fat mass (FM) and fat-free mass (FFM), but to our knowledge
no study has used the gold-standard 4-component model (4CM),
which allows for a more accurate evaluation of the nature of both
elements.
Objective: We measured BC by using the 4CM in 6–12-y-old chil-
dren with CF to 1) compare findings with those of healthy, matched
control children and reference data; 2) relate BC to lung spirometry
[forced expired volume in 1 s (FEV1)]; and 3) compare findings
with those from more commonly used 2CM techniques.
Design: One hundred clinically stable children with CF (57% girls)
aged 6–12 y were measured by using the 4CM. Children with CF
underwent spirometry (FEV1).
Results: Girls with CF had significantly less FM than did healthy
girls, even after adjustment for height and pubertal status; boys with
CF had higher body mass index SD scores than did healthy boys. FM
in girls was positively associated with the FEV1 percentage predicted.
The 2CM FM was significantly different from the 4CM FM, with
differences dependent on sex and condition, although most techni-
ques identified a relation between FM and FEV1 in girls.
Conclusions: Although shorter than healthy children, boys with CF
were heavier and had a BC within the normal range; however, girls
with CF had lower FM than did healthy girls, and this was associ-
ated with poorer lung function. Given the worse prognosis in girls,
this finding merits more attention. The reliability of 2CM techniques
varied with sex and health status. Am J Clin Nutr 2010;92:1332–
43.
INTRODUCTION
Cystic fibrosis (CF) is a lethal, autosomal, recessive genetic
disorder that is most common in white individuals. Historically, it
has been considered that children with CF do not grow normally
because of a negative energy balance caused by the detrimental
effects of the difficulty in breathing, chronic infection and in-
flammation, decreased absorption, and increased nutritional loss
(1). When growth has been suboptimal, there is a negative effect
on physical activity, appetite, and lung function (2). However,
recent research suggests that growth in children with CF has
improved (3, 4). It is also apparent that with improvements in
treatment, life expectancy has increased considerably, and
complications such as osteoporosis have become apparent in
young adults. Consequently, there is an increased focus on
longer-term health as well as short-term health and survival.
Typically, the growth of children with CF is monitored by
using height, weight, and body mass index (BMI) measurements,
but these techniques do not give any indication of the nature of
body composition. The investigation of body composition is
beneficial because it aids understanding of the disease process,
allows for assessment of the effectiveness of medical and nu-
tritional interventions, and may identify those children most at
risk of deterioration. Many previous studies used techniques with
inherent problems related to poor precision or assumptions about
the nature of the fat-free mass (FFM) (5) or inadequate sample
size. In addition, techniques suitable for healthy children are
predicted to be biased when applied to patients (6, 7). The gold-
standard 4-component model (4CM) of body composition, which
was used in this study, allows for a more accurate quantification
of fat mass (FM) and assessment of the nature of FFM (water,
protein, and mineral) because actual measurements of compo-
nents of body composition are made. In patients with CF, it is
important to establish whether specific components of body
composition are independent predictors of clinical outcomes
because this would have implications for treatment regimens.
To our knowledge, no previous study of body composition in
childrenwithCFhas adopted the 4CM.The aimsof this studywere
to 1) compare young childrenwithCF to their healthy counterparts
by using the 4CM, 2) examine associations between body com-
position and lung function in childrenwith CF, and 3) compare the
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findings from the gold-standard 4CM to those from commonly
used 2-component model (2CM) techniques.
SUBJECTS AND METHODS
Subjects
Recruitment started in October 2002 for children with CF aged
6–12 y under the care of Great Ormond Street Hospital for
Children (London, United Kingdom) who were clinically stable
and emotionally able to undergo measurements. The children
with CF were diagnosed on the basis of confirmatory genetics or
a positive sweat test with sodium and chloride concentrations .
60 mmol/L. Healthy children for matched-pair and cross-
sectional reference comparison were recruited for another study
of body composition at the Institute of Child Health (London,
United Kingdom) that started in February 2002. Measurements
were conducted over a 90-min visit to the study center at Great
Ormond Street Hospital for Children after consumption of
a light meal. Ethical permission was obtained from the ethical
committee of the Institute of Child Health. Written consent was
obtained from parents and written assent from children aged
11 y; verbal assent was obtained from children aged ,11 y.
Dual-energy X-ray absorptiometry
Bone mineral content (BMC), bone mineral density (BMD),
and bone area (BA) were measured with a Lunar Prodigy whole-
body scanner (GEMedical Systems, Slough, United Kingdom) in
conjunction with software v.12.1 (2008, Lunar Prodigy; GE
Medical Systems). All scans were performed with the subject
wearing light indoor clothing and with no removable metal
objects present. The typical scan time was 5 min depending on
height. The radiation exposure per whole-body scan was esti-
mated to be 2 lSv, lower than the daily background level. All
scans were performed by one operator (CMW). The precision of
bone density, which was established by repeated measurements
of phantoms on 6 successive days, was ,2%. The precision of
soft tissue analysis for a Lunar DPX-L instrument (regarded by
the manufacturer, GE Medical Systems, as similar to our own
model) established by repeated measurements of humans on 4
successive days was reported as 1% for FFM and 2% for FM (8).
Body volume
Body volume (BV) was measured by using air-displacement
plethysmography (ADP) (Bodpod Instrumentation; Life Mea-
surement Instruments, Concord, CA) according to the manu-
facturer’s instructions as previously described (9). Measurements
were made while the subject wore a close-fitting swimming
costume and hat. The raw-volume values that appeared tran-
siently on the screen were recorded, and to improve precision, the
procedure was repeated until 2 mean values for raw density of
within 0.007 kg/L were obtained (10). Where it was not possible
to achieve 2 such measurements because of breathing irregu-
larities in 3 of the CF children, the mean of all raw volume values
was used after values 6 2 SDs were discarded (achieved over 4
separate tests of a minimum of 8 and maximum of 12 volumes).
An adjustment of the mean raw volume was then made by using
the predicted lung volume (11, 12) and surface area (13) to
obtain the actual BV. All measurements were made by one of 2
operators (JEW and CMW).
Anthropometric measures
Body weight was measured as an integral stage of the Bodpod
Instrumentation procedure (Life Measurement Instruments) to
0.01 kg with the child dressed in a swimsuit. Accuracy was
confirmed by the use of 2 solid weights of known mass.
Standing height was measured to 0.1 cm with a wall-mounted
digital display stadiometer (Holtain, Dyfed, United Kingdom).
BMI was calculated as weight in kilograms divided by the square
of height in meters. Weight, height, and BMI were converted to
SD scores (SDSs) by using UK 1990 reference data (14, 15).
Waist, hip, and midupper arm circumference were measured with
a fiberglass tape, and bicep, tricep, and subscapular and suprailiac
skinfold-thickness measurements were taken in triplicate to the
nearest 0.2 mm and averaged. Measurements were taken on the
left sides of subjects according to the method of Lohman et al (16)
with a Holtain skinfold-thickness caliper.
Deuterium dilution
Total body water (TBW) was assessed by 2H-labeled water
dilution by using a dose equivalent to 0.05 g 2H2O/kg body
weight (99.9 atom percentage excess). Doses were diluted with
water to ’100 mL. Saliva samples were taken predose and 4 h
postdose with absorbent cotton swabs (Sarstedt, Rommelsdorf,
Germany) 30 min after the last ingestion of food or drink.
Deuterium samples were analyzed by Iso-Analytic Ltd (Sand-
bach, United Kingdom) by using the equilibration method of
Scrimgeour et al (17). Briefly, 0.3 mL liquid, along with a vial of
5% platinum on alumina powder (Sigma-Aldrich, Poole, United
Kingdom), was placed in a septum sealed container (Labco,
High Wycombe, United Kingdom) and flushed for 2 min with
hydrogen. Low-enrichment and high-enrichment standard wa-
ters were similarly prepared to normalize data against Standard
Mean Ocean Water-Standard Light Antarctic Precipitation
standards. Samples equilibrated at room temperature for 3 d
before analysis. The head spaces in the containers were analyzed
for deuterium enrichment on a continuous flow-isotope ratio
mass spectrometer (Geo20-20; Europa Scientific, Crewe, United
Kingdom). The accuracy of analyses was checked by measuring
an intermediate water standard within each batch of samples. All
samples were prepared and analyzed in duplicate. The mean SD
of deuterium analyses by the equilibration technique in the
laboratory was ,2.5%. The 2H-dilution space was assumed to
overestimate TBW by a factor of 1.044 (18), and correction was
made for fluid intake during the equilibrium period to derive
actual body water.
2CMs
2CMs of body composition, which distinguished FM and
FFM, were calculated as follows.
Anthropometric measures
Percentage body fat was estimated from skinfold-thickness
measurements by using the age- and sex-specific equations of
Slaughter et al (19) (tricep and subscapular) and Deurenberg et al
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(20) (tricep, bicep, subscapular, and suprailiac). FM was cal-
culated as
ðPercentage fat3weightÞ=100 ð1Þ
Hydrometry
TBW was used to calculate FFM, with assumption for an age-
and sex-specific hydration factor of FFM, (HFFFM) according to
published values of Lohman (21).
FFM ¼ TBWHFFFM ð2Þ
FM was calculated as
FM ¼ weight2 FFM ð3Þ
and
Percentage fat ¼ FM=weight3 100 ð4Þ
Dual-energy X-ray absorptiometry
FM and lean-mass (LM) values were obtained from a whole-
body dual-energy X-ray absorptiometry (DXA) scan as de-
scribed, and FFM was calculated as
LMþ BMC ð5Þ
Densitometry
Whole-body density was calculated from BV (which was
adjusted for residual lung volume and surface-area artifact) and
weight by using ADP (Bodpod Instrumentation; Life Measure-
ment Instruments).
Body density ¼ weight=BV ð6Þ
Percentage fat ¼ ð527=body densityÞ2 485 ð22Þ ð7Þ
and
FM ¼ ðpercentage fat3weightÞ=100 ð8Þ
4CM
The 4CM uses values of BMC, body weight, BV, and TBW to
derive values for mineral, water, fat, and protein as described
previously (22, 23). Assumed densities of the 4 components were
accounted for when calculating FM from the measurements
FM ðin kgÞ ¼ ½ð2:7473BVÞ2 0:7103TBWÞ
þ ½ð1:4603BMCÞ2 ð2:0503 body weightÞ
ð9Þ
and FFM was calculated as the difference between weight and
FM.
Pubertal status
Pubertal stage was self-assessed with line drawings that
showed the different Tanner stages for breast or genital devel-
opment (24). For the purposes of analyses, prepubertal (stage 1)
was considered distinct from pubertal (stages 2–5).
Physical activity
Physical activity levels were assessed by asking the parent to
give a rating of the child’s activity as follows: 1) much less than
peers, 2) less than peers, 3) same as peers, 4) more than peers,
and 5) much more than peers. Because of small numbers, the
lower 2 and upper 2 categories were combined and resulted in
the following 3 groups: less than, same as, and more than peers.
Lung function
Laboratory spirometry [forced expired volume in 1 s (FEV1)]
was measured according to laboratory protocols on the basis of
American Thoracic Society and European Respiratory Society
standards for spirometry (25) adapted for children (26). Values
for analyses were calculated as the FEV1 percentage predicted
compared with a large reference population (27). Children with
FEV1 ,45% were classified as having severe impairment,
children with FEV1 45 and ,65% were classified as having
moderate impairment, children with FEV1 65% and ,85%
were classified as having mild impairment, and children with
FEV1 85% were classified as having normal lung function.
Statistical analyses
Size adjustment and SDS calculation
Characteristics of all children were compared with 1990 UK
reference data to generate SDSs forweight, height, BMI, andwaist
circumference. A method analogous to that of BMI (weight di-
vided by the square of height) was applied to absolute values of
FM, FFM, protein mass (PM) and mineral mass (MM) to remove
the effect of size; the FM index (FMI; FM divided by the square of
height), FFM index (FFMI; FFM divided by the square of height),
PM index (PMI; PM divided by the square of height), and MM
index (MMI;MMdividedby the square of height). Thesevariables
were compared with measurements performed in a contemporary
reference population of 533 healthy subjects aged 4–23 y (JCK
Wells, JE Williams, and MS Fewtrell, unpublished data, 2002–
2007) to produce SDSs. Total and lumbar spine (LS) BMD SDSs
weregenerated from theLunarProdigy software (2008, v.12.1;GE
Medical Systems) by using machine reference data matched for
age, sex, and ethnic group. BMD is a 2-dimensionalmeasurement,
which does not take into account bone size. Small children may
have low BMC or BMD because they have small bones or less
mineral than expected for the size of bone (28). To adjust for
size, the bone mineral apparent density (BMAD), which is a 3-
dimensional “volumetric”measurement,was calculated for theLS
from the BMC and BA as follows (29):
BMAD ¼ BMC=BA1:5 10
and size-adjusted SDSs were calculated by using reference data
collected for the GE Lunar Prodigy (30).
1334 WILLIAMS ET AL
 at University College London on Novem
ber 24, 2010
w
w
w
.ajcn.org
D
ow
nloaded from
 
Comparison of body-composition variables
With the use of a one-sample t test, comparisons were made
between 1) all children and the 1990 UK reference population
for anthropometric SDSs, 2) all children and the contemporary
reference population for body-composition variables SDSs and
by using paired sample t tests (3), and pair-matched children
with CF and healthy children for all anthropometric measures
and body-composition variables. Initial analyses indicated
a strong significant difference between the sexes, and therefore,
they were analyzed separately. General linear models were used
to examine differences between children with CF and healthy
control children by taking into account factors that predicted
body-composition variables with matched pair, group and
puberty as fixed factors and age and height (for nonindexed
variables) as continuous variables. Because total MM is pre-
dominantly bone mineral, MM was also adjusted for bone area
to account for the effect of bone size.
Lung spirometry
Simple regression analyses were used to investigate the re-
lation between body-composition variables and lung spirometry
(FEV1 percentage predicted) in children with CF. Height was
included in the model.
Comparison of 2CMs and 4CM
The method of Bland and Altman (31) was used to assess the
agreement between the values for FM by 4 2CMs and the
criterion 4CM. The mean difference between techniques (bias;
2CM 2 4CM) and the 62 SDs of the difference between
techniques (limits of agreement) were calculated. The bias was
tested for significance from zero by using a paired t test. To
express the bias as a percentage of the mean, the bias of the
individual natural log value · 100 was calculated (32). The ex-
tent to which the magnitude of the bias was related to the
magnitude of the variable was calculated as the correlation be-
tween the difference and the mean of the measured values. All
analyses were performed with the Statistical Package for Social
Sciences 18.0 software (SPSS Inc, Chicago, IL), and P , 0.05
was considered significant.
RESULTS
Subjects
One hundred of 116 eligible children with CF were recruited,
and complete 4CMmeasurements were obtained in 90 children [4
children (3 girls) refused to enter the Bodpod air-displacement
plethysmography instrumentation (Life Measurement Instru-
ments), and 6 postdose isotope dilution samples had inadequate
volumes for analysis (4 girls)]. However, a body-water calcu-
lation was implausible for 5 children (3 girls); therefore, pair
matching with healthy age-, sex-, and ethnicity-matched control
children was made for 85 CF children [boys: 37 (44%); girls: 48
(56%)]. Characteristics of the children are shown in Table 1. The
self-assessed pubertal status for the 170 children was pre-
pubertal for boys [boys with CF: 34 (92%); control boys: 31
(71%)] and girls [girls with CF: 34 (71%); control girls: 29
(60%)]. All subjects with CF, except one girl, were pancreatic
insufficient and had a wide range of pulmonary disease with
TABLE 1
Characteristics of cystic fibrosis (CF) and control children in case-control analyses (n = 85)1
CF boys (n = 37) CF girls (n = 48) Control boys (n = 37) Control girls (n = 48)
Age (y) 9.28 6 0.922 9.55 6 1.62 9.28 6 1.08 9.57 6 1.78
Weight (kg) 30.2 6 6.64 30.0c 6 7.19 30.1 6 6.38 34.6 6 9.36
Height (m) 1.31 6 0.08 1.32c 6 0.11 1.35 6 0.09 1.37 6 0.11
BMI (kg/m2) 17.3b 6 2.23 16.4c 6 1.99 16.4 6 1.79 18.1 6 2.84
Weight SDS 20.01 6 1.05 20.56cf 6 1.04 0.02 6 0.76 0.42e 6 0.98
Height SDS 20.54d 6 1.04 20.59cf 6 1.12 0.06 6 0.86 0.22 6 0.87
BMI SDS 0.43be 6 0.97 20.33cd 6 0.95 20.03 6 0.85 0.39d 6 1.10
Waist (cm) 63.5a 6 6.25 60.2 6 5.5 58.9 6 4.18 62.2 6 7.67
Waist SDS 1.16af 6 20.79 0.69f 6 0.78 0.40e 6 0.63 0.94f 6 1.05
Hip (cm) 68.4 6 6.37 68.2c 6 7.06 69.2 6 6.39 74.6 6 8.63
MUAC (cm) 19.9 6 2.53 19.7c 6 2.59 20.1 6 2.80 22.2 6 3.31
Sum of 4 skinfold thicknesses 34.7 6 19.8 37.1b 6 14.6 56.6 6 165.5 48.4 6 21.1
FEV1 percentage predicted 91.3 6 20.9 77.6 6 18.4 — —
FVC percentage predicted 99.4 6 18.3 83.5 6 15.9 — —
Prepubertal (%)3 92 71 84 60
Pancreatic insufficient (n) 37 47 — —
Liver disease (cases) 1 1 — —
Diabetes (cases) 0 1 — —
Ps aerug (cases) 10 11 — —
Staph aureus (cases) 7 8 — —
1 SDS, SD score compared with UK reference data 1990 (14, 15); MUAC, midupper arm circumference; Sum of 4 skinfold thicknesses, bicep + tricep +
subscapular + suprailiac (n = 79); FEV1 percentage predicted, forced expired volume in 1 s percentage of the expected (27); FVC percentage predicted, forced
vital capacity percentage of the expected (27); Pancreatic insufficient, reduced pancreatic function that required the oral addition of pancreatic enzymes; Ps
aerug, chronic Pseudomonas aeruginosa infection of the lungs; Staph aureus, chronic Staphylococcus aureus infection of the lungs. a,b,cComparisons of CF
boys and control boys or CF girls and control girls (paired t test): aP , 0.05, bP , 0.01, cP , 0.001; d,e,fCF and control children compared with UK 1990
reference data (14, 15) (one-sample t test): dP , 0.05, eP , 0.01, fP , 0.001.
2 Mean 6 SD (all such values).
3 Prepuberty was based on Tanner staging 1 (prepubertal) to stages 2–5 (pubertal).
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a median FEV1 of the predicted value of 85.1% with values
between 32% and 131%; 8 (7 girls) subjects with CF, had
a gastrostomy in situ, 2 (1 girl) subjects with CF had liver dis-
ease, and 1 girl with CF was diabetic. The genotype was ho-
mozygous DF508 for 59 children and heterozygous DF508 for
19 children. Five children had a non-DF508 genotype, and 2
children were of unknown genotype. Sixteen eligible children
with CF (9 girls) who were not recruited and 15 children (10
girls) who were measured and not included in the analyses were
not significantly different with respect to height SDSs, weight
SDSs, and BMI SDSs.
Anthropometric measures
Compared with UK reference data
Characteristics of the children are shown in Table 1. The
healthy children were representative of the 1990 UK reference
data apart from the girls being significantly heavier (P , 0.01)
and both boys and girls having greater waist circumferences
(P , 0.01). Boys with CF were significantly shorter (P , 0.05)
but had a higher BMI SDSs (P , 0.01) and waist circum-
ferences (P , 0.01), and girls with CF were lighter (P , 0.001)
and shorter (P , 0.001) and had lower BMI SDSs (P , 0.05)
and greater waist circumferences (P , 0.01) than the 1990 UK
reference data.
Compared with pair-matched children
Comparisons between children with CF and healthy pair-
matched control children indicated that boys with CF were not
significantly different apart from higher BMI SDSs (P , 0.01)
and waist circumference SDSs (P , 0.05). The range of BMI
SDSs was 21.5 to 2.4 for boys with CF and 21.9 to 2.0 for
control boys. Girls with CF were significantly shorter (P, 0.01)
and lighter (P , 0.01), with lower anthropometric values for all
measures apart from waist circumference (non-significant), than
pair-matched control girls.
Body composition
Comparisons by reference populations and case-control sub-
jects are shown in Table 2 with a summary in Table 3.
Compared with reference data
Comparisons of CF children with a reference population
(Lunar Prodigy reference data for bone and unpublished refer-
ence data for body composition) indicated higher total BMD
SDSs (P , 0.001) and FFMI SDSs (P , 0.01) in boys with CF
and lower LS BMD SDSs (P , 0.001), BMAD SDSs (size
adjusted; P , 0.01), FMI SDSs (P , 0.001), FFMI SDSs (P ,
0.05), and MMI SDSs (P , 0.001) in girls.
Compared with pair-matched children
Boys with CF had significantly higher total BMD SDSs (P ,
0.05) and FFMI SDSs (P , 0.01) than did case-control boys.
Girls with CF had less total BMD SDSs (P , 0.05) and LS
BMD SDSs (P, 0.001) and significantly lower FMI SDSs (P,
0.001) and MMI SDSs (P , 0.001) than did case-control girls.
TABLE 2
Body composition of cystic fibrosis (CF) and control children used in case-matched analyses (n = 85 pairs)1
CF boys (n = 37) CF girls (n = 48) Control boys (n = 37) Control girls (n = 48)
Body volume (L) 28.3 6 6.49 27.8c 6 7.09 27.5 6 6.51 33.6 6 9.41
Total body water (L) 18.0 6 3.12 17.1c 6 3.72 17.9 6 3.71 18.9 6 4.31
Total BMC (kg) 1.05 6 0.21 1.01c 6 0.24 1.07 6 0.24 1.20 6 0.33
Total BMD (g/cm2) 0.90a 6 0.06 20.87b 6 0.05 0.88 6 0.05 0.90 6 0.07
Total BMD SDS 0.58a,f 6 0.66 20.11a 6 0.74 0.23 6 0.05 0.23 6 0.62
LS BMD (g/cm2) 0.73 6 0.08 0.73a 6 0.10 0.71 6 0.08 0.78 6 0.11
LS BMD SDS 20.03 6 0.74 20.49f 6 1.12 20.19 6 0.75 20.05 60.93
LS BMAD SDS 0.18 6 0.96 20.40e 6 1.19 20.12d 6 0.85 20.20 6 1.06
4-Component model
FM (kg) 5.95 6 3.66 6.41c 6 2.93 5.31 6 2.80 9.46 6 4.71
FMI SDS 0.02 6 1.10 20.76c,f 6 0.89 20.22 6 0.97 0.02 6 0.95
Fat (%) 19.0 6 7.84 20.6c 6 5.47 17.8 6 6.14 26.1 6 7.46
FFM (kg) 23.5 6 3.60 22.7c 6 4.98 23.5 6 5.09 25.1 6 5.60
FFMI SDS 0.56b,e 6 0.97 20.39d 6 1.07 20.14 6 1.04 20.08 6 0.94
FFM hydration (%) 75.9 6 2.07 74.9 6 1.97 76.0 6 1.49 75.1 61.54
FFM density (kg/L) 1.087 6 0.007 1.090 60.007 1.087 6 0.005 1.091 6 0.005
Protein (kg) 4.31 6 0.65 4.45 6 1.06 4.30 6 1.18 4.72 6 0.99
PMI SDS 0.36 6 1.36 0.08 6 1.03 20.16 6 1.11 20.05 6 0.97
Mineral (kg) 1.34 6 0.28 1.28c 6 0.28 1.36 6 0.30 1.52 6 0.41
MMI SDS 0.07 6 0.84 20.84c,f 6 1.10 20.23 6 0.87 20.04 6 0.92
Protein:mineral (kg/kg) 3.27 6 0.54 3.51c 6 0.53 3.16 6 0.39 3.16 6 0.41
1 All values are means 6 SDs. BMC, bone mineral content; BMD, bone mineral density; LS BMD, lumbar spine BMD; LS BMAD, LS (L2–L4) bone
mineral apparent density, which is a 3-dimensional “volumetric” measurement that is calculated from the 2-dimensional BMD measured by dual-energy X-ray
absorptiometry [reference data used to calculate LS BMAD SDSs (30)]; SDS, SD score [calculated from 533 contemporary healthy children (JCK Wells, JE
Williams, and MS Fewtrell, unpublished data, 2002–2007)]; FM, fat mass; FMI, FM index (FM divided by the square of height); FFM, fat-free mass; FFMI,
FFM index (FFM divided by the square of height); PMI, protein mass index (protein mass divided by the square of height); MMI, mineral mass index (mineral
mass divided by the square of height). a,b,cComparisons of CF boys and control boys or CF girls and control girls (paired t test): aP , 0.05, bP , 0.01, cP ,
0.001; d,e,fCF and control children compared with reference data (one-sample t test): dP , 0.05, eP , 0.01, fP , 0.001.
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Protein-to-mineral ratio
In the absence of any expectation that total PM would be
abnormal in children with CF, the protein-to-mineral ratio is an
indication of the mineralization of lean tissue. The protein-to-
mineral ratio is presented in Table 2 with a significantly higher
value in girls with CF (P, 0.01) than in healthy girls. However,
this figure did not reveal whether this result was due to high or
low protein or mineral. Comparisons of PMI SDSs indicated no
significant difference (mean 6 SD) (boys with CF: 0.36 6 1.36,
control boys: 20.16 6 1.11; girls with CF: 0.086 1.03, control
girls: 20.05 6 0.97). However, there was a difference in sexes
when MMI SDSs were compared (boys with CF: 0.07 6 0.84,
control boys: 20.23 6 0.87, P = 0.09; girls with CF: 20.846
1.10, control girls: 20.046 0.92, P = 0.001). As shown in
Figures 1 (boys) and 2 (girls) for control children, PMI SDSs
and MMI SDSs were positively correlated (boys: r = 0.39, P =
0.018; girls: r = 0.39, P = 0.006) as expected. However, there
was no such correlation in children with CF (boys: r = 0.17, P =
0.325; girls: r = 0.08, P = 0.596), and the girls in particular were
undermineralized for any given protein values.
Potential confounders that affected body-composition
outcomes
Adjusted mean differences in body composition (CF children2
control children) before and after adjustment for height and
puberty are shown in Tables 4 (boys) and 5 (girls). Boys with
CF had a greater weight (P, 0.1) and waist circumference (P,
0.001) than did control boys. Girls with CF had lower weight
(P , 0.05), FM (P , 0.01), and hip and midupper arm cir-
cumferenc (P , 0.01) than did control girls. An analysis of only
prepubertal girls (n = 24 pairs) confirmed the deficit in FM.
Additional adjustment of MM for bone area (to adjust for bone
size in addition to length) did not affect the outcome in either
sex. To determine whether differences in body composition were
due to different levels of activity, the parent’s rating of the
child’s activity level was added to the model with no effect on
the outcome (data not shown).
Relation between body composition and lung function
The mean (6SD) FEV1 percentage predicted for 83 patients
(one boy and one girl did not perform spirometry) was 91.3 6
20.9% for boys and 77.6 6 18.4% for girls (P , 0.01). A re-
gression analysis of factors associated with the FEV1 percentage
predicted is presented in Table 6. Most indexes of whole-body
fat but not subcutaneous fat were significantly positively asso-
ciated with lung function in girls only (P , 0.05). A similar
model with either FEV1 or FEV1 SDSs indicated a similar
pattern. A plot of the FEV1 percentage predicted and FMI SDSs
for girls is shown in Figure 3 and indicated a positive relation
(r = 0.40, P = 0.005); however, 4 girls had a high FEV1 per-
centage predicted with low FMI SDSs.
TABLE 3
Summary of comparisons (before adjustment for age, height, and puberty)1
Boys with CF
compared with
Girls with CF
compared with
SDS
Pair
match
Reference
population
Pair
match
Reference
population
Weight NS NS Y Y
Height NS Y Y Y
BMI [ [ Y Y
Waist [ [ NS [
FMI NS NS Y Y
FFMI [ [ NS Y
PMI NS NS NS NS
MMI NS NS Y Y
1 CF, cystic fibrosis; SDS, SD score; FMI, fat mass index (fat mass divided
by the square of height); FFMI, fat-free mass index (FFM divided by the square
of height); PMI, protein mass index (protein mass divided by the square of
height); MMI, mineral mass index (mineral mass divided by the square of
height); [, denotes that the CF group had significantly higher scores than did
the comparison group; Y, denotes that the CF group had significantly lower
scores than did the comparison group. Paired t test with pair matches and one-
sample t test for reference data were used. Reference data were from UK 1990
(14, 15) data for weight, height, BMI, and waist; reference data for body-com-
position variables were from 533 children measured by the 4-component model
(JCK Wells, JE Williams, and MS Fewtrell, unpublished data, 2002–2007).
FIGURE 1. Relation between protein mass index (PMI) SD scores (SDS)
and mineral mass index (MMI) SDS in boys. PMI (protein mass divided by the
square of height) and MMI (mineral mass divided by the square of height)
were assessed by the 4-component model of body composition in 37 boys with
cystic fibrosis and 37 healthy control boys. Correlations: for cystic fibrosis
boys, r = 0.166 and P = 0.325; for control boys, r = 0.386 and P = 0.018.
FIGURE 2. Relation between protein mass index (PMI) SD scores (SDS)
and mineral mass index (MMI) SDS in girls. PMI (protein mass divided by the
square of height) and MMI (mineral mass divided by the square of height)
were assessed by the 4-component model of body composition in 48 girls with
cystic fibrosis and 48 healthy control girls. Correlations: for cystic fibrosis
girls, r = 0.079 and P = 0.596; for control girls, r = 0.391 and P = 0.006.
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Comparison between 2CMs and 4CM
A bias (2CM FM 2 4CM FM) was calculated for the 4
methods described (Table 7). The mean FM from skinfold-
thickness measurements was significantly underestimated by
between 3% and 21% depending on sex and whether the chil-
dren had CF or were healthy. Hydrometry was significantly
overestimated by 8–13% in girls only (P , 0.001). Values from
densitometry underestimated FM in girls, although this was only
significant in control girls (8%, P, 0.001), and DXA estimation
of FM was underestimated in control boys by 7% and over-
estimated in girls with CF by 3% (P , 0.05). Correlation
analyses indicated a significant relation between the magnitude
of the bias and the magnitude of FM when using skinfold-
thickness measurements for all control children and girls with
CF and when using DXA in control girls.
DISCUSSION
In this study we 1) compared the body composition of chil-
dren with CF to healthy children by using case-control and
reference populations 2), investigated associations between body
composition and lung function in children with CF, and 3)
compared outcomes obtained by using the gold-standard 4CM to
those from more commonly used 2CM techniques for assessing
body composition.
Body composition
Suboptimal growth in patients with CF affects morbidity and
mortality with stunting (33) and wasting (34) as independent
predictors of survival. Deficits in body composition are most
severe in older patients with reduced bone, LM, and FM (35, 36).
Even with normal BMI, FFM and BMD depletion has been noted
in adults (37, 38) and children and adolescents (39) with CF. Low
weight for height in adults with CF occurs particularly in women
(40), who also die at a younger age than men (41). A previous
study showed that the greatest decline in nutritional status occurs
after the onset of puberty, particularly in girls (42), although other
studies suggest that deterioration in growth and nutritional status
occurs throughout childhood (4, 43, 44). There is a paucity of
body-composition studies in children with CF, and comparison is
difficult because of different methodologies used, sexual di-
morphism, age ranges, and whether appropriate size adjustments
have been applied. However, several recent studies that used
DXA noted a reduction of FM and/or FFM (4, 45, 46), and
Stettler (47) noted a reduction in both FFM by hydrometry and
FM by total-body electrical conductivity in boys only, whereas
Ahmed et al (48), who used skinfold-thickness measurements,
suggested that although both sexes have reduced FM, a reduction
of FFM occurs in older boys. To our knowledge, no previous
study has used a gold-standard technique to assess body com-
position in children with CF.
Our study identified clear sex differences in body composition
in young patients, which indicated that abnormalities in female
patients may be established much earlier than previously con-
sidered (42). Although boys with CF had body composition
similar to healthy control subjects, girls had a deficit of FM. It is
possible that the method we used to categorize pubertal de-
velopment may not have been sensitive to early hormonal
changes; however, the deficit was seen in prepubertal girls. In
TABLE 4
Differences in size and whole-body composition between boys with cystic fibrosis and control boys (n = 37 matched pairs)1
Adjusted for age Adjusted for age and height
Adjusted for age,
height, and puberty
Mean 6 SEM P Mean 6 SEM P Mean 6 SEM P
Weight (kg) 0.7 6 1.1 NS 2.0 6 0.7 ,0.01 2.1 6 0.8 ,0.01
Height (m)2 20.02 6 0.01 NS 20.01 6 0.01 NS
BMI (kg/m2)2 1.0 6 0.4 ,0.05 1.1 6 0.4 ,0.01
TBW (L) 0.1 6 0.5 NS 0.7 6 0.3 ,0.05 0.7 6 0.3 ,0.05
BV (L) 0.7 6 1.1 NS 2.1 6 0.8 ,0.05 2.1 6 0.8 ,0.05
FM (kg) 0.7 6 0.8 NS 1.3 6 0.7 NS 1.3 6 0.7 NS
FFM (kg) 20.1 6 0.6 NS 0.7 6 0.4 NS 0.7 6 0.4 NS
FFM (kg)3 20.05 6 0.61 NS 0.71 6 0.43 NS 0.72 6 0.44 NS
FFM hydration (%) 20.01 6 0.5 NS 20.02 6 0.5 NS 20.04 6 0.5 NS
FFM density (kg/L) 0.000 6 0.000 NS 0.000 6 0.000 NS 0.000 6 0.000 NS
PM (kg) 20.04 6 0.2 NS 0.1 6 0.2 NS 0.0 6 0.2 NS
MM (kg) 20.02 6 0.04 NS 0.03 6 0.02 NS 0.03 6 0.02 NS
MM (kg)3 20.02 6 0.04 NS 0.03 6 0.02 NS 0.03 6 0.02 NS
LS BMAD SDS 0.3 6 0.2 NS 0.2 6 0.2 NS 0.2 6 0.2 NS
Waist circumference (cm) 4.9 6 1.0 ,0.001 5.8 6 0.9 ,0.001 5.8 6 0.9 ,0.001
Hip circumference (cm) 20.2 6 1.2 NS 1.2 6 0.9 NS 1.2 6 0.9 NS
MUAC (cm) 20.1 6 0.5 NS 0.3 6 0.5 NS 0.3 6 0.5 NS
Log4 skinfold thickness 0.04 6 0.1 NS 0.1 6 0.1 NS 0.1 6 0.1 NS
1 TBW, total body water; BV, body volume; FM, fat mass; FFM, fat-free mass; PM, protein mass; MM, mineral mass; LS BMAD SDS, lumbar spine
bone mineral apparent density (size-adjusted bone mineral density) SD score; MUAC, midupper arm circumference; Log4 skinfold thickness, bicep + tricep +
subscapular + suprailiac (n = 36 pairs). General linear model adjusted for group, matched pairs, and puberty as fixed factors and age and height as continuous
variables.
2 Adjusted for age and puberty only.
3 Additionally adjusted for lumbar spine bone area.
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accordance with previous research, children with CF in this study
were shorter than healthy children, but surprisingly, boys had
higher BMI SDSs than did healthy control boys and the reference
population. This was mainly due to 4 boys (boys a through d)
with BMI SDSs .1.64 (95th percentile). BMI and FMI SDSs
for these boys were 1.71 and 1.49 (a), 1.83 and 1.49 (b), 1.96 and
0.32 (c), and 2.42 and 1.99 (d), which indicated that high BMI
SDSs do not always reflect excess fat. Simple skinfold-thickness
measurements identified boy c as having less subcutaneous fat
than the other 3 boys. It may be prudent to identify the nature of
high BMI in these patients and implement dietary interventions
to avoid the complications of excess fat in adult life. Girls with
TABLE 5
Differences in size and whole-body composition between girls with cystic fibrosis and control girls (n = 48 matched pairs)1
Adjusted for age
Adjusted for
age and height
Adjusted for
age, height, and puberty
Mean 6 SEM P Mean 6 SEM P Mean 6 SEM P
Weight (kg) 25.7 6 1.3 ,0.001 22.0 6 1.0 NS 22.0 6 0.9 ,0.05
Height (m)2 20.05 6 0.01 ,0.001 20.05 6 0.01 ,0.001
BMI (kg/m2)2 21.8 6 0.5 ,0.001 21.4 6 0.4 ,0.001
TBW (L) 21.9 6 0.6 ,0.001 20.02 6 0.3 NS 20.04 6 0.3 NS
BV (L) 25.9 6 1.3 ,0.001 22.2 6 1.1 NS 22.2 6 0.9 ,0.05
FM (kg) 23.4 6 0.8 ,0.001 22.1 6 0.8 ,0.01 22.1 6 0.7 ,0.01
FFM (kg) 22.2 6 0.9 ,0.05 0.3 6 0.5 NS 0.3 6 0.4 NS
FFM (kg)3 22.46 6 0.73 ,0.001 0.03 6 0.40 NS 0.02 6 0.37 NS
FFM hydration (%) 20.3 6 0.4 NS 20.4 6 0.5 NS 20.4 6 0.5 NS
FFM density (kg/L) 20.001 6 0.000 NS 0.000 6 0.000 NS 0.000 6 0.000 NS
PM (kg) 20.3 6 0.2 NS 0.2 6 0.1 NS 0.2 6 0.1 NS
MM (kg) 20.3 6 0.1 ,0.001 20.1 6 0.0 NS 20.1 6 0.0 NS
MM (kg)3 20.25 6 0.06 ,0.001 20.07 6 0.04 NS 20.07 6 0.04 NS
LS BMAD SDS 20.2 6 0.3 NS 0.1 6 0.3 NS 0.1 6 0.3 NS
Waist circumference (cm) 22.3 6 1.1 ,0.05 20.3 6 1.1 NS 20.4 6 0.9 NS
Hip circumference (cm) 26.4 6 1.3 ,0.001 23.0 6 1.1 ,0.05 23.0 6 1.0 ,0.01
MUAC (cm) 22.6 6 0.6 ,0.001 21.4 6 0.5 ,0.05 21.4 6 0.5 ,0.01
Log4 skinfold thicknesses 20.2 6 0.1 ,0.01 20.1 6 0.1 NS 20.2 6 0.1 NS
1 TBW, total body water; BV, body volume; FM, fat mass; FFM, fat-free mass; PM, protein mass; MM, mineral mass; LS BMAD SDS, lumbar spine
bone mineral apparent density (size-adjusted bone mineral density) SD score; MUAC, midupper arm circumference; Log4 skinfold thickness, bicep + tricep +
subscapular + suprailiac (n = 45 pairs). General linear model adjusted for group, matched pairs, and puberty as fixed factors and age and height as continuous
variables.
2 Adjusted for age and puberty only.
3 Additionally adjusted for lumbar spine bone area.
TABLE 6
Simple regression analysis of factors associated with forced expired volume in 1 s percentage predicted1
Boys (n = 37) Girls (n = 48)
B SEM t P r2 B SEM t P r2
BMI SDS 5.31 3.68 1.44 0.159 0.057 5.91 2.73 2.16 0.036 0.094
4C FM (kg) 1.25 1.25 1.01 0.321 0.030 3.05 1.11 2.76 0.008 0.151
Log sum of 4 skinfold thicknesses2 7.63 9.16 0.83 0.411 0.021 13.6 8.15 1.67 0.103 0.063
DXA FM (kg) 0.15 1.34 0.11 0.910 1.001 2.25 1.14 1.96 0.056 0.084
Hydrometry FM (kg) 1.24 1.19 1.04 0.307 0.032 2.63 1.14 2.31 0.025 0.112
Densitometry FM (kg) 1.39 1.25 1.11 0.276 0.039 3.04 0.96 3.19 0.003 0.191
4C FFM (kg) 20.25 2.26 20.11 0.911 0.001 1.72 1.53 1.12 0.268 0.032
DXA FFM (kg)3 3.58 2.29 1.57 0.126 0.070 2.05 1.42 1.45 0.156 0.049
Hydrometry FFM (kg) 20.42 2.13 20.20 0.846 0.001 0.94 1.46 0.64 0.525 0.013
Densitometry FFM (kg) 20.48 2.12 20.23 0.823 0.004 21.42 1.74 20.82 0.417 0.019
4C MM (kg)4 8.21 31.7 0.26 0.797 0.003 23.7 23.3 1.02 0.316 0.028
DXA BMC (kg)4 10.9 38.5 0.30 0.788 0.003 47.7 28.8 1.66 0.105 0.065
DXA BMD (g/m3) 247.4 75.6 20.06 0.535 0.012 58.3 66.8 0.87 0.387 0.021
1 SDS, SD score; FM, fat mass; FFM, fat-free mass; 4C, 4-component; DXA, dual-energy X-ray absorptiometry; MM, total body mineral mass; BMC,
bone mineral content; BMD, bone mineral density. Factors, except BMI SDS, were adjusted for height. Each line represents a new model (a separate analysis).
2 n = 36 boys and 45 girls.
3 DXA lean + bone mineral.
4 Also adjusted for lumbar spine bone area.
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CF were smaller overall than control girls, which was perhaps
related to the slightly higher than expected weights of control
girls and the delayed puberty and suboptimal health (indicated
by poorer lung function) of girls with CF.
In healthy individuals, including the healthy children in this
study, proteins and minerals were positively correlated. However,
children with CF did not exhibit this relation; the range of MMI
SDSs for boys with CF was similar to that of control subjects, but
the range for girls was much wider and tended toward the lower
values. Girls with CF showed undermineralization for given
protein values. This suggests that some aspect of the disease
affects the protein-to-mineral relation, particularly in girls, and it
is possible that this represents a direct affect of the CFTR gene on
bone metabolism. More research is needed to see if the alter-
ation in the ratio becomes more pronounced in the boys with age
and whether the difference persists over time.
We previously reported normal BMD and BMAD in thirty-two
8–12-y-old children with CF (49); although boys in the current
study had normal BMD and BMAD values, the values for girls
were significantly lower. The 24 prepubertal girls had normal
bone BMAD but low BMD (P , 0.001), which suggested that
low BMD reflected small size and delayed puberty.
Differences when data from patients were compared with data
from either matched control children or a large reference pop-
ulation are summarized in Table 3, and these highlight some of
the difficulties of comparing studies of different designs. In our
study, boys were identified as shorter than the reference pop-
ulation but not by a case-control analysis, whereas girls had
significantly lower FFMI SDSs than did the reference population
but not compared with matched control subjects. The methods of
matching and analysis must be considered when studies are
compared.
Lung function
There is evidence that improving nutrition can delay de-
terioration in lung function and improve survival (50, 51), but
deficits of bone mass, LM, and FM in young patients with mild
lung disease and normal nutritional status have been reported
(47, 52). A consistent positive relation between FFM and lung
function has been noted in adults (36, 38) and children (45, 53,
54). However, not all studies separated the sexes or size-adjusted
components of body composition. We chose FEV1 as an outcome
measure because it is a good surrogate marker of clinical status
and predicts mortality and showed clear sex differences in the
relation between FEV1 and body composition. Contrary to
previous research, FFM was not associated with the FEV1 per-
centage predicted in either boys or girls, but we identified
a significant positive relation with FM adjusted for height in
girls with CF. This discordance with previous studies may be
because of the methodologies used (in our study the relation was
not identified by skinfold-thickness measurements), the narrow
age range of young children studied, the adjustment of FM for
stature, or the analysis of sexes separately. The sex differences
may reflect differences in body composition during growth, with
relatively greater gains in FFM in boys and FM in girls. It is
likely that the positive association between FM and lung func-
tion in girls is a reflection of their poor nutritional status because
of the generally low FM in this group. However, some girls with
low FM had good lung function (Figure 3); of the 4 girls with
FMI SDSs less than 21.5 and FEV1 .78%, 3 girls were more
physically active than their peer group, and one girl was as
physically active as her peer group. This finding warrants further
investigation and suggests that nutritional and physical therapies
need to be sex specific. We could not analyze our data by ge-
notype and sex because of low numbers in each group.
Methodology
The findings of previous body-composition studies were
influenced by the methodology used. Many studies used height
and weight measurements to assess growth, but these measure-
ments do not provide information about body composition, and
many 2CM techniques used in previous studies, including
skinfold-thickness measurements, bio-electrical impedance,
hydrometry, and densitometry, merely predicted FM and FFM.
The assumptions used (derived from healthy populations) about
the nature of the FFM are likely to be less valid for patients. More
recent studies used DXA to quantify BMC, FM, and FFM;
however, soft tissue assessments were biased in some individuals
(6, 55), which made comparison between patients and control
subjects or comparisons over time (where there is a change in
body size) problematic. Our findings, which compared com-
monly used 2CM techniques with the gold-standard 4CM, il-
lustrated the effect of methodology with a significant bias
(depending on sex and health status) compared with 4CM for all
techniques under investigation. In addition, limits of agreement
for 2CMs varied from 62 to 3kg for skinfold-thickness
measurements to 61 to 2kg for other methods, which indicated
that the accuracy is poor in individuals. All 2CM techniques,
apart from skinfold-thickness measurements, were consistent
with the criterion method in finding FM related to the FEV1
percentage predicted in girls only. However, the comparison of
body composition between children with CF and control
children highlighted different findings with boys having more
FFM by hydrometry and skinfold-thickness measurements.
This is a possible explanation for the contradictory findings of
previous studies.
In the current study, a positive significant relation between FM
and FEV1 percentage predicted in girls was identified by using
FIGURE 3. Relation between percentage predicted forced expired volume
in 1 s (FEV1% predicted) and fat mass index (FMI) SD scores (SDS) in girls
with cystic fibrosis. FMI (FM divided by the square of height) SDS were
assessed by the 4-component model of body composition. Correlation in 47
girls with cystic fibrosis: r = 0.40 and P = 0.005.
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4CM, hydrometry, and densitometry, and FM assessed by using
DXA approached significance. Some studies that used DXA
used LM (ie, tissue that is not fat or bone) and reported the LM
as FFM (usually defined as any tissue that is not fat). Therefore,
we repeated the analyses by using LM from DXA, and still there
was no significant relation in either sex. In addition, with the
exception of King et al (38), most studies did not size adjust FM
and FFM when investigating the relation with the FEV1 per-
centage predicted. Therefore, we repeated our analyses without
height adjustment and showed that no components were sig-
nificantly related to the FEV1 percentage predicted. This sug-
gested that differences in findings between studies may be, in
some part, due to whether height adjustments were made.
All children in this study performed 2 measurement pro-
cedures to improve accuracy (10), but children with CF gener-
ally needed to undergo more ADP measurements to ensure
consistency. It is likely that much of the variation was due to
erratic breathing patterns, and therefore, single ADP measure-
ments in this group may have been inaccurate.
Limitations
We used predicted rather than measured lung volumewhen we
calculated BV by ADP because of the difficulty of performing the
technique for young children. However, a study of children with
CF that derived FFM from ADP concluded that there was no
significant difference in FFM calculations between measured or
predicted lung volumes (56).
Because exercise affects the amount of lean tissue, we repeated
the analyses and took into account parental reported exercise
levels, and there were no differences in outcomes. However,
parental ratings may have been affected by differing expectations
in healthy and chronically ill patients, and this needs to be
addressed in future research.
Conclusions
To our knowledge, this was the first study to use a gold-
standard method to measure body composition in children with
CF. We observed clear sex differences, even in prepubertal
children, and because of the poorer prognosis in girls, these
differences warrant further investigation. Four boys with CF had
BMI SDSs in the obese range, and in 3 cases, this was due to
excess fat. It would seem prudent to carefully monitor children
with high BMI to avoid future health problems because of excess
fat. Finally, our results highlight some of the potential meth-
odologic explanations behind inconsistent findings in previous
TABLE 7
Analysis of mean bias in fat mass measured by 2-component models compared with the 4-component model1
n
Absolute
bias2
Absolute 95% limits
of agreement
Bias as a percentage
of the mean3
P for the
bias from zero4
Correlation
bias/mean r5
P for
correlation
kg kg %
Skinfold thickness6
CF boys 37 20.75 62.90 213.2 ,0.01 20.07 NS
CF girls 48 20.90 62.10 215.7 ,0.001 20.36 ,0.05
Control boys 37 21.00 61.97 218.6 ,0.001 20.62 ,0.001
Control girls 47 21.65 62.52 221.2 ,0.001 20.50 ,0.001
Skinfold thickness7
CF boys 36 20.64 62.94 25.13 ,0.05 20.78 ,0.001
CF girls 45 20.43 61.30 23.56 ,0.05 20.66 ,0.001
Control boys 37 0.30 62.42 210.1 ,0.001 20.79 ,0.001
Control girls 46 21.35 62.98 213.8 ,0.001 20.82 ,0.001
Hydrometry
CF boys 37 0.16 62.27 4.24 NS 20.17 NS
CF girls 48 0.70 61.31 13.1 ,0.001 20.03 NS
Control boys 37 0.30 62.43 3.84 NS 20.22 NS
Control girls 48 0.59 61.01 7.98 ,0.001 20.26 NS
DXA
CF boys 37 20.25 61.93 24.97 NS 20.05 NS
CF girls 48 0.27 61.50 2.97 ,0.05 0.23 NS
Control boys 37 20.29 61.38 26.89 ,0.05 0.13 NS
Control girls 48 0.19 61.77 0.34 NS 0.43 ,0.01
Densitometry
CF boys 37 0.03 61.25 20.36 NS 0.14 NS
CF girls 48 20.21 61.91 25.92 NS 0.11 NS
Control boys 37 0.05 61.53 0.05 NS 0.15 NS
Control girls 48 20.50 61.24 27.72 ,0.001 0.14 NS
1 CF, cystic fibrosis; DXA, dual-energy X-ray absorptiometry. Analyses were conducted by using the method of Bland and Altman (31).
2 The group mean value measured by 2-component models minus the group mean value measured by the 4-component model.
3 The bias of the natural log values · 100.
4 Paired t test.
5 Pearson’s correlation between the bias and mean values in individuals.
6 Calculated by using the age- and sex-specific equations of Slaughter et al (19).
7 Calculated by using the age- and sex-specific equations of Deurenberg et al (20).
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studies. In particular, 2CMs should be used with caution and
always adjusted for age, height, and sex.
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Body-composition reference data for simple and reference techniques
and a 4-component model: a new UK reference child1–3
Jonathan CK Wells, Jane E Williams, Sirinuch Chomtho, Tegan Darch, Carlos Grijalva-Eternod, Kathy Kennedy,
Dalia Haroun, Catherine Wilson, Tim J Cole, and Mary S Fewtrell
ABSTRACT
Background: A routine pediatric clinical assessment of body com-
position is increasingly recommended but has long been hampered by
the following 2 factors: a lack of appropriate techniques and a lack of
reference data with which to interpret individual measurements. Sev-
eral techniques have become available, but reference data are needed.
Objective: We aimed to provide body-composition reference data
for use in clinical practice and research.
Design: Body composition was measured by using a gold standard
4-component model, along with various widely used reference and
bedside methods, in a large, representative sample of British chil-
dren aged from 4 to $20 y. Measurements were made of anthro-
pometric variables (weight, height, 4 skinfold thicknesses, and waist
girth), dual-energy X-ray absorptiometry, body density, bioelectrical
impedance, and total body water, and 4-component fat and fat-free
masses were calculated. Reference charts and SD scores (SDSs)
were constructed for each outcome by using the lambda-mu-sigma
method. The same outcomes were generated for the fat-free mass
index and fat mass index.
Results: Body-composition growth charts and SDSs for 5–20 y
were based on a final sample of 533 individuals. Correlations be-
tween SDSs by using different techniques were $0.68 for adiposity
outcomes and $0.80 for fat-free mass outcomes.
Conclusions: These comprehensive reference data for pediatric
body composition can be used across a variety of techniques. To-
gether with advances in measurement technologies, the data should
greatly enhance the ability of clinicians to assess and monitor body
composition in routine clinical practice and should facilitate the use
of body-composition measurements in research studies. Am J
Clin Nutr doi: 10.3945/ajcn.112.036970.
INTRODUCTION
Growth charts for weight and height have been the backbone of
pediatric clinical assessment of nutritional status for decades (1–
4). However, efforts to obtain more detailed information on
body composition have long been hampered by 2 challenges.
First, methods for the measurement of pediatric body compo-
sition have taken time to develop. Only within the past decade
have techniques such as dual-energy X-ray absorptiometry
(DXA)4, air-displacement plethysmography, bioelectrical im-
pedance analysis (BIA), and isotope dilution become widely
applied in the pediatric population (5). Second, even when such
techniques are available, interpretation is severely hindered by
the lack of appropriate reference data.
Thus, clinical practice has been strongly influenced by the
nature of available data. Reference data for British children’s
skinfold-thickness measurements were provided in the 1970s (1).
More recently, reference data for UK children’s BMI were
published in the 1990s (6) by using Cole’s lambda-mu-sigma
(LMS) method to take into account age changes in the variability
and skewness of data (7). These BMI charts have become the
primary UK reference for the interpretation of nutritional status in
the clinic and have been replicated in many other populations (8–
11). To aid convergence between these approaches, skinfold-
thickness data were also converted to the LMS format (12).
International BMI cutoffs for categorizing overweight and
obesity and underweight have also been published (13, 14). Such
BMI data have been widely adopted, in part because of their value
in predicting clinical outcomes. Nevertheless, the data suffer
from limitations when more-detailed information about fat mass
or fat-free mass is required. Historically, fat-free tissue has been
considered the functional and dynamic component of weight,
with fat mass conceptualized as a relatively inert energy store.
Recent studies that identified numerous hormonal products of
adipose tissue have challenged this view, and adipose tissue is
understood to play a complex regulatory role and exerts many of
its effects on fat-free tissue (15). Therefore, there is increasing
interest in the ability to categorize fat-free mass and fat mass and
monitor their changes over time.
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We previously summarized a number of contexts in which
information about body composition could be of value to the
pediatrician (16) and also described the methodologies available
(5). However, until reference data for children’s body compo-
sition are available, measurements of individual patients will
remain difficult to interpret (17). Reference data for individual
techniques (eg, skinfold thicknesses, BIA, and DXA), have been
reported in the literature (18–25), but to our knowledge, no study
has provided comprehensive reference data on a range of tech-
niques in any single population. In this article, we describe
reference data for a number of different measures of body
composition, which will allow our reference data set to be used
across a variety of techniques.
SUBJECT AND METHODS
A total of 565 normal healthy children, adolescents, and
young adults aged 4–23 y were recruited by using flyers and
newspaper adverts in London and the southeast of England
starting in 2001. There were no exclusion criteria for BMI, and
thus, some individuals were categorized as overweight or
obese, but they were not recruited directly from obesity
weight-loss clinics and had no disease that might have ad-
versely affected growth and development. The lower age limit
of 4 y was chosen on the basis of our previous work because
younger children are unlikely to satisfy the protocol for air-
displacement plethysmography. Data collection was extended
to young adults to cover the entire pediatric age range. Ethical
approval was granted by the Ethical Committee of University
College London Institute of Child Health and Great Ormond
Street Hospital. All individuals attended our body-composition
investigation suite located at Great Ormond Street Hospital for
a 2-h measurement session.
Weight and height were measured by using standard pro-
tocols. Body weight was measured in duplicate as part of the air-
displacement plethysmography protocol. Height was measured
by using a wall-mounted stadiometer (Holtain). BMI (in kg/m2)
was calculated as weight divided by the square of height. Data
on weight, height, and BMI were converted to SD score (SDS)
format by using UK reference data (6, 26). Obesity was defined
as BMI .95th percentile (SDS .1.64), and overweight was
defined as BMI .85th percentile (SDS .1.04) (6). Pubertal
development was assessed by using Tanner staging with self-
assessment based on line drawings.
Skinfold-thickness measurements were performed in triplicate
at the biceps, triceps, subscapular, and suprailiac sites, and the
mean of the 3 values was used.Waist girth was measured by using
a nonstretchable fiberglass tape. BIA was conducted with Tanita
BC418MA instrumentation (Tanita Corp); however, this in-
strument was available only from 2004 onward, and thus, the
sample size was 451 (83% of the total) for this outcome. With
the use of whole-body values for impedance (Z, inU) at 50 kHz, the
impedance index [height2/Z (cm2/U)] was calculated. Numerous
pediatric equations have been published for BIA that have left
users uncertain as to which equation to select for any given
population. Therefore, the BIA output was analyzed in raw units
(in cm2/U) to avoid influencing this outcome by the choice of
one or another equation. This approach prevented the use of BIA
data as an index of adiposity, and therefore, skinfold thicknesses
were the primary bedside approach tested for adiposity. Because
absolute body-composition values obtained by using predictive
equations in combination with such bedside techniques have
high SEEs, our combined skinfold thicknesses plus BIA bedside
approach had the added advantage that fat-free and fat tissues
were assessed by using independent techniques, and error on the
adiposity index should have been independent from error on the
fat-free mass outcome.
FIGURE 1. Distribution of BMI SDS against age in the sample. n = 261
males and 272 females. SDS, SD score.
TABLE 1
Summary statistics for anthropometric measures and weight status by sex1
M (n = 261) F (n = 272)
Weight SDS 0.31 6 1.08 (22.42 to 3.44)2 0.42 6 1.10 (22.75 to 3.46)
Height SDS 0.21 6 0.96 (22.09 to 3.28) 0.34 6 1.02 (22.77 to 3.42)
BMI SDS 0.24 6 1.15 (22.99 to 3.49) 0.31 6 1.15 (23.33 to 3.32)
Percentage of fat (4C model)3 19.2 6 8.0 (4.9–45.5) 27.0 6 8.0 (11.7–46.9)
Prevalence (%)
Overweight 9.2 10.7
Obese 11.5 14.7
1 SDSs were calculated by using UK reference data (6, 25). Overweight was categorized as BMI SDS .1.04 (85th
percentile). Obese was categorized as BMI SDS .1.64 (95th percentile). SDS, SD score; 4C, 4-component.
2Mean 6 SD; range in parentheses (all such values).
3The difference in the percentage of fat between sexes was determined by using multiple regression analysis to
assess the significance of female sex with adjustment for age, P , 0.0001.
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Measurements of total body water (TBW; in L) by using
deuterium dilution, bone mineral content (in kg) by using DXA
(Lunar Prodigy, software version 6.7; GE Medical Systems), and
body volume (in L) in duplicate by using air-displacement
plethysmography (Bodpod; Life Measurements) were obtained
as described previously, with postdose saliva collected after 4–5 h
(27). The deuterium-dilution space was converted to TBW with
the assumption that the degree of overestimation that was at-
tributable to proton exchange was 1.044 (28). Lung volume was
predicted rather than measured in plethysmography measure-
ments because we have shown that a large proportion of children
are unable to complete the lung-volume measurement protocol
satisfactorily. Values for fat-free mass by using DXA were the
sum of lean soft tissue and bone mineral mass.
The 4-component (4C) model is considered the most accurate
in vivo approach for the differentiation of fat and fat-free masses
and is particularly valuable in patients in whom assumptions of
constant fat-free tissue composition are not valid (29, 30). The 4C
model used in this study to calculate lean mass and fat mass (FM)
has been described previously (31, 32) and uses the following
equations:
FM ¼ ð2:7473BVÞ2 ð0:7103TBWÞ
1ð1:4603BMCÞ2 ð2:0503WTÞ ð1Þ
FFM ¼ WT2 FM ð2Þ
where FM is fat mass, BV is body volume, BMC is bone mineral
content, FFM is fat-free mass, and WT is body weight. The pro-
portion of fat in weight (percentage of fat) was calculated as
ðFMOWTÞ3 100 ð3Þ
In our laboratory, the precision is 1% for TBW (32) and 0.24 L
for BV (33). The precision of BMC is 1.1% (34).
Statistics
Analyses were conducted for a range of adiposity and fat-free
mass outcomes. For adiposity, the outcomes were 1) each of the 4
skinfold thicknesses, 2) waist girth, 3) whole-body, arm, leg, and
trunk fat mass from DXA, 4) body density by air-displacement
plethysmography, and 5) 4C fat mass. For fat-free mass, the
outcomes were 1) TBW, 2) height2/Z, 3) whole-body, arm, leg,
and trunk fat-free mass by using DXA, and 4) 4C fat-free mass.
For the 4C data, the fat-free mass index (fat-free mass/height2)
and fat mass index (fat mass/height2) were also calculated, as
described and recommended previously (17, 35). Each of these
variables was converted to an SDS.
Sex-specific values by month of age were obtained for all
body-composition outcomes by using the LMS method (LMS
Chart Maker; Medical Research Council) (7). This statistical
approach, which has been widely used to construct reference data
for traits that incorporate the effects of growth, provides the
following 3 outputs: 1) a smoothed median (M or mu) curve,
which represents how the outcome varies in relation to age, 2)
the CV (S or sigma), which models the scatter of values around
the mean and adjusts for any nonuniform dispersion, and 3) the
skewness (L or lambda), which is addressed by using age-
specific Box-Cox transformation to achieve a normal distri-
bution. Adiposity indexes were fitted by using original age, and
fat-free mass outcomes were fitted by using rescaled age, which
improved the goodness of fit for monotonic data by fitting the M
curve twice. The goodness of fit was assessed by using the
Bayesian Information Criterion, with the addition of an extra unit
of complexity to the model only if it reduced the deviance by
more than loge(N) units, where N was the sample size. As the
precision of the M curve at any age depends on data points at
younger and older ages, precision is lower at the extremes of the
age range. Therefore, we fitted the data for all ages (4–23 y) and
derived LMS values for the age range 5–20 y.
FIGURE 2. Percentiles of fat-free mass, fat mass, fat-free mass index, and
fat mass index by the 4-component model for males (n = 261; left panels)
and females (n = 272; right panels). The second, ninth, 25th, 50th, 75th, 91st,
and 98th percentiles are displayed in ascending order.
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These data represent new body-composition growth charts
available for both the 4Cmodel and individual techniques such as
DXA, TBW, body density, BIA, and skinfold thicknesses. Such
charts allow for the monitoring of adiposity and fat-free mass
over time to improve the understanding of the effects of disease
and treatments. We also calculated values for fat-free mass, fat
mass, fat-free mass index, and fat mass index by the 4Cmodel for
each sex for the following z-score cutoffs: 22, 21.67, 21.33, 0,
1.33, 1.67, and 2, which are equivalent to percentiles of 2.3%,
9.2%, 25.2%, 50%, 74.8%, 90.8%, and 97.7% respectively.
With the use of this statistical approach, all data were con-
verted to an SDS format, and subsequent analyses on subjects
aged 5–20 y were undertaken by using Datadesk 6.1 software
(Data Description Inc). The mean of the 4 individual skinfold-
thickness SDSs was also calculated. We quantified the agree-
ment between the individual SDS with the reference 4C SDS. If
growth charts are to be adopted by clinicians, they will need to
know whether rankings from one technique (eg, skinfold
thicknesses) are consistent with ranking by another (eg, DXA or
the 4C model). The expression of the data in the SDS format
aids such a comparison because, first, it enables the chart rankings
to be compared rather than the raw data and, second, because
body-composition techniques produce outputs in different units
(eg, kg for DXA, kg/m3 for density, mm for skinfold thicknesses,
and cm2/U for BIA), preventing direct comparisons.
Correlation coefficients were calculated for all of the adiposity
and fat-free mass outcomes in each sex. Pearson’s correlation
coefficients were calculated on the assumption that associations
TABLE 2
Fat-free mass reference data for males and females by z score or percentile1
Age
Males Females
z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0 z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0
5.0 y 12.76 13.89 15.08 16.35 17.70 19.13 20.64 11.24 12.27 13.39 14.60 15.91 17.33 18.86
6.0 y 14.10 15.37 16.72 18.16 19.69 21.31 23.03 12.83 14.02 15.30 16.70 18.21 19.85 21.62
7.0 y 15.32 16.73 18.23 19.83 21.54 23.34 25.26 14.49 15.84 17.31 18.91 20.64 22.51 24.55
8.0 y 16.56 18.12 19.79 21.56 23.45 25.45 27.58 16.23 17.77 19.45 21.26 23.24 25.38 27.71
9.0 y 18.02 19.76 21.62 23.61 25.73 27.98 30.38 17.88 19.61 21.49 23.54 25.77 28.20 30.83
10.0 y 19.66 21.62 23.72 25.98 28.38 30.95 33.68 19.56 21.49 23.60 25.89 28.39 31.12 34.08
11.0 y 21.60 23.85 26.28 28.88 31.67 34.64 37.83 21.62 23.79 26.16 28.74 31.56 34.63 37.98
12.0 y 24.06 26.71 29.56 32.63 35.94 39.48 43.27 24.23 26.66 29.31 32.21 35.37 38.82 42.58
13.0 y 27.24 30.36 33.75 37.41 41.35 45.59 50.14 27.06 29.71 32.61 35.76 39.19 42.93 47.00
14.0 y 31.09 34.72 38.65 42.91 47.50 52.44 57.75 29.67 32.46 35.49 38.77 42.34 46.21 50.41
15.0 y 35.03 39.06 43.41 48.12 53.19 58.64 64.50 31.62 34.46 37.54 40.87 44.48 48.38 52.59
16.0 y 38.55 42.82 47.43 52.39 57.73 63.46 69.59 32.81 35.67 38.76 42.10 45.70 49.59 53.78
17.0 y 41.35 45.74 50.47 55.55 60.99 66.82 73.05 33.46 36.32 39.41 42.75 46.34 50.21 54.38
18.0 y 43.45 47.90 52.68 57.80 63.28 69.13 75.38 33.71 36.57 39.67 43.00 46.58 50.45 54.61
19.0 y 45.02 49.50 54.30 59.43 64.92 70.77 77.00 33.75 36.62 39.71 43.04 46.63 50.49 54.65
20.0 y 46.24 50.73 55.54 60.68 66.17 72.01 78.22 33.86 36.73 39.82 43.15 46.73 50.59 54.75
1 z-score equivalents in percentiles are as follows: 22 = 2.3%, 21.33 = 9.2%, 20.67 = 25.2%, 0 = 50%, 0.67 = 74.8%, 1.33 = 90.8%, and 2 = 97.7%.
TABLE 3
Fat mass reference data for males and females by z score or percentile1
Age
Males Females
z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0 z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0
5.0 y 1.37 1.77 2.32 3.11 4.26 6.00 8.72 1.60 2.12 2.87 3.97 5.59 8.09 12.06
6.0 y 1.61 2.09 2.76 3.71 5.11 7.25 10.62 2.02 2.67 3.60 4.95 6.95 9.99 14.78
7.0 y 1.85 2.40 3.18 4.31 5.97 8.52 12.60 2.45 3.23 4.34 5.94 8.29 11.85 17.41
8.0 y 2.08 2.71 3.61 4.91 6.84 9.84 14.66 2.89 3.80 5.09 6.92 9.61 13.66 19.94
9.0 y 2.30 3.01 4.03 5.50 7.72 11.18 16.81 3.34 4.38 5.84 7.91 10.93 15.44 22.37
10.0 y 2.52 3.31 4.44 6.10 8.61 12.56 19.04 3.81 4.97 6.59 8.89 12.23 17.17 24.72
11.0 y 2.73 3.60 4.85 6.70 9.51 13.97 21.37 4.28 5.57 7.36 9.88 13.51 18.86 26.97
12.0 y 2.93 3.89 5.26 7.30 10.42 15.42 23.80 4.76 6.18 8.13 10.86 14.78 20.52 29.15
13.0 y 3.13 4.16 5.66 7.89 11.34 16.90 26.33 5.26 6.80 8.91 11.85 16.04 22.14 31.23
14.0 y 3.32 4.44 6.06 8.49 12.28 18.43 28.96 5.77 7.43 9.69 12.84 17.29 23.72 33.24
15.0 y 3.51 4.71 6.45 9.09 13.22 19.99 31.70 6.29 8.07 10.48 13.82 18.52 25.26 35.17
16.0 y 3.70 4.97 6.84 9.69 14.18 21.59 34.55 6.82 8.72 11.28 14.81 19.74 26.77 37.03
17.0 y 3.87 5.23 7.23 10.28 15.14 23.23 37.53 7.37 9.38 12.09 15.79 20.94 28.24 38.82
18.0 y 4.05 5.48 7.61 10.88 16.12 24.92 40.62 7.93 10.05 12.90 16.78 22.14 29.68 40.53
19.0 y 4.21 5.73 7.99 11.48 17.11 26.64 43.85 8.50 10.74 13.72 17.76 23.32 31.09 42.18
20.0 y 4.38 5.97 8.36 12.08 18.11 28.41 47.21 9.08 11.43 14.55 18.75 24.49 32.46 43.76
1 z-score equivalents in percentiles are as follows: 22 = 2.3%, 21.33 = 9.2%, 20.67 = 25.2%, 0 = 50%, 0.67 = 74.8%, 1.33 = 90.8%, and 2 = 97.7%.
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between different z scores were expected to be linear. For central
adiposity, we also calculated correlations of SDSs for DXA
trunk fat and waist girth. A sex-specific regression analysis was
undertaken for the prediction of the 4C fat mass SDS from each
individual adiposity SDS, and the 4C fat-free mass SDS from
each individual fat-free mass, TBW, or height2/Z SDS. Slopes
and intercepts were assessed for the difference from 1 and 0,
respectively, and the SEE was calculated. Bland-Altman anal-
ysis (36) was used to illustrate the agreement with 4C SDS
values for DXA whole-body SDS, BIA SDS, and average
skinfold-thickness SDS. A minority of subjects (27 boys and 23
girls; ie, 9.3% of the sample) were of non-European ethnicity;
however, this sample size was considered too small to allow
ethnic variability in body composition to be addressed.
RESULTS
Valid data were obtained on 533 individuals. Data on 32 other
individuals were discarded because either one or more of the
basic measurements were unsuccessful (n = 16; mostly very
young children) or the modeling was unsuccessful (n = 16) as
indicated by spurious body-composition data. As shown in
Figure 1, a wide range of BMI SDSs was apparent at all ages.
There was no significant correlation between BMI SDS and age
in either sex.
Data on anthropometric SDS values and the range of per-
centage of fat by sex are shown in Table 1. On average, our
sample was heavier and taller in comparison with the UK ref-
erence data of the early 1990s (P , 0.005 in all cases). Females
unsurprisingly had a significantly greater percentage fat than did
TABLE 4
Fat-free mass index reference data for males and females by z score or percentile1
Age
Males Females
z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0 z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0
5.0 y 11.59 12.13 12.68 13.25 13.84 14.43 15.04 10.75 11.16 11.61 12.11 12.68 13.33 14.07
6.0 y 11.59 12.13 12.69 13.27 13.87 14.49 15.14 10.88 11.32 11.81 12.35 12.94 13.59 14.33
7.0 y 11.50 12.03 12.59 13.17 13.79 14.43 15.11 10.98 11.47 12.00 12.57 13.20 13.89 14.64
8.0 y 11.43 11.95 12.50 13.09 13.72 14.39 15.10 11.05 11.59 12.18 12.81 13.49 14.22 15.03
9.0 y 11.48 11.99 12.55 13.15 13.79 14.49 15.25 11.10 11.69 12.33 13.01 13.76 14.56 15.43
10.0 y 11.61 12.15 12.72 13.35 14.03 14.78 15.59 11.16 11.80 12.49 13.24 14.05 14.93 15.89
11.0 y 11.80 12.38 13.02 13.71 14.48 15.32 16.27 11.31 12.00 12.75 13.56 14.44 15.40 16.45
12.0 y 12.05 12.71 13.44 14.24 15.14 16.15 17.28 11.57 12.29 13.09 13.95 14.91 15.95 17.11
13.0 y 12.45 13.19 14.02 14.95 15.98 17.15 18.49 11.89 12.64 13.47 14.39 15.40 16.52 17.77
14.0 y 12.98 13.81 14.74 15.76 16.91 18.20 19.65 12.24 13.01 13.85 14.80 15.84 17.01 18.33
15.0 y 13.55 14.46 15.46 16.56 17.78 19.13 20.63 12.57 13.33 14.18 15.12 16.18 17.37 18.72
16.0 y 14.07 15.06 16.12 17.28 18.53 19.88 21.36 12.84 13.58 14.41 15.33 16.37 17.56 18.91
17.0 y 14.51 15.57 16.69 17.87 19.13 20.45 21.86 13.03 13.75 14.54 15.43 16.44 17.60 18.93
18.0 y 14.87 15.99 17.15 18.36 19.60 20.88 22.19 13.18 13.85 14.60 15.45 16.41 17.52 18.81
19.0 y 15.14 16.33 17.53 18.74 19.96 21.19 22.42 13.28 13.91 14.61 15.40 16.31 17.37 18.60
20.0 y 15.34 16.60 17.83 19.05 20.24 21.41 22.57 13.35 13.93 14.58 15.32 16.18 17.17 18.35
1 z-score equivalents in centiles are as follows: 22 = 2.3%, 21.33 = 9.2%, 20.67 = 25.2%, 0 = 50%, 0.67 = 74.8%, 1.33 = 90.8%, and 2 = 97.7%
TABLE 5
Fat mass index reference data for males and females by z score or percentile1
Age
Males Females
z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0 z = 22.0 z = 21.33 z = 20.67 z = 0 z = 0.67 z = 1.33 z = 2.0
5.0 y 1.41 1.79 2.26 2.84 3.56 4.45 5.53 1.59 1.99 2.53 3.30 4.42 6.14 8.90
6.0 y 1.24 1.60 2.06 2.65 3.38 4.32 5.49 1.67 2.11 2.70 3.54 4.77 6.63 9.58
7.0 y 1.11 1.44 1.88 2.45 3.20 4.17 5.45 1.75 2.22 2.86 3.77 5.10 7.10 10.24
8.0 y 1.12 1.46 1.92 2.54 3.38 4.52 6.10 1.83 2.33 3.03 4.01 5.43 7.56 10.87
9.0 y 1.29 1.69 2.23 2.98 4.03 5.55 7.76 1.91 2.45 3.19 4.24 5.75 8.00 11.47
10.0 y 1.45 1.89 2.50 3.37 4.66 6.59 9.61 1.98 2.56 3.35 4.46 6.06 8.42 12.00
11.0 y 1.51 1.95 2.59 3.52 4.93 7.17 10.91 2.07 2.68 3.51 4.68 6.35 8.79 12.44
12.0 y 1.45 1.88 2.49 3.40 4.83 7.20 11.43 2.16 2.80 3.68 4.90 6.63 9.12 12.80
13.0 y 1.35 1.75 2.32 3.18 4.57 6.96 11.49 2.26 2.93 3.85 5.11 6.88 9.41 13.07
14.0 y 1.28 1.65 2.19 3.02 4.37 6.76 11.54 2.36 3.06 4.01 5.32 7.12 9.65 13.26
15.0 y 1.23 1.59 2.10 2.90 4.23 6.61 11.54 2.47 3.20 4.18 5.51 7.33 9.85 13.38
16.0 y 1.20 1.55 2.06 2.84 4.15 6.54 11.53 2.59 3.34 4.35 5.70 7.52 10.01 13.43
17.0 y 1.22 1.58 2.10 2.90 4.24 6.69 11.84 2.71 3.49 4.51 5.88 7.69 10.13 13.43
18.0 y 1.32 1.70 2.27 3.14 4.60 7.25 12.78 2.84 3.64 4.68 6.05 7.84 10.22 13.38
19.0 y 1.48 1.92 2.56 3.55 5.19 8.17 14.31 2.98 3.79 4.85 6.21 7.98 10.29 13.31
20.0 y 1.67 2.16 2.89 4.01 5.87 9.21 16.01 3.12 3.95 5.01 6.37 8.11 10.35 13.22
1 z-score equivalents in centiles are as follows: 22 = 2.3%, 21.33 = 9.2%, 20.67 = 25.2%, 0 = 50%, 0.67 = 74.8%, 1.33 = 90.8%, and 2 = 97.7%.
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males (P , 0.0001, adjusted for age). The prevalence of obesity
was 11.5% and 14.7% in males and females, respectively, and
was uncorrelated with age. The numbers of subjects by pubertal
stage 1–5 were 98, 60, 28, 24, and 50 males, respectively, and
87, 48, 34, 22, and 80 females, respectively; pubertal stage in 2
other subjects was not recorded.
LMS percentiles for 4C fat-free mass, 4C fat mass, 4C fat-free
mass index, and 4C fat mass index, respectively, against age for
each sex are shown in Figure 2. Fat-free mass increased with age
in an S-shaped association in both sexes but reached sub-
stantially higher values in males. This sex difference was re-
duced but remained apparent when adjusted for height in the
form of the fat-free mass index. Fat mass had no discernible
curvilinear association with age, which was attributed in part to
differing age-associations of individual fat depots as proxied by
the 4 skinfold thicknesses (data not shown). z score and per-
centile reference data for each of fat-free mass, fat mass, fat-free
mass index, and fat mass index by the 4C model for each sex are
shown in Tables 2–5.
Correlation coefficients for adiposity SDS indexes by sex are
shown in Table 6. All coefficients were $0.68 (P , 0.0001).
Coefficients and SEs for intercepts and slopes for the regression
of 4C fat mass SDS on each individual adiposity SDS value,
together with SEE values, are shown in Table 7. No intercept
differed significantly from 0; however, most slopes were sig-
nificantly ,1, with the exception of DXA fat mass SDS in fe-
males. For DXA fat mass in males, the upper 95% CI of the
slope was just ,1 (0.983). The smallest SEE values were ob-
tained from DXA fat mass SDS (0.33 SDS in males; 0.21 SDS
in females), whereas values for skinfold thicknesses were w0.5
to w0.6 SDS. Thus, in most cases, individual SDS under-
estimated 4C fat SDS in subjects with higher adiposity, and this
effect was minimal for DXA whole-body data. Bland-Altman
analysis of agreement between 4C and DXA values for fat mass
SDS is illustrated in Figure 3 and showed no systematic trend in
bias across the range of adiposity but greater random in-
consistency in subjects of low adiposity.
Correlation coefficients for SDSs for indexes of fat-free mass
by sex are shown in Table 8. All correlations were $0.80 (P ,
0.0001). Coefficients and SEs for intercepts and slopes for the
regression of 4C fat-free mass SDS on each individual proxy
SDS value, together with SEE values, are shown in Table 9. No
intercept differed significantly from 0; however, most slopes
were significantly ,1, with the exception of DXA fat-free mass
SDS in both sexes and TBW SDS in both sexes. SEE values
werew0.2 for DXAwhole-body SDS,w0.2 for TBW SDS, and
TABLE 6
Correlations for adiposity outcomes expressed in SDS format1
M (n = 245) and
F (n = 259) Biceps Triceps Subscapular Suprailiac
Mean
skinfold Density
4C
fat mass
DXA
fat mass
DXA
arm fat
DXA
leg fat
DXA
trunk fat
Biceps — 0.86 0.78 0.76 0.92 20.79 0.84 0.82 0.87 0.81 0.79
Triceps 0.82 — 0.74 0.82 0.93 20.82 0.83 0.83 0.86 0.81 0.81
Subscapular 0.68 0.78 — 0.78 0.90 20.75 0.81 0.84 0.82 0.81 0.83
Suprailiac 0.69 0.80 0.79 — 0.92 20.82 0.83 0.84 0.83 0.81 0.85
Mean skinfold 0.88 0.94 0.90 0.91 — 20.87 0.90 0.91 0.92 0.88 0.89
Density 20.77 20.82 20.76 20.81 20.88 — 20.90 20.87 20.86 20.83 20.86
4C fat mass 0.78 0.84 0.80 0.80 0.89 20.93 — 0.94 0.92 0.93 0.94
DXA fat mass 0.77 0.84 0.81 0.79 0.89 20.88 0.98 — 0.95 0.97 0.98
DXA arm fat 0.81 0.87 0.80 0.79 0.91 20.88 0.95 0.97 — 0.92 0.94
DXA leg fat 0.75 0.82 0.75 0.75 0.85 20.86 0.95 0.97 0.93 — 0.93
DXA trunk fat 0.75 0.82 0.82 0.80 0.88 20.87 0.96 0.98 0.95 0.93 —
1 For Pearson’s correlation coefficients, M values are above the diagonal, and F values are below diagonal. All correlations were significant at P ,
0.0001. DXA, dual-energy X-ray absorptiometry; SDS, SD score; 4C, 4-component.
TABLE 7
Intercepts, slopes, and SEEs for regression of 4C fat mass SDS on individual adiposity SDS1
Predictor
Males (n = 245) Females (n = 259)
Intercept SE Slope SE SEE Intercept SE Slope SE SEE
Biceps 0.044 0.036 0.840 0.036 0.55 0.032 0.040 0.802 0.041 0.63
Triceps 0.027 0.036 0.836 0.036 0.56 0.028 0.034 0.856 0.035 0.54
Subscapular 0.046 0.038 0.821 0.038 0.58 0.032 0.038 0.828 0.039 0.60
Suprailiac 0.037 0.037 0.862 0.038 0.58 0.037 0.039 0.820 0.039 0.61
Mean skinfold 0.038 0.026 0.837 0.026 0.40 0.028 0.027 0.826 0.027 0.41
Density 20.017 0.028 20.892 0.027 0.43 0.021 0.024 20.927 0.024 0.38
DXA fat mass 0.018 0.021 0.941 0.021 0.33 0.010 0.013 0.979 0.013 0.21
DXA arm fat 0.002 0.025 0.926 0.025 0.39 0.017 0.018 0.946 0.018 0.30
DXA leg fat 0.006 0.024 0.931 0.024 0.37 20.002 0.019 0.951 0.019 0.30
DXA trunk fat 0.010 0.023 0.923 0.022 0.35 20.004 0.017 0.962 0.017 0.27
1The 4C fat mass SDS regressed on each individual adiposity SDS. All slopes were significantly different from 1 (P , 0.05) except for DXA fat mass in
girls. DXA, dual-energy X-ray absorptiometry; SDS, SD score; 4C, 4-component.
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w0.44 for BIA SDS. The Bland-Altman analysis of agreement
between 4C and DXA values for fat-free mass SDSs in males
and females are illustrated in Figure 3 and showed no variability
in bias across the range of fat-free mass SDSs.
r2 values calculated from Tables 6 and 8 indicated that DXA fat
SDS accounted for 88% and 96% of the variance in 4C fat SDS in
males and females, respectively, whereas DXA fat-free SDS ac-
counted for 96% and 94% of the variance in 4C fat-free SDS in
males and females, respectively. In both sexes, agreement was
better for fat-free SDS than for fat SDS (Figure 3), which showed
poorer consistency between methods in subjects with low adi-
posity. For central fat, the correlation of DXA trunk fat SDS and
waist SDS was 0.81 in males and 0.83 in females. Therefore,
waist SDS explained 66% and 69% of the variance in trunk fat
SDS in males and females, respectively.
Associations between 4C fat-free mass SDS and BIA SDS in
each sex are shown in Figure 4. r2 values from Table 8 indicated
that height2/Z SDS accounted for 83% and 81% of the variance
in 4C fat-free SDS in males and females, respectively. The as-
sociation between 4C fat mass SDS and the mean of 4 skinfold-
thickness SDSs in each sex is also shown in Figure 4. For each
of the sum of 4 skinfold thicknesses, density, DXA indexes,
and 4C fat mass, r2 values calculated from Table 6 indicated
that each individual adiposity SDS accounted for 66–96% and
61–96% of the variance in other SDSs in males and females,
respectively.
DISCUSSION
Although reference data for children’s body composition have
long been desired, their development is complicated by the
difficulty of obtaining accurate measurements. Advances in
modeling, with the combination of several raw measurements,
have allowed accurate 4C data to be obtained in children $4 y
(31, 32). This approach is unlikely to be widely applied in
clinical practice or research studies because of its expense and
requirement for sophisticated equipment. Several techniques are
used more routinely, including skinfold thicknesses, DXA, and
BIA; however, each method uses different approaches to convert
raw measurements to final body-composition values (37, 38).
FIGURE 3. Bland-Altman plots illustrating the agreement between DXA fat-free mass SDS and 4C fat-free mass SDS (upper panels) and DXA fat SDS
and 4C fat mass SDS (lower panels) in males (n = 245, left side) and females (n = 259, right side). The scatter plot shows agreement between techniques in
individuals, and dotted lines show the mean bias and limits of agreement (62 SD of the bias). DXA, dual-energy X-ray absorptiometry; SDS, SD score; 4C, 4-
component.
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Over the past 2 decades, various pediatric body-composition
reference data have been reported, including skinfold-thickness
data in Spain (19) and the United States (18); BIA data in the
United States (20), Turkey (21) and Japan (22); and DXA data in
Sweden (23), the Netherlands (24), and the United States (25, 39).
These data represent an advance over BMI, which can assess
nutritional status but not fat and fat-free masses or their regional
distribution. However, because of the different theoretical as-
sumptions and population variability in body size and nutritional
status, these heterogeneous data sets cannot easily be compared.
To our knowledge, no study has previously reported reference
data for a wide range of outcomes, which would allow future
studies to benefit from convergence on a common data set, re-
gardless of which technique was used.
We have attempted to resolve this problem by developing ref-
erence charts and SDSs for both the accurate 4C model and
a number of simpler techniques across the age range from 5 to 20 y.
We have further described correlations between SDSs calculated by
using the different techniques and have shown medium-to-high
agreement in all cases. Thus, whether measurements are made by
using skinfold-thickness calipers, DXA, BIA, densitometry, iso-
topes, or the 4C model, there is relatively good ranking consistency,
although different techniques cannot be used interchangeably when
individuals are monitored over time. These new data will aid both
single assessments of children and longitudinal monitoring over
time. They are suitable for use in conditions in which there is no
acute perturbation of water distribution (edema).
From our clinical experience, children with specific diseases
are often able to undergo only a subset of body-composition
measurements. For example, many patients are too sick to un-
dergo plethysmography or DXA but can have BIA or TBW
measured at the bedside (40, 41). Some obese children are too
large to be successfully scanned by DXA and are difficult to
measure by using skinfold-thickness calipers but can undergo
plethysmography (42). When hydration varies beyond the normal
range, and when patients are able to undergo a wider range of
measurements, the 4C model is ideal, as we have shown for
obesity (29), acute lymphoblastic leukemia (30), and cystic fi-
brosis (43). Thus, our reference data should substantially increase
the capacity of clinicians to acquire and interpret data in a wide
range of diseases, which could contribute to a range of com-
ponents of clinical management. For more general community
studies of nutritional status, TBW is the most accurate field
method (32, 44) and can be applied in combination with our
published reference data for hydration (38).
With the comparison between techniques for adiposity, the
highest correlations with 4C fat mass SDS were shown for whole-
body DXA fat mass SDS, with coefficients of 0.98 in females and
0.94 in males and an SEE w0.2 SDS. The next best technique
was density SDS, whereas the individual skinfold-thickness
performed slightly less well (correlations ranged from 0.78 to
0.84, with an SEEw0.6 SDS), but the average of the 4 skinfold-
thickness SDS values had a correlation very similar to that of
density in both sexes and an SEE w0.4 SDS. For 4C fat-free
TABLE 8
Correlations for fat-free mass outcomes expressed in SDS format1
M (n = 245) and
F (n = 259)2
Total
body water 4C FFM DXA FFM DXA arm FFM DXA leg FFM DXA trunk FFM Height2/Z
Total body water — 0.98 0.95 0.84 0.92 0.91 0.90
4C FFM 0.99 — 0.98 0.86 0.95 0.94 0.91
DXA FFM 0.96 0.97 — 0.88 0.96 0.97 0.91
DXA arm FFM 0.86 0.88 0.89 — 0.83 0.80 0.86
DXA leg FFM 0.94 0.95 0.96 0.84 — 0.87 0.89
DXA trunk FFM 0.91 0.93 0.97 0.82 0.87 — 0.86
Height2/Z 0.90 0.90 0.90 0.84 0.87 0.86 —
1 For Pearson’s correlation coefficients, M values are above the diagonal, and F values are below diagonal. All correlations were significant at P ,
0.0001. DXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; SDS, SD score; 4C, 4-component.
2 For bioelectrical impedance analysis, n = 195 M and 227 F.
TABLE 9
Intercepts, slopes, and SEEs for regression of 4C fat-free mass SDS on individual fat-free mass SDS1
Predictor
Males (n = 245)2 Females (n = 259)2
Intercept SE Slope SE SEE Intercept SE Slope SE SEE
Total body water 0.009 0.013 0.985 0.013 0.20 20.002 0.009 0.987 0.009 0.15
DXA FFM 0.002 0.013 0.973 0.013 0.21 20.006 0.014 0.977 0.014 0.23
DXA arm FFM 0.003 0.033 0.864 0.032 0.51 20.014 0.030 0.881 0.030 0.48
DXA leg FFM 0.000 0.021 0.947 0.021 0.33 20.007 0.020 0.949 0.020 0.32
DXA trunk FFM 0.002 0.022 0.920 0.022 0.34 20.004 0.023 0.933 0.023 0.37
Height2/Z 20.012 0.030 0.911 0.030 0.42 20.012 0.029 0.901 0.029 0.44
1The 4C fat-free mass SDS regressed on each individual fat-free mass SDS. All slopes were significantly different from 1 (P , 0.05), except for total
body water and DXA fat-free mass in both sexes. DXA, dual-energy X-ray absorptiometry; FFM, fat-free mass; SDS, SD score; 4C, 4-component.
2 For bioelectrical impedance analysis, n = 195 M and 227 F.
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mass SDS, DXA whole-body fat-free mass SDS likewise showed
the highest correlations in both sexes of 0.98 in males and 0.97 in
females and an SEEw0.2 SDS. Other outcomes also showed high
ranking consistency, with the least successful being DXA arm fat-
free mass SDS (correlations of 0.86 in males and 0.88 in females
and an SEE w0.5 SDS). Therefore, for both primary outcomes,
DXA whole-body SDS proved most consistent for the accurate
ranking of individuals against the reference method, which ex-
plained 88–96% of the variance in 4C SDS values.
Therefore, although the absolute accuracy of DXA remains
imperfect (42, 45, 46), its use for categorizing relative fat and fat-free
masses on the basis of whole-body measurement appears the best
simpler option if the 4Cmodel is not available. Nevertheless, caution
is required before extrapolation of our findings to other DXA in-
strumentation. Pediatric cross-calibration studies have shown rela-
tively good agreement between different machines from a single
manufacturer (47, 48) but poorer agreement between the machines
of different manufacturers (49), and additional research is required
before the use of other DXA instrumentation. Furthermore, for both
DXA and other techniques, the consistency between 4C SDS and
other SDSs was poorer for adiposity at the lower end of the scale,
especially in males, whereas for fat-free mass, techniques ranked
with consistency across the whole range of the outcome (Figures 3
and 4). Thus, even DXA is a poor option compared with the 4C
model when attempting to rank adiposity in leaner individuals.
Ideally, the interpretation of body-composition data requires
adjustment for body size. This adjustment is particularly evident
when children grow between 2 measurement occasions but is also
important if a baseline assessment is made of patients who may
have abnormal weight or height for their age. BMI represents the
established index of weight adjusted for height in pediatric
clinical practice. BMI may be divided into the following 2
components: the fat-free mass index and fat mass index. Each of
these indexes is adjusted for height, and unlike the percentage of
fat, the fat mass index is not confounded by variability in fat-free
mass and, therefore, represents a more objective index of adi-
posity (17, 50). However, it has also been shown that, although
fat-free mass scales with height2, fat mass scales with height
raised to a higher power (eg, height6 in 9 y-old children) (50).
There is currently uncertainty over how best to adjust pediatric
FIGURE 4. Bland-Altman plots illustrating agreement between height2/Z SDS and DXA fat-free mass SDS (upper panels) and the average of 4 skinfold-
thickness SDSs and 4C fat mass SDSs (lower panels) in males (n = 195 for BIA and 245 for skinfold-thicknesses; left side) and females (n = 227 for BIA and
259 for skinfold-thicknesses; right side). The scatter plot shows agreement between techniques in individuals, and dotted lines show the mean bias and limits
of agreement (62 SD of the bias). BIA, bioelectrical impedance analysis; DXA, dual-energy X-ray absorptiometry; SDS, SD score; 4C, 4-component.
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body-composition data for size (51), and therefore, our new
reference data for the 4C fat-free mass index and fat mass index
represent a pragmatic preliminary attempt, which we intend to
address further in future work.
A limitation of our study is that we were unable to extend the
age range below 5 y. We have collected a large amount of isotope
and skinfold-thickness data from 6 wk to 4 y (52); however, these
data were collected a decade earlier than those reported in this
article, and there is a poor statistical fit between the 2 data sets,
most likely because of differential exposure to obesogenic envi-
ronmental factors. Many patients who require body-composition
assessment are aged ,5 y; however, additional technical ad-
vances are required before our approach can be applied in this
age range. A second limitation is that we were unable to include
all possible techniques (eg, MRI and total-body electrical con-
ductivity) or instrumentation. Our Lunar DXA data may not be
appropriate for the instrumentation of other manufacturers, and
our BIA data were collected by using standing instrumentation
in combination with foot plates and hand grips and, hence, will
not be entirely consistent with data collected from supine in-
dividuals by using adhesive electrodes. However, standing BIA
removes a degree of interobserver error because it avoids the
need to place electrodes on anatomical landmarks. A third
limitation is that ethnic variability in our sample was not ade-
quate to allow us to explore this issue in our analysis.
In conclusion, building on the pioneering work of Fomon and
colleagues on their original reference child (53), we have de-
scribed the measurements available in our new reference data set
and provided examples of how the data can be presented; there
are many alternative formats, and a large number of additional
data are available from each of the 2-component techniques. We
anticipate that the most appropriate use of the reference data will
vary in clinical and research settings. To facilitate the use of the
reference data by clinicians and researchers, we intend to make
the data available through an Internet portal (http://www.ucl.ac.
uk/ich/research-ich/nutrition), which will allow individual raw
data for each technique to be entered with age and sex data to
calculate SDSs (7). The graphs will also be available for
download. Although for some purposes (eg, evaluation of car-
diovascular risk), BMI SDS remains adequate for differentiating
clinical status (54, 55), growth charts that allow the partitioning
of weight into its fat and fat-free components are likely to be
valuable for monitoring more-immediate effects of disease and
responses to treatment (16).
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